id	sid	tid	token	lemma	pos
dpc-3650	1	1	dermatology	dermatology	NOUN
dpc-3650	1	2	:	:	PUNCT
dpc-3650	1	3	practical	practical	ADJ
dpc-3650	1	4	and	and	CCONJ
dpc-3650	1	5	conceptual	conceptual	ADJ
dpc-3650	1	6	original	original	ADJ
dpc-3650	1	7	article	article	NOUN
dpc-3650	1	8	|	|	ADV
dpc-3650	1	9	dermatol	dermatol	ADJ
dpc-3650	1	10	pract	pract	NOUN
dpc-3650	1	11	concept	concept	NOUN
dpc-3650	1	12	.	.	PUNCT
dpc-3650	2	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	2	2	1	1	NUM
dpc-3650	2	3	correlation	correlation	NOUN
dpc-3650	2	4	of	of	ADP
dpc-3650	2	5	specific	specific	ADJ
dpc-3650	2	6	inflammatory	inflammatory	ADJ
dpc-3650	2	7	markers	marker	NOUN
dpc-3650	2	8	with	with	ADP
dpc-3650	2	9	the	the	DET
dpc-3650	2	10	occurrence	occurrence	NOUN
dpc-3650	2	11	of	of	ADP
dpc-3650	2	12	depression	depression	NOUN
dpc-3650	2	13	in	in	ADP
dpc-3650	2	14	patients	patient	NOUN
dpc-3650	2	15	with	with	ADP
dpc-3650	2	16	psoriasis	psoriasis	NOUN
dpc-3650	2	17	and	and	CCONJ
dpc-3650	2	18	their	their	PRON
dpc-3650	2	19	use	use	NOUN
dpc-3650	2	20	as	as	ADP
dpc-3650	2	21	biomarkers	biomarker	NOUN
dpc-3650	2	22	for	for	ADP
dpc-3650	2	23	the	the	DET
dpc-3650	2	24	diagnosis	diagnosis	NOUN
dpc-3650	2	25	of	of	ADP
dpc-3650	2	26	depression	depression	NOUN
dpc-3650	2	27	eleni	eleni	PROPN
dpc-3650	2	28	mitsiou1	mitsiou1	PROPN
dpc-3650	2	29	,	,	PUNCT
dpc-3650	2	30	aikaterini	aikaterini	PROPN
dpc-3650	2	31	kyriakou1	kyriakou1	PROPN
dpc-3650	2	32	,	,	PUNCT
dpc-3650	2	33	eleni	eleni	PROPN
dpc-3650	2	34	parlapani2	parlapani2	PROPN
dpc-3650	2	35	,	,	PUNCT
dpc-3650	2	36	anastasia	anastasia	PROPN
dpc-3650	2	37	trigoni1	trigoni1	PROPN
dpc-3650	2	38	,	,	PUNCT
dpc-3650	2	39	myrto	myrto	PROPN
dpc-3650	2	40	trakatelli1	trakatelli1	PROPN
dpc-3650	2	41	,	,	PUNCT
dpc-3650	2	42	zoe	zoe	PROPN
dpc-3650	2	43	apalla1	apalla1	PROPN
dpc-3650	2	44	,	,	PUNCT
dpc-3650	2	45	dimitrios	dimitrio	NOUN
dpc-3650	2	46	 	 	SPACE
dpc-3650	2	47	sotiriadis1	sotiriadis1	NOUN
dpc-3650	2	48	,	,	PUNCT
dpc-3650	2	49	elizabeth	elizabeth	PROPN
dpc-3650	2	50	lazaridou1	lazaridou1	PROPN
dpc-3650	2	51	,	,	PUNCT
dpc-3650	2	52	aikaterini	aikaterini	PROPN
dpc-3650	2	53	patsatsi1	patsatsi1	PROPN
dpc-3650	2	54	1	1	NUM
dpc-3650	2	55	2nd	2nd	ADJ
dpc-3650	2	56	dermatology	dermatology	NOUN
dpc-3650	2	57	department	department	NOUN
dpc-3650	2	58	,	,	PUNCT
dpc-3650	2	59	aristotle	aristotle	PROPN
dpc-3650	2	60	university	university	PROPN
dpc-3650	2	61	school	school	NOUN
dpc-3650	2	62	of	of	ADP
dpc-3650	2	63	medicine	medicine	NOUN
dpc-3650	2	64	,	,	PUNCT
dpc-3650	2	65	papageorgiou	papageorgiou	NOUN
dpc-3650	2	66	hospital	hospital	PROPN
dpc-3650	2	67	,	,	PUNCT
dpc-3650	2	68	thessaloniki	thessaloniki	PROPN
dpc-3650	2	69	,	,	PUNCT
dpc-3650	2	70	greece	greece	PROPN
dpc-3650	2	71	2	2	NUM
dpc-3650	2	72	1st	1st	PROPN
dpc-3650	2	73	department	department	NOUN
dpc-3650	2	74	of	of	ADP
dpc-3650	2	75	psychiatry	psychiatry	NOUN
dpc-3650	2	76	,	,	PUNCT
dpc-3650	2	77	faculty	faculty	NOUN
dpc-3650	2	78	of	of	ADP
dpc-3650	2	79	medicine	medicine	NOUN
dpc-3650	2	80	,	,	PUNCT
dpc-3650	2	81	aristotle	aristotle	PROPN
dpc-3650	2	82	university	university	PROPN
dpc-3650	2	83	of	of	ADP
dpc-3650	2	84	thessaloniki	thessaloniki	PROPN
dpc-3650	2	85	,	,	PUNCT
dpc-3650	2	86	thessaloniki	thessaloniki	PROPN
dpc-3650	2	87	,	,	PUNCT
dpc-3650	2	88	greece	greece	PROPN
dpc-3650	2	89	key	key	ADJ
dpc-3650	2	90	words	word	NOUN
dpc-3650	2	91	:	:	PUNCT
dpc-3650	2	92	psoriasis	psoriasis	NOUN
dpc-3650	2	93	,	,	PUNCT
dpc-3650	2	94	depression	depression	NOUN
dpc-3650	2	95	,	,	PUNCT
dpc-3650	2	96	,	,	PUNCT
dpc-3650	2	97	inflammation	inflammation	NOUN
dpc-3650	2	98	,	,	PUNCT
dpc-3650	2	99	crp	crp	PROPN
dpc-3650	2	100	,	,	PUNCT
dpc-3650	2	101	esr	esr	PROPN
dpc-3650	2	102	citation	citation	NOUN
dpc-3650	2	103	:	:	PUNCT
dpc-3650	2	104	mitsiou	mitsiou	NOUN
dpc-3650	2	105	e	e	NOUN
dpc-3650	2	106	,	,	PUNCT
dpc-3650	2	107	kyriakou	kyriakou	PROPN
dpc-3650	2	108	a	a	X
dpc-3650	2	109	,	,	PUNCT
dpc-3650	2	110	parlapani	parlapani	NOUN
dpc-3650	2	111	e	e	NOUN
dpc-3650	2	112	,	,	PUNCT
dpc-3650	2	113	et	et	PROPN
dpc-3650	2	114	al	al	PROPN
dpc-3650	2	115	.	.	PUNCT
dpc-3650	3	1	correlation	correlation	NOUN
dpc-3650	3	2	of	of	ADP
dpc-3650	3	3	specific	specific	ADJ
dpc-3650	3	4	inflammatory	inflammatory	ADJ
dpc-3650	3	5	markers	marker	NOUN
dpc-3650	3	6	with	with	ADP
dpc-3650	3	7	the	the	DET
dpc-3650	3	8	occurrence	occurrence	NOUN
dpc-3650	3	9	of	of	ADP
dpc-3650	3	10	depression	depression	NOUN
dpc-3650	3	11	in	in	ADP
dpc-3650	3	12	patients	patient	NOUN
dpc-3650	3	13	with	with	ADP
dpc-3650	3	14	psoriasis	psoriasis	NOUN
dpc-3650	3	15	and	and	CCONJ
dpc-3650	3	16	their	their	PRON
dpc-3650	3	17	use	use	NOUN
dpc-3650	3	18	as	as	ADP
dpc-3650	3	19	biomarkers	biomarker	NOUN
dpc-3650	3	20	for	for	ADP
dpc-3650	3	21	the	the	DET
dpc-3650	3	22	diagnosis	diagnosis	NOUN
dpc-3650	3	23	of	of	ADP
dpc-3650	3	24	depression	depression	NOUN
dpc-3650	3	25	.	.	PUNCT
dpc-3650	4	1	dermatol	dermatol	NOUN
dpc-3650	4	2	pract	pract	PROPN
dpc-3650	4	3	concept	concept	NOUN
dpc-3650	4	4	.	.	PUNCT
dpc-3650	5	1	2024;14(2):e2024104	2024;14(2):e2024104	X
dpc-3650	5	2	.	.	PUNCT
dpc-3650	6	1	doi	doi	PROPN
dpc-3650	6	2	:	:	PUNCT
dpc-3650	6	3	https://doi.org/10.5826/dpc.1402a104	https://doi.org/10.5826/dpc.1402a104	PROPN
dpc-3650	6	4	accepted	accept	VERB
dpc-3650	6	5	:	:	PUNCT
dpc-3650	6	6	december	december	PROPN
dpc-3650	6	7	12	12	NUM
dpc-3650	6	8	,	,	PUNCT
dpc-3650	6	9	2023	2023	NUM
dpc-3650	6	10	;	;	PUNCT
dpc-3650	6	11	published	publish	VERB
dpc-3650	6	12	:	:	PUNCT
dpc-3650	7	1	april	april	PROPN
dpc-3650	7	2	2024	2024	NUM
dpc-3650	7	3	copyright	copyright	NOUN
dpc-3650	7	4	:	:	PUNCT
dpc-3650	7	5	©	©	PROPN
dpc-3650	7	6	2024	2024	NUM
dpc-3650	7	7	mitsiou	mitsiou	NOUN
dpc-3650	7	8	et	et	PROPN
dpc-3650	7	9	al	al	PROPN
dpc-3650	7	10	.	.	PUNCT
dpc-3650	8	1	this	this	PRON
dpc-3650	8	2	is	be	AUX
dpc-3650	8	3	an	an	DET
dpc-3650	8	4	open	open	ADJ
dpc-3650	8	5	-	-	PUNCT
dpc-3650	8	6	access	access	NOUN
dpc-3650	8	7	article	article	NOUN
dpc-3650	8	8	distributed	distribute	VERB
dpc-3650	8	9	under	under	ADP
dpc-3650	8	10	the	the	DET
dpc-3650	8	11	terms	term	NOUN
dpc-3650	8	12	of	of	ADP
dpc-3650	8	13	the	the	DET
dpc-3650	8	14	creative	creative	ADJ
dpc-3650	8	15	commons	common	NOUN
dpc-3650	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3650	8	17	license	license	NOUN
dpc-3650	8	18	(	(	PUNCT
dpc-3650	8	19	by	by	ADP
dpc-3650	8	20	-	-	PUNCT
dpc-3650	8	21	nc-4.0	nc-4.0	NOUN
dpc-3650	8	22	)	)	PUNCT
dpc-3650	8	23	,	,	PUNCT
dpc-3650	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3650	8	25	,	,	PUNCT
dpc-3650	8	26	which	which	PRON
dpc-3650	8	27	permits	permit	VERB
dpc-3650	8	28	unrestricted	unrestricted	ADJ
dpc-3650	8	29	noncommercial	noncommercial	ADJ
dpc-3650	8	30	use	use	NOUN
dpc-3650	8	31	,	,	PUNCT
dpc-3650	8	32	distribution	distribution	NOUN
dpc-3650	8	33	,	,	PUNCT
dpc-3650	8	34	and	and	CCONJ
dpc-3650	8	35	reproduction	reproduction	NOUN
dpc-3650	8	36	in	in	ADP
dpc-3650	8	37	any	any	DET
dpc-3650	8	38	medium	medium	NOUN
dpc-3650	8	39	,	,	PUNCT
dpc-3650	8	40	provided	provide	VERB
dpc-3650	8	41	the	the	DET
dpc-3650	8	42	original	original	ADJ
dpc-3650	8	43	authors	author	NOUN
dpc-3650	8	44	and	and	CCONJ
dpc-3650	8	45	source	source	NOUN
dpc-3650	8	46	are	be	AUX
dpc-3650	8	47	credited	credit	VERB
dpc-3650	8	48	.	.	PUNCT
dpc-3650	9	1	funding	funding	NOUN
dpc-3650	9	2	:	:	PUNCT
dpc-3650	9	3	none	none	NOUN
dpc-3650	9	4	.	.	PUNCT
dpc-3650	10	1	competing	compete	VERB
dpc-3650	10	2	interests	interest	NOUN
dpc-3650	10	3	:	:	PUNCT
dpc-3650	10	4	none	none	NOUN
dpc-3650	10	5	.	.	PUNCT
dpc-3650	11	1	authorship	authorship	NOUN
dpc-3650	11	2	:	:	PUNCT
dpc-3650	11	3	all	all	DET
dpc-3650	11	4	authors	author	NOUN
dpc-3650	11	5	have	have	AUX
dpc-3650	11	6	contributed	contribute	VERB
dpc-3650	11	7	significantly	significantly	ADV
dpc-3650	11	8	to	to	ADP
dpc-3650	11	9	this	this	DET
dpc-3650	11	10	publication	publication	NOUN
dpc-3650	11	11	.	.	PUNCT
dpc-3650	12	1	corresponding	correspond	VERB
dpc-3650	12	2	author	author	NOUN
dpc-3650	12	3	:	:	PUNCT
dpc-3650	12	4	eleni	eleni	PROPN
dpc-3650	12	5	mitsiou	mitsiou	PROPN
dpc-3650	12	6	,	,	PUNCT
dpc-3650	12	7	2nd	2nd	ADJ
dpc-3650	12	8	dermatology	dermatology	NOUN
dpc-3650	12	9	department	department	NOUN
dpc-3650	12	10	,	,	PUNCT
dpc-3650	12	11	aristotle	aristotle	PROPN
dpc-3650	12	12	university	university	PROPN
dpc-3650	12	13	school	school	NOUN
dpc-3650	12	14	of	of	ADP
dpc-3650	12	15	medicine	medicine	NOUN
dpc-3650	12	16	,	,	PUNCT
dpc-3650	12	17	elias	elias	PROPN
dpc-3650	12	18	6	6	NUM
dpc-3650	12	19	,	,	PUNCT
dpc-3650	12	20	gr-59132	gr-59132	PROPN
dpc-3650	12	21	,	,	PUNCT
dpc-3650	12	22	veroia	veroia	NOUN
dpc-3650	12	23	(	(	PUNCT
dpc-3650	12	24	greece	greece	PROPN
dpc-3650	12	25	)	)	PUNCT
dpc-3650	12	26	,	,	PUNCT
dpc-3650	12	27	 	 	SPACE
dpc-3650	12	28	tel	tel	PROPN
dpc-3650	12	29	.	.	PROPN
dpc-3650	12	30	+30	+30	NOUN
dpc-3650	12	31	6973032982	6973032982	NUM
dpc-3650	12	32	,	,	PUNCT
dpc-3650	12	33	e	e	NOUN
dpc-3650	12	34	-	-	NOUN
dpc-3650	12	35	mail	mail	NOUN
dpc-3650	12	36	:	:	PUNCT
dpc-3650	12	37	mitsiou_elena@yahoo.gr	mitsiou_elena@yahoo.gr	ADJ
dpc-3650	12	38	introduction	introduction	NOUN
dpc-3650	12	39	:	:	PUNCT
dpc-3650	12	40	psoriasis	psoriasis	NOUN
dpc-3650	12	41	is	be	AUX
dpc-3650	12	42	a	a	DET
dpc-3650	12	43	systemic	systemic	ADJ
dpc-3650	12	44	disease	disease	NOUN
dpc-3650	12	45	of	of	ADP
dpc-3650	12	46	the	the	DET
dpc-3650	12	47	skin	skin	NOUN
dpc-3650	12	48	and	and	CCONJ
dpc-3650	12	49	nails	nail	NOUN
dpc-3650	12	50	associated	associate	VERB
dpc-3650	12	51	with	with	ADP
dpc-3650	12	52	a	a	DET
dpc-3650	12	53	wide	wide	ADJ
dpc-3650	12	54	range	range	NOUN
dpc-3650	12	55	of	of	ADP
dpc-3650	12	56	comorbidities	comorbiditie	NOUN
dpc-3650	12	57	such	such	ADJ
dpc-3650	12	58	as	as	ADP
dpc-3650	12	59	depression	depression	NOUN
dpc-3650	12	60	,	,	PUNCT
dpc-3650	12	61	psoriatic	psoriatic	ADJ
dpc-3650	12	62	arthritis	arthritis	NOUN
dpc-3650	12	63	and	and	CCONJ
dpc-3650	12	64	metabolic	metabolic	NOUN
dpc-3650	12	65	syndrome	syndrome	NOUN
dpc-3650	12	66	.	.	PUNCT
dpc-3650	13	1	objectives	objective	NOUN
dpc-3650	13	2	:	:	PUNCT
dpc-3650	14	1	the	the	DET
dpc-3650	14	2	study	study	NOUN
dpc-3650	14	3	aimed	aim	VERB
dpc-3650	14	4	to	to	PART
dpc-3650	14	5	examine	examine	VERB
dpc-3650	14	6	a	a	DET
dpc-3650	14	7	potential	potential	ADJ
dpc-3650	14	8	association	association	NOUN
dpc-3650	14	9	between	between	ADP
dpc-3650	14	10	inflammatory	inflammatory	ADJ
dpc-3650	14	11	markers	marker	NOUN
dpc-3650	14	12	(	(	PUNCT
dpc-3650	14	13	c	c	NOUN
dpc-3650	14	14	reactive	reactive	ADJ
dpc-3650	14	15	protein	protein	NOUN
dpc-3650	14	16	[	[	X
dpc-3650	14	17	crp	crp	X
dpc-3650	14	18	]	]	X
dpc-3650	14	19	and	and	CCONJ
dpc-3650	14	20	erythrocyte	erythrocyte	NOUN
dpc-3650	14	21	sedimentation	sedimentation	NOUN
dpc-3650	14	22	rate	rate	NOUN
dpc-3650	14	23	[	[	X
dpc-3650	14	24	esr	esr	X
dpc-3650	14	25	]	]	PUNCT
dpc-3650	14	26	)	)	PUNCT
dpc-3650	14	27	and	and	CCONJ
dpc-3650	14	28	depression	depression	NOUN
dpc-3650	14	29	in	in	ADP
dpc-3650	14	30	patients	patient	NOUN
dpc-3650	14	31	with	with	ADP
dpc-3650	14	32	psoriasis	psoriasis	NOUN
dpc-3650	14	33	.	.	PUNCT
dpc-3650	15	1	methods	method	NOUN
dpc-3650	15	2	:	:	PUNCT
dpc-3650	15	3	a	a	DET
dpc-3650	15	4	total	total	NOUN
dpc-3650	15	5	of	of	ADP
dpc-3650	15	6	80	80	NUM
dpc-3650	15	7	individuals	individual	NOUN
dpc-3650	15	8	were	be	AUX
dpc-3650	15	9	enrolled	enrol	VERB
dpc-3650	15	10	in	in	ADP
dpc-3650	15	11	the	the	DET
dpc-3650	15	12	study	study	NOUN
dpc-3650	15	13	.	.	PUNCT
dpc-3650	16	1	case	case	NOUN
dpc-3650	16	2	participants	participant	NOUN
dpc-3650	16	3	included	include	VERB
dpc-3650	16	4	28	28	NUM
dpc-3650	16	5	patients	patient	NOUN
dpc-3650	16	6	diagnosed	diagnose	VERB
dpc-3650	16	7	with	with	ADP
dpc-3650	16	8	psoriasis	psoriasis	NOUN
dpc-3650	16	9	(	(	PUNCT
dpc-3650	16	10	beck	beck	NOUN
dpc-3650	16	11	depression	depression	PROPN
dpc-3650	16	12	inventory	inventory	PROPN
dpc-3650	16	13	-	-	PUNCT
dpc-3650	16	14	ii	ii	NOUN
dpc-3650	16	15	:	:	PUNCT
dpc-3650	16	16	:0	:0	PUNCT
dpc-3650	16	17	-	-	PUNCT
dpc-3650	16	18	13	13	NUM
dpc-3650	16	19	)	)	PUNCT
dpc-3650	16	20	and	and	CCONJ
dpc-3650	16	21	24	24	NUM
dpc-3650	16	22	patients	patient	NOUN
dpc-3650	16	23	diagnosed	diagnose	VERB
dpc-3650	16	24	with	with	ADP
dpc-3650	16	25	psoriasis	psoriasis	NOUN
dpc-3650	16	26	and	and	CCONJ
dpc-3650	16	27	depression	depression	NOUN
dpc-3650	16	28	(	(	PUNCT
dpc-3650	16	29	beck	beck	PROPN
dpc-3650	16	30	depression	depression	PROPN
dpc-3650	16	31	inventory	inventory	PROPN
dpc-3650	16	32	-	-	PUNCT
dpc-3650	16	33	ii:14	ii:14	PROPN
dpc-3650	16	34	-	-	PUNCT
dpc-3650	16	35	63	63	NUM
dpc-3650	16	36	)	)	PUNCT
dpc-3650	16	37	.	.	PUNCT
dpc-3650	17	1	twenty	twenty	NUM
dpc-3650	17	2	-	-	PUNCT
dpc-3650	17	3	eight	eight	NUM
dpc-3650	17	4	(	(	PUNCT
dpc-3650	17	5	28	28	NUM
dpc-3650	17	6	)	)	PUNCT
dpc-3650	17	7	healthy	healthy	ADJ
dpc-3650	17	8	participants	participant	NOUN
dpc-3650	17	9	comprised	comprise	VERB
dpc-3650	17	10	the	the	DET
dpc-3650	17	11	control	control	NOUN
dpc-3650	17	12	group	group	NOUN
dpc-3650	17	13	.	.	PUNCT
dpc-3650	18	1	psoriasis	psoriasis	NOUN
dpc-3650	18	2	severity	severity	NOUN
dpc-3650	18	3	was	be	AUX
dpc-3650	18	4	evaluated	evaluate	VERB
dpc-3650	18	5	by	by	ADP
dpc-3650	18	6	using	use	VERB
dpc-3650	18	7	psoriasis	psoriasis	NOUN
dpc-3650	18	8	area	area	NOUN
dpc-3650	18	9	and	and	CCONJ
dpc-3650	18	10	severity	severity	NOUN
dpc-3650	18	11	index	index	NOUN
dpc-3650	18	12	,	,	PUNCT
dpc-3650	18	13	physician	physician	NOUN
dpc-3650	18	14	global	global	ADJ
dpc-3650	18	15	assessment	assessment	NOUN
dpc-3650	18	16	,	,	PUNCT
dpc-3650	18	17	body	body	NOUN
dpc-3650	18	18	surface	surface	NOUN
dpc-3650	18	19	area	area	NOUN
dpc-3650	18	20	 	 	SPACE
dpc-3650	18	21	and	and	CCONJ
dpc-3650	18	22	dermatology	dermatology	NOUN
dpc-3650	18	23	life	life	NOUN
dpc-3650	18	24	quality	quality	NOUN
dpc-3650	18	25	index	index	NOUN
dpc-3650	18	26	.	.	PUNCT
dpc-3650	19	1	written	write	VERB
dpc-3650	19	2	approval	approval	NOUN
dpc-3650	19	3	was	be	AUX
dpc-3650	19	4	obtained	obtain	VERB
dpc-3650	19	5	for	for	ADP
dpc-3650	19	6	its	its	PRON
dpc-3650	19	7	use	use	NOUN
dpc-3650	19	8	in	in	ADP
dpc-3650	19	9	this	this	DET
dpc-3650	19	10	study	study	NOUN
dpc-3650	19	11	:	:	PUNCT
dpc-3650	19	12	cardiff	cardiff	PROPN
dpc-3650	19	13	university	university	PROPN
dpc-3650	19	14	(	(	PUNCT
dpc-3650	19	15	09/2015	09/2015	PROPN
dpc-3650	19	16	)	)	PUNCT
dpc-3650	19	17	.	.	PUNCT
dpc-3650	20	1	other	other	ADJ
dpc-3650	20	2	factors	factor	NOUN
dpc-3650	20	3	considered	consider	VERB
dpc-3650	20	4	in	in	ADP
dpc-3650	20	5	the	the	DET
dpc-3650	20	6	study	study	NOUN
dpc-3650	20	7	were	be	AUX
dpc-3650	20	8	obesity	obesity	NOUN
dpc-3650	20	9	using	use	VERB
dpc-3650	20	10	the	the	DET
dpc-3650	20	11	body	body	NOUN
dpc-3650	20	12	mass	mass	PROPN
dpc-3650	20	13	index	index	NOUN
dpc-3650	20	14	,	,	PUNCT
dpc-3650	20	15	the	the	DET
dpc-3650	20	16	levels	level	NOUN
dpc-3650	20	17	of	of	ADP
dpc-3650	20	18	stress	stress	NOUN
dpc-3650	20	19	using	use	VERB
dpc-3650	20	20	the	the	DET
dpc-3650	20	21	beck	beck	NOUN
dpc-3650	20	22	anxiety	anxiety	NOUN
dpc-3650	20	23	inventory	inventory	NOUN
dpc-3650	20	24	,	,	PUNCT
dpc-3650	20	25	and	and	CCONJ
dpc-3650	20	26	the	the	DET
dpc-3650	20	27	presence	presence	NOUN
dpc-3650	20	28	of	of	ADP
dpc-3650	20	29	insomnia	insomnia	NOUN
dpc-3650	20	30	using	use	VERB
dpc-3650	20	31	the	the	DET
dpc-3650	20	32	athens	athens	PROPN
dpc-3650	20	33	insomnia	insomnia	PROPN
dpc-3650	20	34	scale	scale	NOUN
dpc-3650	20	35	.	.	PUNCT
dpc-3650	21	1	blood	blood	NOUN
dpc-3650	21	2	draws	draw	VERB
dpc-3650	21	3	and	and	CCONJ
dpc-3650	21	4	inflammatory	inflammatory	ADJ
dpc-3650	21	5	markers	marker	NOUN
dpc-3650	21	6	measurements	measurement	NOUN
dpc-3650	21	7	were	be	AUX
dpc-3650	21	8	performed	perform	VERB
dpc-3650	21	9	for	for	ADP
dpc-3650	21	10	all	all	DET
dpc-3650	21	11	participants	participant	NOUN
dpc-3650	21	12	.	.	PUNCT
dpc-3650	22	1	abstract	abstract	ADJ
dpc-3650	22	2	2	2	NUM
dpc-3650	22	3	original	original	ADJ
dpc-3650	22	4	article	article	NOUN
dpc-3650	22	5	|	|	ADV
dpc-3650	22	6	dermatol	dermatol	ADJ
dpc-3650	22	7	pract	pract	NOUN
dpc-3650	22	8	concept	concept	NOUN
dpc-3650	22	9	.	.	PUNCT
dpc-3650	23	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	23	2	introduction	introduction	NOUN
dpc-3650	23	3	according	accord	VERB
dpc-3650	23	4	to	to	ADP
dpc-3650	23	5	the	the	DET
dpc-3650	23	6	world	world	PROPN
dpc-3650	23	7	health	health	PROPN
dpc-3650	23	8	organization	organization	NOUN
dpc-3650	23	9	,	,	PUNCT
dpc-3650	23	10	psoriasis	psoriasis	NOUN
dpc-3650	23	11	is	be	AUX
dpc-3650	23	12	defined	define	VERB
dpc-3650	23	13	as	as	ADP
dpc-3650	23	14	“	"	PUNCT
dpc-3650	23	15	a	a	DET
dpc-3650	23	16	chronic	chronic	NOUN
dpc-3650	23	17	,	,	PUNCT
dpc-3650	23	18	non	non	ADJ
dpc-3650	23	19	-	-	ADJ
dpc-3650	23	20	communicable	communicable	ADJ
dpc-3650	23	21	,	,	PUNCT
dpc-3650	23	22	painful	painful	ADJ
dpc-3650	23	23	,	,	PUNCT
dpc-3650	23	24	disfiguring	disfigure	VERB
dpc-3650	23	25	and	and	CCONJ
dpc-3650	23	26	disabling	disable	VERB
dpc-3650	23	27	disease	disease	NOUN
dpc-3650	23	28	for	for	ADP
dpc-3650	23	29	which	which	PRON
dpc-3650	23	30	there	there	PRON
dpc-3650	23	31	is	be	VERB
dpc-3650	23	32	no	no	DET
dpc-3650	23	33	cure	cure	NOUN
dpc-3650	23	34	and	and	CCONJ
dpc-3650	23	35	with	with	ADP
dpc-3650	23	36	great	great	ADJ
dpc-3650	23	37	negative	negative	ADJ
dpc-3650	23	38	impact	impact	NOUN
dpc-3650	23	39	on	on	ADP
dpc-3650	23	40	patients	patient	NOUN
dpc-3650	23	41	quality	quality	NOUN
dpc-3650	23	42	of	of	ADP
dpc-3650	23	43	life	life	NOUN
dpc-3650	23	44	(	(	PUNCT
dpc-3650	23	45	qol	qol	NOUN
dpc-3650	23	46	)	)	PUNCT
dpc-3650	23	47	.	.	PUNCT
dpc-3650	24	1	psoriasis	psoriasis	NOUN
dpc-3650	24	2	involves	involve	VERB
dpc-3650	24	3	the	the	DET
dpc-3650	24	4	skin	skin	NOUN
dpc-3650	24	5	and	and	CCONJ
dpc-3650	24	6	nails	nail	NOUN
dpc-3650	24	7	and	and	CCONJ
dpc-3650	24	8	is	be	AUX
dpc-3650	24	9	associated	associate	VERB
dpc-3650	24	10	with	with	ADP
dpc-3650	24	11	a	a	DET
dpc-3650	24	12	number	number	NOUN
dpc-3650	24	13	of	of	ADP
dpc-3650	24	14	comorbidities	comorbiditie	NOUN
dpc-3650	24	15	.	.	PUNCT
dpc-3650	25	1	[	[	X
dpc-3650	25	2	1	1	NUM
dpc-3650	25	3	]	]	PUNCT
dpc-3650	25	4	”	"	PUNCT
dpc-3650	25	5	.	.	PUNCT
dpc-3650	26	1	the	the	DET
dpc-3650	26	2	etiology	etiology	NOUN
dpc-3650	26	3	of	of	ADP
dpc-3650	26	4	psoriasis	psoriasis	NOUN
dpc-3650	26	5	is	be	AUX
dpc-3650	26	6	complex	complex	ADJ
dpc-3650	26	7	and	and	CCONJ
dpc-3650	26	8	has	have	AUX
dpc-3650	26	9	not	not	PART
dpc-3650	26	10	yet	yet	ADV
dpc-3650	26	11	been	be	AUX
dpc-3650	26	12	fully	fully	ADV
dpc-3650	26	13	elucidated	elucidated	ADJ
dpc-3650	26	14	.	.	PUNCT
dpc-3650	27	1	in	in	ADP
dpc-3650	27	2	patients	patient	NOUN
dpc-3650	27	3	with	with	ADP
dpc-3650	27	4	genetic	genetic	ADJ
dpc-3650	27	5	predisposition	predisposition	NOUN
dpc-3650	27	6	,	,	PUNCT
dpc-3650	27	7	inflammation	inflammation	ADJ
dpc-3650	27	8	initiation	initiation	NOUN
dpc-3650	27	9	is	be	AUX
dpc-3650	27	10	triggered	trigger	VERB
dpc-3650	27	11	by	by	ADP
dpc-3650	27	12	an	an	DET
dpc-3650	27	13	exogenous	exogenous	ADJ
dpc-3650	27	14	or	or	CCONJ
dpc-3650	27	15	endogenous	endogenous	ADJ
dpc-3650	27	16	stimulus	stimulus	NOUN
dpc-3650	27	17	,	,	PUNCT
dpc-3650	27	18	leading	lead	VERB
dpc-3650	27	19	to	to	ADP
dpc-3650	27	20	the	the	DET
dpc-3650	27	21	appearance	appearance	NOUN
dpc-3650	27	22	of	of	ADP
dpc-3650	27	23	psoriatic	psoriatic	ADJ
dpc-3650	27	24	plaque	plaque	NOUN
dpc-3650	27	25	.	.	PUNCT
dpc-3650	28	1	several	several	ADJ
dpc-3650	28	2	evidence	evidence	NOUN
dpc-3650	28	3	underline	underline	VERB
dpc-3650	28	4	the	the	DET
dpc-3650	28	5	interaction	interaction	NOUN
dpc-3650	28	6	between	between	ADP
dpc-3650	28	7	host	host	NOUN
dpc-3650	28	8	genetics	genetic	NOUN
dpc-3650	28	9	and	and	CCONJ
dpc-3650	28	10	environmental	environmental	ADJ
dpc-3650	28	11	factors	factor	NOUN
dpc-3650	28	12	in	in	ADP
dpc-3650	28	13	stimulating	stimulate	VERB
dpc-3650	28	14	t	t	NOUN
dpc-3650	28	15	-	-	PUNCT
dpc-3650	28	16	cell	cell	NOUN
dpc-3650	28	17	-	-	PUNCT
dpc-3650	28	18	mediated	mediate	VERB
dpc-3650	28	19	inflammatory	inflammatory	ADJ
dpc-3650	28	20	processes	process	NOUN
dpc-3650	28	21	against	against	ADP
dpc-3650	28	22	self	self	NOUN
dpc-3650	28	23	-	-	PUNCT
dpc-3650	28	24	antigens	antigen	NOUN
dpc-3650	28	25	in	in	ADP
dpc-3650	28	26	psoriasis	psoriasis	NOUN
dpc-3650	28	27	[	[	X
dpc-3650	28	28	2	2	NUM
dpc-3650	28	29	]	]	PUNCT
dpc-3650	28	30	.	.	PUNCT
dpc-3650	29	1	various	various	ADJ
dpc-3650	29	2	other	other	ADJ
dpc-3650	29	3	cells	cell	NOUN
dpc-3650	29	4	including	include	VERB
dpc-3650	29	5	dermal	dermal	ADJ
dpc-3650	29	6	dendritic	dendritic	ADJ
dpc-3650	29	7	cells	cell	NOUN
dpc-3650	29	8	,	,	PUNCT
dpc-3650	29	9	keratinocytes	keratinocyte	NOUN
dpc-3650	29	10	and	and	CCONJ
dpc-3650	29	11	neutrophils	neutrophil	NOUN
dpc-3650	29	12	are	be	AUX
dpc-3650	29	13	involved	involve	VERB
dpc-3650	29	14	in	in	ADP
dpc-3650	29	15	the	the	DET
dpc-3650	29	16	immunopathology	immunopathology	NOUN
dpc-3650	29	17	of	of	ADP
dpc-3650	29	18	psoriasis	psoriasis	NOUN
dpc-3650	29	19	.	.	PUNCT
dpc-3650	30	1	the	the	DET
dpc-3650	30	2	interplay	interplay	NOUN
dpc-3650	30	3	between	between	ADP
dpc-3650	30	4	these	these	DET
dpc-3650	30	5	cells	cell	NOUN
dpc-3650	30	6	creates	create	VERB
dpc-3650	30	7	the	the	DET
dpc-3650	30	8	development	development	NOUN
dpc-3650	30	9	of	of	ADP
dpc-3650	30	10	a	a	DET
dpc-3650	30	11	self	self	NOUN
dpc-3650	30	12	-	-	PUNCT
dpc-3650	30	13	sustained	sustain	VERB
dpc-3650	30	14	cycle	cycle	NOUN
dpc-3650	30	15	of	of	ADP
dpc-3650	30	16	inflammation	inflammation	NOUN
dpc-3650	30	17	around	around	ADP
dpc-3650	30	18	the	the	DET
dpc-3650	30	19	il-23/	il-23/	PROPN
dpc-3650	30	20	il-17	il-17	NUM
dpc-3650	30	21	axis	axis	NOUN
dpc-3650	30	22	.	.	PUNCT
dpc-3650	31	1	lately	lately	ADV
dpc-3650	31	2	,	,	PUNCT
dpc-3650	31	3	research	research	NOUN
dpc-3650	31	4	has	have	AUX
dpc-3650	31	5	been	be	AUX
dpc-3650	31	6	focused	focus	VERB
dpc-3650	31	7	on	on	ADP
dpc-3650	31	8	the	the	DET
dpc-3650	31	9	role	role	NOUN
dpc-3650	31	10	of	of	ADP
dpc-3650	31	11	tissue	tissue	NOUN
dpc-3650	31	12	resident	resident	NOUN
dpc-3650	31	13	memory	memory	NOUN
dpc-3650	31	14	(	(	PUNCT
dpc-3650	31	15	trm	trm	PROPN
dpc-3650	31	16	)	)	PUNCT
dpc-3650	31	17	t	t	PROPN
dpc-3650	31	18	-	-	PUNCT
dpc-3650	31	19	cells	cell	NOUN
dpc-3650	31	20	in	in	ADP
dpc-3650	31	21	the	the	DET
dpc-3650	31	22	course	course	NOUN
dpc-3650	31	23	of	of	ADP
dpc-3650	31	24	lesions	lesion	NOUN
dpc-3650	31	25	formation	formation	NOUN
dpc-3650	31	26	in	in	ADP
dpc-3650	31	27	psoriasis	psoriasis	NOUN
dpc-3650	31	28	.	.	PUNCT
dpc-3650	32	1	trm	trm	PROPN
dpc-3650	32	2	t	t	PROPN
dpc-3650	32	3	-	-	PUNCT
dpc-3650	32	4	cells	cell	NOUN
dpc-3650	32	5	,	,	PUNCT
dpc-3650	32	6	a	a	DET
dpc-3650	32	7	subset	subset	NOUN
dpc-3650	32	8	of	of	ADP
dpc-3650	32	9	t	t	PROPN
dpc-3650	32	10	-	-	PUNCT
dpc-3650	32	11	memory	memory	NOUN
dpc-3650	32	12	cells	cell	NOUN
dpc-3650	32	13	,	,	PUNCT
dpc-3650	32	14	appear	appear	VERB
dpc-3650	32	15	to	to	PART
dpc-3650	32	16	produce	produce	VERB
dpc-3650	32	17	the	the	DET
dpc-3650	32	18	proinflammatory	proinflammatory	ADJ
dpc-3650	32	19	cytokines	cytokine	NOUN
dpc-3650	32	20	il-17	il-17	ADP
dpc-3650	32	21	,	,	PUNCT
dpc-3650	32	22	interferon	interferon	ADJ
dpc-3650	32	23	-	-	PUNCT
dpc-3650	32	24	γ	γ	NOUN
dpc-3650	32	25	and	and	CCONJ
dpc-3650	32	26	il-22	il-22	NOUN
dpc-3650	32	27	.	.	PUNCT
dpc-3650	33	1	interestingly	interestingly	ADV
dpc-3650	33	2	,	,	PUNCT
dpc-3650	33	3	even	even	ADV
dpc-3650	33	4	after	after	ADP
dpc-3650	33	5	the	the	DET
dpc-3650	33	6	remission	remission	NOUN
dpc-3650	33	7	of	of	ADP
dpc-3650	33	8	psoriatic	psoriatic	ADJ
dpc-3650	33	9	lesions	lesion	NOUN
dpc-3650	33	10	following	follow	VERB
dpc-3650	33	11	treatment	treatment	NOUN
dpc-3650	33	12	,	,	PUNCT
dpc-3650	33	13	inflammation	inflammation	NOUN
dpc-3650	33	14	remains	remain	VERB
dpc-3650	33	15	in	in	ADP
dpc-3650	33	16	the	the	DET
dpc-3650	33	17	apparently	apparently	ADV
dpc-3650	33	18	healthy	healthy	ADJ
dpc-3650	33	19	tissue	tissue	NOUN
dpc-3650	33	20	in	in	ADP
dpc-3650	33	21	the	the	DET
dpc-3650	33	22	form	form	NOUN
dpc-3650	33	23	of	of	ADP
dpc-3650	33	24	resident	resident	ADJ
dpc-3650	33	25	trm	trm	ADJ
dpc-3650	33	26	cells	cell	NOUN
dpc-3650	33	27	,	,	PUNCT
dpc-3650	33	28	as	as	ADP
dpc-3650	33	29	trace	trace	NOUN
dpc-3650	33	30	of	of	ADP
dpc-3650	33	31	immunological	immunological	ADJ
dpc-3650	33	32	memory	memory	NOUN
dpc-3650	33	33	[	[	X
dpc-3650	33	34	3	3	NUM
dpc-3650	33	35	]	]	PUNCT
dpc-3650	33	36	.	.	PUNCT
dpc-3650	34	1	depression	depression	NOUN
dpc-3650	34	2	in	in	ADP
dpc-3650	34	3	psoriasis	psoriasis	NOUN
dpc-3650	34	4	has	have	VERB
dpc-3650	34	5	a	a	DET
dpc-3650	34	6	substantial	substantial	ADJ
dpc-3650	34	7	effect	effect	NOUN
dpc-3650	34	8	on	on	ADP
dpc-3650	34	9	the	the	DET
dpc-3650	34	10	quality	quality	NOUN
dpc-3650	34	11	of	of	ADP
dpc-3650	34	12	everyday	everyday	ADJ
dpc-3650	34	13	life	life	NOUN
dpc-3650	34	14	and	and	CCONJ
dpc-3650	34	15	the	the	DET
dpc-3650	34	16	emotional	emotional	ADJ
dpc-3650	34	17	state	state	NOUN
dpc-3650	34	18	of	of	ADP
dpc-3650	34	19	patients	patient	NOUN
dpc-3650	34	20	with	with	ADP
dpc-3650	34	21	psoriasis	psoriasis	NOUN
dpc-3650	34	22	[	[	X
dpc-3650	34	23	4,5	4,5	NUM
dpc-3650	34	24	]	]	PUNCT
dpc-3650	34	25	.	.	PUNCT
dpc-3650	35	1	the	the	DET
dpc-3650	35	2	association	association	NOUN
dpc-3650	35	3	of	of	ADP
dpc-3650	35	4	psoriasis	psoriasis	NOUN
dpc-3650	35	5	with	with	ADP
dpc-3650	35	6	sleep	sleep	NOUN
dpc-3650	35	7	deprivation	deprivation	NOUN
dpc-3650	35	8	,	,	PUNCT
dpc-3650	35	9	nervousness	nervousness	NOUN
dpc-3650	35	10	,	,	PUNCT
dpc-3650	35	11	and	and	CCONJ
dpc-3650	35	12	inability	inability	NOUN
dpc-3650	35	13	to	to	PART
dpc-3650	35	14	relax	relax	VERB
dpc-3650	35	15	have	have	AUX
dpc-3650	35	16	also	also	ADV
dpc-3650	35	17	been	be	AUX
dpc-3650	35	18	shown	show	VERB
dpc-3650	35	19	to	to	PART
dpc-3650	35	20	negatively	negatively	ADV
dpc-3650	35	21	affect	affect	VERB
dpc-3650	35	22	concentration	concentration	NOUN
dpc-3650	35	23	and	and	CCONJ
dpc-3650	35	24	daily	daily	ADJ
dpc-3650	35	25	performance	performance	NOUN
dpc-3650	35	26	[	[	X
dpc-3650	35	27	6,7	6,7	NUM
dpc-3650	35	28	]	]	PUNCT
dpc-3650	35	29	.	.	PUNCT
dpc-3650	36	1	psoriasis	psoriasis	NOUN
dpc-3650	36	2	patients	patient	NOUN
dpc-3650	36	3	are	be	AUX
dpc-3650	36	4	often	often	ADV
dpc-3650	36	5	stigmatized	stigmatize	VERB
dpc-3650	36	6	in	in	ADP
dpc-3650	36	7	their	their	PRON
dpc-3650	36	8	daily	daily	ADJ
dpc-3650	36	9	lives	life	NOUN
dpc-3650	36	10	by	by	ADP
dpc-3650	36	11	their	their	PRON
dpc-3650	36	12	visible	visible	ADJ
dpc-3650	36	13	lesions	lesion	NOUN
dpc-3650	36	14	,	,	PUNCT
dpc-3650	36	15	which	which	PRON
dpc-3650	36	16	negatively	negatively	ADV
dpc-3650	36	17	affects	affect	VERB
dpc-3650	36	18	their	their	PRON
dpc-3650	36	19	mental	mental	ADJ
dpc-3650	36	20	health	health	NOUN
dpc-3650	36	21	state	state	NOUN
dpc-3650	36	22	,	,	PUNCT
dpc-3650	36	23	causing	cause	VERB
dpc-3650	36	24	anxiety	anxiety	NOUN
dpc-3650	36	25	and	and	CCONJ
dpc-3650	36	26	depression	depression	NOUN
dpc-3650	36	27	[	[	X
dpc-3650	36	28	8	8	NUM
dpc-3650	36	29	-	-	SYM
dpc-3650	36	30	11	11	NUM
dpc-3650	36	31	]	]	PUNCT
dpc-3650	36	32	.	.	PUNCT
dpc-3650	37	1	the	the	DET
dpc-3650	37	2	severity	severity	NOUN
dpc-3650	37	3	of	of	ADP
dpc-3650	37	4	the	the	DET
dpc-3650	37	5	depressive	depressive	ADJ
dpc-3650	37	6	symptoms	symptom	NOUN
dpc-3650	37	7	is	be	AUX
dpc-3650	37	8	not	not	PART
dpc-3650	37	9	proportional	proportional	ADJ
dpc-3650	37	10	to	to	ADP
dpc-3650	37	11	the	the	DET
dpc-3650	37	12	severity	severity	NOUN
dpc-3650	37	13	of	of	ADP
dpc-3650	37	14	the	the	DET
dpc-3650	37	15	disease	disease	NOUN
dpc-3650	37	16	.	.	PUNCT
dpc-3650	38	1	psoriasis	psoriasis	NOUN
dpc-3650	38	2	can	can	AUX
dpc-3650	38	3	be	be	AUX
dpc-3650	38	4	mild	mild	ADJ
dpc-3650	38	5	,	,	PUNCT
dpc-3650	38	6	even	even	ADV
dpc-3650	38	7	a	a	DET
dpc-3650	38	8	small	small	ADJ
dpc-3650	38	9	spot	spot	NOUN
dpc-3650	38	10	may	may	AUX
dpc-3650	38	11	affect	affect	VERB
dpc-3650	38	12	the	the	DET
dpc-3650	38	13	mental	mental	ADJ
dpc-3650	38	14	sphere	sphere	NOUN
dpc-3650	38	15	of	of	ADP
dpc-3650	38	16	the	the	DET
dpc-3650	38	17	person	person	NOUN
dpc-3650	38	18	with	with	ADP
dpc-3650	38	19	psoriasis	psoriasis	NOUN
dpc-3650	38	20	[	[	X
dpc-3650	38	21	12	12	NUM
dpc-3650	38	22	]	]	PUNCT
dpc-3650	38	23	.	.	PUNCT
dpc-3650	39	1	it	it	PRON
dpc-3650	39	2	seems	seem	VERB
dpc-3650	39	3	that	that	SCONJ
dpc-3650	39	4	the	the	DET
dpc-3650	39	5	onset	onset	NOUN
dpc-3650	39	6	of	of	ADP
dpc-3650	39	7	depression	depression	NOUN
dpc-3650	39	8	is	be	AUX
dpc-3650	39	9	more	more	ADV
dpc-3650	39	10	common	common	ADJ
dpc-3650	39	11	in	in	ADP
dpc-3650	39	12	women	woman	NOUN
dpc-3650	39	13	compared	compare	VERB
dpc-3650	39	14	to	to	ADP
dpc-3650	39	15	men	man	NOUN
dpc-3650	39	16	and	and	CCONJ
dpc-3650	39	17	in	in	ADP
dpc-3650	39	18	those	those	DET
dpc-3650	39	19	younger	young	ADJ
dpc-3650	39	20	than	than	ADP
dpc-3650	39	21	31	31	NUM
dpc-3650	39	22	years	year	NOUN
dpc-3650	40	1	[	[	X
dpc-3650	40	2	13	13	NUM
dpc-3650	40	3	]	]	PUNCT
dpc-3650	40	4	.	.	PUNCT
dpc-3650	41	1	overall	overall	ADJ
dpc-3650	41	2	,	,	PUNCT
dpc-3650	41	3	depression	depression	NOUN
dpc-3650	41	4	,	,	PUNCT
dpc-3650	41	5	which	which	PRON
dpc-3650	41	6	very	very	ADV
dpc-3650	41	7	often	often	ADV
dpc-3650	41	8	accompanies	accompany	VERB
dpc-3650	41	9	psoriasis	psoriasis	NOUN
dpc-3650	41	10	,	,	PUNCT
dpc-3650	41	11	is	be	AUX
dpc-3650	41	12	characterized	characterize	VERB
dpc-3650	41	13	by	by	ADP
dpc-3650	41	14	depressed	depressed	ADJ
dpc-3650	41	15	mood	mood	NOUN
dpc-3650	41	16	,	,	PUNCT
dpc-3650	41	17	anhedonia	anhedonia	NOUN
dpc-3650	41	18	and	and	CCONJ
dpc-3650	41	19	loss	loss	NOUN
dpc-3650	41	20	of	of	ADP
dpc-3650	41	21	interest	interest	NOUN
dpc-3650	41	22	,	,	PUNCT
dpc-3650	41	23	social	social	ADJ
dpc-3650	41	24	withdrawal	withdrawal	NOUN
dpc-3650	41	25	,	,	PUNCT
dpc-3650	41	26	sleep	sleep	NOUN
dpc-3650	41	27	,	,	PUNCT
dpc-3650	41	28	and	and	CCONJ
dpc-3650	41	29	appetite	appetite	ADJ
dpc-3650	41	30	disturbances	disturbance	NOUN
dpc-3650	41	31	.	.	PUNCT
dpc-3650	42	1	many	many	ADJ
dpc-3650	42	2	times	time	NOUN
dpc-3650	42	3	,	,	PUNCT
dpc-3650	42	4	patients	patient	NOUN
dpc-3650	42	5	suffering	suffer	VERB
dpc-3650	42	6	from	from	ADP
dpc-3650	42	7	psoriasis	psoriasis	NOUN
dpc-3650	42	8	are	be	AUX
dpc-3650	42	9	possessed	possess	VERB
dpc-3650	42	10	by	by	ADP
dpc-3650	42	11	feelings	feeling	NOUN
dpc-3650	42	12	of	of	ADP
dpc-3650	42	13	shame	shame	NOUN
dpc-3650	42	14	,	,	PUNCT
dpc-3650	42	15	not	not	PART
dpc-3650	42	16	feeling	feel	VERB
dpc-3650	42	17	comfortable	comfortable	ADJ
dpc-3650	42	18	in	in	ADP
dpc-3650	42	19	their	their	PRON
dpc-3650	42	20	interpersonal	interpersonal	ADJ
dpc-3650	42	21	relationships	relationship	NOUN
dpc-3650	42	22	,	,	PUNCT
dpc-3650	42	23	and	and	CCONJ
dpc-3650	42	24	do	do	AUX
dpc-3650	42	25	not	not	PART
dpc-3650	42	26	want	want	VERB
dpc-3650	42	27	to	to	PART
dpc-3650	42	28	be	be	AUX
dpc-3650	42	29	touched	touch	VERB
dpc-3650	42	30	(	(	PUNCT
dpc-3650	42	31	sexual	sexual	ADJ
dpc-3650	42	32	dysfunction	dysfunction	NOUN
dpc-3650	42	33	often	often	ADV
dpc-3650	42	34	coexists	coexist	VERB
dpc-3650	42	35	)	)	PUNCT
dpc-3650	42	36	.	.	PUNCT
dpc-3650	43	1	there	there	PRON
dpc-3650	43	2	is	be	VERB
dpc-3650	43	3	a	a	DET
dpc-3650	43	4	mutual	mutual	ADJ
dpc-3650	43	5	relationship	relationship	NOUN
dpc-3650	43	6	between	between	ADP
dpc-3650	43	7	psoriasis	psoriasis	NOUN
dpc-3650	43	8	and	and	CCONJ
dpc-3650	43	9	depression	depression	NOUN
dpc-3650	43	10	,	,	PUNCT
dpc-3650	43	11	patients	patient	NOUN
dpc-3650	43	12	with	with	ADP
dpc-3650	43	13	psoriasis	psoriasis	NOUN
dpc-3650	43	14	show	show	VERB
dpc-3650	43	15	a	a	DET
dpc-3650	43	16	higher	high	ADJ
dpc-3650	43	17	degree	degree	NOUN
dpc-3650	43	18	of	of	ADP
dpc-3650	43	19	depression	depression	NOUN
dpc-3650	43	20	than	than	ADP
dpc-3650	43	21	healthy	healthy	ADJ
dpc-3650	43	22	people	people	NOUN
dpc-3650	43	23	,	,	PUNCT
dpc-3650	43	24	and	and	CCONJ
dpc-3650	43	25	patients	patient	NOUN
dpc-3650	43	26	with	with	ADP
dpc-3650	43	27	depression	depression	NOUN
dpc-3650	43	28	show	show	VERB
dpc-3650	43	29	more	more	ADJ
dpc-3650	43	30	psoriasis	psoriasis	NOUN
dpc-3650	43	31	[	[	X
dpc-3650	43	32	14	14	NUM
dpc-3650	43	33	]	]	PUNCT
dpc-3650	43	34	.	.	PUNCT
dpc-3650	44	1	although	although	SCONJ
dpc-3650	44	2	still	still	ADV
dpc-3650	44	3	relatively	relatively	ADV
dpc-3650	44	4	unknown	unknown	ADJ
dpc-3650	44	5	,	,	PUNCT
dpc-3650	44	6	it	it	PRON
dpc-3650	44	7	has	have	AUX
dpc-3650	44	8	been	be	AUX
dpc-3650	44	9	postulated	postulate	VERB
dpc-3650	44	10	that	that	SCONJ
dpc-3650	44	11	psoriasis	psoriasis	NOUN
dpc-3650	44	12	in	in	ADP
dpc-3650	44	13	younger	young	ADJ
dpc-3650	44	14	adults	adult	NOUN
dpc-3650	44	15	may	may	AUX
dpc-3650	44	16	have	have	AUX
dpc-3650	44	17	even	even	ADV
dpc-3650	44	18	greater	great	ADJ
dpc-3650	44	19	psychological	psychological	ADJ
dpc-3650	44	20	impact	impact	NOUN
dpc-3650	44	21	as	as	SCONJ
dpc-3650	44	22	they	they	PRON
dpc-3650	44	23	are	be	AUX
dpc-3650	44	24	more	more	ADV
dpc-3650	44	25	prone	prone	ADJ
dpc-3650	44	26	to	to	ADP
dpc-3650	44	27	addictive	addictive	ADJ
dpc-3650	44	28	behaviors	behavior	NOUN
dpc-3650	44	29	,	,	PUNCT
dpc-3650	44	30	such	such	ADJ
dpc-3650	44	31	as	as	ADP
dpc-3650	44	32	alcohol	alcohol	NOUN
dpc-3650	44	33	,	,	PUNCT
dpc-3650	44	34	experience	experience	NOUN
dpc-3650	44	35	loneliness	loneliness	NOUN
dpc-3650	44	36	,	,	PUNCT
dpc-3650	44	37	stigmatization	stigmatization	NOUN
dpc-3650	44	38	,	,	PUNCT
dpc-3650	44	39	and	and	CCONJ
dpc-3650	44	40	low	low	ADJ
dpc-3650	44	41	self	self	NOUN
dpc-3650	44	42	-	-	PUNCT
dpc-3650	44	43	esteem	esteem	NOUN
dpc-3650	44	44	,	,	PUNCT
dpc-3650	44	45	while	while	SCONJ
dpc-3650	44	46	,	,	PUNCT
dpc-3650	44	47	suicidal	suicidal	ADJ
dpc-3650	44	48	ideations	ideation	NOUN
dpc-3650	44	49	are	be	AUX
dpc-3650	44	50	also	also	ADV
dpc-3650	44	51	more	more	ADV
dpc-3650	44	52	intense	intense	ADJ
dpc-3650	44	53	,	,	PUNCT
dpc-3650	44	54	covid-19	covid-19	PROPN
dpc-3650	44	55	–	–	PUNCT
dpc-3650	44	56	related	relate	VERB
dpc-3650	44	57	stress	stress	NOUN
dpc-3650	44	58	as	as	ADV
dpc-3650	44	59	well	well	ADV
dpc-3650	44	60	as	as	ADP
dpc-3650	44	61	the	the	DET
dpc-3650	44	62	continued	continue	VERB
dpc-3650	44	63	economic	economic	ADJ
dpc-3650	44	64	pressure	pressure	NOUN
dpc-3650	44	65	experienced	experience	VERB
dpc-3650	44	66	by	by	ADP
dpc-3650	44	67	humanity	humanity	NOUN
dpc-3650	44	68	in	in	ADP
dpc-3650	44	69	the	the	DET
dpc-3650	44	70	recent	recent	ADJ
dpc-3650	44	71	years	year	NOUN
dpc-3650	44	72	have	have	AUX
dpc-3650	44	73	triggered	trigger	VERB
dpc-3650	44	74	the	the	DET
dpc-3650	44	75	occurrence	occurrence	NOUN
dpc-3650	44	76	of	of	ADP
dpc-3650	44	77	psoriasis	psoriasis	NOUN
dpc-3650	44	78	and	and	CCONJ
dpc-3650	44	79	have	have	AUX
dpc-3650	44	80	greatly	greatly	ADV
dpc-3650	44	81	increased	increase	VERB
dpc-3650	44	82	the	the	DET
dpc-3650	44	83	incidence	incidence	NOUN
dpc-3650	44	84	of	of	ADP
dpc-3650	44	85	disease	disease	NOUN
dpc-3650	44	86	relapses	relapse	NOUN
dpc-3650	44	87	,	,	PUNCT
dpc-3650	44	88	and	and	CCONJ
dpc-3650	44	89	depressive	depressive	ADJ
dpc-3650	44	90	illness	illness	NOUN
dpc-3650	44	91	.	.	PUNCT
dpc-3650	45	1	[	[	X
dpc-3650	45	2	15	15	NUM
dpc-3650	45	3	-	-	SYM
dpc-3650	45	4	17	17	NUM
dpc-3650	45	5	]	]	PUNCT
dpc-3650	45	6	.	.	PUNCT
dpc-3650	46	1	the	the	DET
dpc-3650	46	2	immunological	immunological	ADJ
dpc-3650	46	3	background	background	NOUN
dpc-3650	46	4	in	in	ADP
dpc-3650	46	5	the	the	DET
dpc-3650	46	6	pathophysiology	pathophysiology	NOUN
dpc-3650	46	7	of	of	ADP
dpc-3650	46	8	depression	depression	NOUN
dpc-3650	46	9	has	have	AUX
dpc-3650	46	10	been	be	AUX
dpc-3650	46	11	illustrated	illustrate	VERB
dpc-3650	46	12	by	by	ADP
dpc-3650	46	13	several	several	ADJ
dpc-3650	46	14	studies	study	NOUN
dpc-3650	46	15	.	.	PUNCT
dpc-3650	47	1	furthermore	furthermore	ADV
dpc-3650	47	2	,	,	PUNCT
dpc-3650	47	3	it	it	PRON
dpc-3650	47	4	has	have	AUX
dpc-3650	47	5	been	be	AUX
dpc-3650	47	6	shown	show	VERB
dpc-3650	47	7	that	that	SCONJ
dpc-3650	47	8	there	there	PRON
dpc-3650	47	9	are	be	VERB
dpc-3650	47	10	common	common	ADJ
dpc-3650	47	11	pathogenetic	pathogenetic	ADJ
dpc-3650	47	12	mechanisms	mechanism	NOUN
dpc-3650	47	13	in	in	ADP
dpc-3650	47	14	psoriasis	psoriasis	NOUN
dpc-3650	47	15	and	and	CCONJ
dpc-3650	47	16	depression	depression	NOUN
dpc-3650	47	17	.	.	PUNCT
dpc-3650	48	1	these	these	DET
dpc-3650	48	2	two	two	NUM
dpc-3650	48	3	facts	fact	NOUN
dpc-3650	48	4	can	can	AUX
dpc-3650	48	5	justify	justify	VERB
dpc-3650	48	6	the	the	DET
dpc-3650	48	7	occurrence	occurrence	NOUN
dpc-3650	48	8	of	of	ADP
dpc-3650	48	9	increased	increase	VERB
dpc-3650	48	10	pro	pro	ADJ
dpc-3650	48	11	-	-	ADJ
dpc-3650	48	12	inflammatory	inflammatory	ADJ
dpc-3650	48	13	cytokines	cytokine	NOUN
dpc-3650	48	14	such	such	ADJ
dpc-3650	48	15	as	as	ADP
dpc-3650	48	16	creactive	creactive	ADJ
dpc-3650	48	17	protein	protein	NOUN
dpc-3650	48	18	(	(	PUNCT
dpc-3650	48	19	crp	crp	PROPN
dpc-3650	48	20	)	)	PUNCT
dpc-3650	48	21	,	,	PUNCT
dpc-3650	48	22	tnf	tnf	PROPN
dpc-3650	48	23	-	-	PUNCT
dpc-3650	48	24	a	a	NOUN
dpc-3650	48	25	,	,	PUNCT
dpc-3650	48	26	il-17	il-17	X
dpc-3650	48	27	,	,	PUNCT
dpc-3650	48	28	and	and	CCONJ
dpc-3650	48	29	il-6	il-6	NOUN
dpc-3650	48	30	in	in	ADP
dpc-3650	48	31	both	both	DET
dpc-3650	48	32	diseases	disease	NOUN
dpc-3650	48	33	[	[	X
dpc-3650	48	34	18	18	NUM
dpc-3650	48	35	-	-	SYM
dpc-3650	48	36	26	26	NUM
dpc-3650	48	37	]	]	PUNCT
dpc-3650	48	38	while	while	SCONJ
dpc-3650	48	39	the	the	DET
dpc-3650	48	40	brain	brain	NOUN
dpc-3650	48	41	barrier	barrier	NOUN
dpc-3650	48	42	has	have	AUX
dpc-3650	48	43	been	be	AUX
dpc-3650	48	44	shown	show	VERB
dpc-3650	48	45	to	to	PART
dpc-3650	48	46	be	be	AUX
dpc-3650	48	47	affected	affect	VERB
dpc-3650	48	48	,	,	PUNCT
dpc-3650	48	49	as	as	ADV
dpc-3650	48	50	well	well	ADV
dpc-3650	48	51	.	.	PUNCT
dpc-3650	49	1	stress	stress	NOUN
dpc-3650	49	2	may	may	AUX
dpc-3650	49	3	also	also	ADV
dpc-3650	49	4	play	play	VERB
dpc-3650	49	5	a	a	DET
dpc-3650	49	6	role	role	NOUN
dpc-3650	49	7	in	in	ADP
dpc-3650	49	8	the	the	DET
dpc-3650	49	9	exacerbation	exacerbation	NOUN
dpc-3650	49	10	of	of	ADP
dpc-3650	49	11	psoriasis	psoriasis	NOUN
dpc-3650	49	12	,	,	PUNCT
dpc-3650	49	13	by	by	ADP
dpc-3650	49	14	dysregulation	dysregulation	NOUN
dpc-3650	49	15	of	of	ADP
dpc-3650	49	16	the	the	DET
dpc-3650	49	17	hypothalamic	hypothalamic	ADJ
dpc-3650	49	18	–	–	PUNCT
dpc-3650	49	19	pituitary	pituitary	ADJ
dpc-3650	49	20	–	–	PUNCT
dpc-3650	49	21	adrenal	adrenal	ADJ
dpc-3650	49	22	(	(	PUNCT
dpc-3650	49	23	hpa	hpa	NOUN
dpc-3650	49	24	)	)	PUNCT
dpc-3650	49	25	axis	axis	NOUN
dpc-3650	49	26	,	,	PUNCT
dpc-3650	49	27	sympathetic	sympathetic	ADJ
dpc-3650	49	28	–	–	PUNCT
dpc-3650	49	29	adrenal	adrenal	ADJ
dpc-3650	49	30	–	–	PUNCT
dpc-3650	49	31	medullary	medullary	ADJ
dpc-3650	49	32	axis	axis	NOUN
dpc-3650	49	33	,	,	PUNCT
dpc-3650	49	34	peripheral	peripheral	ADJ
dpc-3650	49	35	nervous	nervous	ADJ
dpc-3650	49	36	system	system	NOUN
dpc-3650	49	37	,	,	PUNCT
dpc-3650	49	38	and	and	CCONJ
dpc-3650	49	39	immune	immune	ADJ
dpc-3650	49	40	system	system	NOUN
dpc-3650	49	41	[	[	X
dpc-3650	49	42	27	27	NUM
dpc-3650	49	43	]	]	PUNCT
dpc-3650	49	44	.	.	PUNCT
dpc-3650	50	1	stress	stress	NOUN
dpc-3650	50	2	-	-	PUNCT
dpc-3650	50	3	related	relate	VERB
dpc-3650	50	4	increased	increase	VERB
dpc-3650	50	5	cortisol	cortisol	NOUN
dpc-3650	50	6	levels	level	NOUN
dpc-3650	50	7	(	(	PUNCT
dpc-3650	50	8	due	due	ADP
dpc-3650	50	9	to	to	ADP
dpc-3650	50	10	increased	increase	VERB
dpc-3650	50	11	acth	acth	NOUN
dpc-3650	50	12	production	production	NOUN
dpc-3650	50	13	)	)	PUNCT
dpc-3650	50	14	have	have	AUX
dpc-3650	50	15	also	also	ADV
dpc-3650	50	16	been	be	AUX
dpc-3650	50	17	associated	associate	VERB
dpc-3650	50	18	with	with	ADP
dpc-3650	50	19	psoriasis	psoriasis	NOUN
dpc-3650	50	20	exacerbation	exacerbation	NOUN
dpc-3650	50	21	[	[	X
dpc-3650	50	22	28	28	NUM
dpc-3650	50	23	]	]	PUNCT
dpc-3650	50	24	.	.	PUNCT
dpc-3650	51	1	an	an	DET
dpc-3650	51	2	important	important	ADJ
dpc-3650	51	3	role	role	NOUN
dpc-3650	51	4	in	in	ADP
dpc-3650	51	5	the	the	DET
dpc-3650	51	6	appearance	appearance	NOUN
dpc-3650	51	7	of	of	ADP
dpc-3650	51	8	depression	depression	NOUN
dpc-3650	51	9	on	on	ADP
dpc-3650	51	10	brain	brain	NOUN
dpc-3650	51	11	skin	skin	NOUN
dpc-3650	51	12	axis	axis	NOUN
dpc-3650	51	13	,	,	PUNCT
dpc-3650	51	14	has	have	AUX
dpc-3650	51	15	been	be	AUX
dpc-3650	51	16	shown	show	VERB
dpc-3650	51	17	[	[	X
dpc-3650	51	18	28	28	NUM
dpc-3650	51	19	]	]	PUNCT
dpc-3650	51	20	with	with	ADP
dpc-3650	51	21	the	the	DET
dpc-3650	51	22	release	release	NOUN
dpc-3650	51	23	of	of	ADP
dpc-3650	51	24	the	the	DET
dpc-3650	51	25	acth	acth	ADJ
dpc-3650	51	26	hormone	hormone	NOUN
dpc-3650	51	27	and	and	CCONJ
dpc-3650	51	28	the	the	DET
dpc-3650	51	29	release	release	NOUN
dpc-3650	51	30	of	of	ADP
dpc-3650	51	31	inflammatory	inflammatory	ADJ
dpc-3650	51	32	factors	factor	NOUN
dpc-3650	51	33	:	:	PUNCT
dpc-3650	51	34	ifn	ifn	PROPN
dpc-3650	51	35	-	-	PUNCT
dpc-3650	51	36	a.	a.	NOUN
dpc-3650	51	37	il-2	il-2	PROPN
dpc-3650	51	38	,	,	PUNCT
dpc-3650	51	39	il-6	il-6	NUM
dpc-3650	51	40	,	,	PUNCT
dpc-3650	51	41	il1β	il1β	PROPN
dpc-3650	51	42	and	and	CCONJ
dpc-3650	51	43	tnf	tnf	PROPN
dpc-3650	51	44	-	-	PUNCT
dpc-3650	51	45	α	α	PROPN
dpc-3650	51	46	.	.	PUNCT
dpc-3650	52	1	methods	method	NOUN
dpc-3650	52	2	participants	participant	NOUN
dpc-3650	52	3	all	all	DET
dpc-3650	52	4	participants	participant	NOUN
dpc-3650	52	5	were	be	AUX
dpc-3650	52	6	recruited	recruit	VERB
dpc-3650	52	7	from	from	ADP
dpc-3650	52	8	the	the	DET
dpc-3650	52	9	psoriasis	psoriasis	NOUN
dpc-3650	52	10	outpatient	outpatient	NOUN
dpc-3650	52	11	clinic	clinic	NOUN
dpc-3650	52	12	of	of	ADP
dpc-3650	52	13	the	the	DET
dpc-3650	52	14	2nd	2nd	ADJ
dpc-3650	52	15	department	department	NOUN
dpc-3650	52	16	of	of	ADP
dpc-3650	52	17	dermatology	dermatology	NOUN
dpc-3650	52	18	and	and	CCONJ
dpc-3650	52	19	venereology	venereology	NOUN
dpc-3650	52	20	,	,	PUNCT
dpc-3650	52	21	aristotle	aristotle	PROPN
dpc-3650	52	22	university	university	PROPN
dpc-3650	52	23	of	of	ADP
dpc-3650	52	24	thessaloniki	thessaloniki	PROPN
dpc-3650	52	25	.	.	PUNCT
dpc-3650	53	1	the	the	DET
dpc-3650	53	2	study	study	NOUN
dpc-3650	53	3	was	be	AUX
dpc-3650	53	4	approved	approve	VERB
dpc-3650	53	5	by	by	ADP
dpc-3650	53	6	the	the	DET
dpc-3650	53	7	scientific	scientific	ADJ
dpc-3650	53	8	committee	committee	NOUN
dpc-3650	53	9	of	of	ADP
dpc-3650	53	10	papageorgiou	papageorgiou	PROPN
dpc-3650	53	11	general	general	PROPN
dpc-3650	53	12	hospital	hospital	NOUN
dpc-3650	53	13	after	after	ADP
dpc-3650	53	14	permission	permission	NOUN
dpc-3650	53	15	from	from	ADP
dpc-3650	53	16	the	the	DET
dpc-3650	53	17	results	result	NOUN
dpc-3650	53	18	:	:	PUNCT
dpc-3650	53	19	both	both	DET
dpc-3650	53	20	crp	crp	PROPN
dpc-3650	53	21	and	and	CCONJ
dpc-3650	53	22	esr	esr	PROPN
dpc-3650	53	23	levels	level	NOUN
dpc-3650	53	24	were	be	AUX
dpc-3650	53	25	higher	high	ADJ
dpc-3650	53	26	in	in	ADP
dpc-3650	53	27	the	the	DET
dpc-3650	53	28	case	case	NOUN
dpc-3650	53	29	group	group	NOUN
dpc-3650	53	30	(	(	PUNCT
dpc-3650	53	31	ie	ie	X
dpc-3650	53	32	psoriasis	psoriasis	NOUN
dpc-3650	53	33	and	and	CCONJ
dpc-3650	53	34	depression	depression	NOUN
dpc-3650	53	35	and	and	CCONJ
dpc-3650	53	36	psoriasis	psoriasis	NOUN
dpc-3650	53	37	)	)	PUNCT
dpc-3650	53	38	compared	compare	VERB
dpc-3650	53	39	to	to	ADP
dpc-3650	53	40	healthy	healthy	ADJ
dpc-3650	53	41	controls	control	NOUN
dpc-3650	53	42	.	.	PUNCT
dpc-3650	54	1	furthermore	furthermore	ADV
dpc-3650	54	2	,	,	PUNCT
dpc-3650	54	3	psoriatic	psoriatic	ADJ
dpc-3650	54	4	patients	patient	NOUN
dpc-3650	54	5	with	with	ADP
dpc-3650	54	6	depression	depression	NOUN
dpc-3650	54	7	showed	show	VERB
dpc-3650	54	8	increased	increase	VERB
dpc-3650	54	9	crp	crp	PROPN
dpc-3650	54	10	and	and	CCONJ
dpc-3650	54	11	esr	esr	PROPN
dpc-3650	54	12	levels	level	NOUN
dpc-3650	54	13	compared	compare	VERB
dpc-3650	54	14	to	to	ADP
dpc-3650	54	15	those	those	PRON
dpc-3650	54	16	of	of	ADP
dpc-3650	54	17	psoriatic	psoriatic	ADJ
dpc-3650	54	18	patients	patient	NOUN
dpc-3650	54	19	without	without	ADP
dpc-3650	54	20	depression	depression	NOUN
dpc-3650	54	21	.	.	PUNCT
dpc-3650	55	1	conclusions	conclusion	NOUN
dpc-3650	55	2	:	:	PUNCT
dpc-3650	55	3	the	the	DET
dpc-3650	55	4	evaluation	evaluation	NOUN
dpc-3650	55	5	of	of	ADP
dpc-3650	55	6	both	both	DET
dpc-3650	55	7	crp	crp	PROPN
dpc-3650	55	8	and	and	CCONJ
dpc-3650	55	9	esr	esr	PROPN
dpc-3650	55	10	and	and	CCONJ
dpc-3650	55	11	their	their	PRON
dpc-3650	55	12	use	use	NOUN
dpc-3650	55	13	to	to	PART
dpc-3650	55	14	detect	detect	VERB
dpc-3650	55	15	the	the	DET
dpc-3650	55	16	presence	presence	NOUN
dpc-3650	55	17	of	of	ADP
dpc-3650	55	18	depression	depression	NOUN
dpc-3650	55	19	in	in	ADP
dpc-3650	55	20	patients	patient	NOUN
dpc-3650	55	21	with	with	ADP
dpc-3650	55	22	psoriasis	psoriasis	NOUN
dpc-3650	55	23	can	can	AUX
dpc-3650	55	24	be	be	AUX
dpc-3650	55	25	an	an	DET
dpc-3650	55	26	important	important	ADJ
dpc-3650	55	27	tool	tool	NOUN
dpc-3650	55	28	for	for	ADP
dpc-3650	55	29	their	their	PRON
dpc-3650	55	30	holistic	holistic	ADJ
dpc-3650	55	31	treatment	treatment	NOUN
dpc-3650	55	32	of	of	ADP
dpc-3650	55	33	theirs	theirs	PRON
dpc-3650	55	34	.	.	PUNCT
dpc-3650	56	1	original	original	ADJ
dpc-3650	56	2	article	article	NOUN
dpc-3650	56	3	|	|	ADV
dpc-3650	56	4	dermatol	dermatol	ADJ
dpc-3650	56	5	pract	pract	NOUN
dpc-3650	56	6	concept	concept	NOUN
dpc-3650	56	7	.	.	PUNCT
dpc-3650	57	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	57	2	3	3	NUM
dpc-3650	57	3	hellenic	hellenic	ADJ
dpc-3650	57	4	data	data	PROPN
dpc-3650	57	5	protection	protection	PROPN
dpc-3650	57	6	authority	authority	NOUN
dpc-3650	57	7	.	.	PUNCT
dpc-3650	58	1	all	all	DET
dpc-3650	58	2	the	the	DET
dpc-3650	58	3	participants	participant	NOUN
dpc-3650	58	4	were	be	AUX
dpc-3650	58	5	thoroughly	thoroughly	ADV
dpc-3650	58	6	informed	inform	VERB
dpc-3650	58	7	about	about	ADP
dpc-3650	58	8	the	the	DET
dpc-3650	58	9	scope	scope	NOUN
dpc-3650	58	10	of	of	ADP
dpc-3650	58	11	the	the	DET
dpc-3650	58	12	study	study	NOUN
dpc-3650	58	13	and	and	CCONJ
dpc-3650	58	14	were	be	AUX
dpc-3650	58	15	provided	provide	VERB
dpc-3650	58	16	with	with	ADP
dpc-3650	58	17	written	write	VERB
dpc-3650	58	18	informed	inform	VERB
dpc-3650	58	19	consent	consent	NOUN
dpc-3650	58	20	,	,	PUNCT
dpc-3650	58	21	without	without	ADP
dpc-3650	58	22	receiving	receive	VERB
dpc-3650	58	23	any	any	DET
dpc-3650	58	24	financial	financial	ADJ
dpc-3650	58	25	benefits	benefit	NOUN
dpc-3650	58	26	.	.	PUNCT
dpc-3650	59	1	a	a	DET
dpc-3650	59	2	total	total	ADJ
dpc-3650	59	3	number	number	NOUN
dpc-3650	59	4	of	of	ADP
dpc-3650	59	5	52	52	NUM
dpc-3650	59	6	patients	patient	NOUN
dpc-3650	59	7	(	(	PUNCT
dpc-3650	59	8	ie	ie	X
dpc-3650	59	9	,	,	PUNCT
dpc-3650	59	10	case	case	NOUN
dpc-3650	59	11	participants	participant	NOUN
dpc-3650	59	12	)	)	PUNCT
dpc-3650	59	13	was	be	AUX
dpc-3650	59	14	enrolled	enrol	VERB
dpc-3650	59	15	in	in	ADP
dpc-3650	59	16	the	the	DET
dpc-3650	59	17	study	study	NOUN
dpc-3650	59	18	of	of	ADP
dpc-3650	59	19	whom	whom	PRON
dpc-3650	59	20	28	28	NUM
dpc-3650	59	21	were	be	AUX
dpc-3650	59	22	diagnosed	diagnose	VERB
dpc-3650	59	23	with	with	ADP
dpc-3650	59	24	psoriasis	psoriasis	NOUN
dpc-3650	59	25	(	(	PUNCT
dpc-3650	59	26	beck	beck	NOUN
dpc-3650	59	27	depression	depression	PROPN
dpc-3650	59	28	inventory	inventory	PROPN
dpc-3650	59	29	-	-	PUNCT
dpc-3650	59	30	ii	ii	NOUN
dpc-3650	59	31	:	:	PUNCT
dpc-3650	59	32	:0	:0	PUNCT
dpc-3650	59	33	-	-	PUNCT
dpc-3650	59	34	13	13	NUM
dpc-3650	59	35	)	)	PUNCT
dpc-3650	59	36	,	,	PUNCT
dpc-3650	59	37	and	and	CCONJ
dpc-3650	59	38	24	24	NUM
dpc-3650	59	39	were	be	AUX
dpc-3650	59	40	diagnosed	diagnose	VERB
dpc-3650	59	41	with	with	ADP
dpc-3650	59	42	psoriasis	psoriasis	NOUN
dpc-3650	59	43	and	and	CCONJ
dpc-3650	59	44	depression	depression	NOUN
dpc-3650	59	45	(	(	PUNCT
dpc-3650	59	46	beck	beck	PROPN
dpc-3650	59	47	depression	depression	PROPN
dpc-3650	59	48	inventory	inventory	PROPN
dpc-3650	59	49	-	-	PUNCT
dpc-3650	59	50	ii:14	ii:14	PROPN
dpc-3650	59	51	-	-	PUNCT
dpc-3650	59	52	63	63	NUM
dpc-3650	59	53	)	)	PUNCT
dpc-3650	59	54	.	.	PUNCT
dpc-3650	60	1	twenty	twenty	NUM
dpc-3650	60	2	-	-	PUNCT
dpc-3650	60	3	eight	eight	NUM
dpc-3650	60	4	(	(	PUNCT
dpc-3650	60	5	28	28	NUM
dpc-3650	60	6	)	)	PUNCT
dpc-3650	60	7	controls	control	NOUN
dpc-3650	60	8	(	(	PUNCT
dpc-3650	60	9	ie	ie	X
dpc-3650	60	10	,	,	PUNCT
dpc-3650	60	11	healthy	healthy	ADJ
dpc-3650	60	12	participants	participant	NOUN
dpc-3650	60	13	)	)	PUNCT
dpc-3650	60	14	were	be	AUX
dpc-3650	60	15	also	also	ADV
dpc-3650	60	16	included	include	VERB
dpc-3650	60	17	in	in	ADP
dpc-3650	60	18	the	the	DET
dpc-3650	60	19	study	study	NOUN
dpc-3650	60	20	.	.	PUNCT
dpc-3650	61	1	the	the	DET
dpc-3650	61	2	final	final	ADJ
dpc-3650	61	3	diagnosis	diagnosis	NOUN
dpc-3650	61	4	of	of	ADP
dpc-3650	61	5	depression	depression	NOUN
dpc-3650	61	6	was	be	AUX
dpc-3650	61	7	made	make	VERB
dpc-3650	61	8	by	by	ADP
dpc-3650	61	9	a	a	DET
dpc-3650	61	10	psychiatrist	psychiatrist	NOUN
dpc-3650	61	11	.	.	PUNCT
dpc-3650	62	1	as	as	ADP
dpc-3650	62	2	a	a	DET
dpc-3650	62	3	result	result	NOUN
dpc-3650	62	4	,	,	PUNCT
dpc-3650	62	5	two	two	NUM
dpc-3650	62	6	of	of	ADP
dpc-3650	62	7	our	our	PRON
dpc-3650	62	8	patients	patient	NOUN
dpc-3650	62	9	with	with	ADP
dpc-3650	62	10	psoriasis	psoriasis	NOUN
dpc-3650	62	11	and	and	CCONJ
dpc-3650	62	12	depression	depression	NOUN
dpc-3650	62	13	were	be	AUX
dpc-3650	62	14	excluded	exclude	VERB
dpc-3650	62	15	from	from	ADP
dpc-3650	62	16	the	the	DET
dpc-3650	62	17	second	second	ADJ
dpc-3650	62	18	blood	blood	NOUN
dpc-3650	62	19	sampling	sample	VERB
dpc-3650	62	20	because	because	SCONJ
dpc-3650	62	21	they	they	PRON
dpc-3650	62	22	needed	need	VERB
dpc-3650	62	23	to	to	PART
dpc-3650	62	24	receive	receive	VERB
dpc-3650	62	25	systemic	systemic	ADJ
dpc-3650	62	26	antidepressant	antidepressant	ADJ
dpc-3650	62	27	treatment	treatment	NOUN
dpc-3650	62	28	.	.	PUNCT
dpc-3650	63	1	blood	blood	NOUN
dpc-3650	63	2	samples	sample	NOUN
dpc-3650	63	3	were	be	AUX
dpc-3650	63	4	taken	take	VERB
dpc-3650	63	5	from	from	ADP
dpc-3650	63	6	all	all	DET
dpc-3650	63	7	participants	participant	NOUN
dpc-3650	63	8	for	for	ADP
dpc-3650	63	9	the	the	DET
dpc-3650	63	10	identification	identification	NOUN
dpc-3650	63	11	and	and	CCONJ
dpc-3650	63	12	measurement	measurement	NOUN
dpc-3650	63	13	of	of	ADP
dpc-3650	63	14	crp	crp	PROPN
dpc-3650	63	15	and	and	CCONJ
dpc-3650	63	16	erythrocyte	erythrocyte	PROPN
dpc-3650	63	17	sedimentation	sedimentation	NOUN
dpc-3650	63	18	rate	rate	NOUN
dpc-3650	63	19	(	(	PUNCT
dpc-3650	63	20	esr	esr	PROPN
dpc-3650	63	21	)	)	PUNCT
dpc-3650	63	22	,	,	PUNCT
dpc-3650	63	23	as	as	ADP
dpc-3650	63	24	markers	marker	NOUN
dpc-3650	63	25	of	of	ADP
dpc-3650	63	26	inflammation	inflammation	NOUN
dpc-3650	63	27	.	.	PUNCT
dpc-3650	64	1	the	the	DET
dpc-3650	64	2	following	follow	VERB
dpc-3650	64	3	inclusion	inclusion	NOUN
dpc-3650	64	4	criteria	criterion	NOUN
dpc-3650	64	5	were	be	AUX
dpc-3650	64	6	applied	apply	VERB
dpc-3650	64	7	:	:	PUNCT
dpc-3650	64	8	(	(	PUNCT
dpc-3650	64	9	a	a	X
dpc-3650	64	10	)	)	PUNCT
dpc-3650	64	11	the	the	DET
dpc-3650	64	12	patient	patient	NOUN
dpc-3650	64	13	suffers	suffer	VERB
dpc-3650	64	14	from	from	ADP
dpc-3650	64	15	moderate	moderate	ADJ
dpc-3650	64	16	to	to	ADP
dpc-3650	64	17	severe	severe	ADJ
dpc-3650	64	18	psoriasis	psoriasis	NOUN
dpc-3650	64	19	(	(	PUNCT
dpc-3650	64	20	body	body	NOUN
dpc-3650	64	21	surface	surface	NOUN
dpc-3650	64	22	area	area	NOUN
dpc-3650	65	1	[	[	X
dpc-3650	65	2	bsa	bsa	X
dpc-3650	65	3	]	]	X
dpc-3650	65	4	>	>	X
dpc-3650	65	5	10	10	NUM
dpc-3650	65	6	or	or	CCONJ
dpc-3650	65	7	psoriasis	psoriasis	NOUN
dpc-3650	65	8	area	area	NOUN
dpc-3650	65	9	and	and	CCONJ
dpc-3650	65	10	severity	severity	NOUN
dpc-3650	65	11	index	index	NOUN
dpc-3650	65	12	[	[	X
dpc-3650	65	13	pasi	pasi	NOUN
dpc-3650	65	14	]	]	PUNCT
dpc-3650	65	15	>	>	X
dpc-3650	65	16	10	10	NUM
dpc-3650	65	17	and	and	CCONJ
dpc-3650	65	18	dermatology	dermatology	NOUN
dpc-3650	65	19	life	life	NOUN
dpc-3650	65	20	quality	quality	NOUN
dpc-3650	65	21	index	index	NOUN
dpc-3650	65	22	[	[	X
dpc-3650	65	23	dlqi	dlqi	X
dpc-3650	65	24	]	]	PUNCT
dpc-3650	65	25	>	>	X
dpc-3650	65	26	10	10	NUM
dpc-3650	65	27	)	)	PUNCT
dpc-3650	65	28	.	.	PUNCT
dpc-3650	66	1	(	(	PUNCT
dpc-3650	66	2	b	b	X
dpc-3650	66	3	)	)	PUNCT
dpc-3650	66	4	the	the	DET
dpc-3650	66	5	patient	patient	NOUN
dpc-3650	66	6	suffers	suffer	VERB
dpc-3650	66	7	from	from	ADP
dpc-3650	66	8	moderate	moderate	ADJ
dpc-3650	66	9	to	to	ADP
dpc-3650	66	10	severe	severe	ADJ
dpc-3650	66	11	depression	depression	NOUN
dpc-3650	66	12	.	.	PUNCT
dpc-3650	67	1	(	(	PUNCT
dpc-3650	67	2	c	c	X
dpc-3650	67	3	)	)	PUNCT
dpc-3650	67	4	the	the	DET
dpc-3650	67	5	patient	patient	NOUN
dpc-3650	67	6	should	should	AUX
dpc-3650	67	7	not	not	PART
dpc-3650	67	8	follow	follow	VERB
dpc-3650	67	9	systemic	systemic	ADJ
dpc-3650	67	10	treatment	treatment	NOUN
dpc-3650	67	11	for	for	ADP
dpc-3650	67	12	psoriasis	psoriasis	NOUN
dpc-3650	67	13	or	or	CCONJ
dpc-3650	67	14	depression	depression	NOUN
dpc-3650	67	15	at	at	ADP
dpc-3650	67	16	the	the	DET
dpc-3650	67	17	time	time	NOUN
dpc-3650	67	18	of	of	ADP
dpc-3650	67	19	joining	join	VERB
dpc-3650	67	20	the	the	DET
dpc-3650	67	21	study	study	NOUN
dpc-3650	67	22	.	.	PUNCT
dpc-3650	68	1	(	(	PUNCT
dpc-3650	68	2	d	d	X
dpc-3650	68	3	)	)	PUNCT
dpc-3650	68	4	if	if	SCONJ
dpc-3650	68	5	a	a	DET
dpc-3650	68	6	patient	patient	NOUN
dpc-3650	68	7	was	be	AUX
dpc-3650	68	8	taking	take	VERB
dpc-3650	68	9	systemic	systemic	ADJ
dpc-3650	68	10	treatment	treatment	NOUN
dpc-3650	68	11	for	for	ADP
dpc-3650	68	12	psoriasis	psoriasis	NOUN
dpc-3650	68	13	or	or	CCONJ
dpc-3650	68	14	for	for	ADP
dpc-3650	68	15	depression	depression	NOUN
dpc-3650	68	16	,	,	PUNCT
dpc-3650	68	17	the	the	DET
dpc-3650	68	18	period	period	NOUN
dpc-3650	68	19	stopped	stop	VERB
dpc-3650	68	20	for	for	ADP
dpc-3650	68	21	the	the	DET
dpc-3650	68	22	respective	respective	ADJ
dpc-3650	68	23	treatment	treatment	NOUN
dpc-3650	68	24	should	should	AUX
dpc-3650	68	25	not	not	PART
dpc-3650	68	26	be	be	AUX
dpc-3650	68	27	shorter	short	ADJ
dpc-3650	68	28	than	than	ADP
dpc-3650	68	29	the	the	DET
dpc-3650	68	30	period	period	NOUN
dpc-3650	68	31	calculated	calculate	VERB
dpc-3650	68	32	according	accord	VERB
dpc-3650	68	33	to	to	ADP
dpc-3650	68	34	the	the	DET
dpc-3650	68	35	formula	formula	NOUN
dpc-3650	68	36	:	:	PUNCT
dpc-3650	68	37	t1/2	t1/2	NOUN
dpc-3650	68	38	(	(	PUNCT
dpc-3650	68	39	half	half	ADJ
dpc-3650	68	40	-	-	PUNCT
dpc-3650	68	41	life	life	NOUN
dpc-3650	68	42	time	time	NOUN
dpc-3650	68	43	of	of	ADP
dpc-3650	68	44	the	the	DET
dpc-3650	68	45	drug	drug	NOUN
dpc-3650	68	46	he	he	PRON
dpc-3650	68	47	was	be	AUX
dpc-3650	68	48	taking	take	VERB
dpc-3650	68	49	x	x	PROPN
dpc-3650	68	50	5	5	NUM
dpc-3650	68	51	,	,	PUNCT
dpc-3650	68	52	according	accord	VERB
dpc-3650	68	53	to	to	ADP
dpc-3650	68	54	drugs	drugs	PROPN
dpc-3650	68	55	spc	spc	PROPN
dpc-3650	68	56	(	(	PUNCT
dpc-3650	68	57	summary	summary	NOUN
dpc-3650	68	58	of	of	ADP
dpc-3650	68	59	product	product	NOUN
dpc-3650	68	60	characteristics	characteristic	NOUN
dpc-3650	68	61	)	)	PUNCT
dpc-3650	69	1	[	[	X
dpc-3650	69	2	68	68	NUM
dpc-3650	69	3	]	]	PUNCT
dpc-3650	69	4	.	.	PUNCT
dpc-3650	70	1	(	(	PUNCT
dpc-3650	70	2	e	e	NOUN
dpc-3650	70	3	)	)	PUNCT
dpc-3650	70	4	initiation	initiation	NOUN
dpc-3650	70	5	after	after	ADP
dpc-3650	70	6	admission	admission	NOUN
dpc-3650	70	7	to	to	PART
dpc-3650	70	8	study	study	VERB
dpc-3650	70	9	systemic	systemic	ADJ
dpc-3650	70	10	therapy	therapy	NOUN
dpc-3650	70	11	for	for	ADP
dpc-3650	70	12	psoriasis	psoriasis	NOUN
dpc-3650	70	13	.	.	PUNCT
dpc-3650	71	1	(	(	PUNCT
dpc-3650	71	2	f	f	X
dpc-3650	71	3	)	)	PUNCT
dpc-3650	71	4	greek	greek	NOUN
dpc-3650	71	5	as	as	ADP
dpc-3650	71	6	a	a	DET
dpc-3650	71	7	native	native	ADJ
dpc-3650	71	8	language	language	NOUN
dpc-3650	71	9	.	.	PUNCT
dpc-3650	72	1	(	(	PUNCT
dpc-3650	72	2	g	g	NOUN
dpc-3650	72	3	)	)	PUNCT
dpc-3650	72	4	healthy	healthy	ADJ
dpc-3650	72	5	at	at	ADP
dpc-3650	72	6	the	the	DET
dpc-3650	72	7	time/	time/	NUM
dpc-3650	72	8	not	not	PART
dpc-3650	72	9	fever	fever	NOUN
dpc-3650	72	10	/	/	SYM
dpc-3650	72	11	not	not	PART
dpc-3650	72	12	infection	infection	NOUN
dpc-3650	72	13	.	.	PUNCT
dpc-3650	73	1	specific	specific	ADJ
dpc-3650	73	2	conditions	condition	NOUN
dpc-3650	73	3	that	that	PRON
dpc-3650	73	4	were	be	AUX
dpc-3650	73	5	considered	consider	VERB
dpc-3650	73	6	as	as	SCONJ
dpc-3650	73	7	exclusion	exclusion	NOUN
dpc-3650	73	8	criteria	criterion	NOUN
dpc-3650	73	9	were	be	AUX
dpc-3650	73	10	:	:	PUNCT
dpc-3650	73	11	(	(	PUNCT
dpc-3650	73	12	a	a	X
dpc-3650	73	13	)	)	PUNCT
dpc-3650	73	14	adults	adult	NOUN
dpc-3650	73	15	over	over	ADP
dpc-3650	73	16	65	65	NUM
dpc-3650	73	17	years	year	NOUN
dpc-3650	73	18	of	of	ADP
dpc-3650	73	19	age	age	NOUN
dpc-3650	73	20	.	.	PUNCT
dpc-3650	74	1	(	(	PUNCT
dpc-3650	74	2	b	b	X
dpc-3650	74	3	)	)	PUNCT
dpc-3650	74	4	under	under	ADP
dpc-3650	74	5	18	18	NUM
dpc-3650	74	6	years	year	NOUN
dpc-3650	74	7	of	of	ADP
dpc-3650	74	8	age	age	NOUN
dpc-3650	74	9	.	.	PUNCT
dpc-3650	75	1	(	(	PUNCT
dpc-3650	75	2	c	c	X
dpc-3650	75	3	)	)	PUNCT
dpc-3650	75	4	pregnancy	pregnancy	NOUN
dpc-3650	75	5	/	/	SYM
dpc-3650	75	6	breastfeeding	breastfeeding	NOUN
dpc-3650	75	7	.	.	PUNCT
dpc-3650	76	1	(	(	PUNCT
dpc-3650	76	2	d	d	X
dpc-3650	76	3	)	)	PUNCT
dpc-3650	76	4	mild	mild	ADJ
dpc-3650	76	5	psoriasis	psoriasis	NOUN
dpc-3650	76	6	:	:	PUNCT
dpc-3650	76	7	bsa	bsa	PROPN
dpc-3650	76	8	≤	≤	PROPN
dpc-3650	76	9	10	10	NUM
dpc-3650	76	10	,	,	PUNCT
dpc-3650	76	11	pasi	pasi	VERB
dpc-3650	76	12	≤	≤	NUM
dpc-3650	76	13	10	10	NUM
dpc-3650	76	14	and	and	CCONJ
dpc-3650	76	15	dlqi	dlqi	VERB
dpc-3650	76	16	≤	≤	NUM
dpc-3650	76	17	10	10	NUM
dpc-3650	77	1	[	[	X
dpc-3650	77	2	19	19	NUM
dpc-3650	77	3	]	]	PUNCT
dpc-3650	77	4	.	.	PUNCT
dpc-3650	78	1	(	(	PUNCT
dpc-3650	78	2	e	e	NOUN
dpc-3650	78	3	)	)	PUNCT
dpc-3650	78	4	diagnosed	diagnose	VERB
dpc-3650	78	5	psoriatic	psoriatic	ADJ
dpc-3650	78	6	arthritis	arthritis	NOUN
dpc-3650	78	7	.	.	PUNCT
dpc-3650	79	1	(	(	PUNCT
dpc-3650	79	2	f	f	X
dpc-3650	79	3	)	)	PUNCT
dpc-3650	79	4	coexistence	coexistence	NOUN
dpc-3650	79	5	of	of	ADP
dpc-3650	79	6	another	another	DET
dpc-3650	79	7	autoimmune	autoimmune	ADJ
dpc-3650	79	8	disease	disease	NOUN
dpc-3650	79	9	.	.	PUNCT
dpc-3650	80	1	(	(	PUNCT
dpc-3650	80	2	g	g	NOUN
dpc-3650	80	3	)	)	PUNCT
dpc-3650	80	4	immunosuppression	immunosuppression	NOUN
dpc-3650	80	5	.	.	PUNCT
dpc-3650	81	1	(	(	PUNCT
dpc-3650	81	2	h	h	NOUN
dpc-3650	81	3	)	)	PUNCT
dpc-3650	81	4	malignancy	malignancy	NOUN
dpc-3650	81	5	.	.	PUNCT
dpc-3650	82	1	(	(	PUNCT
dpc-3650	82	2	i	i	NOUN
dpc-3650	82	3	)	)	PUNCT
dpc-3650	82	4	puva	puva	PROPN
dpc-3650	82	5	.	.	PUNCT
dpc-3650	83	1	(	(	PUNCT
dpc-3650	83	2	j	j	NOUN
dpc-3650	83	3	)	)	PUNCT
dpc-3650	83	4	patients	patient	NOUN
dpc-3650	83	5	with	with	ADP
dpc-3650	83	6	erythrodermic	erythrodermic	ADJ
dpc-3650	83	7	psoriasis	psoriasis	NOUN
dpc-3650	83	8	.	.	PUNCT
dpc-3650	84	1	(	(	PUNCT
dpc-3650	84	2	k	k	X
dpc-3650	84	3	)	)	PUNCT
dpc-3650	84	4	patients	patient	NOUN
dpc-3650	84	5	with	with	ADP
dpc-3650	84	6	pustular	pustular	ADJ
dpc-3650	84	7	psoriasis	psoriasis	NOUN
dpc-3650	84	8	.	.	PUNCT
dpc-3650	85	1	(	(	PUNCT
dpc-3650	85	2	l	l	NOUN
dpc-3650	85	3	)	)	PUNCT
dpc-3650	85	4	patients	patient	NOUN
dpc-3650	85	5	with	with	ADP
dpc-3650	85	6	palmoplantar	palmoplantar	NOUN
dpc-3650	85	7	psoriasis	psoriasis	NOUN
dpc-3650	85	8	.	.	PUNCT
dpc-3650	86	1	(	(	PUNCT
dpc-3650	86	2	m	m	NOUN
dpc-3650	86	3	)	)	PUNCT
dpc-3650	86	4	patients	patient	NOUN
dpc-3650	86	5	receiving	receive	VERB
dpc-3650	86	6	systemic	systemic	ADJ
dpc-3650	86	7	treatment	treatment	NOUN
dpc-3650	86	8	for	for	ADP
dpc-3650	86	9	psoriasis	psoriasis	NOUN
dpc-3650	86	10	or	or	CCONJ
dpc-3650	86	11	depression	depression	NOUN
dpc-3650	86	12	over	over	ADP
dpc-3650	86	13	a	a	DET
dpc-3650	86	14	shorter	short	ADJ
dpc-3650	86	15	period	period	NOUN
dpc-3650	86	16	calculated	calculate	VERB
dpc-3650	86	17	according	accord	VERB
dpc-3650	86	18	to	to	ADP
dpc-3650	86	19	the	the	DET
dpc-3650	86	20	formula	formula	NOUN
dpc-3650	86	21	:	:	PUNCT
dpc-3650	86	22	t1/2	t1/2	NOUN
dpc-3650	86	23	(	(	PUNCT
dpc-3650	86	24	drug	drug	NOUN
dpc-3650	86	25	half	half	ADJ
dpc-3650	86	26	-	-	PUNCT
dpc-3650	86	27	life	life	NOUN
dpc-3650	86	28	)	)	PUNCT
dpc-3650	86	29	x	x	SYM
dpc-3650	86	30	5	5	NUM
dpc-3650	86	31	according	accord	VERB
dpc-3650	86	32	to	to	ADP
dpc-3650	86	33	drugs	drugs	PROPN
dpc-3650	86	34	spc	spc	PROPN
dpc-3650	86	35	(	(	PUNCT
dpc-3650	86	36	summary	summary	NOUN
dpc-3650	86	37	of	of	ADP
dpc-3650	86	38	product	product	NOUN
dpc-3650	86	39	characteristics	characteristic	NOUN
dpc-3650	86	40	)	)	PUNCT
dpc-3650	87	1	[	[	X
dpc-3650	87	2	68	68	NUM
dpc-3650	87	3	]	]	PUNCT
dpc-3650	87	4	.	.	PUNCT
dpc-3650	88	1	(	(	PUNCT
dpc-3650	88	2	n	n	CCONJ
dpc-3650	88	3	)	)	PUNCT
dpc-3650	88	4	psychiatric	psychiatric	ADJ
dpc-3650	88	5	disorders	disorder	NOUN
dpc-3650	88	6	other	other	ADJ
dpc-3650	88	7	than	than	ADP
dpc-3650	88	8	depression	depression	NOUN
dpc-3650	88	9	included	include	VERB
dpc-3650	88	10	substance	substance	NOUN
dpc-3650	88	11	dependence	dependence	NOUN
dpc-3650	88	12	disorder	disorder	NOUN
dpc-3650	88	13	.	.	PUNCT
dpc-3650	89	1	(	(	PUNCT
dpc-3650	89	2	o	o	NOUN
dpc-3650	89	3	)	)	PUNCT
dpc-3650	89	4	fever	fever	NOUN
dpc-3650	89	5	or	or	CCONJ
dpc-3650	89	6	any	any	DET
dpc-3650	89	7	type	type	NOUN
dpc-3650	89	8	of	of	ADP
dpc-3650	89	9	infection	infection	NOUN
dpc-3650	89	10	.	.	PUNCT
dpc-3650	90	1	(	(	PUNCT
dpc-3650	90	2	p	p	X
dpc-3650	90	3	)	)	PUNCT
dpc-3650	90	4	crohn	crohn	NOUN
dpc-3650	90	5	disease	disease	NOUN
dpc-3650	90	6	(	(	PUNCT
dpc-3650	90	7	q	q	NOUN
dpc-3650	90	8	)	)	PUNCT
dpc-3650	90	9	anemia	anemia	NOUN
dpc-3650	90	10	.	.	PUNCT
dpc-3650	91	1	time	time	NOUN
dpc-3650	91	2	points	point	NOUN
dpc-3650	91	3	selection	selection	NOUN
dpc-3650	91	4	a.	a.	NOUN
dpc-3650	91	5	for	for	ADP
dpc-3650	91	6	healthy	healthy	ADJ
dpc-3650	91	7	controls	control	NOUN
dpc-3650	91	8	(	(	PUNCT
dpc-3650	91	9	i	i	NOUN
dpc-3650	91	10	)	)	PUNCT
dpc-3650	91	11	day	day	NOUN
dpc-3650	91	12	0	0	NUM
dpc-3650	91	13	:	:	PUNCT
dpc-3650	91	14	taking	take	VERB
dpc-3650	91	15	informed	informed	ADJ
dpc-3650	91	16	consent	consent	NOUN
dpc-3650	91	17	and	and	CCONJ
dpc-3650	91	18	history	history	NOUN
dpc-3650	91	19	of	of	ADP
dpc-3650	91	20	the	the	DET
dpc-3650	91	21	patient	patient	NOUN
dpc-3650	91	22	,	,	PUNCT
dpc-3650	91	23	filling	fill	VERB
dpc-3650	91	24	out	out	ADP
dpc-3650	91	25	questionnaires	questionnaire	NOUN
dpc-3650	91	26	,	,	PUNCT
dpc-3650	91	27	and	and	CCONJ
dpc-3650	91	28	blood	blood	NOUN
dpc-3650	91	29	sampling	sample	VERB
dpc-3650	91	30	for	for	ADP
dpc-3650	91	31	the	the	DET
dpc-3650	91	32	measurement	measurement	NOUN
dpc-3650	91	33	of	of	ADP
dpc-3650	91	34	crp	crp	PROPN
dpc-3650	91	35	,	,	PUNCT
dpc-3650	91	36	esr	esr	PROPN
dpc-3650	91	37	.	.	PROPN
dpc-3650	91	38	b.	b.	PROPN
dpc-3650	92	1	for	for	ADP
dpc-3650	92	2	patients	patient	NOUN
dpc-3650	92	3	with	with	ADP
dpc-3650	92	4	psoriasis	psoriasis	NOUN
dpc-3650	92	5	and	and	CCONJ
dpc-3650	92	6	depression	depression	NOUN
dpc-3650	92	7	and	and	CCONJ
dpc-3650	92	8	patients	patient	NOUN
dpc-3650	92	9	with	with	ADP
dpc-3650	92	10	psoriasis	psoriasis	NOUN
dpc-3650	92	11	:	:	PUNCT
dpc-3650	92	12	(	(	PUNCT
dpc-3650	92	13	i	i	NOUN
dpc-3650	92	14	)	)	PUNCT
dpc-3650	92	15	day	day	NOUN
dpc-3650	92	16	0	0	NUM
dpc-3650	92	17	:	:	PUNCT
dpc-3650	92	18	taking	take	VERB
dpc-3650	92	19	informed	informed	ADJ
dpc-3650	92	20	consents	consent	NOUN
dpc-3650	92	21	and	and	CCONJ
dpc-3650	92	22	history	history	NOUN
dpc-3650	92	23	of	of	ADP
dpc-3650	92	24	the	the	DET
dpc-3650	92	25	patient	patient	NOUN
dpc-3650	92	26	,	,	PUNCT
dpc-3650	92	27	filling	fill	VERB
dpc-3650	92	28	out	out	ADP
dpc-3650	92	29	questionnaires	questionnaire	NOUN
dpc-3650	92	30	,	,	PUNCT
dpc-3650	92	31	blood	blood	NOUN
dpc-3650	92	32	sampling	sample	VERB
dpc-3650	92	33	for	for	ADP
dpc-3650	92	34	the	the	DET
dpc-3650	92	35	measurement	measurement	NOUN
dpc-3650	92	36	of	of	ADP
dpc-3650	92	37	crp	crp	PROPN
dpc-3650	92	38	and	and	CCONJ
dpc-3650	92	39	esr	esr	PROPN
dpc-3650	92	40	,	,	PUNCT
dpc-3650	92	41	initiation	initiation	NOUN
dpc-3650	92	42	of	of	ADP
dpc-3650	92	43	systemic	systemic	ADJ
dpc-3650	92	44	treatment	treatment	NOUN
dpc-3650	92	45	for	for	ADP
dpc-3650	92	46	psoriasis	psoriasis	NOUN
dpc-3650	92	47	(	(	PUNCT
dpc-3650	92	48	ii	ii	NOUN
dpc-3650	92	49	)	)	PUNCT
dpc-3650	92	50	3	3	NUM
dpc-3650	92	51	months	month	NOUN
dpc-3650	92	52	later	later	ADV
dpc-3650	92	53	since	since	SCONJ
dpc-3650	92	54	day	day	NOUN
dpc-3650	92	55	0	0	PUNCT
dpc-3650	92	56	and	and	CCONJ
dpc-3650	92	57	if	if	SCONJ
dpc-3650	92	58	the	the	DET
dpc-3650	92	59	same	same	ADJ
dpc-3650	92	60	systemic	systemic	ADJ
dpc-3650	92	61	treatment	treatment	NOUN
dpc-3650	92	62	for	for	ADP
dpc-3650	92	63	psoriasis	psoriasis	NOUN
dpc-3650	92	64	continues	continue	VERB
dpc-3650	92	65	:	:	PUNCT
dpc-3650	92	66	history	history	NOUN
dpc-3650	92	67	taking	taking	NOUN
dpc-3650	92	68	,	,	PUNCT
dpc-3650	92	69	filling	fill	VERB
dpc-3650	92	70	out	out	ADP
dpc-3650	92	71	questionnaires	questionnaire	NOUN
dpc-3650	92	72	,	,	PUNCT
dpc-3650	92	73	blood	blood	NOUN
dpc-3650	92	74	sampling	sample	VERB
dpc-3650	92	75	for	for	ADP
dpc-3650	92	76	the	the	DET
dpc-3650	92	77	measurement	measurement	NOUN
dpc-3650	92	78	of	of	ADP
dpc-3650	92	79	crp	crp	PROPN
dpc-3650	92	80	and	and	CCONJ
dpc-3650	92	81	esr	esr	PROPN
dpc-3650	92	82	.	.	PUNCT
dpc-3650	92	83	psoriasis	psoriasis	NOUN
dpc-3650	92	84	assessment	assessment	NOUN
dpc-3650	92	85	tools	tool	NOUN
dpc-3650	92	86	/	/	SYM
dpc-3650	92	87	methods	method	NOUN
dpc-3650	92	88	psoriasis	psoriasis	NOUN
dpc-3650	92	89	area	area	NOUN
dpc-3650	92	90	severity	severity	NOUN
dpc-3650	92	91	index	index	NOUN
dpc-3650	92	92	(	(	PUNCT
dpc-3650	92	93	pasi)[29,30	pasi)[29,30	NOUN
dpc-3650	92	94	]	]	PUNCT
dpc-3650	92	95	physician	physician	NOUN
dpc-3650	92	96	global	global	ADJ
dpc-3650	92	97	assessment	assessment	NOUN
dpc-3650	92	98	(	(	PUNCT
dpc-3650	92	99	pga	pga	PROPN
dpc-3650	92	100	):	):	PUNCT
dpc-3650	92	101	pga	pga	NOUN
dpc-3650	92	102	score	score	NOUN
dpc-3650	92	103	is	be	AUX
dpc-3650	92	104	a	a	DET
dpc-3650	92	105	physician	physician	NOUN
dpc-3650	92	106	-	-	PUNCT
dpc-3650	92	107	reported	report	VERB
dpc-3650	92	108	measure	measure	NOUN
dpc-3650	92	109	of	of	ADP
dpc-3650	92	110	psoriasis	psoriasis	NOUN
dpc-3650	92	111	severity	severity	NOUN
dpc-3650	92	112	,	,	PUNCT
dpc-3650	92	113	using	use	VERB
dpc-3650	92	114	a	a	DET
dpc-3650	92	115	6	6	NUM
dpc-3650	92	116	-	-	PUNCT
dpc-3650	92	117	point	point	NOUN
dpc-3650	92	118	measure	measure	NOUN
dpc-3650	92	119	.	.	PUNCT
dpc-3650	93	1	lower	low	ADJ
dpc-3650	93	2	pga	pga	PROPN
dpc-3650	93	3	scores	score	NOUN
dpc-3650	93	4	indicate	indicate	VERB
dpc-3650	93	5	a	a	DET
dpc-3650	93	6	better	well	ADJ
dpc-3650	93	7	skin	skin	NOUN
dpc-3650	93	8	condition	condition	NOUN
dpc-3650	93	9	[	[	X
dpc-3650	93	10	31,32	31,32	NUM
dpc-3650	93	11	]	]	X
dpc-3650	93	12	.	.	PUNCT
dpc-3650	94	1	body	body	NOUN
dpc-3650	94	2	surface	surface	NOUN
dpc-3650	94	3	area	area	NOUN
dpc-3650	94	4	(	(	PUNCT
dpc-3650	94	5	bsa	bsa	PROPN
dpc-3650	94	6	):	):	PUNCT
dpc-3650	94	7	the	the	DET
dpc-3650	94	8	palming	palming	NOUN
dpc-3650	94	9	method	method	NOUN
dpc-3650	94	10	is	be	AUX
dpc-3650	94	11	used	use	VERB
dpc-3650	94	12	for	for	ADP
dpc-3650	94	13	the	the	DET
dpc-3650	94	14	calculation	calculation	NOUN
dpc-3650	94	15	,	,	PUNCT
dpc-3650	94	16	considering	consider	VERB
dpc-3650	94	17	that	that	SCONJ
dpc-3650	94	18	one	one	NUM
dpc-3650	94	19	palm	palm	NOUN
dpc-3650	94	20	of	of	ADP
dpc-3650	94	21	the	the	DET
dpc-3650	94	22	hand	hand	NOUN
dpc-3650	94	23	is	be	AUX
dpc-3650	94	24	about	about	ADV
dpc-3650	94	25	1	1	NUM
dpc-3650	94	26	%	%	NOUN
dpc-3650	94	27	of	of	ADP
dpc-3650	94	28	the	the	DET
dpc-3650	94	29	body	body	NOUN
dpc-3650	94	30	surface	surface	NOUN
dpc-3650	95	1	[	[	X
dpc-3650	95	2	33,34	33,34	NOUN
dpc-3650	95	3	]	]	SYM
dpc-3650	95	4	.	.	PUNCT
dpc-3650	96	1	dermatology	dermatology	NOUN
dpc-3650	96	2	life	life	NOUN
dpc-3650	96	3	quality	quality	NOUN
dpc-3650	96	4	index	index	NOUN
dpc-3650	96	5	(	(	PUNCT
dpc-3650	96	6	dlqi	dlqi	VERB
dpc-3650	96	7	):	):	PUNCT
dpc-3650	96	8	all	all	DET
dpc-3650	96	9	questions	question	NOUN
dpc-3650	96	10	refer	refer	VERB
dpc-3650	96	11	to	to	ADP
dpc-3650	96	12	the	the	DET
dpc-3650	96	13	last	last	ADJ
dpc-3650	96	14	week	week	NOUN
dpc-3650	96	15	before	before	ADP
dpc-3650	96	16	the	the	DET
dpc-3650	96	17	exam	exam	NOUN
dpc-3650	96	18	.	.	PUNCT
dpc-3650	97	1	higher	high	ADJ
dpc-3650	97	2	dlqi	dlqi	PROPN
dpc-3650	97	3	scores	score	NOUN
dpc-3650	97	4	indicate	indicate	VERB
dpc-3650	97	5	lower	low	ADJ
dpc-3650	97	6	quality	quality	NOUN
dpc-3650	97	7	of	of	ADP
dpc-3650	97	8	life	life	NOUN
dpc-3650	97	9	[	[	X
dpc-3650	97	10	35	35	NUM
dpc-3650	97	11	]	]	PUNCT
dpc-3650	97	12	.	.	PUNCT
dpc-3650	98	1	beck	beck	PROPN
dpc-3650	98	2	depression	depression	PROPN
dpc-3650	98	3	inventory	inventory	PROPN
dpc-3650	98	4	-	-	PUNCT
dpc-3650	98	5	ii	ii	PROPN
dpc-3650	98	6	(	(	PUNCT
dpc-3650	98	7	bdi	bdi	PROPN
dpc-3650	98	8	-	-	PUNCT
dpc-3650	98	9	ii	ii	PROPN
dpc-3650	98	10	):	):	PUNCT
dpc-3650	98	11	a	a	DET
dpc-3650	98	12	21	21	NUM
dpc-3650	98	13	-	-	PUNCT
dpc-3650	98	14	item	item	NOUN
dpc-3650	98	15	self	self	NOUN
dpc-3650	98	16	report	report	NOUN
dpc-3650	98	17	instrument	instrument	NOUN
dpc-3650	98	18	,	,	PUNCT
dpc-3650	98	19	measuring	measure	VERB
dpc-3650	98	20	different	different	ADJ
dpc-3650	98	21	aspects	aspect	NOUN
dpc-3650	98	22	of	of	ADP
dpc-3650	98	23	depression	depression	NOUN
dpc-3650	98	24	on	on	ADP
dpc-3650	98	25	a	a	DET
dpc-3650	98	26	4	4	NUM
dpc-3650	98	27	-	-	PUNCT
dpc-3650	98	28	point	point	NOUN
dpc-3650	98	29	severity	severity	NOUN
dpc-3650	98	30	scale	scale	NOUN
dpc-3650	98	31	during	during	ADP
dpc-3650	98	32	the	the	DET
dpc-3650	98	33	last	last	ADJ
dpc-3650	98	34	two	two	NUM
dpc-3650	98	35	weeks	week	NOUN
dpc-3650	99	1	[	[	X
dpc-3650	99	2	36,37	36,37	X
dpc-3650	99	3	]	]	PUNCT
dpc-3650	99	4	.	.	PUNCT
dpc-3650	100	1	body	body	NOUN
dpc-3650	100	2	mass	mass	PROPN
dpc-3650	100	3	index	index	NOUN
dpc-3650	100	4	(	(	PUNCT
dpc-3650	100	5	bmi	bmi	PROPN
dpc-3650	100	6	):	):	PUNCT
dpc-3650	100	7	it	it	PRON
dpc-3650	100	8	is	be	AUX
dpc-3650	100	9	calculated	calculate	VERB
dpc-3650	100	10	based	base	VERB
dpc-3650	100	11	on	on	ADP
dpc-3650	100	12	the	the	DET
dpc-3650	100	13	formula	formula	NOUN
dpc-3650	100	14	:	:	PUNCT
dpc-3650	100	15	bmi	bmi	PROPN
dpc-3650	100	16	=	=	PUNCT
dpc-3650	100	17	weight(kg)/heigh)2	weight(kg)/heigh)2	NOUN
dpc-3650	100	18	(	(	PUNCT
dpc-3650	100	19	m2	m2	PROPN
dpc-3650	100	20	)	)	PUNCT
dpc-3650	100	21	and	and	CCONJ
dpc-3650	100	22	determines	determine	VERB
dpc-3650	100	23	the	the	DET
dpc-3650	100	24	ideal	ideal	ADJ
dpc-3650	100	25	weight	weight	NOUN
dpc-3650	100	26	of	of	ADP
dpc-3650	100	27	each	each	DET
dpc-3650	100	28	person	person	NOUN
dpc-3650	100	29	based	base	VERB
dpc-3650	100	30	on	on	ADP
dpc-3650	100	31	height	height	NOUN
dpc-3650	100	32	and	and	CCONJ
dpc-3650	100	33	kilograms	kilogram	NOUN
dpc-3650	100	34	.	.	PUNCT
dpc-3650	101	1	recent	recent	ADJ
dpc-3650	101	2	data	datum	NOUN
dpc-3650	101	3	lead	lead	VERB
dpc-3650	101	4	to	to	ADP
dpc-3650	101	5	the	the	DET
dpc-3650	101	6	conclusion	conclusion	NOUN
dpc-3650	101	7	that	that	SCONJ
dpc-3650	101	8	obesity	obesity	NOUN
dpc-3650	101	9	is	be	AUX
dpc-3650	101	10	not	not	PART
dpc-3650	101	11	just	just	ADV
dpc-3650	101	12	epidemiologically	epidemiologically	ADV
dpc-3650	101	13	related	relate	VERB
dpc-3650	101	14	as	as	ADP
dpc-3650	101	15	a	a	DET
dpc-3650	101	16	comorbidity	comorbidity	NOUN
dpc-3650	101	17	with	with	ADP
dpc-3650	101	18	psoriasis	psoriasis	NOUN
dpc-3650	101	19	but	but	CCONJ
dpc-3650	101	20	is	be	AUX
dpc-3650	101	21	a	a	DET
dpc-3650	101	22	causative	causative	ADJ
dpc-3650	101	23	risk	risk	NOUN
dpc-3650	101	24	factor	factor	NOUN
dpc-3650	101	25	for	for	ADP
dpc-3650	101	26	the	the	DET
dpc-3650	101	27	onset	onset	NOUN
dpc-3650	101	28	or	or	CCONJ
dpc-3650	101	29	worsening	worsen	VERB
dpc-3650	101	30	of	of	ADP
dpc-3650	101	31	psoriasis	psoriasis	NOUN
dpc-3650	101	32	.	.	PUNCT
dpc-3650	102	1	obesity	obesity	NOUN
dpc-3650	102	2	is	be	AUX
dpc-3650	102	3	therefore	therefore	ADV
dpc-3650	102	4	related	relate	VERB
dpc-3650	102	5	to	to	ADP
dpc-3650	102	6	psoriasis	psoriasis	NOUN
dpc-3650	102	7	with	with	ADP
dpc-3650	102	8	common	common	ADJ
dpc-3650	102	9	inflammatory	inflammatory	ADJ
dpc-3650	102	10	factors	factor	NOUN
dpc-3650	102	11	while	while	SCONJ
dpc-3650	102	12	it	it	PRON
dpc-3650	102	13	is	be	AUX
dpc-3650	102	14	mainly	mainly	ADV
dpc-3650	102	15	characterized	characterize	VERB
dpc-3650	102	16	by	by	ADP
dpc-3650	102	17	increased	increase	VERB
dpc-3650	102	18	leptin	leptin	NOUN
dpc-3650	102	19	,	,	PUNCT
dpc-3650	102	20	resistin	resistin	NOUN
dpc-3650	102	21	,	,	PUNCT
dpc-3650	102	22	and	and	CCONJ
dpc-3650	102	23	chemerin	chemerin	NOUN
dpc-3650	102	24	but	but	CCONJ
dpc-3650	102	25	also	also	ADV
dpc-3650	102	26	decreased	decrease	VERB
dpc-3650	102	27	adiponectin	adiponectin	NOUN
dpc-3650	102	28	(	(	PUNCT
dpc-3650	102	29	adipocytokines	adipocytokine	NOUN
dpc-3650	102	30	)	)	PUNCT
dpc-3650	103	1	[	[	X
dpc-3650	103	2	38,39	38,39	NOUN
dpc-3650	103	3	]	]	X
dpc-3650	103	4	.	.	PUNCT
dpc-3650	103	5	athens	athens	PROPN
dpc-3650	103	6	insomnia	insomnia	PROPN
dpc-3650	103	7	scale	scale	NOUN
dpc-3650	103	8	(	(	PUNCT
dpc-3650	103	9	ais	ais	PROPN
dpc-3650	103	10	):	):	PUNCT
dpc-3650	103	11	the	the	DET
dpc-3650	103	12	athens	athens	PROPN
dpc-3650	103	13	insomnia	insomnia	PROPN
dpc-3650	103	14	scale	scale	NOUN
dpc-3650	103	15	is	be	AUX
dpc-3650	103	16	an	an	DET
dpc-3650	103	17	effective	effective	ADJ
dpc-3650	103	18	and	and	CCONJ
dpc-3650	103	19	easy	easy	ADJ
dpc-3650	103	20	sleep	sleep	NOUN
dpc-3650	103	21	analysis	analysis	NOUN
dpc-3650	103	22	tool	tool	NOUN
dpc-3650	103	23	.	.	PUNCT
dpc-3650	104	1	there	there	PRON
dpc-3650	104	2	are	be	VERB
dpc-3650	104	3	studies	study	NOUN
dpc-3650	104	4	that	that	PRON
dpc-3650	104	5	report	report	VERB
dpc-3650	104	6	that	that	SCONJ
dpc-3650	104	7	inflammation	inflammation	ADJ
dpc-3650	104	8	markers	marker	NOUN
dpc-3650	104	9	are	be	AUX
dpc-3650	104	10	affected	affect	VERB
dpc-3650	104	11	by	by	ADP
dpc-3650	104	12	sleep	sleep	NOUN
dpc-3650	104	13	quality	quality	NOUN
dpc-3650	105	1	[	[	X
dpc-3650	105	2	40,41,42,7	40,41,42,7	PROPN
dpc-3650	105	3	,	,	PUNCT
dpc-3650	105	4	]	]	PUNCT
dpc-3650	105	5	.	.	PUNCT
dpc-3650	106	1	beck	beck	PROPN
dpc-3650	106	2	anxiety	anxiety	PROPN
dpc-3650	106	3	inventory	inventory	PROPN
dpc-3650	106	4	(	(	PUNCT
dpc-3650	106	5	bai	bai	PROPN
dpc-3650	106	6	):	):	PUNCT
dpc-3650	106	7	it	it	PRON
dpc-3650	106	8	is	be	AUX
dpc-3650	106	9	a	a	DET
dpc-3650	106	10	self	self	NOUN
dpc-3650	106	11	-	-	PUNCT
dpc-3650	106	12	report	report	NOUN
dpc-3650	106	13	assessment	assessment	NOUN
dpc-3650	106	14	for	for	ADP
dpc-3650	106	15	measuring	measure	VERB
dpc-3650	106	16	various	various	ADJ
dpc-3650	106	17	stress	stress	NOUN
dpc-3650	106	18	symptoms	symptom	NOUN
dpc-3650	106	19	by	by	ADP
dpc-3650	106	20	patients	patient	NOUN
dpc-3650	106	21	during	during	ADP
dpc-3650	106	22	the	the	DET
dpc-3650	106	23	last	last	ADJ
dpc-3650	106	24	week	week	NOUN
dpc-3650	106	25	since	since	SCONJ
dpc-3650	106	26	completing	complete	VERB
dpc-3650	106	27	the	the	DET
dpc-3650	106	28	questionnaire	questionnaire	NOUN
dpc-3650	106	29	(	(	PUNCT
dpc-3650	106	30	ie	ie	X
dpc-3650	106	31	,	,	PUNCT
dpc-3650	106	32	day	day	NOUN
dpc-3650	106	33	0	0	NUM
dpc-3650	106	34	)	)	PUNCT
dpc-3650	106	35	.	.	PUNCT
dpc-3650	107	1	if	if	SCONJ
dpc-3650	107	2	the	the	DET
dpc-3650	107	3	symptoms	symptom	NOUN
dpc-3650	107	4	persist	persist	VERB
dpc-3650	107	5	,	,	PUNCT
dpc-3650	107	6	the	the	DET
dpc-3650	107	7	help	help	NOUN
dpc-3650	107	8	of	of	ADP
dpc-3650	107	9	a	a	DET
dpc-3650	107	10	mental	mental	ADJ
dpc-3650	107	11	health	health	NOUN
dpc-3650	107	12	specialist	specialist	NOUN
dpc-3650	107	13	may	may	AUX
dpc-3650	107	14	be	be	AUX
dpc-3650	107	15	needed	need	VERB
dpc-3650	107	16	[	[	X
dpc-3650	107	17	43	43	NUM
dpc-3650	107	18	]	]	PUNCT
dpc-3650	107	19	.	.	PUNCT
dpc-3650	108	1	inflammation	inflammation	NOUN
dpc-3650	108	2	markers	marker	NOUN
dpc-3650	108	3	crp	crp	PROPN
dpc-3650	108	4	crp	crp	PROPN
dpc-3650	108	5	belongs	belong	VERB
dpc-3650	108	6	to	to	ADP
dpc-3650	108	7	the	the	DET
dpc-3650	108	8	acute	acute	ADJ
dpc-3650	108	9	phase	phase	NOUN
dpc-3650	108	10	proteins	protein	NOUN
dpc-3650	108	11	and	and	CCONJ
dpc-3650	108	12	its	its	PRON
dpc-3650	108	13	levels	level	NOUN
dpc-3650	108	14	increase	increase	VERB
dpc-3650	108	15	in	in	ADP
dpc-3650	108	16	the	the	DET
dpc-3650	108	17	serum	serum	NOUN
dpc-3650	108	18	immediately	immediately	ADV
dpc-3650	108	19	after	after	ADP
dpc-3650	108	20	the	the	DET
dpc-3650	108	21	onset	onset	NOUN
dpc-3650	108	22	of	of	ADP
dpc-3650	108	23	the	the	DET
dpc-3650	108	24	inflammatory	inflammatory	ADJ
dpc-3650	108	25	reaction	reaction	NOUN
dpc-3650	108	26	.	.	PUNCT
dpc-3650	109	1	it	it	PRON
dpc-3650	109	2	is	be	AUX
dpc-3650	109	3	produced	produce	VERB
dpc-3650	109	4	exclusively	exclusively	ADV
dpc-3650	109	5	in	in	ADP
dpc-3650	109	6	the	the	DET
dpc-3650	109	7	liver	liver	NOUN
dpc-3650	109	8	and	and	CCONJ
dpc-3650	109	9	exhibits	exhibit	VERB
dpc-3650	109	10	both	both	DET
dpc-3650	109	11	pro	pro	ADJ
dpc-3650	109	12	-	-	ADJ
dpc-3650	109	13	inflammatory	inflammatory	ADJ
dpc-3650	109	14	and	and	CCONJ
dpc-3650	109	15	anti	anti	ADJ
dpc-3650	109	16	-	-	ADJ
dpc-3650	109	17	inflammatory	inflammatory	ADJ
dpc-3650	109	18	properties	property	NOUN
dpc-3650	109	19	and	and	CCONJ
dpc-3650	109	20	plays	play	VERB
dpc-3650	109	21	a	a	DET
dpc-3650	109	22	role	role	NOUN
dpc-3650	109	23	in	in	ADP
dpc-3650	109	24	the	the	DET
dpc-3650	109	25	non	non	ADJ
dpc-3650	109	26	-	-	ADJ
dpc-3650	109	27	specific	specific	ADJ
dpc-3650	109	28	response	response	NOUN
dpc-3650	109	29	4	4	NUM
dpc-3650	109	30	original	original	ADJ
dpc-3650	109	31	article	article	NOUN
dpc-3650	109	32	|	|	ADV
dpc-3650	109	33	dermatol	dermatol	ADJ
dpc-3650	109	34	pract	pract	NOUN
dpc-3650	109	35	concept	concept	NOUN
dpc-3650	109	36	.	.	PUNCT
dpc-3650	110	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	110	2	gender	gender	NOUN
dpc-3650	110	3	,	,	PUNCT
dpc-3650	110	4	and	and	CCONJ
dpc-3650	110	5	treatment	treatment	NOUN
dpc-3650	110	6	.	.	PUNCT
dpc-3650	110	7	  	  	SPACE
dpc-3650	110	8	statistical	statistical	ADJ
dpc-3650	110	9	significance	significance	NOUN
dpc-3650	110	10	was	be	AUX
dpc-3650	110	11	set	set	VERB
dpc-3650	110	12	at	at	ADP
dpc-3650	110	13	0.05	0.05	NUM
dpc-3650	110	14	and	and	CCONJ
dpc-3650	110	15	the	the	DET
dpc-3650	110	16	analysis	analysis	NOUN
dpc-3650	110	17	was	be	AUX
dpc-3650	110	18	carried	carry	VERB
dpc-3650	110	19	out	out	ADP
dpc-3650	110	20	using	use	VERB
dpc-3650	110	21	statistica	statistica	NOUN
dpc-3650	110	22	v	v	ADP
dpc-3650	110	23	12.0	12.0	NUM
dpc-3650	110	24	.	.	PUNCT
dpc-3650	111	1	results	result	VERB
dpc-3650	111	2	characteristics	characteristic	NOUN
dpc-3650	111	3	of	of	ADP
dpc-3650	111	4	participants	participant	NOUN
dpc-3650	111	5	their	their	PRON
dpc-3650	111	6	baseline	baseline	PROPN
dpc-3650	111	7	characteristics	characteristic	NOUN
dpc-3650	111	8	appear	appear	VERB
dpc-3650	111	9	in	in	ADP
dpc-3650	111	10	table	table	NOUN
dpc-3650	111	11	1	1	NUM
dpc-3650	111	12	and	and	CCONJ
dpc-3650	111	13	other	other	ADJ
dpc-3650	111	14	epidemiological	epidemiological	ADJ
dpc-3650	111	15	characteristics	characteristic	NOUN
dpc-3650	111	16	in	in	ADP
dpc-3650	111	17	table	table	NOUN
dpc-3650	111	18	1	1	NUM
dpc-3650	111	19	below	below	ADV
dpc-3650	111	20	.	.	PUNCT
dpc-3650	112	1	other	other	ADJ
dpc-3650	112	2	clinical	clinical	ADJ
dpc-3650	112	3	characteristics	characteristic	NOUN
dpc-3650	112	4	of	of	ADP
dpc-3650	112	5	individuals	individual	NOUN
dpc-3650	112	6	enrolled	enrol	VERB
dpc-3650	112	7	in	in	ADP
dpc-3650	112	8	the	the	DET
dpc-3650	112	9	study	study	NOUN
dpc-3650	112	10	appears	appear	VERB
dpc-3650	112	11	in	in	ADP
dpc-3650	112	12	table	table	NOUN
dpc-3650	112	13	2	2	NUM
dpc-3650	112	14	based	base	VERB
dpc-3650	112	15	on	on	ADP
dpc-3650	112	16	a	a	DET
dpc-3650	112	17	semi	semi	ADJ
dpc-3650	112	18	-	-	ADJ
dpc-3650	112	19	structured	structured	ADJ
dpc-3650	112	20	interview	interview	NOUN
dpc-3650	112	21	and	and	CCONJ
dpc-3650	112	22	patients	patient	NOUN
dpc-3650	112	23	’	'	PUNCT
dpc-3650	112	24	medical	medical	ADJ
dpc-3650	112	25	records	record	NOUN
dpc-3650	112	26	.	.	PUNCT
dpc-3650	113	1	the	the	DET
dpc-3650	113	2	study	study	NOUN
dpc-3650	113	3	examines	examine	VERB
dpc-3650	113	4	the	the	DET
dpc-3650	113	5	difference	difference	NOUN
dpc-3650	113	6	observed	observe	VERB
dpc-3650	113	7	in	in	ADP
dpc-3650	113	8	crp	crp	PROPN
dpc-3650	113	9	and	and	CCONJ
dpc-3650	113	10	esr	esr	PROPN
dpc-3650	113	11	values	value	NOUN
dpc-3650	113	12	among	among	ADP
dpc-3650	113	13	the	the	DET
dpc-3650	113	14	three	three	NUM
dpc-3650	113	15	groups	group	NOUN
dpc-3650	113	16	at	at	ADP
dpc-3650	113	17	baseline	baseline	NOUN
dpc-3650	113	18	,	,	PUNCT
dpc-3650	113	19	as	as	ADV
dpc-3650	113	20	well	well	ADV
dpc-3650	113	21	as	as	ADP
dpc-3650	113	22	the	the	DET
dpc-3650	113	23	changes	change	NOUN
dpc-3650	113	24	observed	observe	VERB
dpc-3650	113	25	within	within	ADP
dpc-3650	113	26	a	a	DET
dpc-3650	113	27	period	period	NOUN
dpc-3650	113	28	of	of	ADP
dpc-3650	113	29	three	three	NUM
dpc-3650	113	30	months	month	NOUN
dpc-3650	113	31	in	in	ADP
dpc-3650	113	32	the	the	DET
dpc-3650	113	33	two	two	NUM
dpc-3650	113	34	groups	group	NOUN
dpc-3650	113	35	.	.	PUNCT
dpc-3650	114	1	(	(	PUNCT
dpc-3650	114	2	psoriasis	psoriasis	NOUN
dpc-3650	114	3	,	,	PUNCT
dpc-3650	114	4	psoriasis	psoriasis	NOUN
dpc-3650	114	5	and	and	CCONJ
dpc-3650	114	6	depression	depression	NOUN
dpc-3650	114	7	)	)	PUNCT
dpc-3650	114	8	.	.	PUNCT
dpc-3650	115	1	regarding	regard	VERB
dpc-3650	115	2	differences	difference	NOUN
dpc-3650	115	3	at	at	ADP
dpc-3650	115	4	baseline	baseline	NOUN
dpc-3650	115	5	and	and	CCONJ
dpc-3650	115	6	 	 	SPACE
dpc-3650	115	7	esr	esr	NOUN
dpc-3650	115	8	,	,	PUNCT
dpc-3650	115	9	statistically	statistically	ADV
dpc-3650	115	10	significant	significant	ADJ
dpc-3650	115	11	differences	difference	NOUN
dpc-3650	115	12	were	be	AUX
dpc-3650	115	13	observed	observe	VERB
dpc-3650	115	14	between	between	ADP
dpc-3650	115	15	groups	group	NOUN
dpc-3650	115	16	(	(	PUNCT
dpc-3650	115	17	f2,76=	f2,76=	ADP
dpc-3650	115	18	6.312	6.312	NUM
dpc-3650	115	19	p	p	NOUN
dpc-3650	115	20	=	=	NOUN
dpc-3650	115	21	0.03	0.03	NUM
dpc-3650	115	22	)	)	PUNCT
dpc-3650	115	23	,	,	PUNCT
dpc-3650	115	24	after	after	ADP
dpc-3650	115	25	adjusting	adjust	VERB
dpc-3650	115	26	for	for	ADP
dpc-3650	115	27	baseline	baseline	ADJ
dpc-3650	115	28	bmi	bmi	NOUN
dpc-3650	115	29	values	value	NOUN
dpc-3650	115	30	.	.	PUNCT
dpc-3650	116	1	specifically	specifically	ADV
dpc-3650	116	2	,	,	PUNCT
dpc-3650	116	3	patients	patient	NOUN
dpc-3650	116	4	suffering	suffer	VERB
dpc-3650	116	5	from	from	ADP
dpc-3650	116	6	psoriasis	psoriasis	NOUN
dpc-3650	116	7	and	and	CCONJ
dpc-3650	116	8	depression	depression	NOUN
dpc-3650	116	9	showed	show	VERB
dpc-3650	116	10	higher	high	ADJ
dpc-3650	116	11	levels	level	NOUN
dpc-3650	116	12	of	of	ADP
dpc-3650	116	13	esr	esr	PROPN
dpc-3650	116	14	than	than	ADP
dpc-3650	116	15	patients	patient	NOUN
dpc-3650	116	16	diagnosed	diagnose	VERB
dpc-3650	116	17	with	with	ADP
dpc-3650	116	18	psoriasis	psoriasis	NOUN
dpc-3650	116	19	but	but	CCONJ
dpc-3650	116	20	no	no	DET
dpc-3650	116	21	depression	depression	NOUN
dpc-3650	116	22	(	(	PUNCT
dpc-3650	116	23	p	p	X
dpc-3650	116	24	=	=	NOUN
dpc-3650	116	25	0.032	0.032	NUM
dpc-3650	116	26	)	)	PUNCT
dpc-3650	116	27	.	.	PUNCT
dpc-3650	117	1	the	the	DET
dpc-3650	117	2	difference	difference	NOUN
dpc-3650	117	3	between	between	ADP
dpc-3650	117	4	patients	patient	NOUN
dpc-3650	117	5	suffering	suffer	VERB
dpc-3650	117	6	psoriasis	psoriasis	NOUN
dpc-3650	117	7	and	and	CCONJ
dpc-3650	117	8	depression	depression	NOUN
dpc-3650	117	9	vs	vs	ADP
dpc-3650	117	10	controls	control	NOUN
dpc-3650	117	11	was	be	AUX
dpc-3650	117	12	also	also	ADV
dpc-3650	117	13	statistically	statistically	ADV
dpc-3650	117	14	significant	significant	ADJ
dpc-3650	117	15	as	as	SCONJ
dpc-3650	117	16	the	the	DET
dpc-3650	117	17	adjusted	adjust	VERB
dpc-3650	117	18	p	p	NOUN
dpc-3650	117	19	value	value	NOUN
dpc-3650	117	20	for	for	ADP
dpc-3650	117	21	multiple	multiple	ADJ
dpc-3650	117	22	comparisons	comparison	NOUN
dpc-3650	117	23	was	be	AUX
dpc-3650	117	24	found	find	VERB
dpc-3650	117	25	to	to	PART
dpc-3650	117	26	be	be	AUX
dpc-3650	117	27	0.022	0.022	NUM
dpc-3650	117	28	.	.	PUNCT
dpc-3650	118	1	no	no	DET
dpc-3650	118	2	differences	difference	NOUN
dpc-3650	118	3	were	be	AUX
dpc-3650	118	4	observed	observe	VERB
dpc-3650	118	5	between	between	ADP
dpc-3650	118	6	patients	patient	NOUN
dpc-3650	118	7	with	with	ADP
dpc-3650	118	8	psoriasis	psoriasis	NOUN
dpc-3650	118	9	and	and	CCONJ
dpc-3650	118	10	controls	control	NOUN
dpc-3650	118	11	(	(	PUNCT
dpc-3650	118	12	p	p	X
dpc-3650	118	13	=	=	NOUN
dpc-3650	118	14	1.000	1.000	NUM
dpc-3650	118	15	)	)	PUNCT
dpc-3650	118	16	.	.	PUNCT
dpc-3650	119	1	the	the	DET
dpc-3650	119	2	distribution	distribution	NOUN
dpc-3650	119	3	of	of	ADP
dpc-3650	119	4	data	datum	NOUN
dpc-3650	119	5	is	be	AUX
dpc-3650	119	6	displayed	display	VERB
dpc-3650	119	7	by	by	ADP
dpc-3650	119	8	a	a	DET
dpc-3650	119	9	boxplot	boxplot	NOUN
dpc-3650	119	10	-	-	PUNCT
dpc-3650	119	11	type	type	NOUN
dpc-3650	119	12	of	of	ADP
dpc-3650	119	13	diagram	diagram	NOUN
dpc-3650	119	14	in	in	ADP
dpc-3650	119	15	figure	figure	NOUN
dpc-3650	119	16	1	1	NUM
dpc-3650	119	17	.	.	PUNCT
dpc-3650	119	18	regarding	regard	VERB
dpc-3650	119	19	crp	crp	PROPN
dpc-3650	119	20	measurements	measurement	NOUN
dpc-3650	119	21	at	at	ADP
dpc-3650	119	22	baseline	baseline	ADJ
dpc-3650	119	23	,	,	PUNCT
dpc-3650	119	24	statistically	statistically	ADV
dpc-3650	119	25	significant	significant	ADJ
dpc-3650	119	26	differences	difference	NOUN
dpc-3650	119	27	were	be	AUX
dpc-3650	119	28	observed	observe	VERB
dpc-3650	119	29	between	between	ADP
dpc-3650	119	30	healthy	healthy	ADJ
dpc-3650	119	31	controls	control	NOUN
dpc-3650	119	32	and	and	CCONJ
dpc-3650	119	33	both	both	DET
dpc-3650	119	34	groups	group	NOUN
dpc-3650	119	35	of	of	ADP
dpc-3650	119	36	patients	patient	NOUN
dpc-3650	119	37	suffering	suffer	VERB
dpc-3650	119	38	from	from	ADP
dpc-3650	119	39	psoriasis	psoriasis	NOUN
dpc-3650	119	40	,	,	PUNCT
dpc-3650	119	41	with	with	ADP
dpc-3650	119	42	or	or	CCONJ
dpc-3650	119	43	without	without	ADP
dpc-3650	119	44	depression	depression	NOUN
dpc-3650	119	45	(	(	PUNCT
dpc-3650	119	46	f2,76=	f2,76=	NOUN
dpc-3650	119	47	6.937	6.937	NUM
dpc-3650	119	48	,	,	PUNCT
dpc-3650	119	49	p	p	NOUN
dpc-3650	119	50	=	=	NOUN
dpc-3650	119	51	0.002	0.002	NUM
dpc-3650	119	52	)	)	PUNCT
dpc-3650	119	53	.	.	PUNCT
dpc-3650	120	1	specifically	specifically	ADV
dpc-3650	120	2	,	,	PUNCT
dpc-3650	120	3	higher	high	ADJ
dpc-3650	120	4	crp	crp	PROPN
dpc-3650	120	5	levels	level	NOUN
dpc-3650	120	6	were	be	AUX
dpc-3650	120	7	observed	observe	VERB
dpc-3650	120	8	in	in	ADP
dpc-3650	120	9	psoriasis	psoriasis	NOUN
dpc-3650	120	10	and	and	CCONJ
dpc-3650	120	11	depression	depression	NOUN
dpc-3650	120	12	group	group	NOUN
dpc-3650	120	13	compared	compare	VERB
dpc-3650	120	14	to	to	ADP
dpc-3650	120	15	controls	control	NOUN
dpc-3650	120	16	(	(	PUNCT
dpc-3650	120	17	p	p	NOUN
dpc-3650	120	18	=	=	NOUN
dpc-3650	120	19	0.001	0.001	NUM
dpc-3650	120	20	)	)	PUNCT
dpc-3650	120	21	while	while	SCONJ
dpc-3650	120	22	the	the	DET
dpc-3650	120	23	psoriasis	psoriasis	NOUN
dpc-3650	120	24	group	group	NOUN
dpc-3650	120	25	did	do	AUX
dpc-3650	120	26	not	not	PART
dpc-3650	120	27	differ	differ	VERB
dpc-3650	120	28	from	from	ADP
dpc-3650	120	29	the	the	DET
dpc-3650	120	30	psoriasis	psoriasis	NOUN
dpc-3650	120	31	and	and	CCONJ
dpc-3650	120	32	depression	depression	NOUN
dpc-3650	120	33	group	group	NOUN
dpc-3650	120	34	(	(	PUNCT
dpc-3650	120	35	p	p	X
dpc-3650	120	36	=	=	NOUN
dpc-3650	120	37	0.210	0.210	NUM
dpc-3650	120	38	)	)	PUNCT
dpc-3650	120	39	or	or	CCONJ
dpc-3650	120	40	the	the	DET
dpc-3650	120	41	control	control	NOUN
dpc-3650	120	42	group	group	NOUN
dpc-3650	120	43	(	(	PUNCT
dpc-3650	120	44	p	p	X
dpc-3650	120	45	=	=	PROPN
dpc-3650	120	46	0129	0129	NUM
dpc-3650	120	47	)	)	PUNCT
dpc-3650	120	48	.	.	PUNCT
dpc-3650	121	1	(	(	PUNCT
dpc-3650	121	2	innate/	innate/	ADV
dpc-3650	121	3	adaptive	adaptive	ADJ
dpc-3650	121	4	immunity	immunity	NOUN
dpc-3650	121	5	)	)	PUNCT
dpc-3650	121	6	.	.	PUNCT
dpc-3650	122	1	it	it	PRON
dpc-3650	122	2	belongs	belong	VERB
dpc-3650	122	3	to	to	ADP
dpc-3650	122	4	blood	blood	NOUN
dpc-3650	122	5	tests	test	NOUN
dpc-3650	122	6	.	.	PUNCT
dpc-3650	123	1	the	the	DET
dpc-3650	123	2	detection	detection	NOUN
dpc-3650	123	3	of	of	ADP
dpc-3650	123	4	c	c	NOUN
dpc-3650	123	5	-	-	PUNCT
dpc-3650	123	6	reactive	reactive	ADJ
dpc-3650	123	7	protein	protein	NOUN
dpc-3650	123	8	levels	level	NOUN
dpc-3650	123	9	in	in	ADP
dpc-3650	123	10	the	the	DET
dpc-3650	123	11	blood	blood	NOUN
dpc-3650	123	12	is	be	AUX
dpc-3650	123	13	easy	easy	ADJ
dpc-3650	123	14	,	,	PUNCT
dpc-3650	123	15	no	no	DET
dpc-3650	123	16	special	special	ADJ
dpc-3650	123	17	procedures	procedure	NOUN
dpc-3650	123	18	were	be	AUX
dpc-3650	123	19	required	require	VERB
dpc-3650	123	20	,	,	PUNCT
dpc-3650	123	21	and	and	CCONJ
dpc-3650	123	22	cheap	cheap	ADJ
dpc-3650	123	23	.	.	PUNCT
dpc-3650	124	1	the	the	DET
dpc-3650	124	2	measurement	measurement	NOUN
dpc-3650	124	3	was	be	AUX
dpc-3650	124	4	carried	carry	VERB
dpc-3650	124	5	out	out	ADP
dpc-3650	124	6	with	with	ADP
dpc-3650	124	7	the	the	DET
dpc-3650	124	8	petia	petia	NOUN
dpc-3650	124	9	method	method	NOUN
dpc-3650	124	10	(	(	PUNCT
dpc-3650	124	11	particle	particle	NOUN
dpc-3650	124	12	enhanced	enhance	VERB
dpc-3650	124	13	turbidimetric	turbidimetric	ADJ
dpc-3650	124	14	immunoassay	immunoassay	PROPN
dpc-3650	124	15	)	)	PUNCT
dpc-3650	125	1	[	[	X
dpc-3650	125	2	44	44	NUM
dpc-3650	125	3	]	]	PUNCT
dpc-3650	125	4	.	.	PUNCT
dpc-3650	126	1	the	the	DET
dpc-3650	126	2	normal	normal	ADJ
dpc-3650	126	3	value	value	NOUN
dpc-3650	126	4	of	of	ADP
dpc-3650	126	5	crp	crp	PROPN
dpc-3650	126	6	levels	level	NOUN
dpc-3650	126	7	:	:	PUNCT
dpc-3650	126	8	is	be	AUX
dpc-3650	126	9	less	less	ADJ
dpc-3650	126	10	than	than	ADP
dpc-3650	126	11	0.3	0.3	NUM
dpc-3650	126	12	mg	mg	PROPN
dpc-3650	126	13	/	/	SYM
dpc-3650	126	14	dl	dl	PROPN
dpc-3650	126	15	.	.	PUNCT
dpc-3650	126	16	esr	esr	PROPN
dpc-3650	126	17	esr	esr	PROPN
dpc-3650	126	18	is	be	AUX
dpc-3650	126	19	the	the	DET
dpc-3650	126	20	rate	rate	NOUN
dpc-3650	126	21	at	at	ADP
dpc-3650	126	22	which	which	PRON
dpc-3650	126	23	red	red	ADJ
dpc-3650	126	24	blood	blood	NOUN
dpc-3650	126	25	cells	cell	NOUN
dpc-3650	126	26	settle	settle	VERB
dpc-3650	126	27	in	in	ADP
dpc-3650	126	28	the	the	DET
dpc-3650	126	29	plasma	plasma	NOUN
dpc-3650	126	30	and	and	CCONJ
dpc-3650	126	31	is	be	AUX
dpc-3650	126	32	expressed	express	VERB
dpc-3650	126	33	in	in	ADP
dpc-3650	126	34	mm	mm	PROPN
dpc-3650	126	35	per	per	ADP
dpc-3650	126	36	hour	hour	NOUN
dpc-3650	126	37	.	.	PUNCT
dpc-3650	127	1	it	it	PRON
dpc-3650	127	2	is	be	AUX
dpc-3650	127	3	classified	classify	VERB
dpc-3650	127	4	in	in	ADP
dpc-3650	127	5	blood	blood	NOUN
dpc-3650	127	6	tests	test	NOUN
dpc-3650	127	7	.	.	PUNCT
dpc-3650	128	1	no	no	DET
dpc-3650	128	2	special	special	ADJ
dpc-3650	128	3	procedures	procedure	NOUN
dpc-3650	128	4	are	be	AUX
dpc-3650	128	5	required	require	VERB
dpc-3650	128	6	before	before	ADP
dpc-3650	128	7	blood	blood	NOUN
dpc-3650	128	8	sampling	sampling	NOUN
dpc-3650	128	9	.	.	PUNCT
dpc-3650	129	1	for	for	ADP
dpc-3650	129	2	blood	blood	NOUN
dpc-3650	129	3	,	,	PUNCT
dpc-3650	129	4	the	the	DET
dpc-3650	129	5	collection	collection	NOUN
dpc-3650	129	6	is	be	AUX
dpc-3650	129	7	used	use	VERB
dpc-3650	129	8	special	special	ADJ
dpc-3650	129	9	closed	closed	ADJ
dpc-3650	129	10	tubes	tube	NOUN
dpc-3650	129	11	of	of	ADP
dpc-3650	129	12	vacuum	vacuum	PROPN
dpc-3650	129	13	air	air	NOUN
dpc-3650	129	14	with	with	ADP
dpc-3650	129	15	sodium	sodium	NOUN
dpc-3650	129	16	citrate	citrate	NOUN
dpc-3650	129	17	(	(	PUNCT
dpc-3650	129	18	sodium	sodium	NOUN
dpc-3650	129	19	citrate	citrate	NOUN
dpc-3650	129	20	3.2	3.2	NUM
dpc-3650	129	21	%	%	NOUN
dpc-3650	129	22	)	)	PUNCT
dpc-3650	129	23	,	,	PUNCT
dpc-3650	129	24	usually	usually	ADV
dpc-3650	129	25	black	black	ADJ
dpc-3650	129	26	in	in	ADP
dpc-3650	129	27	color	color	NOUN
dpc-3650	129	28	.	.	PUNCT
dpc-3650	130	1	the	the	DET
dpc-3650	130	2	westergren	westergren	PROPN
dpc-3650	130	3	method	method	VERB
dpc-3650	130	4	measures	measure	NOUN
dpc-3650	130	5	the	the	DET
dpc-3650	130	6	distance	distance	NOUN
dpc-3650	130	7	in	in	ADP
dpc-3650	130	8	millimeters	millimeters	PROPN
dpc-3650	130	9	(	(	PUNCT
dpc-3650	130	10	mm	mm	INTJ
dpc-3650	130	11	)	)	PUNCT
dpc-3650	130	12	that	that	SCONJ
dpc-3650	130	13	red	red	ADJ
dpc-3650	130	14	blood	blood	NOUN
dpc-3650	130	15	cells	cell	NOUN
dpc-3650	130	16	in	in	ADP
dpc-3650	130	17	anticoagulated	anticoagulate	VERB
dpc-3650	130	18	whole	whole	ADJ
dpc-3650	130	19	blood	blood	NOUN
dpc-3650	130	20	fall	fall	VERB
dpc-3650	130	21	to	to	ADP
dpc-3650	130	22	the	the	DET
dpc-3650	130	23	bottom	bottom	NOUN
dpc-3650	130	24	of	of	ADP
dpc-3650	130	25	a	a	DET
dpc-3650	130	26	standard	standard	ADJ
dpc-3650	130	27	upright	upright	NOUN
dpc-3650	130	28	,	,	PUNCT
dpc-3650	130	29	elongated	elongate	VERB
dpc-3650	130	30	tube	tube	NOUN
dpc-3650	130	31	(	(	PUNCT
dpc-3650	130	32	westergren	westergren	NOUN
dpc-3650	130	33	tube	tube	PROPN
dpc-3650	130	34	)	)	PUNCT
dpc-3650	130	35	over	over	ADP
dpc-3650	130	36	the	the	DET
dpc-3650	130	37	course	course	NOUN
dpc-3650	130	38	of	of	ADP
dpc-3650	130	39	one	one	NUM
dpc-3650	130	40	hour	hour	NOUN
dpc-3650	130	41	because	because	SCONJ
dpc-3650	130	42	of	of	ADP
dpc-3650	130	43	gravity	gravity	NOUN
dpc-3650	130	44	[	[	X
dpc-3650	130	45	45	45	NUM
dpc-3650	130	46	]	]	PUNCT
dpc-3650	130	47	.	.	PUNCT
dpc-3650	131	1	the	the	DET
dpc-3650	131	2	normal	normal	ADJ
dpc-3650	131	3	value	value	NOUN
dpc-3650	131	4	varies	vary	VERB
dpc-3650	131	5	between	between	ADP
dpc-3650	131	6	10	10	NUM
dpc-3650	131	7	and	and	CCONJ
dpc-3650	131	8	15	15	NUM
dpc-3650	131	9	mm	mm	NOUN
dpc-3650	131	10	in	in	ADP
dpc-3650	131	11	the	the	DET
dpc-3650	131	12	first	first	ADJ
dpc-3650	131	13	hour	hour	NOUN
dpc-3650	131	14	(	(	PUNCT
dpc-3650	131	15	for	for	ADP
dpc-3650	131	16	women	woman	NOUN
dpc-3650	131	17	12	12	NUM
dpc-3650	131	18	-	-	SYM
dpc-3650	131	19	20	20	NUM
dpc-3650	131	20	mm	mm	NOUN
dpc-3650	131	21	)	)	PUNCT
dpc-3650	131	22	.	.	PUNCT
dpc-3650	132	1	the	the	DET
dpc-3650	132	2	esr	esr	PROPN
dpc-3650	132	3	test	test	NOUN
dpc-3650	132	4	is	be	AUX
dpc-3650	132	5	not	not	PART
dpc-3650	132	6	specific	specific	ADJ
dpc-3650	132	7	for	for	ADP
dpc-3650	132	8	any	any	DET
dpc-3650	132	9	disease	disease	NOUN
dpc-3650	132	10	but	but	CCONJ
dpc-3650	132	11	is	be	AUX
dpc-3650	132	12	used	use	VERB
dpc-3650	132	13	in	in	ADP
dpc-3650	132	14	conjunction	conjunction	NOUN
dpc-3650	132	15	with	with	ADP
dpc-3650	132	16	other	other	ADJ
dpc-3650	132	17	tests	test	NOUN
dpc-3650	132	18	to	to	PART
dpc-3650	132	19	identify	identify	VERB
dpc-3650	132	20	increased	increase	VERB
dpc-3650	132	21	inflammatory	inflammatory	ADJ
dpc-3650	132	22	activity	activity	NOUN
dpc-3650	132	23	.	.	PUNCT
dpc-3650	133	1	statistical	statistical	ADJ
dpc-3650	133	2	analysis	analysis	NOUN
dpc-3650	133	3	baseline	baseline	NOUN
dpc-3650	133	4	differences	difference	NOUN
dpc-3650	133	5	in	in	ADP
dpc-3650	133	6	esr	esr	PROPN
dpc-3650	133	7	and	and	CCONJ
dpc-3650	133	8	crp	crp	PROPN
dpc-3650	133	9	levels	level	NOUN
dpc-3650	133	10	among	among	ADP
dpc-3650	133	11	groups	group	NOUN
dpc-3650	133	12	were	be	AUX
dpc-3650	133	13	analyzed	analyze	VERB
dpc-3650	133	14	using	use	VERB
dpc-3650	133	15	regression	regression	NOUN
dpc-3650	133	16	models	model	NOUN
dpc-3650	133	17	and	and	CCONJ
dpc-3650	133	18	adjusting	adjust	VERB
dpc-3650	133	19	for	for	ADP
dpc-3650	133	20	bmi	bmi	NOUN
dpc-3650	133	21	values	value	NOUN
dpc-3650	133	22	.	.	PUNCT
dpc-3650	134	1	multiple	multiple	ADJ
dpc-3650	134	2	comparison	comparison	NOUN
dpc-3650	134	3	tests	test	NOUN
dpc-3650	134	4	were	be	AUX
dpc-3650	134	5	applied	apply	VERB
dpc-3650	134	6	to	to	PART
dpc-3650	134	7	determine	determine	VERB
dpc-3650	134	8	statistically	statistically	ADV
dpc-3650	134	9	significant	significant	ADJ
dpc-3650	134	10	pairwise	pairwise	NOUN
dpc-3650	134	11	differences	difference	NOUN
dpc-3650	134	12	based	base	VERB
dpc-3650	134	13	on	on	ADP
dpc-3650	134	14	bonferroni	bonferroni	NOUN
dpc-3650	134	15	adjusted	adjust	VERB
dpc-3650	134	16	pvalues	pvalue	NOUN
dpc-3650	134	17	.	.	PUNCT
dpc-3650	135	1	repeated	repeat	VERB
dpc-3650	135	2	measures	measure	NOUN
dpc-3650	135	3	general	general	ADJ
dpc-3650	135	4	linear	linear	NOUN
dpc-3650	135	5	models	model	NOUN
dpc-3650	135	6	were	be	AUX
dpc-3650	135	7	applied	apply	VERB
dpc-3650	135	8	to	to	PART
dpc-3650	135	9	examine	examine	VERB
dpc-3650	135	10	the	the	DET
dpc-3650	135	11	differences	difference	NOUN
dpc-3650	135	12	between	between	ADP
dpc-3650	135	13	the	the	DET
dpc-3650	135	14	two	two	NUM
dpc-3650	135	15	-	-	PUNCT
dpc-3650	135	16	time	time	NOUN
dpc-3650	135	17	points	point	NOUN
dpc-3650	135	18	and	and	CCONJ
dpc-3650	135	19	between	between	ADP
dpc-3650	135	20	the	the	DET
dpc-3650	135	21	two	two	NUM
dpc-3650	135	22	groups	group	NOUN
dpc-3650	135	23	of	of	ADP
dpc-3650	135	24	patients	patient	NOUN
dpc-3650	135	25	regarding	regard	VERB
dpc-3650	135	26	crp	crp	PROPN
dpc-3650	135	27	and	and	CCONJ
dpc-3650	135	28	esr	esr	PROPN
dpc-3650	135	29	levels	level	NOUN
dpc-3650	135	30	.	.	PUNCT
dpc-3650	136	1	the	the	DET
dpc-3650	136	2	changes	change	NOUN
dpc-3650	136	3	were	be	AUX
dpc-3650	136	4	adjusted	adjust	VERB
dpc-3650	136	5	for	for	ADP
dpc-3650	136	6	baseline	baseline	ADJ
dpc-3650	136	7	values	value	NOUN
dpc-3650	136	8	of	of	ADP
dpc-3650	136	9	bmi	bmi	NOUN
dpc-3650	136	10	,	,	PUNCT
dpc-3650	136	11	pasi	pasi	NOUN
dpc-3650	136	12	score	score	PROPN
dpc-3650	136	13	,	,	PUNCT
dpc-3650	136	14	bga	bga	PROPN
dpc-3650	136	15	score	score	NOUN
dpc-3650	136	16	,	,	PUNCT
dpc-3650	136	17	  	  	SPACE
dpc-3650	136	18	bsa	bsa	PROPN
dpc-3650	136	19	  	  	SPACE
dpc-3650	136	20	score	score	NOUN
dpc-3650	136	21	,	,	PUNCT
dpc-3650	136	22	  	  	SPACE
dpc-3650	136	23	dlqi	dlqi	NOUN
dpc-3650	136	24	score	score	NOUN
dpc-3650	136	25	,	,	PUNCT
dpc-3650	136	26	bai	bai	PROPN
dpc-3650	136	27	score	score	NOUN
dpc-3650	136	28	,	,	PUNCT
dpc-3650	136	29	ais	ais	PROPN
dpc-3650	136	30	score	score	NOUN
dpc-3650	136	31	,	,	PUNCT
dpc-3650	136	32	age	age	NOUN
dpc-3650	136	33	,	,	PUNCT
dpc-3650	136	34	table	table	NOUN
dpc-3650	136	35	1	1	NUM
dpc-3650	136	36	baseline	baseline	PROPN
dpc-3650	136	37	characteristics	characteristic	NOUN
dpc-3650	136	38	group	group	NOUN
dpc-3650	136	39	healthy	healthy	ADJ
dpc-3650	136	40	controls	control	VERB
dpc-3650	136	41	psoriasis	psoriasis	NOUN
dpc-3650	136	42	and	and	CCONJ
dpc-3650	136	43	depression	depression	NOUN
dpc-3650	136	44	psoriasis	psoriasis	NOUN
dpc-3650	136	45	mean	mean	NOUN
dpc-3650	136	46	deviation	deviation	NOUN
dpc-3650	136	47	mean	mean	VERB
dpc-3650	136	48	deviation	deviation	NOUN
dpc-3650	136	49	mean	mean	VERB
dpc-3650	136	50	deviation	deviation	NOUN
dpc-3650	136	51	age	age	NOUN
dpc-3650	136	52	46.11	46.11	NUM
dpc-3650	136	53	11.10	11.10	NUM
dpc-3650	136	54	47.96	47.96	NUM
dpc-3650	136	55	11.83	11.83	NUM
dpc-3650	136	56	49.39	49.39	NUM
dpc-3650	136	57	12.72	12.72	NUM
dpc-3650	136	58	age	age	NOUN
dpc-3650	136	59	of	of	ADP
dpc-3650	136	60	onset	onset	NOUN
dpc-3650	136	61	of	of	ADP
dpc-3650	136	62	psoriasis	psoriasis	NOUN
dpc-3650	136	63	.	.	PUNCT
dpc-3650	136	64	.	.	PUNCT
dpc-3650	137	1	32.21	32.21	NUM
dpc-3650	137	2	16.08	16.08	NUM
dpc-3650	137	3	32.68	32.68	NUM
dpc-3650	137	4	15.21	15.21	NUM
dpc-3650	137	5	group	group	NOUN
dpc-3650	137	6	healthy	healthy	ADJ
dpc-3650	137	7	controls	control	VERB
dpc-3650	137	8	psoriasis	psoriasis	NOUN
dpc-3650	137	9	and	and	CCONJ
dpc-3650	137	10	depression	depression	NOUN
dpc-3650	137	11	psoriasis	psoriasis	NOUN
dpc-3650	137	12	n	n	PRON
dpc-3650	137	13	%	%	NOUN
dpc-3650	137	14	n	n	PRON
dpc-3650	137	15	%	%	NOUN
dpc-3650	137	16	n	n	PRON
dpc-3650	137	17	%	%	NOUN
dpc-3650	137	18	gender	gender	NOUN
dpc-3650	137	19	male	male	NOUN
dpc-3650	137	20	8.0	8.0	NUM
dpc-3650	137	21	28.6	28.6	NUM
dpc-3650	137	22	%	%	NOUN
dpc-3650	137	23	14.0	14.0	NUM
dpc-3650	137	24	58.3	58.3	NUM
dpc-3650	137	25	%	%	NOUN
dpc-3650	137	26	25.0	25.0	NUM
dpc-3650	137	27	89.3	89.3	NUM
dpc-3650	137	28	%	%	NOUN
dpc-3650	137	29	female	female	NOUN
dpc-3650	137	30	20.0	20.0	NUM
dpc-3650	137	31	71.4	71.4	NUM
dpc-3650	137	32	%	%	NOUN
dpc-3650	137	33	10.0	10.0	NUM
dpc-3650	137	34	41.7	41.7	NUM
dpc-3650	137	35	%	%	NOUN
dpc-3650	137	36	3.0	3.0	NUM
dpc-3650	137	37	10.7	10.7	NUM
dpc-3650	137	38	%	%	NOUN
dpc-3650	137	39	family	family	NOUN
dpc-3650	137	40	history	history	NOUN
dpc-3650	137	41	of	of	ADP
dpc-3650	137	42	psoriasis	psoriasis	NOUN
dpc-3650	138	1	yes	yes	INTJ
dpc-3650	138	2	.0	.0	NUM
dpc-3650	139	1	0.0	0.0	NUM
dpc-3650	139	2	%	%	NOUN
dpc-3650	139	3	4.0	4.0	NUM
dpc-3650	139	4	16.7	16.7	NUM
dpc-3650	139	5	%	%	NOUN
dpc-3650	139	6	10.0	10.0	NUM
dpc-3650	139	7	35.7	35.7	NUM
dpc-3650	139	8	%	%	NOUN
dpc-3650	139	9	no	no	DET
dpc-3650	139	10	.0	.0	NUM
dpc-3650	139	11	0.0	0.0	NUM
dpc-3650	139	12	%	%	NOUN
dpc-3650	139	13	20.0	20.0	NUM
dpc-3650	139	14	83.3	83.3	NUM
dpc-3650	139	15	%	%	NOUN
dpc-3650	139	16	18.0	18.0	NUM
dpc-3650	139	17	64.3	64.3	NUM
dpc-3650	139	18	%	%	NOUN
dpc-3650	139	19	original	original	ADJ
dpc-3650	139	20	article	article	NOUN
dpc-3650	139	21	|	|	ADV
dpc-3650	139	22	dermatol	dermatol	ADJ
dpc-3650	139	23	pract	pract	NOUN
dpc-3650	139	24	concept	concept	NOUN
dpc-3650	139	25	.	.	PUNCT
dpc-3650	140	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	140	2	5	5	NUM
dpc-3650	140	3	comparing	compare	VERB
dpc-3650	140	4	the	the	DET
dpc-3650	140	5	two	two	NUM
dpc-3650	140	6	disease	disease	NOUN
dpc-3650	140	7	groups	group	NOUN
dpc-3650	140	8	,	,	PUNCT
dpc-3650	140	9	regarding	regard	VERB
dpc-3650	140	10	esr	esr	PROPN
dpc-3650	140	11	,	,	PUNCT
dpc-3650	140	12	the	the	DET
dpc-3650	140	13	initially	initially	ADV
dpc-3650	140	14	observed	observe	VERB
dpc-3650	140	15	differences	difference	NOUN
dpc-3650	140	16	at	at	ADP
dpc-3650	140	17	baseline	baseline	NOUN
dpc-3650	140	18	remain	remain	VERB
dpc-3650	140	19	statistically	statistically	ADV
dpc-3650	140	20	significant	significant	ADJ
dpc-3650	140	21	after	after	ADP
dpc-3650	140	22	adjusting	adjust	VERB
dpc-3650	140	23	for	for	ADP
dpc-3650	140	24	bmi	bmi	NOUN
dpc-3650	140	25	,	,	PUNCT
dpc-3650	140	26	pasi	pasi	NOUN
dpc-3650	140	27	score	score	PROPN
dpc-3650	140	28	,	,	PUNCT
dpc-3650	140	29	bga	bga	PROPN
dpc-3650	140	30	score	score	PROPN
dpc-3650	140	31	,	,	PUNCT
dpc-3650	140	32	bsa	bsa	PROPN
dpc-3650	140	33	score	score	NOUN
dpc-3650	140	34	,	,	PUNCT
dpc-3650	140	35	dlqi	dlqi	ADJ
dpc-3650	140	36	score	score	NOUN
dpc-3650	140	37	,	,	PUNCT
dpc-3650	140	38	bai	bai	PROPN
dpc-3650	140	39	score	score	NOUN
dpc-3650	140	40	,	,	PUNCT
dpc-3650	140	41	ais	ais	PROPN
dpc-3650	140	42	score	score	NOUN
dpc-3650	140	43	,	,	PUNCT
dpc-3650	140	44	age	age	NOUN
dpc-3650	140	45	,	,	PUNCT
dpc-3650	140	46	gender	gender	NOUN
dpc-3650	140	47	,	,	PUNCT
dpc-3650	140	48	and	and	CCONJ
dpc-3650	140	49	treatment	treatment	NOUN
dpc-3650	140	50	(	(	PUNCT
dpc-3650	140	51	p	p	X
dpc-3650	140	52	=	=	NOUN
dpc-3650	140	53	0.048	0.048	NUM
dpc-3650	140	54	)	)	PUNCT
dpc-3650	140	55	.	.	PUNCT
dpc-3650	141	1	the	the	DET
dpc-3650	141	2	differences	difference	NOUN
dpc-3650	141	3	,	,	PUNCT
dpc-3650	141	4	3	3	NUM
dpc-3650	141	5	months	month	NOUN
dpc-3650	141	6	later	later	ADV
dpc-3650	141	7	,	,	PUNCT
dpc-3650	141	8	remain	remain	VERB
dpc-3650	141	9	statistically	statistically	ADV
dpc-3650	141	10	significant	significant	ADJ
dpc-3650	141	11	(	(	PUNCT
dpc-3650	141	12	p	p	X
dpc-3650	141	13	=	=	NOUN
dpc-3650	141	14	0.025	0.025	NUM
dpc-3650	141	15	)	)	PUNCT
dpc-3650	141	16	.	.	PUNCT
dpc-3650	142	1	regarding	regard	VERB
dpc-3650	142	2	crp	crp	PROPN
dpc-3650	142	3	,	,	PUNCT
dpc-3650	142	4	the	the	DET
dpc-3650	142	5	distribution	distribution	NOUN
dpc-3650	142	6	of	of	ADP
dpc-3650	142	7	data	datum	NOUN
dpc-3650	142	8	is	be	AUX
dpc-3650	142	9	displayed	display	VERB
dpc-3650	142	10	by	by	ADP
dpc-3650	142	11	a	a	DET
dpc-3650	142	12	boxplot	boxplot	NOUN
dpc-3650	142	13	-	-	PUNCT
dpc-3650	142	14	type	type	NOUN
dpc-3650	142	15	of	of	ADP
dpc-3650	142	16	diagram	diagram	NOUN
dpc-3650	142	17	in	in	ADP
dpc-3650	142	18	figure	figure	NOUN
dpc-3650	142	19	2	2	NUM
dpc-3650	142	20	.	.	PUNCT
dpc-3650	142	21	differences	difference	NOUN
dpc-3650	142	22	in	in	ADP
dpc-3650	142	23	esr	esr	PROPN
dpc-3650	142	24	and	and	CCONJ
dpc-3650	142	25	crp	crp	PROPN
dpc-3650	142	26	levels	level	NOUN
dpc-3650	142	27	were	be	AUX
dpc-3650	142	28	examined	examine	VERB
dpc-3650	142	29	between	between	ADP
dpc-3650	142	30	the	the	DET
dpc-3650	142	31	two	two	NUM
dpc-3650	142	32	-	-	PUNCT
dpc-3650	142	33	time	time	NOUN
dpc-3650	142	34	points	point	NOUN
dpc-3650	142	35	(	(	PUNCT
dpc-3650	142	36	baseline	baseline	NOUN
dpc-3650	142	37	and	and	CCONJ
dpc-3650	142	38	three	three	NUM
dpc-3650	142	39	months	month	NOUN
dpc-3650	142	40	period	period	NOUN
dpc-3650	142	41	)	)	PUNCT
dpc-3650	142	42	for	for	ADP
dpc-3650	142	43	the	the	DET
dpc-3650	142	44	two	two	NUM
dpc-3650	142	45	groups	group	NOUN
dpc-3650	142	46	of	of	ADP
dpc-3650	142	47	patients	patient	NOUN
dpc-3650	142	48	(	(	PUNCT
dpc-3650	142	49	table	table	NOUN
dpc-3650	142	50	4	4	NUM
dpc-3650	142	51	)	)	PUNCT
dpc-3650	142	52	.	.	PUNCT
dpc-3650	143	1	no	no	DET
dpc-3650	143	2	significant	significant	ADJ
dpc-3650	143	3	changes	change	NOUN
dpc-3650	143	4	in	in	ADP
dpc-3650	143	5	esr	esr	PROPN
dpc-3650	143	6	or	or	CCONJ
dpc-3650	143	7	crp	crp	PROPN
dpc-3650	143	8	values	value	NOUN
dpc-3650	143	9	were	be	AUX
dpc-3650	143	10	observed	observe	VERB
dpc-3650	143	11	in	in	ADP
dpc-3650	143	12	either	either	DET
dpc-3650	143	13	group	group	NOUN
dpc-3650	143	14	.	.	PUNCT
dpc-3650	144	1	table	table	NOUN
dpc-3650	144	2	2	2	NUM
dpc-3650	144	3	summarizes	summarize	NOUN
dpc-3650	144	4	the	the	DET
dpc-3650	144	5	clinical	clinical	ADJ
dpc-3650	144	6	characteristics	characteristic	NOUN
dpc-3650	144	7	of	of	ADP
dpc-3650	144	8	individuals	individual	NOUN
dpc-3650	144	9	enrolled	enrol	VERB
dpc-3650	144	10	in	in	ADP
dpc-3650	144	11	the	the	DET
dpc-3650	144	12	study	study	NOUN
dpc-3650	144	13	group	group	NOUN
dpc-3650	144	14	healthy	healthy	ADJ
dpc-3650	144	15	controls	control	NOUN
dpc-3650	144	16	psoriasis+	psoriasis+	PART
dpc-3650	144	17	depression	depression	NOUN
dpc-3650	144	18	psoriasis	psoriasis	NOUN
dpc-3650	144	19	n	n	PRON
dpc-3650	144	20	%	%	NOUN
dpc-3650	144	21	n	n	PRON
dpc-3650	144	22	%	%	NOUN
dpc-3650	145	1	n	n	CCONJ
dpc-3650	145	2	%	%	NOUN
dpc-3650	145	3	psoriatric	psoriatric	ADJ
dpc-3650	145	4	nails	nail	NOUN
dpc-3650	146	1	yes	yes	INTJ
dpc-3650	146	2	.0	.0	NUM
dpc-3650	146	3	0.0	0.0	NUM
dpc-3650	146	4	%	%	NOUN
dpc-3650	146	5	16.0	16.0	NUM
dpc-3650	146	6	66.7	66.7	NUM
dpc-3650	146	7	%	%	NOUN
dpc-3650	146	8	16.0	16.0	NUM
dpc-3650	146	9	57.1	57.1	NUM
dpc-3650	146	10	%	%	NOUN
dpc-3650	146	11	.0	.0	NUM
dpc-3650	146	12	0.0	0.0	NUM
dpc-3650	146	13	%	%	NOUN
dpc-3650	146	14	8.0	8.0	NUM
dpc-3650	146	15	33.3	33.3	NUM
dpc-3650	146	16	%	%	NOUN
dpc-3650	146	17	12.0	12.0	NUM
dpc-3650	146	18	42.9	42.9	NUM
dpc-3650	146	19	%	%	NOUN
dpc-3650	146	20	treatment	treatment	NOUN
dpc-3650	146	21	for	for	ADP
dpc-3650	146	22	psoriasis	psoriasis	NOUN
dpc-3650	146	23	:	:	PUNCT
dpc-3650	146	24	treatment	treatment	NOUN
dpc-3650	146	25	conventional	conventional	ADJ
dpc-3650	146	26	.0	.0	NUM
dpc-3650	146	27	0.0	0.0	NUM
dpc-3650	146	28	%	%	NOUN
dpc-3650	146	29	5.0	5.0	NUM
dpc-3650	146	30	23.8	23.8	NUM
dpc-3650	146	31	%	%	NOUN
dpc-3650	146	32	5.0	5.0	NUM
dpc-3650	146	33	19.2	19.2	NUM
dpc-3650	146	34	%	%	NOUN
dpc-3650	146	35	biologics	biologic	NOUN
dpc-3650	146	36	.0	.0	NUM
dpc-3650	146	37	0.0	0.0	NUM
dpc-3650	146	38	%	%	NOUN
dpc-3650	146	39	16.0	16.0	NUM
dpc-3650	146	40	76.2	76.2	NUM
dpc-3650	146	41	%	%	NOUN
dpc-3650	146	42	21.0	21.0	NUM
dpc-3650	146	43	80.8	80.8	NUM
dpc-3650	146	44	%	%	NOUN
dpc-3650	146	45	chemoprophylaxis	chemoprophylaxis	NOUN
dpc-3650	146	46	.0	.0	NUM
dpc-3650	146	47	0.0	0.0	NUM
dpc-3650	146	48	%	%	NOUN
dpc-3650	146	49	20.0	20.0	NUM
dpc-3650	146	50	83.3	83.3	NUM
dpc-3650	146	51	%	%	NOUN
dpc-3650	146	52	20.0	20.0	NUM
dpc-3650	146	53	71.4	71.4	NUM
dpc-3650	146	54	%	%	NOUN
dpc-3650	146	55	past	past	ADP
dpc-3650	146	56	.0	.0	NUM
dpc-3650	146	57	0.0	0.0	NUM
dpc-3650	146	58	%	%	NOUN
dpc-3650	146	59	4.0	4.0	NUM
dpc-3650	146	60	16.7	16.7	NUM
dpc-3650	146	61	%	%	NOUN
dpc-3650	146	62	7.0	7.0	NUM
dpc-3650	146	63	25.0	25.0	NUM
dpc-3650	146	64	%	%	NOUN
dpc-3650	146	65	now	now	ADV
dpc-3650	146	66	.0	.0	NUM
dpc-3650	146	67	0.0	0.0	NUM
dpc-3650	146	68	%	%	NOUN
dpc-3650	146	69	.0	.0	NUM
dpc-3650	146	70	0.0	0.0	NUM
dpc-3650	146	71	%	%	NOUN
dpc-3650	146	72	1.0	1.0	NUM
dpc-3650	146	73	3.6	3.6	NUM
dpc-3650	146	74	%	%	NOUN
dpc-3650	146	75	mental	mental	ADJ
dpc-3650	146	76	health	health	NOUN
dpc-3650	146	77	:	:	PUNCT
dpc-3650	146	78	family	family	NOUN
dpc-3650	146	79	history	history	NOUN
dpc-3650	146	80	of	of	ADP
dpc-3650	146	81	depression	depression	NOUN
dpc-3650	146	82	yes	yes	INTJ
dpc-3650	146	83	2.0	2.0	NUM
dpc-3650	146	84	7.1	7.1	NUM
dpc-3650	146	85	%	%	NOUN
dpc-3650	146	86	3.0	3.0	NUM
dpc-3650	146	87	12.5	12.5	NUM
dpc-3650	146	88	%	%	NOUN
dpc-3650	146	89	1.0	1.0	NUM
dpc-3650	146	90	3.6	3.6	NUM
dpc-3650	146	91	%	%	NOUN
dpc-3650	146	92	no	no	DET
dpc-3650	146	93	26.0	26.0	NUM
dpc-3650	146	94	92.9	92.9	NUM
dpc-3650	146	95	%	%	NOUN
dpc-3650	146	96	21.0	21.0	NUM
dpc-3650	146	97	87.5	87.5	NUM
dpc-3650	146	98	%	%	NOUN
dpc-3650	146	99	27.0	27.0	NUM
dpc-3650	146	100	96.4	96.4	NUM
dpc-3650	146	101	%	%	NOUN
dpc-3650	146	102	suicidal	suicidal	ADJ
dpc-3650	146	103	ideation	ideation	NOUN
dpc-3650	147	1	yes	yes	INTJ
dpc-3650	147	2	.0	.0	NUM
dpc-3650	147	3	0.0	0.0	NUM
dpc-3650	147	4	%	%	NOUN
dpc-3650	147	5	3.0	3.0	NUM
dpc-3650	147	6	12.5	12.5	NUM
dpc-3650	147	7	%	%	NOUN
dpc-3650	147	8	1.0	1.0	NUM
dpc-3650	147	9	3.6	3.6	NUM
dpc-3650	147	10	%	%	NOUN
dpc-3650	147	11	no	no	DET
dpc-3650	147	12	28.0	28.0	NUM
dpc-3650	147	13	100.0	100.0	NUM
dpc-3650	147	14	%	%	NOUN
dpc-3650	147	15	21.0	21.0	NUM
dpc-3650	147	16	87.5	87.5	NUM
dpc-3650	147	17	%	%	NOUN
dpc-3650	147	18	27.0	27.0	NUM
dpc-3650	147	19	96.4	96.4	NUM
dpc-3650	147	20	%	%	NOUN
dpc-3650	147	21	co	co	NOUN
dpc-3650	147	22	-	-	NOUN
dpc-3650	147	23	morbidities	morbidity	NOUN
dpc-3650	147	24	:	:	PUNCT
dpc-3650	147	25	hypertension	hypertension	NOUN
dpc-3650	147	26	yes	yes	INTJ
dpc-3650	147	27	7.0	7.0	NUM
dpc-3650	147	28	25.0	25.0	NUM
dpc-3650	147	29	%	%	NOUN
dpc-3650	147	30	9.0	9.0	NUM
dpc-3650	147	31	37.5	37.5	NUM
dpc-3650	147	32	%	%	NOUN
dpc-3650	147	33	5.0	5.0	NUM
dpc-3650	147	34	17.9	17.9	NUM
dpc-3650	147	35	%	%	NOUN
dpc-3650	147	36	no	no	DET
dpc-3650	147	37	21.0	21.0	NUM
dpc-3650	147	38	75.0	75.0	NUM
dpc-3650	147	39	%	%	NOUN
dpc-3650	147	40	15.0	15.0	NUM
dpc-3650	147	41	62.5	62.5	NUM
dpc-3650	147	42	%	%	NOUN
dpc-3650	147	43	23.0	23.0	NUM
dpc-3650	147	44	82.1	82.1	NUM
dpc-3650	147	45	%	%	NOUN
dpc-3650	147	46	cardiovascular	cardiovascular	ADJ
dpc-3650	147	47	disease	disease	NOUN
dpc-3650	148	1	yes	yes	INTJ
dpc-3650	148	2	.0	.0	NUM
dpc-3650	148	3	0.0	0.0	NUM
dpc-3650	148	4	%	%	NOUN
dpc-3650	148	5	5.0	5.0	NUM
dpc-3650	148	6	20.8	20.8	NUM
dpc-3650	148	7	%	%	NOUN
dpc-3650	148	8	2.0	2.0	NUM
dpc-3650	148	9	7.1	7.1	NUM
dpc-3650	148	10	%	%	NOUN
dpc-3650	148	11	no	no	DET
dpc-3650	148	12	28.0	28.0	NUM
dpc-3650	148	13	100.0	100.0	NUM
dpc-3650	148	14	%	%	NOUN
dpc-3650	148	15	19.0	19.0	NUM
dpc-3650	148	16	79.2	79.2	NUM
dpc-3650	148	17	%	%	NOUN
dpc-3650	148	18	26.0	26.0	NUM
dpc-3650	148	19	92.9	92.9	NUM
dpc-3650	148	20	%	%	NOUN
dpc-3650	148	21	diabetes	diabetes	NOUN
dpc-3650	148	22	yes	yes	INTJ
dpc-3650	148	23	4.0	4.0	NUM
dpc-3650	148	24	14.3	14.3	NUM
dpc-3650	148	25	%	%	NOUN
dpc-3650	148	26	3.0	3.0	NUM
dpc-3650	148	27	12.5	12.5	NUM
dpc-3650	148	28	%	%	NOUN
dpc-3650	148	29	4.0	4.0	NUM
dpc-3650	148	30	14.3	14.3	NUM
dpc-3650	148	31	%	%	NOUN
dpc-3650	148	32	no	no	DET
dpc-3650	148	33	24.0	24.0	NUM
dpc-3650	148	34	85.7	85.7	NUM
dpc-3650	148	35	%	%	NOUN
dpc-3650	148	36	21.0	21.0	NUM
dpc-3650	148	37	87.5	87.5	NUM
dpc-3650	148	38	%	%	NOUN
dpc-3650	148	39	24.0	24.0	NUM
dpc-3650	148	40	85.7	85.7	NUM
dpc-3650	148	41	%	%	NOUN
dpc-3650	148	42	dyslipidemia	dyslipidemia	NOUN
dpc-3650	148	43	yes	yes	INTJ
dpc-3650	149	1	4.0	4.0	NUM
dpc-3650	149	2	14.3	14.3	NUM
dpc-3650	149	3	%	%	NOUN
dpc-3650	149	4	9.0	9.0	NUM
dpc-3650	149	5	37.5	37.5	NUM
dpc-3650	149	6	%	%	NOUN
dpc-3650	149	7	8.0	8.0	NUM
dpc-3650	149	8	28.6	28.6	NUM
dpc-3650	149	9	%	%	NOUN
dpc-3650	149	10	no	no	DET
dpc-3650	149	11	24.0	24.0	NUM
dpc-3650	149	12	85.7	85.7	NUM
dpc-3650	149	13	%	%	NOUN
dpc-3650	149	14	15.0	15.0	NUM
dpc-3650	149	15	62.5	62.5	NUM
dpc-3650	149	16	%	%	NOUN
dpc-3650	149	17	20.0	20.0	NUM
dpc-3650	149	18	71.4	71.4	NUM
dpc-3650	149	19	%	%	NOUN
dpc-3650	149	20	health	health	NOUN
dpc-3650	149	21	habits	habit	NOUN
dpc-3650	149	22	:	:	PUNCT
dpc-3650	149	23	smoking	smoke	VERB
dpc-3650	149	24	yes	yes	INTJ
dpc-3650	149	25	15.0	15.0	NUM
dpc-3650	149	26	53.6	53.6	NUM
dpc-3650	149	27	%	%	NOUN
dpc-3650	149	28	10.0	10.0	NUM
dpc-3650	149	29	41.7	41.7	NUM
dpc-3650	149	30	%	%	NOUN
dpc-3650	149	31	16.0	16.0	NUM
dpc-3650	149	32	57.1	57.1	NUM
dpc-3650	149	33	%	%	NOUN
dpc-3650	149	34	no	no	DET
dpc-3650	149	35	13.0	13.0	NUM
dpc-3650	149	36	46.4	46.4	NUM
dpc-3650	149	37	%	%	NOUN
dpc-3650	149	38	14.0	14.0	NUM
dpc-3650	149	39	58.3	58.3	NUM
dpc-3650	149	40	%	%	NOUN
dpc-3650	149	41	12.0	12.0	NUM
dpc-3650	149	42	42.9	42.9	NUM
dpc-3650	149	43	%	%	NOUN
dpc-3650	149	44	alcohol	alcohol	NOUN
dpc-3650	149	45	consumption	consumption	NOUN
dpc-3650	149	46	yes	yes	INTJ
dpc-3650	149	47	10.0	10.0	NUM
dpc-3650	149	48	35.7	35.7	NUM
dpc-3650	149	49	%	%	NOUN
dpc-3650	149	50	8.0	8.0	NUM
dpc-3650	149	51	33.3	33.3	NUM
dpc-3650	149	52	%	%	NOUN
dpc-3650	149	53	19.0	19.0	NUM
dpc-3650	149	54	67.9	67.9	NUM
dpc-3650	149	55	%	%	NOUN
dpc-3650	149	56	no	no	DET
dpc-3650	149	57	18.0	18.0	NUM
dpc-3650	149	58	64.3	64.3	NUM
dpc-3650	149	59	%	%	NOUN
dpc-3650	149	60	16.0	16.0	NUM
dpc-3650	149	61	66.7	66.7	NUM
dpc-3650	149	62	%	%	NOUN
dpc-3650	149	63	9.0	9.0	NUM
dpc-3650	149	64	32.1	32.1	NUM
dpc-3650	149	65	%	%	NOUN
dpc-3650	149	66	drug	drug	NOUN
dpc-3650	149	67	use	use	NOUN
dpc-3650	149	68	yes	yes	INTJ
dpc-3650	149	69	.0	.0	NUM
dpc-3650	149	70	0.0	0.0	NUM
dpc-3650	149	71	%	%	NOUN
dpc-3650	149	72	.0	.0	NUM
dpc-3650	149	73	0.0	0.0	NUM
dpc-3650	149	74	%	%	NOUN
dpc-3650	149	75	1.0	1.0	NUM
dpc-3650	149	76	3.6	3.6	NUM
dpc-3650	149	77	%	%	NOUN
dpc-3650	149	78	no	no	DET
dpc-3650	149	79	28.0	28.0	NUM
dpc-3650	149	80	100.0	100.0	NUM
dpc-3650	149	81	%	%	NOUN
dpc-3650	149	82	24.0	24.0	NUM
dpc-3650	149	83	100.0	100.0	NUM
dpc-3650	149	84	%	%	NOUN
dpc-3650	149	85	27.0	27.0	NUM
dpc-3650	149	86	96.4	96.4	NUM
dpc-3650	149	87	%	%	NOUN
dpc-3650	149	88	sports	sport	NOUN
dpc-3650	149	89	activity	activity	NOUN
dpc-3650	149	90	yes	yes	INTJ
dpc-3650	149	91	8.0	8.0	NUM
dpc-3650	149	92	28.6	28.6	NUM
dpc-3650	149	93	%	%	NOUN
dpc-3650	149	94	7.0	7.0	NUM
dpc-3650	149	95	29.2	29.2	NUM
dpc-3650	149	96	%	%	NOUN
dpc-3650	149	97	4.0	4.0	NUM
dpc-3650	149	98	14.3	14.3	NUM
dpc-3650	149	99	%	%	NOUN
dpc-3650	149	100	no	no	DET
dpc-3650	149	101	20.0	20.0	NUM
dpc-3650	149	102	71.4	71.4	NUM
dpc-3650	149	103	%	%	NOUN
dpc-3650	149	104	17.0	17.0	NUM
dpc-3650	149	105	70.8	70.8	NUM
dpc-3650	149	106	%	%	NOUN
dpc-3650	149	107	24.0	24.0	NUM
dpc-3650	149	108	85.7	85.7	NUM
dpc-3650	149	109	%	%	NOUN
dpc-3650	149	110	sex	sex	NOUN
dpc-3650	149	111	life	life	NOUN
dpc-3650	149	112	:	:	PUNCT
dpc-3650	149	113	sexual	sexual	ADJ
dpc-3650	149	114	activity	activity	NOUN
dpc-3650	149	115	yes	yes	ADV
dpc-3650	149	116	24.0	24.0	NUM
dpc-3650	149	117	85.7	85.7	NUM
dpc-3650	149	118	%	%	NOUN
dpc-3650	149	119	15.0	15.0	NUM
dpc-3650	149	120	62.5	62.5	NUM
dpc-3650	149	121	%	%	NOUN
dpc-3650	149	122	23.0	23.0	NUM
dpc-3650	149	123	82.1	82.1	NUM
dpc-3650	149	124	%	%	NOUN
dpc-3650	149	125	no	no	DET
dpc-3650	149	126	4.0	4.0	NUM
dpc-3650	149	127	14.3	14.3	NUM
dpc-3650	149	128	%	%	NOUN
dpc-3650	149	129	9.0	9.0	NUM
dpc-3650	149	130	37.5	37.5	NUM
dpc-3650	149	131	%	%	NOUN
dpc-3650	149	132	5.0	5.0	NUM
dpc-3650	149	133	17.9	17.9	NUM
dpc-3650	149	134	%	%	NOUN
dpc-3650	149	135	sexual	sexual	ADJ
dpc-3650	149	136	activity	activity	NOUN
dpc-3650	149	137	/	/	PUNCT
dpc-3650	149	138	affected	affect	VERB
dpc-3650	149	139	by	by	ADP
dpc-3650	149	140	psoriasis	psoriasis	NOUN
dpc-3650	149	141	yes	yes	INTJ
dpc-3650	149	142	.0	.0	NUM
dpc-3650	149	143	0.0	0.0	NUM
dpc-3650	149	144	%	%	NOUN
dpc-3650	149	145	14.0	14.0	NUM
dpc-3650	149	146	58.3	58.3	NUM
dpc-3650	149	147	%	%	NOUN
dpc-3650	149	148	7.0	7.0	NUM
dpc-3650	149	149	25.0	25.0	NUM
dpc-3650	149	150	%	%	NOUN
dpc-3650	149	151	no	no	DET
dpc-3650	149	152	.0	.0	NUM
dpc-3650	149	153	0.0	0.0	NUM
dpc-3650	149	154	%	%	NOUN
dpc-3650	149	155	10.0	10.0	NUM
dpc-3650	149	156	41.7	41.7	NUM
dpc-3650	149	157	%	%	NOUN
dpc-3650	149	158	21.0	21.0	NUM
dpc-3650	149	159	75.0	75.0	NUM
dpc-3650	149	160	%	%	NOUN
dpc-3650	149	161	6	6	NUM
dpc-3650	149	162	original	original	ADJ
dpc-3650	149	163	article	article	NOUN
dpc-3650	149	164	|	|	ADV
dpc-3650	149	165	dermatol	dermatol	ADJ
dpc-3650	149	166	pract	pract	NOUN
dpc-3650	149	167	concept	concept	NOUN
dpc-3650	149	168	.	.	PUNCT
dpc-3650	150	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	150	2	figure	figure	NOUN
dpc-3650	150	3	1	1	NUM
dpc-3650	150	4	.	.	PUNCT
dpc-3650	150	5	comparative	comparative	ADJ
dpc-3650	150	6	boxplot	boxplot	NOUN
dpc-3650	150	7	of	of	ADP
dpc-3650	150	8	erythrocyte	erythrocyte	PROPN
dpc-3650	150	9	sedimentation	sedimentation	NOUN
dpc-3650	150	10	rate	rate	NOUN
dpc-3650	150	11	(	(	PUNCT
dpc-3650	150	12	esr	esr	PROPN
dpc-3650	150	13	)	)	PUNCT
dpc-3650	150	14	baseline	baseline	NOUN
dpc-3650	150	15	values	value	NOUN
dpc-3650	150	16	.	.	PUNCT
dpc-3650	151	1	figure	figure	NOUN
dpc-3650	151	2	2	2	NUM
dpc-3650	151	3	.	.	PUNCT
dpc-3650	151	4	comparative	comparative	ADJ
dpc-3650	151	5	boxplot	boxplot	NOUN
dpc-3650	151	6	of	of	ADP
dpc-3650	151	7	creactive	creactive	ADJ
dpc-3650	151	8	protein	protein	NOUN
dpc-3650	151	9	(	(	PUNCT
dpc-3650	151	10	crp	crp	NOUN
dpc-3650	151	11	)	)	PUNCT
dpc-3650	151	12	baseline	baseline	NOUN
dpc-3650	151	13	values	value	NOUN
dpc-3650	151	14	.	.	PUNCT
dpc-3650	152	1	table	table	NOUN
dpc-3650	152	2	3	3	NUM
dpc-3650	152	3	.	.	PUNCT
dpc-3650	153	1	distribution	distribution	NOUN
dpc-3650	153	2	on	on	ADP
dpc-3650	153	3	erythrocyte	erythrocyte	PROPN
dpc-3650	153	4	sedimentation	sedimentation	NOUN
dpc-3650	153	5	rate	rate	NOUN
dpc-3650	153	6	and	and	CCONJ
dpc-3650	153	7	creactive	creactive	ADJ
dpc-3650	153	8	protein	protein	NOUN
dpc-3650	153	9	values	value	NOUN
dpc-3650	153	10	in	in	ADP
dpc-3650	153	11	the	the	DET
dpc-3650	153	12	three	three	NUM
dpc-3650	153	13	groups	group	NOUN
dpc-3650	153	14	across	across	ADP
dpc-3650	153	15	the	the	DET
dpc-3650	153	16	two	two	NUM
dpc-3650	153	17	time	time	NOUN
dpc-3650	153	18	points	point	VERB
dpc-3650	153	19	esr	esr	PROPN
dpc-3650	153	20	at	at	ADP
dpc-3650	153	21	baseline	baseline	PROPN
dpc-3650	153	22	crp	crp	PROPN
dpc-3650	153	23	at	at	ADP
dpc-3650	153	24	baseline	baseline	ADJ
dpc-3650	153	25	median	median	ADJ
dpc-3650	153	26	range	range	NOUN
dpc-3650	153	27	median	median	ADJ
dpc-3650	153	28	range	range	NOUN
dpc-3650	153	29	group	group	NOUN
dpc-3650	153	30	•	•	ADP
dpc-3650	153	31	healthy	healthy	ADJ
dpc-3650	153	32	controls	control	VERB
dpc-3650	153	33	6.00	6.00	NUM
dpc-3650	153	34	20.00	20.00	NUM
dpc-3650	153	35	.15	.15	NUM
dpc-3650	153	36	.50	.50	NUM
dpc-3650	153	37	•	•	NOUN
dpc-3650	153	38	psoriasis	psoriasis	NOUN
dpc-3650	153	39	and	and	CCONJ
dpc-3650	153	40	depression	depression	NOUN
dpc-3650	153	41	12.50a	12.50a	NUM
dpc-3650	153	42	50.00	50.00	NUM
dpc-3650	153	43	.50b	.50b	PROPN
dpc-3650	153	44	1.73	1.73	NUM
dpc-3650	153	45	•	•	NOUN
dpc-3650	153	46	psoriasis	psoriasis	NOUN
dpc-3650	153	47	5.00	5.00	NUM
dpc-3650	153	48	28.00	28.00	NUM
dpc-3650	153	49	.28	.28	NUM
dpc-3650	153	50	b	b	NUM
dpc-3650	153	51	1.68	1.68	NUM
dpc-3650	153	52	a	a	DET
dpc-3650	153	53	significantly	significantly	ADV
dpc-3650	153	54	higher	high	ADJ
dpc-3650	153	55	esr	esr	PROPN
dpc-3650	153	56	levels	level	NOUN
dpc-3650	153	57	versus	versus	ADP
dpc-3650	153	58	patients	patient	NOUN
dpc-3650	153	59	with	with	ADP
dpc-3650	153	60	psoriasis	psoriasis	NOUN
dpc-3650	153	61	crp	crp	NOUN
dpc-3650	153	62	=	=	NOUN
dpc-3650	153	63	creactive	creactive	ADJ
dpc-3650	153	64	protein	protein	NOUN
dpc-3650	153	65	;	;	PUNCT
dpc-3650	153	66	esr	esr	PROPN
dpc-3650	153	67	=	=	PUNCT
dpc-3650	153	68	erythrocyte	erythrocyte	PROPN
dpc-3650	153	69	sedimentation	sedimentation	NOUN
dpc-3650	153	70	rate	rate	NOUN
dpc-3650	153	71	.	.	PUNCT
dpc-3650	154	1	b	b	NOUN
dpc-3650	154	2	significantly	significantly	ADV
dpc-3650	154	3	higher	high	ADJ
dpc-3650	154	4	crp	crp	PROPN
dpc-3650	154	5	levels	level	NOUN
dpc-3650	154	6	vs	vs	ADP
dpc-3650	154	7	healthy	healthy	ADJ
dpc-3650	154	8	controls	control	NOUN
dpc-3650	154	9	table	table	NOUN
dpc-3650	154	10	4	4	NUM
dpc-3650	154	11	.	.	PUNCT
dpc-3650	155	1	distribution	distribution	NOUN
dpc-3650	155	2	on	on	ADP
dpc-3650	155	3	erythrocyte	erythrocyte	PROPN
dpc-3650	155	4	sedimentation	sedimentation	NOUN
dpc-3650	155	5	rate	rate	NOUN
dpc-3650	155	6	and	and	CCONJ
dpc-3650	155	7	creactive	creactive	ADJ
dpc-3650	155	8	protein	protein	NOUN
dpc-3650	155	9	values	value	NOUN
dpc-3650	155	10	in	in	ADP
dpc-3650	155	11	the	the	DET
dpc-3650	155	12	two	two	NUM
dpc-3650	155	13	groups	group	NOUN
dpc-3650	155	14	across	across	ADP
dpc-3650	155	15	the	the	DET
dpc-3650	155	16	two	two	NUM
dpc-3650	155	17	time	time	NOUN
dpc-3650	155	18	points	point	NOUN
dpc-3650	155	19	group	group	NOUN
dpc-3650	155	20	psoriasis	psoriasis	NOUN
dpc-3650	155	21	and	and	CCONJ
dpc-3650	155	22	depression	depression	NOUN
dpc-3650	155	23	psoriasis	psoriasis	NOUN
dpc-3650	155	24	median	median	ADJ
dpc-3650	155	25	range	range	NOUN
dpc-3650	155	26	median	median	ADJ
dpc-3650	155	27	range	range	NOUN
dpc-3650	155	28	esr	esr	PROPN
dpc-3650	155	29	at	at	ADP
dpc-3650	155	30	baseline	baseline	NOUN
dpc-3650	155	31	12.50a	12.50a	NUM
dpc-3650	155	32	50.00	50.00	NUM
dpc-3650	155	33	5.00	5.00	NUM
dpc-3650	155	34	28.00	28.00	NUM
dpc-3650	155	35	esr	esr	NOUN
dpc-3650	155	36	at	at	ADP
dpc-3650	155	37	3	3	NUM
dpc-3650	155	38	m	m	PROPN
dpc-3650	155	39	10.00	10.00	NUM
dpc-3650	155	40	a	a	DET
dpc-3650	155	41	58.00	58.00	NUM
dpc-3650	155	42	4.00	4.00	NUM
dpc-3650	155	43	28.00	28.00	NUM
dpc-3650	155	44	crp	crp	NOUN
dpc-3650	155	45	at	at	ADP
dpc-3650	155	46	baseline	baseline	PROPN
dpc-3650	155	47	.50	.50	NUM
dpc-3650	155	48	1.73	1.73	NUM
dpc-3650	155	49	.28	.28	NUM
dpc-3650	155	50	1.68	1.68	NUM
dpc-3650	155	51	crp	crp	NOUN
dpc-3650	155	52	at	at	ADP
dpc-3650	155	53	3	3	NUM
dpc-3650	155	54	m	m	NOUN
dpc-3650	155	55	.31	.31	NUM
dpc-3650	155	56	5.47	5.47	NUM
dpc-3650	155	57	.21	.21	NUM
dpc-3650	155	58	1.66	1.66	NUM
dpc-3650	155	59	a	a	DET
dpc-3650	155	60	significantly	significantly	ADV
dpc-3650	155	61	higher	high	ADJ
dpc-3650	155	62	erythrocyte	erythrocyte	PROPN
dpc-3650	155	63	sedimentation	sedimentation	NOUN
dpc-3650	155	64	rate	rate	NOUN
dpc-3650	155	65	levels	level	NOUN
dpc-3650	155	66	versus	versus	ADP
dpc-3650	155	67	patients	patient	NOUN
dpc-3650	155	68	with	with	ADP
dpc-3650	155	69	psoriasis	psoriasis	NOUN
dpc-3650	155	70	no	no	DET
dpc-3650	155	71	differences	difference	NOUN
dpc-3650	155	72	were	be	AUX
dpc-3650	155	73	observed	observe	VERB
dpc-3650	155	74	between	between	ADP
dpc-3650	155	75	the	the	DET
dpc-3650	155	76	two	two	NUM
dpc-3650	155	77	groups	group	NOUN
dpc-3650	155	78	of	of	ADP
dpc-3650	155	79	patients	patient	NOUN
dpc-3650	155	80	at	at	ADP
dpc-3650	155	81	either	either	DET
dpc-3650	155	82	time	time	NOUN
dpc-3650	155	83	point	point	NOUN
dpc-3650	155	84	.	.	PUNCT
dpc-3650	156	1	subgroup	subgroup	NOUN
dpc-3650	156	2	analysis	analysis	NOUN
dpc-3650	156	3	indicated	indicate	VERB
dpc-3650	156	4	significantly	significantly	ADV
dpc-3650	156	5	higher	high	ADJ
dpc-3650	156	6	esr	esr	PROPN
dpc-3650	156	7	levels	level	NOUN
dpc-3650	156	8	in	in	ADP
dpc-3650	156	9	women	woman	NOUN
dpc-3650	156	10	at	at	ADP
dpc-3650	156	11	3	3	NUM
dpc-3650	156	12	months	month	NOUN
dpc-3650	156	13	(	(	PUNCT
dpc-3650	156	14	median=29	median=29	NOUN
dpc-3650	156	15	,	,	PUNCT
dpc-3650	156	16	range	range	NOUN
dpc-3650	156	17	=	=	NOUN
dpc-3650	156	18	56	56	NUM
dpc-3650	156	19	)	)	PUNCT
dpc-3650	156	20	,	,	PUNCT
dpc-3650	156	21	compared	compare	VERB
dpc-3650	156	22	to	to	ADP
dpc-3650	156	23	men	man	NOUN
dpc-3650	156	24	(	(	PUNCT
dpc-3650	156	25	median=4	median=4	PROPN
dpc-3650	156	26	,	,	PUNCT
dpc-3650	156	27	range	range	NOUN
dpc-3650	156	28	=	=	SYM
dpc-3650	156	29	39	39	NUM
dpc-3650	156	30	)	)	PUNCT
dpc-3650	156	31	,	,	PUNCT
dpc-3650	156	32	p	p	X
dpc-3650	156	33	=	=	NOUN
dpc-3650	156	34	0.005	0.005	NUM
dpc-3650	156	35	.	.	PUNCT
dpc-3650	157	1	the	the	DET
dpc-3650	157	2	beck	beck	NOUN
dpc-3650	157	3	anxiety	anxiety	NOUN
dpc-3650	157	4	score	score	NOUN
dpc-3650	157	5	was	be	AUX
dpc-3650	157	6	positively	positively	ADV
dpc-3650	157	7	correlated	correlate	VERB
dpc-3650	157	8	to	to	ADP
dpc-3650	157	9	crp	crp	PROPN
dpc-3650	157	10	values	value	NOUN
dpc-3650	157	11	at	at	ADP
dpc-3650	157	12	baseline	baseline	NOUN
dpc-3650	157	13	(	(	PUNCT
dpc-3650	157	14	p	p	X
dpc-3650	157	15	=	=	NOUN
dpc-3650	157	16	0.027	0.027	NUM
dpc-3650	157	17	)	)	PUNCT
dpc-3650	157	18	and	and	CCONJ
dpc-3650	157	19	at	at	ADP
dpc-3650	157	20	3	3	NUM
dpc-3650	157	21	months	month	NOUN
dpc-3650	157	22	as	as	ADV
dpc-3650	157	23	well	well	ADV
dpc-3650	157	24	(	(	PUNCT
dpc-3650	157	25	p	p	X
dpc-3650	157	26	=	=	NOUN
dpc-3650	157	27	0.009	0.009	NUM
dpc-3650	157	28	)	)	PUNCT
dpc-3650	157	29	.	.	PUNCT
dpc-3650	158	1	finally	finally	ADV
dpc-3650	158	2	,	,	PUNCT
dpc-3650	158	3	higher	high	ADJ
dpc-3650	158	4	crp	crp	PROPN
dpc-3650	158	5	values	value	NOUN
dpc-3650	158	6	were	be	AUX
dpc-3650	158	7	observed	observe	VERB
dpc-3650	158	8	in	in	ADP
dpc-3650	158	9	patients	patient	NOUN
dpc-3650	158	10	with	with	ADP
dpc-3650	158	11	higher	high	ADJ
dpc-3650	158	12	bmi	bmi	NOUN
dpc-3650	158	13	value	value	NOUN
dpc-3650	158	14	at	at	ADP
dpc-3650	158	15	baseline	baseline	NOUN
dpc-3650	158	16	(	(	PUNCT
dpc-3650	158	17	p	p	X
dpc-3650	158	18	<	<	X
dpc-3650	158	19	0.001	0.001	NUM
dpc-3650	158	20	)	)	PUNCT
dpc-3650	158	21	.	.	PUNCT
dpc-3650	159	1	conclusions	conclusion	NOUN
dpc-3650	159	2	the	the	DET
dpc-3650	159	3	aim	aim	NOUN
dpc-3650	159	4	of	of	ADP
dpc-3650	159	5	the	the	DET
dpc-3650	159	6	study	study	NOUN
dpc-3650	159	7	was	be	AUX
dpc-3650	159	8	to	to	PART
dpc-3650	159	9	investigate	investigate	VERB
dpc-3650	159	10	a	a	DET
dpc-3650	159	11	potential	potential	ADJ
dpc-3650	159	12	significant	significant	ADJ
dpc-3650	159	13	difference	difference	NOUN
dpc-3650	159	14	in	in	ADP
dpc-3650	159	15	the	the	DET
dpc-3650	159	16	levels	level	NOUN
dpc-3650	159	17	of	of	ADP
dpc-3650	159	18	inflammatory	inflammatory	ADJ
dpc-3650	159	19	markers	marker	NOUN
dpc-3650	159	20	crp	crp	PROPN
dpc-3650	159	21	and	and	CCONJ
dpc-3650	159	22	esr	esr	PROPN
dpc-3650	159	23	between	between	ADP
dpc-3650	159	24	patients	patient	NOUN
dpc-3650	159	25	with	with	ADP
dpc-3650	159	26	psoriasis	psoriasis	NOUN
dpc-3650	159	27	and	and	CCONJ
dpc-3650	159	28	patients	patient	NOUN
dpc-3650	159	29	with	with	ADP
dpc-3650	159	30	psoriasis	psoriasis	NOUN
dpc-3650	159	31	and	and	CCONJ
dpc-3650	159	32	depression	depression	NOUN
dpc-3650	159	33	.	.	PUNCT
dpc-3650	160	1	the	the	DET
dpc-3650	160	2	potential	potential	ADJ
dpc-3650	160	3	influence	influence	NOUN
dpc-3650	160	4	of	of	ADP
dpc-3650	160	5	a	a	DET
dpc-3650	160	6	three	three	NUM
dpc-3650	160	7	-	-	PUNCT
dpc-3650	160	8	month	month	NOUN
dpc-3650	160	9	systematic	systematic	ADJ
dpc-3650	160	10	treatment	treatment	NOUN
dpc-3650	160	11	for	for	ADP
dpc-3650	160	12	psoriasis	psoriasis	NOUN
dpc-3650	160	13	on	on	ADP
dpc-3650	160	14	the	the	DET
dpc-3650	160	15	inflammatory	inflammatory	ADJ
dpc-3650	160	16	original	original	ADJ
dpc-3650	160	17	article	article	NOUN
dpc-3650	160	18	|	|	ADV
dpc-3650	160	19	dermatol	dermatol	ADJ
dpc-3650	160	20	pract	pract	NOUN
dpc-3650	160	21	concept	concept	NOUN
dpc-3650	160	22	.	.	PUNCT
dpc-3650	161	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	161	2	7	7	NUM
dpc-3650	161	3	activity	activity	NOUN
dpc-3650	161	4	has	have	AUX
dpc-3650	161	5	not	not	PART
dpc-3650	161	6	been	be	AUX
dpc-3650	161	7	studied	study	VERB
dpc-3650	161	8	[	[	PUNCT
dpc-3650	161	9	60	60	NUM
dpc-3650	161	10	]	]	PUNCT
dpc-3650	161	11	.	.	PUNCT
dpc-3650	162	1	an	an	DET
dpc-3650	162	2	older	old	ADJ
dpc-3650	162	3	drug	drug	NOUN
dpc-3650	162	4	still	still	ADV
dpc-3650	162	5	used	use	VERB
dpc-3650	162	6	against	against	ADP
dpc-3650	162	7	psoriasis	psoriasis	NOUN
dpc-3650	162	8	is	be	AUX
dpc-3650	162	9	methotrexate	methotrexate	VERB
dpc-3650	162	10	.	.	PUNCT
dpc-3650	163	1	the	the	DET
dpc-3650	163	2	antidepressant	antidepressant	ADJ
dpc-3650	163	3	effect	effect	NOUN
dpc-3650	163	4	of	of	ADP
dpc-3650	163	5	methotrexate	methotrexate	NOUN
dpc-3650	163	6	has	have	AUX
dpc-3650	163	7	not	not	PART
dpc-3650	163	8	been	be	AUX
dpc-3650	163	9	studied	study	VERB
dpc-3650	163	10	.	.	PUNCT
dpc-3650	164	1	conversely	conversely	ADV
dpc-3650	164	2	,	,	PUNCT
dpc-3650	164	3	depressive	depressive	ADJ
dpc-3650	164	4	symptomatology	symptomatology	NOUN
dpc-3650	164	5	is	be	AUX
dpc-3650	164	6	reported	report	VERB
dpc-3650	164	7	as	as	ADP
dpc-3650	164	8	an	an	DET
dpc-3650	164	9	adverse	adverse	ADJ
dpc-3650	164	10	drug	drug	NOUN
dpc-3650	164	11	effect	effect	NOUN
dpc-3650	164	12	.	.	PUNCT
dpc-3650	165	1	αt	αt	NOUN
dpc-3650	165	2	the	the	DET
dpc-3650	165	3	end	end	NOUN
dpc-3650	165	4	it	it	PRON
dpc-3650	165	5	would	would	AUX
dpc-3650	165	6	be	be	AUX
dpc-3650	165	7	good	good	ADJ
dpc-3650	165	8	to	to	PART
dpc-3650	165	9	inform	inform	VERB
dpc-3650	165	10	our	our	PRON
dpc-3650	165	11	patients	patient	NOUN
dpc-3650	165	12	about	about	ADP
dpc-3650	165	13	their	their	PRON
dpc-3650	165	14	condition	condition	NOUN
dpc-3650	165	15	and	and	CCONJ
dpc-3650	165	16	direct	direct	VERB
dpc-3650	165	17	them	they	PRON
dpc-3650	165	18	to	to	ADP
dpc-3650	165	19	the	the	DET
dpc-3650	165	20	appropriate	appropriate	ADJ
dpc-3650	165	21	specialist	specialist	NOUN
dpc-3650	165	22	for	for	ADP
dpc-3650	165	23	them	they	PRON
dpc-3650	165	24	(	(	PUNCT
dpc-3650	165	25	psychiatrist	psychiatrist	NOUN
dpc-3650	165	26	or	or	CCONJ
dpc-3650	165	27	psychologist	psychologist	NOUN
dpc-3650	165	28	or	or	CCONJ
dpc-3650	165	29	both	both	PRON
dpc-3650	165	30	of	of	ADP
dpc-3650	165	31	them	they	PRON
dpc-3650	165	32	)	)	PUNCT
dpc-3650	165	33	.	.	PUNCT
dpc-3650	166	1	regarding	regard	VERB
dpc-3650	166	2	pharmacologic	pharmacologic	ADJ
dpc-3650	166	3	treatment	treatment	NOUN
dpc-3650	166	4	,	,	PUNCT
dpc-3650	166	5	there	there	PRON
dpc-3650	166	6	are	be	VERB
dpc-3650	166	7	studies	study	NOUN
dpc-3650	166	8	that	that	PRON
dpc-3650	166	9	evaluated	evaluate	VERB
dpc-3650	166	10	the	the	DET
dpc-3650	166	11	efficacy	efficacy	NOUN
dpc-3650	166	12	of	of	ADP
dpc-3650	166	13	antidepressants	antidepressant	NOUN
dpc-3650	166	14	,	,	PUNCT
dpc-3650	166	15	mainly	mainly	ADV
dpc-3650	166	16	selective	selective	ADJ
dpc-3650	166	17	serotonin	serotonin	NOUN
dpc-3650	166	18	reuptake	reuptake	NOUN
dpc-3650	166	19	inhibitors	inhibitor	NOUN
dpc-3650	166	20	.	.	PUNCT
dpc-3650	167	1	nowadays	nowadays	ADV
dpc-3650	167	2	we	we	PRON
dpc-3650	167	3	know	know	VERB
dpc-3650	167	4	the	the	DET
dpc-3650	167	5	role	role	NOUN
dpc-3650	167	6	of	of	ADP
dpc-3650	167	7	the	the	DET
dpc-3650	167	8	brain	brain	NOUN
dpc-3650	167	9	-	-	PUNCT
dpc-3650	167	10	skin	skin	NOUN
dpc-3650	167	11	axis	axis	NOUN
dpc-3650	167	12	[	[	X
dpc-3650	167	13	28	28	NUM
dpc-3650	167	14	]	]	PUNCT
dpc-3650	167	15	in	in	ADP
dpc-3650	167	16	psoriasis	psoriasis	NOUN
dpc-3650	167	17	and	and	CCONJ
dpc-3650	167	18	depression	depression	NOUN
dpc-3650	167	19	,	,	PUNCT
dpc-3650	167	20	which	which	PRON
dpc-3650	167	21	among	among	ADP
dpc-3650	167	22	others	other	NOUN
dpc-3650	167	23	leads	lead	VERB
dpc-3650	167	24	to	to	ADP
dpc-3650	167	25	decreased	decrease	VERB
dpc-3650	167	26	serotonin	serotonin	NOUN
dpc-3650	167	27	levels	level	NOUN
dpc-3650	167	28	.	.	PUNCT
dpc-3650	168	1	serotonin	serotonin	NOUN
dpc-3650	168	2	is	be	AUX
dpc-3650	168	3	considered	consider	VERB
dpc-3650	168	4	the	the	DET
dpc-3650	168	5	“	"	PUNCT
dpc-3650	168	6	happiness	happiness	NOUN
dpc-3650	168	7	hormone	hormone	NOUN
dpc-3650	168	8	”	"	PUNCT
dpc-3650	168	9	because	because	SCONJ
dpc-3650	168	10	it	it	PRON
dpc-3650	168	11	affects	affect	VERB
dpc-3650	168	12	mood	mood	NOUN
dpc-3650	168	13	and	and	CCONJ
dpc-3650	168	14	high	high	ADJ
dpc-3650	168	15	levels	level	NOUN
dpc-3650	168	16	of	of	ADP
dpc-3650	168	17	serotonin	serotonin	NOUN
dpc-3650	168	18	are	be	AUX
dpc-3650	168	19	associated	associate	VERB
dpc-3650	168	20	with	with	ADP
dpc-3650	168	21	elevated	elevated	ADJ
dpc-3650	168	22	mood	mood	NOUN
dpc-3650	168	23	and	and	CCONJ
dpc-3650	168	24	feelings	feeling	NOUN
dpc-3650	168	25	of	of	ADP
dpc-3650	168	26	joy	joy	NOUN
dpc-3650	168	27	.	.	PUNCT
dpc-3650	169	1	low	low	ADJ
dpc-3650	169	2	levels	level	NOUN
dpc-3650	169	3	of	of	ADP
dpc-3650	169	4	serotonin	serotonin	NOUN
dpc-3650	169	5	(	(	PUNCT
dpc-3650	169	6	serotonergic	serotonergic	ADJ
dpc-3650	169	7	disbalance	disbalance	NOUN
dpc-3650	169	8	)	)	PUNCT
dpc-3650	169	9	are	be	AUX
dpc-3650	169	10	the	the	DET
dpc-3650	169	11	key	key	NOUN
dpc-3650	169	12	to	to	ADP
dpc-3650	169	13	pathophysiological	pathophysiological	ADJ
dpc-3650	169	14	mechanisms	mechanism	NOUN
dpc-3650	169	15	in	in	ADP
dpc-3650	169	16	depression	depression	NOUN
dpc-3650	169	17	[	[	X
dpc-3650	169	18	62	62	NUM
dpc-3650	169	19	]	]	PUNCT
dpc-3650	169	20	.	.	PUNCT
dpc-3650	170	1	brain	brain	NOUN
dpc-3650	170	2	skin	skin	NOUN
dpc-3650	170	3	axis	axis	NOUN
dpc-3650	170	4	[	[	X
dpc-3650	170	5	28	28	NUM
dpc-3650	170	6	]	]	PUNCT
dpc-3650	170	7	by	by	ADP
dpc-3650	170	8	the	the	DET
dpc-3650	170	9	release	release	NOUN
dpc-3650	170	10	of	of	ADP
dpc-3650	170	11	the	the	DET
dpc-3650	170	12	acth	acth	ADJ
dpc-3650	170	13	hormone	hormone	NOUN
dpc-3650	170	14	,	,	PUNCT
dpc-3650	170	15	which	which	PRON
dpc-3650	170	16	has	have	VERB
dpc-3650	170	17	receptors	receptor	NOUN
dpc-3650	170	18	among	among	ADP
dpc-3650	170	19	others	other	NOUN
dpc-3650	170	20	in	in	ADP
dpc-3650	170	21	the	the	DET
dpc-3650	170	22	skin	skin	NOUN
dpc-3650	170	23	,	,	PUNCT
dpc-3650	170	24	leads	lead	VERB
dpc-3650	170	25	to	to	ADP
dpc-3650	170	26	the	the	DET
dpc-3650	170	27	degranulation	degranulation	NOUN
dpc-3650	170	28	of	of	ADP
dpc-3650	170	29	mastocytes	mastocyte	NOUN
dpc-3650	170	30	and	and	CCONJ
dpc-3650	170	31	the	the	DET
dpc-3650	170	32	release	release	NOUN
dpc-3650	170	33	of	of	ADP
dpc-3650	170	34	inflammatory	inflammatory	ADJ
dpc-3650	170	35	factors	factor	NOUN
dpc-3650	170	36	:	:	PUNCT
dpc-3650	170	37	ifn	ifn	PROPN
dpc-3650	170	38	-	-	PUNCT
dpc-3650	170	39	a	a	NOUN
dpc-3650	170	40	and	and	CCONJ
dpc-3650	170	41	the	the	DET
dpc-3650	170	42	il-2	il-2	ADJ
dpc-3650	170	43	,	,	PUNCT
dpc-3650	170	44	il-6	il-6	NUM
dpc-3650	170	45	,	,	PUNCT
dpc-3650	170	46	il1β	il1β	PROPN
dpc-3650	170	47	,	,	PUNCT
dpc-3650	170	48	tnf	tnf	PROPN
dpc-3650	170	49	-	-	PUNCT
dpc-3650	170	50	α	α	PROPN
dpc-3650	170	51	by	by	ADP
dpc-3650	170	52	increasing	increase	VERB
dpc-3650	170	53	the	the	DET
dpc-3650	170	54	production	production	NOUN
dpc-3650	170	55	of	of	ADP
dpc-3650	170	56	the	the	DET
dpc-3650	170	57	enzyme	enzyme	NOUN
dpc-3650	170	58	indoleamine	indoleamine	NOUN
dpc-3650	170	59	2,3	2,3	NUM
dpc-3650	170	60	-	-	NOUN
dpc-3650	170	61	dioxygenase	dioxygenase	NOUN
dpc-3650	170	62	.	.	PUNCT
dpc-3650	171	1	this	this	DET
dpc-3650	171	2	enzyme	enzyme	NOUN
dpc-3650	171	3	(	(	PUNCT
dpc-3650	171	4	indoleamine	indoleamine	NOUN
dpc-3650	171	5	2,3dioxygenase	2,3dioxygenase	NUM
dpc-3650	171	6	)	)	PUNCT
dpc-3650	171	7	catalyzes	catalyze	VERB
dpc-3650	171	8	tryptophan	tryptophan	NOUN
dpc-3650	171	9	into	into	ADP
dpc-3650	171	10	various	various	ADJ
dpc-3650	171	11	other	other	ADJ
dpc-3650	171	12	products	product	NOUN
dpc-3650	171	13	.	.	PUNCT
dpc-3650	172	1	serotonin	serotonin	NOUN
dpc-3650	172	2	is	be	AUX
dpc-3650	172	3	produced	produce	VERB
dpc-3650	172	4	from	from	ADP
dpc-3650	172	5	tryptophan	tryptophan	NOUN
dpc-3650	172	6	,	,	PUNCT
dpc-3650	172	7	resulting	result	VERB
dpc-3650	172	8	in	in	ADP
dpc-3650	172	9	decreased	decrease	VERB
dpc-3650	172	10	serotonin	serotonin	NOUN
dpc-3650	172	11	production	production	NOUN
dpc-3650	172	12	due	due	ADP
dpc-3650	172	13	to	to	ADP
dpc-3650	172	14	reduced	reduce	VERB
dpc-3650	172	15	tryptophan	tryptophan	NOUN
dpc-3650	172	16	and	and	CCONJ
dpc-3650	172	17	its	its	PRON
dpc-3650	172	18	products	product	NOUN
dpc-3650	172	19	[	[	X
dpc-3650	172	20	63	63	NUM
dpc-3650	172	21	]	]	PUNCT
dpc-3650	172	22	.	.	PUNCT
dpc-3650	173	1	the	the	DET
dpc-3650	173	2	relationship	relationship	NOUN
dpc-3650	173	3	between	between	ADP
dpc-3650	173	4	the	the	DET
dpc-3650	173	5	use	use	NOUN
dpc-3650	173	6	of	of	ADP
dpc-3650	173	7	antidepressants	antidepressant	NOUN
dpc-3650	173	8	for	for	ADP
dpc-3650	173	9	the	the	DET
dpc-3650	173	10	treatment	treatment	NOUN
dpc-3650	173	11	of	of	ADP
dpc-3650	173	12	depression	depression	NOUN
dpc-3650	173	13	and	and	CCONJ
dpc-3650	173	14	the	the	DET
dpc-3650	173	15	reduction	reduction	NOUN
dpc-3650	173	16	of	of	ADP
dpc-3650	173	17	inflammation	inflammation	NOUN
dpc-3650	173	18	and	and	CCONJ
dpc-3650	173	19	specifically	specifically	ADV
dpc-3650	173	20	the	the	DET
dpc-3650	173	21	reduction	reduction	NOUN
dpc-3650	173	22	of	of	ADP
dpc-3650	173	23	crp	crp	PROPN
dpc-3650	173	24	has	have	AUX
dpc-3650	173	25	also	also	ADV
dpc-3650	173	26	been	be	AUX
dpc-3650	173	27	studied	study	VERB
dpc-3650	173	28	[	[	PUNCT
dpc-3650	173	29	64	64	NUM
dpc-3650	173	30	]	]	PUNCT
dpc-3650	173	31	.	.	PUNCT
dpc-3650	174	1	however	however	ADV
dpc-3650	174	2	,	,	PUNCT
dpc-3650	174	3	there	there	PRON
dpc-3650	174	4	is	be	VERB
dpc-3650	174	5	also	also	ADV
dpc-3650	174	6	an	an	DET
dpc-3650	174	7	opinion	opinion	NOUN
dpc-3650	174	8	that	that	SCONJ
dpc-3650	174	9	although	although	SCONJ
dpc-3650	174	10	antidepressants	antidepressant	NOUN
dpc-3650	174	11	may	may	AUX
dpc-3650	174	12	alleviate	alleviate	VERB
dpc-3650	174	13	psychiatric	psychiatric	ADJ
dpc-3650	174	14	symptoms	symptom	NOUN
dpc-3650	174	15	,	,	PUNCT
dpc-3650	174	16	there	there	PRON
dpc-3650	174	17	is	be	VERB
dpc-3650	174	18	evidence	evidence	NOUN
dpc-3650	174	19	that	that	SCONJ
dpc-3650	174	20	they	they	PRON
dpc-3650	174	21	may	may	AUX
dpc-3650	174	22	be	be	AUX
dpc-3650	174	23	associated	associate	VERB
dpc-3650	174	24	with	with	ADP
dpc-3650	174	25	psoriasis	psoriasis	NOUN
dpc-3650	174	26	symptoms	symptom	NOUN
dpc-3650	174	27	exacerbation	exacerbation	NOUN
dpc-3650	174	28	[	[	X
dpc-3650	174	29	63	63	NUM
dpc-3650	174	30	]	]	PUNCT
dpc-3650	174	31	.	.	PUNCT
dpc-3650	175	1	concerning	concern	VERB
dpc-3650	175	2	other	other	ADJ
dpc-3650	175	3	therapeutic	therapeutic	ADJ
dpc-3650	175	4	approaches	approach	NOUN
dpc-3650	175	5	,	,	PUNCT
dpc-3650	175	6	a	a	DET
dpc-3650	175	7	meta	meta	ADJ
dpc-3650	175	8	-	-	PUNCT
dpc-3650	175	9	analysis	analysis	NOUN
dpc-3650	175	10	revealed	reveal	VERB
dpc-3650	175	11	encouraging	encouraging	ADJ
dpc-3650	175	12	results	result	NOUN
dpc-3650	175	13	with	with	ADP
dpc-3650	175	14	respect	respect	NOUN
dpc-3650	175	15	to	to	ADP
dpc-3650	175	16	the	the	DET
dpc-3650	175	17	psychotherapeutic	psychotherapeutic	ADJ
dpc-3650	175	18	interventions	intervention	NOUN
dpc-3650	175	19	effectiveness	effectiveness	NOUN
dpc-3650	175	20	on	on	ADP
dpc-3650	175	21	psoriasis	psoriasis	NOUN
dpc-3650	175	22	outcomes	outcome	NOUN
dpc-3650	176	1	[	[	X
dpc-3650	176	2	65	65	NUM
dpc-3650	176	3	]	]	PUNCT
dpc-3650	176	4	.	.	PUNCT
dpc-3650	177	1	cognitive	cognitive	ADJ
dpc-3650	177	2	behavioral	behavioral	ADJ
dpc-3650	177	3	therapy	therapy	NOUN
dpc-3650	177	4	may	may	AUX
dpc-3650	177	5	be	be	AUX
dpc-3650	177	6	a	a	DET
dpc-3650	177	7	promising	promising	ADJ
dpc-3650	177	8	complementary	complementary	ADJ
dpc-3650	177	9	approach	approach	NOUN
dpc-3650	177	10	for	for	ADP
dpc-3650	177	11	psoriasis	psoriasis	NOUN
dpc-3650	177	12	patients	patient	NOUN
dpc-3650	177	13	with	with	ADP
dpc-3650	177	14	depressive	depressive	ADJ
dpc-3650	177	15	symptoms	symptom	NOUN
dpc-3650	177	16	[	[	X
dpc-3650	177	17	66	66	NUM
dpc-3650	177	18	]	]	PUNCT
dpc-3650	177	19	.	.	PUNCT
dpc-3650	178	1	still	still	ADV
dpc-3650	178	2	,	,	PUNCT
dpc-3650	178	3	further	further	ADJ
dpc-3650	178	4	research	research	NOUN
dpc-3650	178	5	is	be	AUX
dpc-3650	178	6	warranted	warrant	VERB
dpc-3650	178	7	in	in	ADP
dpc-3650	178	8	this	this	DET
dpc-3650	178	9	field	field	NOUN
dpc-3650	178	10	.	.	PUNCT
dpc-3650	179	1	positive	positive	ADJ
dpc-3650	179	2	psychology	psychology	NOUN
dpc-3650	179	3	interventions	intervention	NOUN
dpc-3650	179	4	strive	strive	VERB
dpc-3650	179	5	towards	towards	ADP
dpc-3650	179	6	consolidating	consolidate	VERB
dpc-3650	179	7	psychological	psychological	ADJ
dpc-3650	179	8	resources	resource	NOUN
dpc-3650	179	9	and	and	CCONJ
dpc-3650	179	10	nourishing	nourish	VERB
dpc-3650	179	11	positive	positive	ADJ
dpc-3650	179	12	cognitions	cognition	NOUN
dpc-3650	179	13	and	and	CCONJ
dpc-3650	179	14	feelings	feeling	NOUN
dpc-3650	179	15	[	[	X
dpc-3650	179	16	67	67	NUM
dpc-3650	179	17	]	]	PUNCT
dpc-3650	179	18	.	.	PUNCT
dpc-3650	180	1	in	in	ADP
dpc-3650	180	2	conclusion	conclusion	NOUN
dpc-3650	180	3	,	,	PUNCT
dpc-3650	180	4	psoriasis	psoriasis	NOUN
dpc-3650	180	5	is	be	AUX
dpc-3650	180	6	a	a	DET
dpc-3650	180	7	disease	disease	NOUN
dpc-3650	180	8	requiring	require	VERB
dpc-3650	180	9	a	a	DET
dpc-3650	180	10	multidimensional	multidimensional	ADJ
dpc-3650	180	11	therapeutic	therapeutic	ADJ
dpc-3650	180	12	approach	approach	NOUN
dpc-3650	180	13	.	.	PUNCT
dpc-3650	181	1	our	our	PRON
dpc-3650	181	2	study	study	NOUN
dpc-3650	181	3	is	be	AUX
dpc-3650	181	4	based	base	VERB
dpc-3650	181	5	on	on	ADP
dpc-3650	181	6	limited	limited	ADJ
dpc-3650	181	7	and	and	CCONJ
dpc-3650	181	8	preliminary	preliminary	ADJ
dpc-3650	181	9	data	datum	NOUN
dpc-3650	181	10	.	.	PUNCT
dpc-3650	182	1	more	more	ADJ
dpc-3650	182	2	studies	study	NOUN
dpc-3650	182	3	are	be	AUX
dpc-3650	182	4	needed	need	VERB
dpc-3650	182	5	to	to	PART
dpc-3650	182	6	help	help	VERB
dpc-3650	182	7	address	address	VERB
dpc-3650	182	8	this	this	DET
dpc-3650	182	9	important	important	ADJ
dpc-3650	182	10	correlation	correlation	NOUN
dpc-3650	182	11	of	of	ADP
dpc-3650	182	12	specific	specific	ADJ
dpc-3650	182	13	inflammatory	inflammatory	ADJ
dpc-3650	182	14	markers	marker	NOUN
dpc-3650	182	15	with	with	ADP
dpc-3650	182	16	the	the	DET
dpc-3650	182	17	occurrence	occurrence	NOUN
dpc-3650	182	18	of	of	ADP
dpc-3650	182	19	depression	depression	NOUN
dpc-3650	182	20	in	in	ADP
dpc-3650	182	21	patients	patient	NOUN
dpc-3650	182	22	with	with	ADP
dpc-3650	182	23	psoriasis	psoriasis	NOUN
dpc-3650	182	24	.	.	PUNCT
dpc-3650	183	1	the	the	DET
dpc-3650	183	2	measurement	measurement	NOUN
dpc-3650	183	3	of	of	ADP
dpc-3650	183	4	the	the	DET
dpc-3650	183	5	values	value	NOUN
dpc-3650	183	6	of	of	ADP
dpc-3650	183	7	crp	crp	PROPN
dpc-3650	183	8	and	and	CCONJ
dpc-3650	183	9	esr	esr	PROPN
dpc-3650	183	10	and	and	CCONJ
dpc-3650	183	11	their	their	PRON
dpc-3650	183	12	use	use	NOUN
dpc-3650	183	13	to	to	PART
dpc-3650	183	14	detect	detect	VERB
dpc-3650	183	15	the	the	DET
dpc-3650	183	16	possibility	possibility	NOUN
dpc-3650	183	17	of	of	ADP
dpc-3650	183	18	the	the	DET
dpc-3650	183	19	presence	presence	NOUN
dpc-3650	183	20	of	of	ADP
dpc-3650	183	21	depression	depression	NOUN
dpc-3650	183	22	can	can	AUX
dpc-3650	183	23	be	be	AUX
dpc-3650	183	24	an	an	DET
dpc-3650	183	25	important	important	ADJ
dpc-3650	183	26	tool	tool	NOUN
dpc-3650	183	27	for	for	ADP
dpc-3650	183	28	the	the	DET
dpc-3650	183	29	holistic	holistic	ADJ
dpc-3650	183	30	treatment	treatment	NOUN
dpc-3650	183	31	of	of	ADP
dpc-3650	183	32	our	our	PRON
dpc-3650	183	33	patients	patient	NOUN
dpc-3650	183	34	with	with	ADP
dpc-3650	183	35	psoriasis	psoriasis	NOUN
dpc-3650	183	36	.	.	PUNCT
dpc-3650	184	1	markers	marker	NOUN
dpc-3650	184	2	levels	level	NOUN
dpc-3650	184	3	was	be	AUX
dpc-3650	184	4	also	also	ADV
dpc-3650	184	5	examined	examine	VERB
dpc-3650	184	6	(	(	PUNCT
dpc-3650	184	7	conventional	conventional	ADJ
dpc-3650	184	8	systemic	systemic	ADJ
dpc-3650	184	9	therapy	therapy	NOUN
dpc-3650	184	10	,	,	PUNCT
dpc-3650	184	11	biologics	biologic	NOUN
dpc-3650	184	12	)	)	PUNCT
dpc-3650	184	13	.	.	PUNCT
dpc-3650	185	1	we	we	PRON
dpc-3650	185	2	chose	choose	VERB
dpc-3650	185	3	to	to	PART
dpc-3650	185	4	study	study	VERB
dpc-3650	185	5	these	these	DET
dpc-3650	185	6	specific	specific	ADJ
dpc-3650	185	7	indicators	indicator	NOUN
dpc-3650	185	8	of	of	ADP
dpc-3650	185	9	inflammation	inflammation	NOUN
dpc-3650	185	10	,	,	PUNCT
dpc-3650	185	11	because	because	SCONJ
dpc-3650	185	12	they	they	PRON
dpc-3650	185	13	are	be	AUX
dpc-3650	185	14	easy	easy	ADJ
dpc-3650	185	15	and	and	CCONJ
dpc-3650	185	16	economical	economical	ADJ
dpc-3650	185	17	to	to	PART
dpc-3650	185	18	measure	measure	VERB
dpc-3650	185	19	,	,	PUNCT
dpc-3650	185	20	while	while	SCONJ
dpc-3650	185	21	no	no	DET
dpc-3650	185	22	special	special	ADJ
dpc-3650	185	23	preparation	preparation	NOUN
dpc-3650	185	24	for	for	ADP
dpc-3650	185	25	the	the	DET
dpc-3650	185	26	patient	patient	NOUN
dpc-3650	185	27	is	be	AUX
dpc-3650	185	28	needed	need	VERB
dpc-3650	185	29	and	and	CCONJ
dpc-3650	185	30	they	they	PRON
dpc-3650	185	31	are	be	AUX
dpc-3650	185	32	done	do	VERB
dpc-3650	185	33	with	with	ADP
dpc-3650	185	34	a	a	DET
dpc-3650	185	35	simple	simple	ADJ
dpc-3650	185	36	blood	blood	NOUN
dpc-3650	185	37	draw	draw	NOUN
dpc-3650	185	38	.	.	PUNCT
dpc-3650	186	1	specific	specific	ADJ
dpc-3650	186	2	inflammatory	inflammatory	ADJ
dpc-3650	186	3	marker	marker	NOUN
dpc-3650	186	4	as	as	ADP
dpc-3650	186	5	crp	crp	PROPN
dpc-3650	186	6	,	,	PUNCT
dpc-3650	186	7	is	be	AUX
dpc-3650	186	8	influenced	influence	VERB
dpc-3650	186	9	by	by	ADP
dpc-3650	186	10	other	other	ADJ
dpc-3650	186	11	factors	factor	NOUN
dpc-3650	186	12	such	such	ADJ
dpc-3650	186	13	as	as	ADP
dpc-3650	186	14	body	body	NOUN
dpc-3650	186	15	weight	weight	NOUN
dpc-3650	186	16	[	[	X
dpc-3650	186	17	46	46	NUM
dpc-3650	186	18	]	]	PUNCT
dpc-3650	186	19	,	,	PUNCT
dpc-3650	186	20	gender	gender	NOUN
dpc-3650	186	21	(	(	PUNCT
dpc-3650	186	22	female	female	ADJ
dpc-3650	186	23	gender	gender	NOUN
dpc-3650	186	24	may	may	AUX
dpc-3650	186	25	be	be	AUX
dpc-3650	186	26	associated	associate	VERB
dpc-3650	186	27	with	with	ADP
dpc-3650	186	28	increased	increase	VERB
dpc-3650	186	29	prevalence	prevalence	NOUN
dpc-3650	186	30	of	of	ADP
dpc-3650	186	31	depressive	depressive	ADJ
dpc-3650	186	32	symptoms	symptom	NOUN
dpc-3650	187	1	[	[	X
dpc-3650	187	2	48	48	NUM
dpc-3650	187	3	]	]	PUNCT
dpc-3650	187	4	and	and	CCONJ
dpc-3650	187	5	levels	level	NOUN
dpc-3650	187	6	of	of	ADP
dpc-3650	187	7	anxiety	anxiety	NOUN
dpc-3650	187	8	and	and	CCONJ
dpc-3650	187	9	insomnia	insomnia	NOUN
dpc-3650	188	1	[	[	X
dpc-3650	188	2	43	43	NUM
dpc-3650	188	3	]	]	PUNCT
dpc-3650	188	4	.	.	PUNCT
dpc-3650	189	1	we	we	PRON
dpc-3650	189	2	also	also	ADV
dpc-3650	189	3	know	know	VERB
dpc-3650	189	4	about	about	ADP
dpc-3650	189	5	the	the	DET
dpc-3650	189	6	immunological	immunological	ADJ
dpc-3650	189	7	background	background	NOUN
dpc-3650	189	8	of	of	ADP
dpc-3650	189	9	depression	depression	NOUN
dpc-3650	189	10	and	and	CCONJ
dpc-3650	189	11	its	its	PRON
dpc-3650	189	12	relationship	relationship	NOUN
dpc-3650	189	13	with	with	ADP
dpc-3650	189	14	the	the	DET
dpc-3650	189	15	severity	severity	NOUN
dpc-3650	189	16	of	of	ADP
dpc-3650	189	17	psoriasis	psoriasis	NOUN
dpc-3650	189	18	skin	skin	NOUN
dpc-3650	189	19	lesions	lesion	NOUN
dpc-3650	189	20	[	[	X
dpc-3650	189	21	47,49	47,49	X
dpc-3650	189	22	]	]	PUNCT
dpc-3650	189	23	which	which	PRON
dpc-3650	189	24	affects	affect	VERB
dpc-3650	189	25	different	different	ADJ
dpc-3650	189	26	aspects	aspect	NOUN
dpc-3650	189	27	of	of	ADP
dpc-3650	189	28	a	a	DET
dpc-3650	189	29	patient	patient	ADJ
dpc-3650	189	30	life	life	NOUN
dpc-3650	189	31	,	,	PUNCT
dpc-3650	189	32	including	include	VERB
dpc-3650	189	33	family	family	NOUN
dpc-3650	189	34	and	and	CCONJ
dpc-3650	189	35	sexual	sexual	ADJ
dpc-3650	189	36	life	life	NOUN
dpc-3650	189	37	[	[	X
dpc-3650	189	38	50	50	NUM
dpc-3650	189	39	]	]	PUNCT
dpc-3650	189	40	,	,	PUNCT
dpc-3650	189	41	and	and	CCONJ
dpc-3650	189	42	has	have	VERB
dpc-3650	189	43	an	an	DET
dpc-3650	189	44	impact	impact	NOUN
dpc-3650	189	45	on	on	ADP
dpc-3650	189	46	the	the	DET
dpc-3650	189	47	patient	patient	ADJ
dpc-3650	189	48	quality	quality	NOUN
dpc-3650	189	49	of	of	ADP
dpc-3650	189	50	life	life	NOUN
dpc-3650	189	51	[	[	X
dpc-3650	189	52	50	50	NUM
dpc-3650	189	53	]	]	PUNCT
dpc-3650	189	54	and	and	CCONJ
dpc-3650	189	55	can	can	AUX
dpc-3650	189	56	lead	lead	VERB
dpc-3650	189	57	,	,	PUNCT
dpc-3650	189	58	in	in	ADP
dpc-3650	189	59	more	more	ADV
dpc-3650	189	60	serious	serious	ADJ
dpc-3650	189	61	cases	case	NOUN
dpc-3650	189	62	,	,	PUNCT
dpc-3650	189	63	to	to	ADP
dpc-3650	189	64	increased	increase	VERB
dpc-3650	189	65	suicidal	suicidal	ADJ
dpc-3650	189	66	ideation	ideation	NOUN
dpc-3650	190	1	[	[	X
dpc-3650	190	2	51	51	NUM
dpc-3650	190	3	]	]	PUNCT
dpc-3650	190	4	.	.	PUNCT
dpc-3650	191	1	the	the	DET
dpc-3650	191	2	results	result	NOUN
dpc-3650	191	3	of	of	ADP
dpc-3650	191	4	our	our	PRON
dpc-3650	191	5	study	study	NOUN
dpc-3650	191	6	confirm	confirm	VERB
dpc-3650	191	7	the	the	DET
dpc-3650	191	8	publications	publication	NOUN
dpc-3650	191	9	so	so	ADV
dpc-3650	191	10	far	far	ADV
dpc-3650	191	11	as	as	SCONJ
dpc-3650	191	12	we	we	PRON
dpc-3650	191	13	found	find	VERB
dpc-3650	191	14	significantly	significantly	ADV
dpc-3650	191	15	higher	high	ADJ
dpc-3650	191	16	esr	esr	PROPN
dpc-3650	191	17	in	in	ADP
dpc-3650	191	18	women	woman	NOUN
dpc-3650	191	19	with	with	ADP
dpc-3650	191	20	psoriasis	psoriasis	NOUN
dpc-3650	191	21	and	and	CCONJ
dpc-3650	191	22	depression	depression	NOUN
dpc-3650	191	23	and	and	CCONJ
dpc-3650	191	24	higher	high	ADJ
dpc-3650	191	25	crp	crp	PROPN
dpc-3650	191	26	was	be	AUX
dpc-3650	191	27	observed	observe	VERB
dpc-3650	191	28	in	in	ADP
dpc-3650	191	29	patients	patient	NOUN
dpc-3650	191	30	with	with	ADP
dpc-3650	191	31	higher	high	ADJ
dpc-3650	191	32	bmi	bmi	NOUN
dpc-3650	191	33	at	at	ADP
dpc-3650	191	34	baseline	baseline	NOUN
dpc-3650	191	35	.	.	PUNCT
dpc-3650	192	1	regarding	regard	VERB
dpc-3650	192	2	crp	crp	PROPN
dpc-3650	192	3	and	and	CCONJ
dpc-3650	192	4	esr	esr	PROPN
dpc-3650	192	5	,	,	PUNCT
dpc-3650	192	6	measurements	measurement	NOUN
dpc-3650	192	7	were	be	AUX
dpc-3650	192	8	found	find	VERB
dpc-3650	192	9	higher	high	ADJ
dpc-3650	192	10	crp	crp	NOUN
dpc-3650	192	11	and	and	CCONJ
dpc-3650	192	12	esr	esr	PROPN
dpc-3650	192	13	levels	level	NOUN
dpc-3650	192	14	in	in	ADP
dpc-3650	192	15	patients	patient	NOUN
dpc-3650	192	16	with	with	ADP
dpc-3650	192	17	psoriasis	psoriasis	NOUN
dpc-3650	192	18	and	and	CCONJ
dpc-3650	192	19	depression	depression	NOUN
dpc-3650	192	20	and	and	CCONJ
dpc-3650	192	21	psoriasis	psoriasis	NOUN
dpc-3650	192	22	vs	vs	ADP
dpc-3650	192	23	healthy	healthy	ADJ
dpc-3650	192	24	controls	control	NOUN
dpc-3650	192	25	and	and	CCONJ
dpc-3650	192	26	higher	high	ADJ
dpc-3650	192	27	crp	crp	NOUN
dpc-3650	192	28	and	and	CCONJ
dpc-3650	192	29	esr	esr	PROPN
dpc-3650	192	30	levels	level	NOUN
dpc-3650	192	31	in	in	ADP
dpc-3650	192	32	patients	patient	NOUN
dpc-3650	192	33	with	with	ADP
dpc-3650	192	34	psoriasis	psoriasis	NOUN
dpc-3650	192	35	and	and	CCONJ
dpc-3650	192	36	depression	depression	NOUN
dpc-3650	192	37	vs	vs	ADP
dpc-3650	192	38	patients	patient	NOUN
dpc-3650	192	39	with	with	ADP
dpc-3650	192	40	psoriasis	psoriasis	NOUN
dpc-3650	192	41	.	.	PUNCT
dpc-3650	193	1	instead	instead	ADV
dpc-3650	193	2	,	,	PUNCT
dpc-3650	193	3	no	no	DET
dpc-3650	193	4	significant	significant	ADJ
dpc-3650	193	5	changes	change	NOUN
dpc-3650	193	6	in	in	ADP
dpc-3650	193	7	crp	crp	PROPN
dpc-3650	193	8	or	or	CCONJ
dpc-3650	193	9	esr	esr	PROPN
dpc-3650	193	10	values	value	NOUN
dpc-3650	193	11	were	be	AUX
dpc-3650	193	12	observed	observe	VERB
dpc-3650	193	13	between	between	ADP
dpc-3650	193	14	the	the	DET
dpc-3650	193	15	two	two	NUM
dpc-3650	193	16	-	-	PUNCT
dpc-3650	193	17	time	time	NOUN
dpc-3650	193	18	points	point	NOUN
dpc-3650	193	19	(	(	PUNCT
dpc-3650	193	20	baseline	baseline	NOUN
dpc-3650	193	21	and	and	CCONJ
dpc-3650	193	22	three	three	NUM
dpc-3650	193	23	months	month	NOUN
dpc-3650	193	24	)	)	PUNCT
dpc-3650	193	25	after	after	ADP
dpc-3650	193	26	systemic	systemic	ADJ
dpc-3650	193	27	therapy	therapy	NOUN
dpc-3650	193	28	for	for	ADP
dpc-3650	193	29	psoriasis	psoriasis	NOUN
dpc-3650	193	30	for	for	ADP
dpc-3650	193	31	the	the	DET
dpc-3650	193	32	two	two	NUM
dpc-3650	193	33	groups	group	NOUN
dpc-3650	193	34	of	of	ADP
dpc-3650	193	35	patients	patient	NOUN
dpc-3650	193	36	(	(	PUNCT
dpc-3650	193	37	psoriasis	psoriasis	NOUN
dpc-3650	193	38	and	and	CCONJ
dpc-3650	193	39	depression	depression	NOUN
dpc-3650	193	40	and	and	CCONJ
dpc-3650	193	41	psoriasis	psoriasis	NOUN
dpc-3650	193	42	)	)	PUNCT
dpc-3650	193	43	.	.	PUNCT
dpc-3650	194	1	we	we	PRON
dpc-3650	194	2	consider	consider	VERB
dpc-3650	194	3	that	that	SCONJ
dpc-3650	194	4	the	the	DET
dpc-3650	194	5	3	3	NUM
dpc-3650	194	6	-	-	PUNCT
dpc-3650	194	7	month	month	NOUN
dpc-3650	194	8	period	period	NOUN
dpc-3650	194	9	between	between	ADP
dpc-3650	194	10	the	the	DET
dpc-3650	194	11	2	2	NUM
dpc-3650	194	12	measurements	measurement	NOUN
dpc-3650	194	13	was	be	AUX
dpc-3650	194	14	too	too	ADV
dpc-3650	194	15	short	short	ADJ
dpc-3650	194	16	to	to	PART
dpc-3650	194	17	allow	allow	VERB
dpc-3650	194	18	safe	safe	ADJ
dpc-3650	194	19	conclusions	conclusion	NOUN
dpc-3650	194	20	on	on	ADP
dpc-3650	194	21	the	the	DET
dpc-3650	194	22	possible	possible	ADJ
dpc-3650	194	23	reduction	reduction	NOUN
dpc-3650	194	24	of	of	ADP
dpc-3650	194	25	crp	crp	PROPN
dpc-3650	194	26	and	and	CCONJ
dpc-3650	194	27	esr	esr	PROPN
dpc-3650	194	28	after	after	ADP
dpc-3650	194	29	systemic	systemic	ADJ
dpc-3650	194	30	treatment	treatment	NOUN
dpc-3650	194	31	for	for	ADP
dpc-3650	194	32	psoriasis	psoriasis	NOUN
dpc-3650	194	33	that	that	PRON
dpc-3650	194	34	patients	patient	NOUN
dpc-3650	194	35	received	receive	VERB
dpc-3650	194	36	.	.	PUNCT
dpc-3650	195	1	therefore	therefore	ADV
dpc-3650	195	2	,	,	PUNCT
dpc-3650	195	3	based	base	VERB
dpc-3650	195	4	our	our	PRON
dpc-3650	195	5	results	result	NOUN
dpc-3650	195	6	of	of	ADP
dpc-3650	195	7	our	our	PRON
dpc-3650	195	8	study	study	NOUN
dpc-3650	195	9	,	,	PUNCT
dpc-3650	195	10	it	it	PRON
dpc-3650	195	11	would	would	AUX
dpc-3650	195	12	be	be	AUX
dpc-3650	195	13	better	well	ADJ
dpc-3650	195	14	to	to	PART
dpc-3650	195	15	measure	measure	VERB
dpc-3650	195	16	them	they	PRON
dpc-3650	195	17	at	at	ADP
dpc-3650	195	18	baseline	baseline	NOUN
dpc-3650	195	19	.	.	PUNCT
dpc-3650	196	1	their	their	PRON
dpc-3650	196	2	increased	increase	VERB
dpc-3650	196	3	values	value	NOUN
dpc-3650	196	4	can	can	AUX
dpc-3650	196	5	alert	alert	VERB
dpc-3650	196	6	us	we	PRON
dpc-3650	196	7	not	not	PART
dpc-3650	196	8	only	only	ADV
dpc-3650	196	9	to	to	ADP
dpc-3650	196	10	the	the	DET
dpc-3650	196	11	possibility	possibility	NOUN
dpc-3650	196	12	of	of	ADP
dpc-3650	196	13	co	co	NOUN
dpc-3650	196	14	-	-	NOUN
dpc-3650	196	15	morbidities	morbidity	NOUN
dpc-3650	196	16	such	such	ADJ
dpc-3650	196	17	as	as	ADP
dpc-3650	196	18	psoriatic	psoriatic	ADJ
dpc-3650	196	19	arthritis	arthritis	NOUN
dpc-3650	196	20	[	[	X
dpc-3650	196	21	52	52	NUM
dpc-3650	196	22	]	]	PUNCT
dpc-3650	196	23	or	or	CCONJ
dpc-3650	196	24	cardiovascular	cardiovascular	ADJ
dpc-3650	196	25	disease	disease	NOUN
dpc-3650	196	26	[	[	X
dpc-3650	196	27	53	53	NUM
dpc-3650	196	28	]	]	PUNCT
dpc-3650	196	29	or	or	CCONJ
dpc-3650	196	30	depression	depression	NOUN
dpc-3650	196	31	.	.	PUNCT
dpc-3650	197	1	if	if	SCONJ
dpc-3650	197	2	it	it	PRON
dpc-3650	197	3	is	be	AUX
dpc-3650	197	4	also	also	ADV
dpc-3650	197	5	confirmed	confirm	VERB
dpc-3650	197	6	the	the	DET
dpc-3650	197	7	existence	existence	NOUN
dpc-3650	197	8	of	of	ADP
dpc-3650	197	9	depression	depression	NOUN
dpc-3650	197	10	with	with	ADP
dpc-3650	197	11	the	the	DET
dpc-3650	197	12	use	use	NOUN
dpc-3650	197	13	of	of	ADP
dpc-3650	197	14	special	special	ADJ
dpc-3650	197	15	questionnaires	questionnaire	NOUN
dpc-3650	197	16	,	,	PUNCT
dpc-3650	197	17	such	such	ADJ
dpc-3650	197	18	as	as	ADP
dpc-3650	197	19	beck	beck	NOUN
dpc-3650	197	20	,	,	PUNCT
dpc-3650	197	21	it	it	PRON
dpc-3650	197	22	is	be	AUX
dpc-3650	197	23	an	an	DET
dpc-3650	197	24	important	important	ADJ
dpc-3650	197	25	help	help	NOUN
dpc-3650	197	26	for	for	ADP
dpc-3650	197	27	us	we	PRON
dpc-3650	197	28	,	,	PUNCT
dpc-3650	197	29	as	as	ADP
dpc-3650	197	30	the	the	DET
dpc-3650	197	31	treating	treat	VERB
dpc-3650	197	32	doctors	doctor	NOUN
dpc-3650	197	33	,	,	PUNCT
dpc-3650	197	34	of	of	ADP
dpc-3650	197	35	choosing	choose	VERB
dpc-3650	197	36	the	the	DET
dpc-3650	197	37	appropriate	appropriate	ADJ
dpc-3650	197	38	treatment	treatment	NOUN
dpc-3650	197	39	for	for	ADP
dpc-3650	197	40	our	our	PRON
dpc-3650	197	41	patients	patient	NOUN
dpc-3650	197	42	suffering	suffer	VERB
dpc-3650	197	43	from	from	ADP
dpc-3650	197	44	psoriasis	psoriasis	NOUN
dpc-3650	197	45	.	.	PUNCT
dpc-3650	198	1	in	in	ADP
dpc-3650	198	2	the	the	DET
dpc-3650	198	3	literature	literature	NOUN
dpc-3650	198	4	,	,	PUNCT
dpc-3650	198	5	there	there	PRON
dpc-3650	198	6	are	be	VERB
dpc-3650	198	7	studies	study	NOUN
dpc-3650	198	8	which	which	PRON
dpc-3650	198	9	found	find	VERB
dpc-3650	198	10	an	an	DET
dpc-3650	198	11	improvement	improvement	NOUN
dpc-3650	198	12	in	in	ADP
dpc-3650	198	13	the	the	DET
dpc-3650	198	14	depressive	depressive	ADJ
dpc-3650	198	15	symptoms	symptom	NOUN
dpc-3650	198	16	of	of	ADP
dpc-3650	198	17	patients	patient	NOUN
dpc-3650	198	18	with	with	ADP
dpc-3650	198	19	psoriasis	psoriasis	NOUN
dpc-3650	198	20	after	after	ADP
dpc-3650	198	21	systematic	systematic	ADJ
dpc-3650	198	22	medication	medication	NOUN
dpc-3650	198	23	for	for	ADP
dpc-3650	198	24	psoriasis	psoriasis	NOUN
dpc-3650	198	25	,	,	PUNCT
dpc-3650	198	26	and	and	CCONJ
dpc-3650	198	27	after	after	ADP
dpc-3650	198	28	the	the	DET
dpc-3650	198	29	administration	administration	NOUN
dpc-3650	198	30	of	of	ADP
dpc-3650	198	31	specific	specific	ADJ
dpc-3650	198	32	biological	biological	ADJ
dpc-3650	198	33	factors	factor	NOUN
dpc-3650	199	1	[	[	X
dpc-3650	199	2	54,61	54,61	X
dpc-3650	199	3	]	]	PUNCT
dpc-3650	199	4	such	such	ADJ
dpc-3650	199	5	as	as	ADP
dpc-3650	199	6	etanercept[55,56	etanercept[55,56	PROPN
dpc-3650	199	7	]	]	PUNCT
dpc-3650	199	8	,	,	PUNCT
dpc-3650	199	9	adalimumab	adalimumab	NOUN
dpc-3650	199	10	[	[	X
dpc-3650	199	11	57	57	NUM
dpc-3650	199	12	]	]	PUNCT
dpc-3650	199	13	,	,	PUNCT
dpc-3650	199	14	ustekinumab	ustekinumab	NOUN
dpc-3650	200	1	[	[	X
dpc-3650	200	2	58	58	NUM
dpc-3650	200	3	,	,	PUNCT
dpc-3650	200	4	]	]	X
dpc-3650	200	5	,	,	PUNCT
dpc-3650	200	6	while	while	SCONJ
dpc-3650	200	7	there	there	PRON
dpc-3650	200	8	are	be	VERB
dpc-3650	200	9	also	also	ADV
dpc-3650	200	10	drugs	drug	NOUN
dpc-3650	200	11	that	that	PRON
dpc-3650	200	12	can	can	AUX
dpc-3650	200	13	worsen	worsen	VERB
dpc-3650	200	14	it	it	PRON
dpc-3650	200	15	such	such	ADJ
dpc-3650	200	16	as	as	ADP
dpc-3650	200	17	apremilast	apremilast	NOUN
dpc-3650	200	18	[	[	X
dpc-3650	200	19	59	59	NUM
dpc-3650	200	20	]	]	PUNCT
dpc-3650	200	21	.	.	PUNCT
dpc-3650	201	1	from	from	ADP
dpc-3650	201	2	conventional	conventional	ADJ
dpc-3650	201	3	drugs	drug	NOUN
dpc-3650	201	4	even	even	ADV
dpc-3650	201	5	though	though	SCONJ
dpc-3650	201	6	cyclosporine	cyclosporine	NOUN
dpc-3650	201	7	has	have	AUX
dpc-3650	201	8	been	be	AUX
dpc-3650	201	9	shown	show	VERB
dpc-3650	201	10	to	to	PART
dpc-3650	201	11	inhibit	inhibit	VERB
dpc-3650	201	12	th1	th1	NOUN
dpc-3650	201	13	and	and	CCONJ
dpc-3650	201	14	th17	th17	PROPN
dpc-3650	201	15	pathways	pathway	NOUN
dpc-3650	201	16	exhibiting	exhibit	VERB
dpc-3650	201	17	multifactorial	multifactorial	ADJ
dpc-3650	201	18	and	and	CCONJ
dpc-3650	201	19	suppressive	suppressive	ADJ
dpc-3650	201	20	anti	anti	ADJ
dpc-3650	201	21	-	-	ADJ
dpc-3650	201	22	psoriatic	psoriatic	ADJ
dpc-3650	201	23	activity	activity	NOUN
dpc-3650	201	24	,	,	PUNCT
dpc-3650	201	25	its	its	PRON
dpc-3650	201	26	antidepressant	antidepressant	ADJ
dpc-3650	201	27	8	8	NUM
dpc-3650	201	28	original	original	ADJ
dpc-3650	201	29	article	article	NOUN
dpc-3650	201	30	|	|	ADV
dpc-3650	201	31	dermatol	dermatol	ADJ
dpc-3650	201	32	pract	pract	NOUN
dpc-3650	201	33	concept	concept	NOUN
dpc-3650	201	34	.	.	PUNCT
dpc-3650	202	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	202	2	study	study	NOUN
dpc-3650	202	3	.	.	PUNCT
dpc-3650	203	1	skin	skin	NOUN
dpc-3650	203	2	health	health	PROPN
dpc-3650	203	3	dis	dis	PROPN
dpc-3650	203	4	.	.	PUNCT
dpc-3650	203	5	2022;2(3):e145	2022;2(3):e145	PROPN
dpc-3650	203	6	.	.	PUNCT
dpc-3650	204	1	doi	doi	NOUN
dpc-3650	204	2	:	:	PUNCT
dpc-3650	204	3	10.1002	10.1002	NUM
dpc-3650	204	4	/	/	SYM
dpc-3650	204	5	ski2.145	ski2.145	NOUN
dpc-3650	204	6	.	.	PUNCT
dpc-3650	205	1	pmid	pmid	NOUN
dpc-3650	205	2	:	:	PUNCT
dpc-3650	205	3	36092261	36092261	NUM
dpc-3650	205	4	.	.	PUNCT
dpc-3650	206	1	pmcid	pmcid	NOUN
dpc-3650	206	2	:	:	PUNCT
dpc-3650	206	3	pmc9435449	pmc9435449	NOUN
dpc-3650	206	4	.	.	PUNCT
dpc-3650	207	1	16	16	NUM
dpc-3650	207	2	.	.	PUNCT
dpc-3650	208	1	wang	wang	PROPN
dpc-3650	208	2	q	q	PROPN
dpc-3650	208	3	,	,	PUNCT
dpc-3650	208	4	luo	luo	PROPN
dpc-3650	208	5	y	y	PROPN
dpc-3650	208	6	,	,	PUNCT
dpc-3650	208	7	lv	lv	PROPN
dpc-3650	208	8	c	c	X
dpc-3650	208	9	,	,	PUNCT
dpc-3650	208	10	et	et	PROPN
dpc-3650	208	11	al	al	PROPN
dpc-3650	208	12	.	.	PROPN
dpc-3650	208	13	nonadherence	nonadherence	PROPN
dpc-3650	208	14	to	to	ADP
dpc-3650	208	15	treatment	treatment	NOUN
dpc-3650	208	16	and	and	CCONJ
dpc-3650	208	17	patient	patient	NOUN
dpc-3650	208	18	-	-	PUNCT
dpc-3650	208	19	reported	report	VERB
dpc-3650	208	20	outcomes	outcome	NOUN
dpc-3650	208	21	of	of	ADP
dpc-3650	208	22	psoriasis	psoriasis	NOUN
dpc-3650	208	23	during	during	ADP
dpc-3650	208	24	the	the	DET
dpc-3650	208	25	covid-19	covid-19	PROPN
dpc-3650	208	26	epidemic	epidemic	NOUN
dpc-3650	208	27	:	:	PUNCT
dpc-3650	208	28	a	a	DET
dpc-3650	208	29	web	web	NOUN
dpc-3650	208	30	-	-	PUNCT
dpc-3650	208	31	based	base	VERB
dpc-3650	208	32	survey	survey	NOUN
dpc-3650	208	33	.	.	PUNCT
dpc-3650	209	1	patient	patient	ADJ
dpc-3650	209	2	prefer	prefer	NOUN
dpc-3650	209	3	adherence	adherence	NOUN
dpc-3650	209	4	.	.	PUNCT
dpc-3650	210	1	2020;14:1403	2020;14:1403	NUM
dpc-3650	210	2	-	-	SYM
dpc-3650	210	3	1409	1409	NUM
dpc-3650	210	4	.	.	PUNCT
dpc-3650	211	1	doi	doi	NOUN
dpc-3650	211	2	:	:	PUNCT
dpc-3650	211	3	10.2147	10.2147	NUM
dpc-3650	211	4	/	/	SYM
dpc-3650	211	5	ppa.s263843	ppa.s263843	NOUN
dpc-3650	211	6	.	.	PUNCT
dpc-3650	212	1	pmid	pmid	NOUN
dpc-3650	212	2	:	:	PUNCT
dpc-3650	212	3	32884243	32884243	NUM
dpc-3650	212	4	.	.	PUNCT
dpc-3650	213	1	pmcid	pmcid	NOUN
dpc-3650	213	2	:	:	PUNCT
dpc-3650	213	3	pmc7431943	pmc7431943	ADV
dpc-3650	213	4	.	.	PUNCT
dpc-3650	214	1	17	17	NUM
dpc-3650	214	2	.	.	PUNCT
dpc-3650	215	1	narang	narang	PROPN
dpc-3650	215	2	t	t	PROPN
dpc-3650	215	3	,	,	PUNCT
dpc-3650	215	4	bhandari	bhandari	PROPN
dpc-3650	215	5	a	a	PROPN
dpc-3650	215	6	,	,	PUNCT
dpc-3650	215	7	mehta	mehta	PROPN
dpc-3650	215	8	h	h	PROPN
dpc-3650	215	9	,	,	PUNCT
dpc-3650	215	10	narang	narang	PROPN
dpc-3650	215	11	k	k	PROPN
dpc-3650	215	12	,	,	PUNCT
dpc-3650	215	13	handa	handa	PROPN
dpc-3650	215	14	s	s	PROPN
dpc-3650	215	15	,	,	PUNCT
dpc-3650	215	16	dogra	dogra	PROPN
dpc-3650	215	17	s.	s.	PROPN
dpc-3650	215	18	effect	effect	NOUN
dpc-3650	215	19	of	of	ADP
dpc-3650	215	20	lockdown	lockdown	NOUN
dpc-3650	215	21	due	due	ADP
dpc-3650	215	22	to	to	ADP
dpc-3650	215	23	covid-19	covid-19	PROPN
dpc-3650	215	24	on	on	ADP
dpc-3650	215	25	health	health	NOUN
dpc-3650	215	26	and	and	CCONJ
dpc-3650	215	27	lifestyle	lifestyle	NOUN
dpc-3650	215	28	of	of	ADP
dpc-3650	215	29	psoriasis	psoriasis	NOUN
dpc-3650	215	30	patients	patient	NOUN
dpc-3650	215	31	:	:	PUNCT
dpc-3650	215	32	a	a	DET
dpc-3650	215	33	web	web	NOUN
dpc-3650	215	34	-	-	PUNCT
dpc-3650	215	35	based	base	VERB
dpc-3650	215	36	survey	survey	NOUN
dpc-3650	215	37	.	.	PUNCT
dpc-3650	216	1	indian	indian	ADJ
dpc-3650	216	2	dermatol	dermatol	NOUN
dpc-3650	216	3	online	online	PROPN
dpc-3650	216	4	j.	j.	PROPN
dpc-3650	216	5	2022;13(5):625	2022;13(5):625	PROPN
dpc-3650	216	6	-	-	PUNCT
dpc-3650	216	7	628	628	NUM
dpc-3650	216	8	.	.	PUNCT
dpc-3650	217	1	doi	doi	NOUN
dpc-3650	217	2	:	:	PUNCT
dpc-3650	217	3	10.4103	10.4103	NUM
dpc-3650	217	4	/	/	SYM
dpc-3650	217	5	idoj.idoj_46_22	idoj.idoj_46_22	PROPN
dpc-3650	217	6	.	.	PUNCT
dpc-3650	218	1	pmid	pmid	NOUN
dpc-3650	218	2	:	:	PUNCT
dpc-3650	218	3	36304639	36304639	NUM
dpc-3650	218	4	.	.	PUNCT
dpc-3650	219	1	pmcid	pmcid	NOUN
dpc-3650	219	2	:	:	PUNCT
dpc-3650	219	3	pmc9595162	pmc9595162	NOUN
dpc-3650	219	4	.	.	PUNCT
dpc-3650	220	1	18	18	NUM
dpc-3650	220	2	.	.	X
dpc-3650	220	3	postal	postal	PROPN
dpc-3650	220	4	m	m	PROPN
dpc-3650	220	5	,	,	PUNCT
dpc-3650	220	6	appenzeller	appenzeller	PROPN
dpc-3650	220	7	s.	s.	PROPN
dpc-3650	220	8	the	the	DET
dpc-3650	220	9	importance	importance	NOUN
dpc-3650	220	10	of	of	ADP
dpc-3650	220	11	cytokines	cytokine	NOUN
dpc-3650	220	12	and	and	CCONJ
dpc-3650	220	13	autoantibodies	autoantibody	NOUN
dpc-3650	220	14	in	in	ADP
dpc-3650	220	15	depression	depression	NOUN
dpc-3650	220	16	.	.	PUNCT
dpc-3650	221	1	autoimmun	autoimmun	PROPN
dpc-3650	221	2	rev	rev	PROPN
dpc-3650	221	3	.	.	PROPN
dpc-3650	222	1	2015;14(1):30	2015;14(1):30	NUM
dpc-3650	222	2	-	-	SYM
dpc-3650	222	3	35	35	NUM
dpc-3650	222	4	.	.	PUNCT
dpc-3650	222	5	doi	doi	NOUN
dpc-3650	222	6	:	:	PUNCT
dpc-3650	222	7	10.1016	10.1016	NUM
dpc-3650	222	8	/	/	SYM
dpc-3650	222	9	j.autrev.2014.09.001	j.autrev.2014.09.001	NOUN
dpc-3650	222	10	.	.	PUNCT
dpc-3650	223	1	pmid	pmid	NOUN
dpc-3650	223	2	:	:	PUNCT
dpc-3650	223	3	25242344	25242344	NUM
dpc-3650	223	4	.	.	PUNCT
dpc-3650	224	1	19	19	NUM
dpc-3650	224	2	.	.	PUNCT
dpc-3650	225	1	bai	bai	PROPN
dpc-3650	225	2	ym	ym	PROPN
dpc-3650	225	3	,	,	PUNCT
dpc-3650	225	4	su	su	PROPN
dpc-3650	225	5	tp	tp	PROPN
dpc-3650	225	6	,	,	PUNCT
dpc-3650	225	7	li	li	PROPN
dpc-3650	225	8	ct	ct	PROPN
dpc-3650	225	9	,	,	PUNCT
dpc-3650	225	10	et	et	PROPN
dpc-3650	225	11	al	al	PROPN
dpc-3650	225	12	.	.	PROPN
dpc-3650	225	13	comparison	comparison	NOUN
dpc-3650	225	14	of	of	ADP
dpc-3650	225	15	pro	pro	ADJ
dpc-3650	225	16	-	-	ADJ
dpc-3650	225	17	inflammatory	inflammatory	ADJ
dpc-3650	225	18	cytokines	cytokine	NOUN
dpc-3650	225	19	among	among	ADP
dpc-3650	225	20	patients	patient	NOUN
dpc-3650	225	21	with	with	ADP
dpc-3650	225	22	bipolar	bipolar	ADJ
dpc-3650	225	23	disorder	disorder	NOUN
dpc-3650	225	24	and	and	CCONJ
dpc-3650	225	25	unipolar	unipolar	ADJ
dpc-3650	225	26	depression	depression	NOUN
dpc-3650	225	27	and	and	CCONJ
dpc-3650	225	28	normal	normal	ADJ
dpc-3650	225	29	controls	control	NOUN
dpc-3650	225	30	.	.	PUNCT
dpc-3650	226	1	bipolar	bipolar	ADJ
dpc-3650	226	2	disord	disord	NOUN
dpc-3650	226	3	.	.	PUNCT
dpc-3650	227	1	2015;17(3	2015;17(3	NUM
dpc-3650	227	2	):	):	PUNCT
dpc-3650	227	3	269	269	NUM
dpc-3650	227	4	-	-	SYM
dpc-3650	227	5	277	277	NUM
dpc-3650	227	6	.	.	PUNCT
dpc-3650	228	1	doi	doi	NOUN
dpc-3650	228	2	:	:	PUNCT
dpc-3650	228	3	10.1111	10.1111	NUM
dpc-3650	228	4	/	/	SYM
dpc-3650	228	5	bdi.12259	bdi.12259	PROPN
dpc-3650	228	6	.	.	PUNCT
dpc-3650	229	1	pmid	pmid	NOUN
dpc-3650	229	2	:	:	PUNCT
dpc-3650	229	3	25257835	25257835	NUM
dpc-3650	229	4	.	.	PUNCT
dpc-3650	230	1	20	20	NUM
dpc-3650	230	2	.	.	PUNCT
dpc-3650	230	3	audet	audet	PROPN
dpc-3650	230	4	mc	mc	PROPN
dpc-3650	230	5	,	,	PUNCT
dpc-3650	230	6	mcquaid	mcquaid	PROPN
dpc-3650	230	7	rj	rj	PROPN
dpc-3650	230	8	,	,	PUNCT
dpc-3650	230	9	merali	merali	VERB
dpc-3650	230	10	z	z	PROPN
dpc-3650	230	11	,	,	PUNCT
dpc-3650	230	12	anisman	anisman	PROPN
dpc-3650	230	13	h.	h.	PROPN
dpc-3650	230	14	cytokine	cytokine	PROPN
dpc-3650	230	15	variations	variation	NOUN
dpc-3650	230	16	and	and	CCONJ
dpc-3650	230	17	mood	mood	NOUN
dpc-3650	230	18	disorders	disorder	NOUN
dpc-3650	230	19	:	:	PUNCT
dpc-3650	230	20	influence	influence	NOUN
dpc-3650	230	21	of	of	ADP
dpc-3650	230	22	social	social	ADJ
dpc-3650	230	23	stressors	stressor	NOUN
dpc-3650	230	24	and	and	CCONJ
dpc-3650	230	25	social	social	ADJ
dpc-3650	230	26	support	support	NOUN
dpc-3650	230	27	.	.	PUNCT
dpc-3650	231	1	front	front	ADJ
dpc-3650	231	2	neurosci	neurosci	PROPN
dpc-3650	231	3	.	.	PUNCT
dpc-3650	232	1	2014;8:416	2014;8:416	NUM
dpc-3650	232	2	.	.	PUNCT
dpc-3650	233	1	doi	doi	NOUN
dpc-3650	233	2	:	:	PUNCT
dpc-3650	233	3	10.3389	10.3389	NUM
dpc-3650	233	4	/	/	SYM
dpc-3650	233	5	fnins	fnin	NOUN
dpc-3650	233	6	.2014.00416	.2014.00416	X
dpc-3650	233	7	.	.	PUNCT
dpc-3650	234	1	pmid	pmid	NOUN
dpc-3650	234	2	:	:	PUNCT
dpc-3650	234	3	25565946	25565946	NUM
dpc-3650	234	4	.	.	PUNCT
dpc-3650	235	1	pmcid	pmcid	NOUN
dpc-3650	235	2	:	:	PUNCT
dpc-3650	235	3	pmc4267188	pmc4267188	NOUN
dpc-3650	235	4	.	.	PUNCT
dpc-3650	236	1	21	21	NUM
dpc-3650	236	2	.	.	PUNCT
dpc-3650	237	1	momeni	momeni	PROPN
dpc-3650	237	2	m	m	PROPN
dpc-3650	237	3	,	,	PUNCT
dpc-3650	237	4	ghorban	ghorban	PROPN
dpc-3650	237	5	k	k	PROPN
dpc-3650	237	6	,	,	PUNCT
dpc-3650	237	7	dadmanesh	dadmanesh	PROPN
dpc-3650	237	8	m	m	PROPN
dpc-3650	237	9	,	,	PUNCT
dpc-3650	237	10	et	et	PROPN
dpc-3650	237	11	al	al	PROPN
dpc-3650	237	12	.	.	PROPN
dpc-3650	237	13	differential	differential	ADJ
dpc-3650	237	14	pattern	pattern	NOUN
dpc-3650	237	15	of	of	ADP
dpc-3650	237	16	cytokine	cytokine	ADJ
dpc-3650	237	17	production	production	NOUN
dpc-3650	237	18	by	by	ADP
dpc-3650	237	19	depressed	depressed	ADJ
dpc-3650	237	20	medical	medical	ADJ
dpc-3650	237	21	students	student	NOUN
dpc-3650	237	22	;	;	PUNCT
dpc-3650	237	23	evidence	evidence	NOUN
dpc-3650	237	24	for	for	ADP
dpc-3650	237	25	involvement	involvement	NOUN
dpc-3650	237	26	of	of	ADP
dpc-3650	237	27	cytokine	cytokine	ADJ
dpc-3650	237	28	network	network	NOUN
dpc-3650	237	29	in	in	ADP
dpc-3650	237	30	pathology	pathology	NOUN
dpc-3650	237	31	of	of	ADP
dpc-3650	237	32	depression	depression	NOUN
dpc-3650	237	33	.	.	PUNCT
dpc-3650	238	1	clin	clin	PROPN
dpc-3650	238	2	lab	lab	PROPN
dpc-3650	238	3	.	.	PUNCT
dpc-3650	239	1	2014;60(3):435	2014;60(3):435	NUM
dpc-3650	239	2	-	-	SYM
dpc-3650	239	3	440	440	NUM
dpc-3650	239	4	.	.	PUNCT
dpc-3650	240	1	doi	doi	NOUN
dpc-3650	240	2	:	:	PUNCT
dpc-3650	240	3	10.7754	10.7754	NUM
dpc-3650	240	4	/	/	SYM
dpc-3650	240	5	clin	clin	PROPN
dpc-3650	240	6	.lab.2013.130238	.lab.2013.130238	NUM
dpc-3650	240	7	.	.	PUNCT
dpc-3650	241	1	pmid	pmid	NOUN
dpc-3650	241	2	:	:	PUNCT
dpc-3650	241	3	24697120	24697120	NUM
dpc-3650	241	4	.	.	PUNCT
dpc-3650	242	1	22	22	NUM
dpc-3650	242	2	.	.	PUNCT
dpc-3650	243	1	dahl	dahl	PROPN
dpc-3650	243	2	j	j	PROPN
dpc-3650	243	3	,	,	PUNCT
dpc-3650	243	4	ormstad	ormstad	NOUN
dpc-3650	243	5	h	h	NOUN
dpc-3650	243	6	,	,	PUNCT
dpc-3650	243	7	aass	aass	PROPN
dpc-3650	243	8	hc	hc	PROPN
dpc-3650	243	9	,	,	PUNCT
dpc-3650	243	10	et	et	PROPN
dpc-3650	243	11	al	al	PROPN
dpc-3650	243	12	.	.	PUNCT
dpc-3650	244	1	the	the	DET
dpc-3650	244	2	plasma	plasma	NOUN
dpc-3650	244	3	levels	level	NOUN
dpc-3650	244	4	of	of	ADP
dpc-3650	244	5	various	various	ADJ
dpc-3650	244	6	cytokines	cytokine	NOUN
dpc-3650	244	7	are	be	AUX
dpc-3650	244	8	increased	increase	VERB
dpc-3650	244	9	during	during	ADP
dpc-3650	244	10	ongoing	ongoing	ADJ
dpc-3650	244	11	depression	depression	NOUN
dpc-3650	244	12	and	and	CCONJ
dpc-3650	244	13	are	be	AUX
dpc-3650	244	14	reduced	reduce	VERB
dpc-3650	244	15	to	to	ADP
dpc-3650	244	16	normal	normal	ADJ
dpc-3650	244	17	levels	level	NOUN
dpc-3650	244	18	after	after	ADP
dpc-3650	244	19	recovery	recovery	NOUN
dpc-3650	244	20	.	.	PUNCT
dpc-3650	245	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
dpc-3650	245	2	.	.	PUNCT
dpc-3650	246	1	2014;45:77	2014;45:77	NUM
dpc-3650	246	2	-	-	SYM
dpc-3650	246	3	86	86	NUM
dpc-3650	246	4	.	.	PUNCT
dpc-3650	247	1	doi	doi	NOUN
dpc-3650	247	2	:	:	PUNCT
dpc-3650	247	3	10.1016	10.1016	NUM
dpc-3650	247	4	/	/	SYM
dpc-3650	247	5	j.psyneuen.2014.03.019	j.psyneuen.2014.03.019	PROPN
dpc-3650	247	6	.	.	PUNCT
dpc-3650	248	1	pmid	pmid	NOUN
dpc-3650	248	2	:	:	PUNCT
dpc-3650	248	3	24845179	24845179	NUM
dpc-3650	248	4	.	.	PUNCT
dpc-3650	249	1	23	23	NUM
dpc-3650	249	2	.	.	PUNCT
dpc-3650	250	1	chocano	chocano	PROPN
dpc-3650	250	2	-	-	PUNCT
dpc-3650	250	3	bedoya	bedoya	PROPN
dpc-3650	250	4	po	po	PROPN
dpc-3650	250	5	,	,	PUNCT
dpc-3650	250	6	mirzaei	mirzaei	PROPN
dpc-3650	250	7	f	f	PROPN
dpc-3650	250	8	,	,	PUNCT
dpc-3650	250	9	o’reilly	o’reilly	ADV
dpc-3650	250	10	ej	ej	X
dpc-3650	250	11	,	,	PUNCT
dpc-3650	250	12	et	et	PROPN
dpc-3650	250	13	al	al	PROPN
dpc-3650	250	14	.	.	PUNCT
dpc-3650	251	1	c	c	X
dpc-3650	251	2	-	-	PUNCT
dpc-3650	251	3	reactive	reactive	ADJ
dpc-3650	251	4	protein	protein	NOUN
dpc-3650	251	5	,	,	PUNCT
dpc-3650	251	6	interleukin-6	interleukin-6	NUM
dpc-3650	251	7	,	,	PUNCT
dpc-3650	251	8	soluble	soluble	ADJ
dpc-3650	251	9	tumor	tumor	NOUN
dpc-3650	251	10	necrosis	necrosis	NOUN
dpc-3650	251	11	factor	factor	NOUN
dpc-3650	251	12	α	α	NOUN
dpc-3650	251	13	receptor	receptor	NOUN
dpc-3650	251	14	2	2	NUM
dpc-3650	251	15	and	and	CCONJ
dpc-3650	251	16	incident	incident	NOUN
dpc-3650	251	17	clinical	clinical	ADJ
dpc-3650	251	18	depression	depression	NOUN
dpc-3650	251	19	.	.	PUNCT
dpc-3650	252	1	j	j	PROPN
dpc-3650	252	2	affect	affect	VERB
dpc-3650	252	3	disord	disord	NOUN
dpc-3650	252	4	.	.	PUNCT
dpc-3650	253	1	2014;163	2014;163	NUM
dpc-3650	253	2	:	:	PUNCT
dpc-3650	254	1	25	25	NUM
dpc-3650	254	2	-	-	SYM
dpc-3650	254	3	32	32	NUM
dpc-3650	254	4	.	.	PUNCT
dpc-3650	254	5	doi	doi	NOUN
dpc-3650	254	6	:	:	PUNCT
dpc-3650	254	7	10.1016	10.1016	NUM
dpc-3650	254	8	/	/	SYM
dpc-3650	254	9	j.jad.2014.03.023	j.jad.2014.03.023	PROPN
dpc-3650	254	10	.	.	PUNCT
dpc-3650	255	1	pmid	pmid	NOUN
dpc-3650	255	2	:	:	PUNCT
dpc-3650	255	3	24836084	24836084	NUM
dpc-3650	255	4	.	.	PUNCT
dpc-3650	256	1	pmcid	pmcid	NOUN
dpc-3650	256	2	:	:	PUNCT
dpc-3650	256	3	pmc4029945	pmc4029945	ADJ
dpc-3650	256	4	.	.	PUNCT
dpc-3650	257	1	24	24	NUM
dpc-3650	257	2	.	.	PUNCT
dpc-3650	258	1	kannan	kannan	PROPN
dpc-3650	258	2	s	s	PROPN
dpc-3650	258	3	,	,	PUNCT
dpc-3650	258	4	heller	heller	NOUN
dpc-3650	258	5	mm	mm	PROPN
dpc-3650	258	6	,	,	PUNCT
dpc-3650	258	7	lee	lee	PROPN
dpc-3650	258	8	es	es	PROPN
dpc-3650	258	9	,	,	PUNCT
dpc-3650	258	10	koo	koo	PROPN
dpc-3650	258	11	jy	jy	PROPN
dpc-3650	258	12	.	.	PUNCT
dpc-3650	259	1	the	the	DET
dpc-3650	259	2	role	role	NOUN
dpc-3650	259	3	of	of	ADP
dpc-3650	259	4	tumor	tumor	NOUN
dpc-3650	259	5	necrosis	necrosis	NOUN
dpc-3650	259	6	factor	factor	NOUN
dpc-3650	259	7	-	-	PUNCT
dpc-3650	259	8	alpha	alpha	NOUN
dpc-3650	259	9	and	and	CCONJ
dpc-3650	259	10	other	other	ADJ
dpc-3650	259	11	cytokines	cytokine	NOUN
dpc-3650	259	12	in	in	ADP
dpc-3650	259	13	depression	depression	NOUN
dpc-3650	259	14	:	:	PUNCT
dpc-3650	259	15	what	what	PRON
dpc-3650	259	16	dermatologists	dermatologist	NOUN
dpc-3650	259	17	should	should	AUX
dpc-3650	259	18	know	know	VERB
dpc-3650	259	19	.	.	PUNCT
dpc-3650	260	1	j	j	PROPN
dpc-3650	260	2	dermatolog	dermatolog	PROPN
dpc-3650	260	3	treat	treat	NOUN
dpc-3650	260	4	.	.	PUNCT
dpc-3650	261	1	2013;24(2):148	2013;24(2):148	NUM
dpc-3650	261	2	-	-	SYM
dpc-3650	261	3	152	152	NUM
dpc-3650	261	4	.	.	PUNCT
dpc-3650	262	1	doi	doi	NOUN
dpc-3650	262	2	:	:	PUNCT
dpc-3650	262	3	10.3109/09546634.2011.619159	10.3109/09546634.2011.619159	NUM
dpc-3650	262	4	.	.	PUNCT
dpc-3650	263	1	pmid	pmid	NOUN
dpc-3650	263	2	:	:	PUNCT
dpc-3650	263	3	21888569	21888569	NUM
dpc-3650	263	4	.	.	PUNCT
dpc-3650	264	1	25	25	NUM
dpc-3650	264	2	.	.	PUNCT
dpc-3650	265	1	young	young	PROPN
dpc-3650	265	2	jj	jj	PROPN
dpc-3650	265	3	,	,	PUNCT
dpc-3650	265	4	bruno	bruno	PROPN
dpc-3650	265	5	d	d	PROPN
dpc-3650	265	6	,	,	PUNCT
dpc-3650	265	7	pomara	pomara	PROPN
dpc-3650	265	8	n.	n.	PROPN
dpc-3650	265	9	a	a	DET
dpc-3650	265	10	review	review	NOUN
dpc-3650	265	11	of	of	ADP
dpc-3650	265	12	the	the	DET
dpc-3650	265	13	relationship	relationship	NOUN
dpc-3650	265	14	between	between	ADP
dpc-3650	265	15	proinflammatory	proinflammatory	ADJ
dpc-3650	265	16	cytokines	cytokine	NOUN
dpc-3650	265	17	and	and	CCONJ
dpc-3650	265	18	major	major	ADJ
dpc-3650	265	19	depressive	depressive	ADJ
dpc-3650	265	20	disorder	disorder	NOUN
dpc-3650	265	21	.	.	PUNCT
dpc-3650	266	1	j	j	PROPN
dpc-3650	266	2	affect	affect	VERB
dpc-3650	266	3	disord	disord	NOUN
dpc-3650	266	4	.	.	PUNCT
dpc-3650	267	1	2014;169:15	2014;169:15	NUM
dpc-3650	267	2	-	-	SYM
dpc-3650	267	3	20	20	NUM
dpc-3650	267	4	.	.	PUNCT
dpc-3650	268	1	doi	doi	NOUN
dpc-3650	268	2	:	:	PUNCT
dpc-3650	268	3	10.1016	10.1016	NUM
dpc-3650	268	4	/	/	SYM
dpc-3650	268	5	j	j	PROPN
dpc-3650	268	6	.jad.2014.07.032	.jad.2014.07.032	PUNCT
dpc-3650	268	7	.	.	PUNCT
dpc-3650	269	1	pmid	pmid	NOUN
dpc-3650	269	2	:	:	PUNCT
dpc-3650	269	3	25128861	25128861	NUM
dpc-3650	269	4	.	.	PUNCT
dpc-3650	270	1	26	26	NUM
dpc-3650	270	2	.	.	PUNCT
dpc-3650	271	1	momeni	momeni	PROPN
dpc-3650	271	2	m	m	PROPN
dpc-3650	271	3	,	,	PUNCT
dpc-3650	271	4	ghorban	ghorban	PROPN
dpc-3650	271	5	k	k	PROPN
dpc-3650	271	6	,	,	PUNCT
dpc-3650	271	7	dadmanesh	dadmanesh	PROPN
dpc-3650	271	8	m	m	PROPN
dpc-3650	271	9	,	,	PUNCT
dpc-3650	271	10	et	et	PROPN
dpc-3650	271	11	al	al	PROPN
dpc-3650	271	12	.	.	PROPN
dpc-3650	271	13	differential	differential	ADJ
dpc-3650	271	14	pattern	pattern	NOUN
dpc-3650	271	15	of	of	ADP
dpc-3650	271	16	cytokine	cytokine	ADJ
dpc-3650	271	17	production	production	NOUN
dpc-3650	271	18	by	by	ADP
dpc-3650	271	19	depressed	depressed	ADJ
dpc-3650	271	20	medical	medical	ADJ
dpc-3650	271	21	students	student	NOUN
dpc-3650	271	22	;	;	PUNCT
dpc-3650	271	23	evidence	evidence	NOUN
dpc-3650	271	24	for	for	ADP
dpc-3650	271	25	involvement	involvement	NOUN
dpc-3650	271	26	of	of	ADP
dpc-3650	271	27	cytokine	cytokine	ADJ
dpc-3650	271	28	network	network	NOUN
dpc-3650	271	29	in	in	ADP
dpc-3650	271	30	pathology	pathology	NOUN
dpc-3650	271	31	of	of	ADP
dpc-3650	271	32	depression	depression	NOUN
dpc-3650	271	33	.	.	PUNCT
dpc-3650	272	1	clin	clin	PROPN
dpc-3650	272	2	lab	lab	PROPN
dpc-3650	272	3	.	.	PUNCT
dpc-3650	273	1	2014;60(3):435	2014;60(3):435	NUM
dpc-3650	273	2	-	-	SYM
dpc-3650	273	3	440	440	NUM
dpc-3650	273	4	.	.	PUNCT
dpc-3650	274	1	doi	doi	NOUN
dpc-3650	274	2	:	:	PUNCT
dpc-3650	274	3	10.7754	10.7754	NUM
dpc-3650	274	4	/	/	SYM
dpc-3650	274	5	clin	clin	PROPN
dpc-3650	274	6	.lab.2013.130238	.lab.2013.130238	NUM
dpc-3650	274	7	.	.	PUNCT
dpc-3650	275	1	pmid	pmid	NOUN
dpc-3650	275	2	:	:	PUNCT
dpc-3650	275	3	24697120	24697120	NUM
dpc-3650	275	4	.	.	PUNCT
dpc-3650	276	1	27	27	NUM
dpc-3650	276	2	.	.	PUNCT
dpc-3650	277	1	wei	wei	PROPN
dpc-3650	277	2	tq	tq	PROPN
dpc-3650	277	3	,	,	PUNCT
dpc-3650	277	4	kramer	kramer	PROPN
dpc-3650	277	5	s	s	PROPN
dpc-3650	277	6	,	,	PUNCT
dpc-3650	277	7	chu	chu	PROPN
dpc-3650	277	8	vp	vp	PROPN
dpc-3650	277	9	,	,	PUNCT
dpc-3650	277	10	et	et	PROPN
dpc-3650	277	11	al	al	PROPN
dpc-3650	277	12	.	.	PUNCT
dpc-3650	278	1	an	an	DET
dpc-3650	278	2	improved	improved	ADJ
dpc-3650	278	3	automated	automate	VERB
dpc-3650	278	4	immunoassay	immunoassay	NOUN
dpc-3650	278	5	for	for	ADP
dpc-3650	278	6	c	c	NOUN
dpc-3650	278	7	-	-	PUNCT
dpc-3650	278	8	reactive	reactive	ADJ
dpc-3650	278	9	protein	protein	NOUN
dpc-3650	278	10	on	on	ADP
dpc-3650	278	11	the	the	DET
dpc-3650	278	12	dimension	dimension	NOUN
dpc-3650	278	13	clinical	clinical	ADJ
dpc-3650	278	14	chemistry	chemistry	NOUN
dpc-3650	278	15	system	system	NOUN
dpc-3650	278	16	.	.	PUNCT
dpc-3650	279	1	j	j	PROPN
dpc-3650	279	2	autom	autom	PROPN
dpc-3650	279	3	methods	methods	PROPN
dpc-3650	279	4	manag	manag	VERB
dpc-3650	279	5	chem	chem	NOUN
dpc-3650	279	6	.	.	PUNCT
dpc-3650	280	1	2000;22(5):125	2000;22(5):125	NUM
dpc-3650	280	2	-	-	PUNCT
dpc-3650	280	3	131	131	NUM
dpc-3650	280	4	.	.	PUNCT
dpc-3650	281	1	doi	doi	NOUN
dpc-3650	281	2	:	:	PUNCT
dpc-3650	281	3	10.1155	10.1155	NUM
dpc-3650	281	4	/	/	SYM
dpc-3650	281	5	s1463924600000195	s1463924600000195	NOUN
dpc-3650	281	6	.	.	PUNCT
dpc-3650	282	1	pmid	pmid	NOUN
dpc-3650	282	2	:	:	PUNCT
dpc-3650	282	3	18924698	18924698	NUM
dpc-3650	282	4	.	.	PUNCT
dpc-3650	283	1	pmcid	pmcid	ADJ
dpc-3650	283	2	:	:	PUNCT
dpc-3650	283	3	pmc2562849	pmc2562849	NOUN
dpc-3650	283	4	.	.	PUNCT
dpc-3650	284	1	28	28	NUM
dpc-3650	284	2	.	.	PUNCT
dpc-3650	285	1	marek	marek	PROPN
dpc-3650	285	2	-	-	PUNCT
dpc-3650	285	3	jozefowicz	jozefowicz	NOUN
dpc-3650	285	4	l	l	NOUN
dpc-3650	285	5	,	,	PUNCT
dpc-3650	285	6	czajkowski	czajkowski	ADJ
dpc-3650	285	7	r	r	NOUN
dpc-3650	285	8	,	,	PUNCT
dpc-3650	285	9	borkowska	borkowska	X
dpc-3650	285	10	a	a	PRON
dpc-3650	285	11	,	,	PUNCT
dpc-3650	285	12	et	et	PROPN
dpc-3650	285	13	al	al	PROPN
dpc-3650	285	14	.	.	PUNCT
dpc-3650	286	1	the	the	DET
dpc-3650	286	2	brain	brain	NOUN
dpc-3650	286	3	-	-	PUNCT
dpc-3650	286	4	skin	skin	NOUN
dpc-3650	286	5	axis	axis	NOUN
dpc-3650	286	6	in	in	ADP
dpc-3650	286	7	psoriasis	psoriasis	NOUN
dpc-3650	286	8	-	-	PUNCT
dpc-3650	286	9	psychological	psychological	ADJ
dpc-3650	286	10	,	,	PUNCT
dpc-3650	286	11	psychiatric	psychiatric	ADJ
dpc-3650	286	12	,	,	PUNCT
dpc-3650	286	13	hormonal	hormonal	ADJ
dpc-3650	286	14	,	,	PUNCT
dpc-3650	286	15	and	and	CCONJ
dpc-3650	286	16	dermatological	dermatological	ADJ
dpc-3650	286	17	aspects	aspect	NOUN
dpc-3650	286	18	.	.	PUNCT
dpc-3650	287	1	int	int	PROPN
dpc-3650	287	2	j	j	PROPN
dpc-3650	287	3	mol	mol	ADP
dpc-3650	287	4	sci	sci	PROPN
dpc-3650	287	5	.	.	PUNCT
dpc-3650	288	1	2022;23(2):669	2022;23(2):669	NOUN
dpc-3650	288	2	.	.	PUNCT
dpc-3650	289	1	doi	doi	NOUN
dpc-3650	289	2	:	:	PUNCT
dpc-3650	289	3	10.3390	10.3390	NUM
dpc-3650	289	4	/	/	SYM
dpc-3650	289	5	ijms23020669	ijms23020669	PROPN
dpc-3650	289	6	.	.	PUNCT
dpc-3650	290	1	pmid	pmid	NOUN
dpc-3650	290	2	:	:	PUNCT
dpc-3650	290	3	35054853	35054853	NUM
dpc-3650	290	4	.	.	PUNCT
dpc-3650	291	1	pmcid	pmcid	NOUN
dpc-3650	291	2	:	:	PUNCT
dpc-3650	291	3	pmc8776235	pmc8776235	PROPN
dpc-3650	291	4	.	.	PUNCT
dpc-3650	292	1	references	reference	NOUN
dpc-3650	292	2	1	1	NUM
dpc-3650	292	3	.	.	PUNCT
dpc-3650	292	4	global	global	ADJ
dpc-3650	292	5	report	report	NOUN
dpc-3650	292	6	on	on	ADP
dpc-3650	292	7	psoriasis	psoriasis	NOUN
dpc-3650	292	8	,	,	PUNCT
dpc-3650	292	9	world	world	NOUN
dpc-3650	292	10	health	health	NOUN
dpc-3650	292	11	organization	organization	NOUN
dpc-3650	292	12	26	26	NUM
dpc-3650	292	13	october	october	PROPN
dpc-3650	292	14	2016	2016	NUM
dpc-3650	292	15	,	,	PUNCT
dpc-3650	292	16	page	page	NOUN
dpc-3650	292	17	10	10	NUM
dpc-3650	292	18	2	2	NUM
dpc-3650	292	19	.	.	PUNCT
dpc-3650	293	1	pr.c.e.m.griffiths	pr.c.e.m.griffith	VERB
dpc-3650	293	2	md	md	PROPN
dpc-3650	293	3	et	et	PROPN
dpc-3650	293	4	al	al	PROPN
dpc-3650	293	5	,	,	PUNCT
dpc-3650	293	6	psoriasis	psoriasis	NOUN
dpc-3650	293	7	,	,	PUNCT
dpc-3650	293	8	lancet	lancet	NOUN
dpc-3650	293	9	,	,	PUNCT
dpc-3650	293	10	vol	vol	NOUN
dpc-3650	293	11	397	397	NUM
dpc-3650	293	12	april3	april3	NOUN
dpc-3650	293	13	,	,	PUNCT
dpc-3650	293	14	2021	2021	NUM
dpc-3650	293	15	3	3	NUM
dpc-3650	293	16	.	.	PUNCT
dpc-3650	294	1	chen	chen	PROPN
dpc-3650	294	2	l	l	PROPN
dpc-3650	294	3	,	,	PUNCT
dpc-3650	294	4	shen	shen	PROPN
dpc-3650	294	5	z.	z.	PROPN
dpc-3650	294	6	tissue	tissue	PROPN
dpc-3650	294	7	-	-	PUNCT
dpc-3650	294	8	resident	resident	NOUN
dpc-3650	294	9	memory	memory	NOUN
dpc-3650	294	10	t	t	NOUN
dpc-3650	294	11	cells	cell	NOUN
dpc-3650	294	12	and	and	CCONJ
dpc-3650	294	13	their	their	PRON
dpc-3650	294	14	biological	biological	ADJ
dpc-3650	294	15	characteristics	characteristic	NOUN
dpc-3650	294	16	in	in	ADP
dpc-3650	294	17	the	the	DET
dpc-3650	294	18	recurrence	recurrence	NOUN
dpc-3650	294	19	of	of	ADP
dpc-3650	294	20	inflammatory	inflammatory	ADJ
dpc-3650	294	21	skin	skin	NOUN
dpc-3650	294	22	disorders	disorder	NOUN
dpc-3650	294	23	.	.	PUNCT
dpc-3650	295	1	cell	cell	NOUN
dpc-3650	295	2	mol	mol	ADP
dpc-3650	295	3	immunol	immunol	NOUN
dpc-3650	295	4	.	.	PUNCT
dpc-3650	296	1	2020;17(1):64	2020;17(1):64	NUM
dpc-3650	296	2	-	-	SYM
dpc-3650	296	3	75	75	NUM
dpc-3650	296	4	.	.	PUNCT
dpc-3650	297	1	doi	doi	NOUN
dpc-3650	297	2	:	:	PUNCT
dpc-3650	297	3	10.1038	10.1038	NUM
dpc-3650	297	4	/s41423	/s41423	SYM
dpc-3650	297	5	-	-	PUNCT
dpc-3650	297	6	019	019	NUM
dpc-3650	297	7	-	-	PUNCT
dpc-3650	297	8	0291	0291	NUM
dpc-3650	297	9	-	-	PUNCT
dpc-3650	297	10	4	4	NUM
dpc-3650	297	11	.	.	PUNCT
dpc-3650	298	1	pmid	pmid	NOUN
dpc-3650	298	2	:	:	PUNCT
dpc-3650	298	3	31595056	31595056	NUM
dpc-3650	298	4	.	.	PUNCT
dpc-3650	299	1	pmcid	pmcid	ADJ
dpc-3650	299	2	:	:	PUNCT
dpc-3650	299	3	pmc6952397	pmc6952397	ADJ
dpc-3650	299	4	.	.	PUNCT
dpc-3650	300	1	4	4	X
dpc-3650	300	2	.	.	X
dpc-3650	300	3	palijan	palijan	PROPN
dpc-3650	300	4	tz	tz	PROPN
dpc-3650	300	5	,	,	PUNCT
dpc-3650	300	6	kovacević	kovacević	PROPN
dpc-3650	300	7	d	d	X
dpc-3650	300	8	,	,	PUNCT
dpc-3650	300	9	koić	koić	PROPN
dpc-3650	300	10	e	e	PROPN
dpc-3650	300	11	,	,	PUNCT
dpc-3650	300	12	ruzić	ruzić	PROPN
dpc-3650	300	13	k	k	PROPN
dpc-3650	300	14	,	,	PUNCT
dpc-3650	300	15	dervinja	dervinja	PROPN
dpc-3650	300	16	f.	f.	PROPN
dpc-3650	301	1	the	the	DET
dpc-3650	301	2	impact	impact	NOUN
dpc-3650	301	3	of	of	ADP
dpc-3650	301	4	psoriasis	psoriasis	NOUN
dpc-3650	301	5	on	on	ADP
dpc-3650	301	6	the	the	DET
dpc-3650	301	7	quality	quality	NOUN
dpc-3650	301	8	of	of	ADP
dpc-3650	301	9	life	life	NOUN
dpc-3650	301	10	and	and	CCONJ
dpc-3650	301	11	psychological	psychological	ADJ
dpc-3650	301	12	characteristics	characteristic	NOUN
dpc-3650	301	13	of	of	ADP
dpc-3650	301	14	persons	person	NOUN
dpc-3650	301	15	suffering	suffer	VERB
dpc-3650	301	16	from	from	ADP
dpc-3650	301	17	psoriasis	psoriasis	NOUN
dpc-3650	301	18	.	.	PUNCT
dpc-3650	302	1	coll	coll	PROPN
dpc-3650	302	2	antropol	antropol	PROPN
dpc-3650	302	3	.	.	PUNCT
dpc-3650	303	1	2011;35	2011;35	NUM
dpc-3650	303	2	suppl	suppl	ADJ
dpc-3650	303	3	2:81	2:81	NUM
dpc-3650	303	4	-	-	SYM
dpc-3650	303	5	85	85	NUM
dpc-3650	303	6	.	.	PUNCT
dpc-3650	303	7	pmid	pmid	NOUN
dpc-3650	303	8	:	:	PUNCT
dpc-3650	303	9	22220410	22220410	NUM
dpc-3650	303	10	.	.	PUNCT
dpc-3650	304	1	5	5	NUM
dpc-3650	304	2	.	.	PUNCT
dpc-3650	305	1	[	[	X
dpc-3650	305	2	han	han	PROPN
dpc-3650	305	3	c	c	PROPN
dpc-3650	305	4	,	,	PUNCT
dpc-3650	305	5	lofland	lofland	PROPN
dpc-3650	305	6	jh	jh	PROPN
dpc-3650	305	7	,	,	PUNCT
dpc-3650	305	8	zhao	zhao	PROPN
dpc-3650	305	9	n	n	CCONJ
dpc-3650	305	10	,	,	PUNCT
dpc-3650	305	11	schenkel	schenkel	PROPN
dpc-3650	305	12	b.	b.	PROPN
dpc-3650	305	13	increased	increase	VERB
dpc-3650	305	14	prevalence	prevalence	NOUN
dpc-3650	305	15	of	of	ADP
dpc-3650	305	16	psychiatric	psychiatric	ADJ
dpc-3650	305	17	disorders	disorder	NOUN
dpc-3650	305	18	and	and	CCONJ
dpc-3650	305	19	health	health	NOUN
dpc-3650	305	20	care	care	NOUN
dpc-3650	305	21	-	-	PUNCT
dpc-3650	305	22	associated	associate	VERB
dpc-3650	305	23	costs	cost	NOUN
dpc-3650	305	24	among	among	ADP
dpc-3650	305	25	patients	patient	NOUN
dpc-3650	305	26	with	with	ADP
dpc-3650	305	27	moderate	moderate	ADJ
dpc-3650	305	28	-	-	PUNCT
dpc-3650	305	29	to	to	ADP
dpc-3650	305	30	-	-	PUNCT
dpc-3650	305	31	severe	severe	ADJ
dpc-3650	305	32	psoriasis	psoriasis	NOUN
dpc-3650	305	33	.	.	PUNCT
dpc-3650	306	1	j	j	NOUN
dpc-3650	306	2	drugs	drug	NOUN
dpc-3650	306	3	dermatol	dermatol	NOUN
dpc-3650	306	4	.	.	PUNCT
dpc-3650	307	1	2011;10(8):843	2011;10(8):843	NUM
dpc-3650	307	2	-	-	PUNCT
dpc-3650	307	3	850	850	NUM
dpc-3650	307	4	.	.	PUNCT
dpc-3650	308	1	pmid	pmid	NOUN
dpc-3650	308	2	:	:	PUNCT
dpc-3650	308	3	21818505	21818505	NUM
dpc-3650	308	4	.	.	PUNCT
dpc-3650	309	1	6	6	X
dpc-3650	309	2	.	.	X
dpc-3650	309	3	gowda	gowda	PROPN
dpc-3650	309	4	s	s	PROPN
dpc-3650	309	5	,	,	PUNCT
dpc-3650	309	6	goldblum	goldblum	PROPN
dpc-3650	309	7	om	om	PROPN
dpc-3650	309	8	,	,	PUNCT
dpc-3650	309	9	mccall	mccall	PROPN
dpc-3650	309	10	wv	wv	PROPN
dpc-3650	309	11	,	,	PUNCT
dpc-3650	309	12	feldman	feldman	PROPN
dpc-3650	309	13	sr	sr	PROPN
dpc-3650	309	14	.	.	PUNCT
dpc-3650	310	1	factors	factor	NOUN
dpc-3650	310	2	affecting	affect	VERB
dpc-3650	310	3	sleep	sleep	NOUN
dpc-3650	310	4	quality	quality	NOUN
dpc-3650	310	5	in	in	ADP
dpc-3650	310	6	patients	patient	NOUN
dpc-3650	310	7	with	with	ADP
dpc-3650	310	8	psoriasis	psoriasis	NOUN
dpc-3650	310	9	.	.	PUNCT
dpc-3650	311	1	j	j	PROPN
dpc-3650	311	2	am	be	AUX
dpc-3650	311	3	acad	acad	ADJ
dpc-3650	311	4	dermatol	dermatol	NOUN
dpc-3650	311	5	.	.	PUNCT
dpc-3650	312	1	2010;63(1):114	2010;63(1):114	NUM
dpc-3650	312	2	-	-	SYM
dpc-3650	312	3	123	123	NUM
dpc-3650	312	4	.	.	PUNCT
dpc-3650	313	1	doi	doi	NOUN
dpc-3650	313	2	:	:	PUNCT
dpc-3650	313	3	10.1016	10.1016	NUM
dpc-3650	313	4	/	/	SYM
dpc-3650	313	5	j.jaad.2009.07.003	j.jaad.2009.07.003	PROPN
dpc-3650	313	6	.	.	PUNCT
dpc-3650	314	1	pmid	pmid	NOUN
dpc-3650	314	2	:	:	PUNCT
dpc-3650	314	3	19944485	19944485	NUM
dpc-3650	314	4	.	.	PUNCT
dpc-3650	315	1	7	7	X
dpc-3650	315	2	.	.	X
dpc-3650	315	3	shutty	shutty	PROPN
dpc-3650	315	4	bg	bg	PROPN
dpc-3650	315	5	,	,	PUNCT
dpc-3650	315	6	west	west	PROPN
dpc-3650	315	7	c	c	PROPN
dpc-3650	315	8	,	,	PUNCT
dpc-3650	315	9	huang	huang	PROPN
dpc-3650	315	10	ke	ke	PROPN
dpc-3650	315	11	,	,	PUNCT
dpc-3650	315	12	et	et	PROPN
dpc-3650	315	13	al	al	PROPN
dpc-3650	315	14	.	.	PUNCT
dpc-3650	315	15	sleep	sleep	NOUN
dpc-3650	315	16	disturbances	disturbance	NOUN
dpc-3650	315	17	in	in	ADP
dpc-3650	315	18	psoriasis	psoriasis	NOUN
dpc-3650	315	19	.	.	PUNCT
dpc-3650	316	1	dermatol	dermatol	NOUN
dpc-3650	316	2	online	online	PROPN
dpc-3650	316	3	j.	j.	PROPN
dpc-3650	316	4	2013;19(1):1	2013;19(1):1	PROPN
dpc-3650	316	5	.	.	PUNCT
dpc-3650	317	1	pmid	pmid	NOUN
dpc-3650	317	2	:	:	PUNCT
dpc-3650	317	3	23374943	23374943	NUM
dpc-3650	317	4	.	.	PUNCT
dpc-3650	318	1	8	8	X
dpc-3650	318	2	.	.	X
dpc-3650	318	3	eskin	eskin	PROPN
dpc-3650	318	4	m	m	PROPN
dpc-3650	318	5	,	,	PUNCT
dpc-3650	318	6	savk	savk	PROPN
dpc-3650	318	7	e	e	NOUN
dpc-3650	318	8	,	,	PUNCT
dpc-3650	318	9	uslu	uslu	PROPN
dpc-3650	318	10	m	m	PROPN
dpc-3650	318	11	,	,	PUNCT
dpc-3650	318	12	küçükaydoğan	küçükaydoğan	PROPN
dpc-3650	318	13	n.	n.	PROPN
dpc-3650	318	14	social	social	ADJ
dpc-3650	318	15	problem	problem	NOUN
dpc-3650	318	16	solving	solving	NOUN
dpc-3650	318	17	,	,	PUNCT
dpc-3650	318	18	perceived	perceive	VERB
dpc-3650	318	19	stress	stress	NOUN
dpc-3650	318	20	,	,	PUNCT
dpc-3650	318	21	negative	negative	ADJ
dpc-3650	318	22	life	life	NOUN
dpc-3650	318	23	events	event	NOUN
dpc-3650	318	24	,	,	PUNCT
dpc-3650	318	25	depression	depression	NOUN
dpc-3650	318	26	and	and	CCONJ
dpc-3650	318	27	life	life	NOUN
dpc-3650	318	28	satisfaction	satisfaction	NOUN
dpc-3650	318	29	in	in	ADP
dpc-3650	318	30	psoriasis	psoriasis	NOUN
dpc-3650	318	31	.	.	PUNCT
dpc-3650	319	1	j	j	PROPN
dpc-3650	319	2	eur	eur	PROPN
dpc-3650	319	3	acad	acad	PROPN
dpc-3650	319	4	dermatol	dermatol	NOUN
dpc-3650	319	5	venereol	venereol	NOUN
dpc-3650	319	6	.	.	PUNCT
dpc-3650	320	1	2014;28(11):1553	2014;28(11):1553	NUM
dpc-3650	320	2	-	-	SYM
dpc-3650	320	3	1559	1559	NUM
dpc-3650	320	4	.	.	PUNCT
dpc-3650	321	1	doi	doi	NOUN
dpc-3650	321	2	:	:	PUNCT
dpc-3650	321	3	10.1111	10.1111	NUM
dpc-3650	321	4	/	/	SYM
dpc-3650	321	5	jdv.12355	jdv.12355	ADP
dpc-3650	321	6	.	.	PUNCT
dpc-3650	322	1	pmid	pmid	NOUN
dpc-3650	322	2	:	:	PUNCT
dpc-3650	322	3	24404894	24404894	NUM
dpc-3650	322	4	.	.	PUNCT
dpc-3650	323	1	9	9	NUM
dpc-3650	323	2	.	.	X
dpc-3650	323	3	dowlatshahi	dowlatshahi	PROPN
dpc-3650	323	4	ea	ea	NOUN
dpc-3650	323	5	,	,	PUNCT
dpc-3650	323	6	wakkee	wakkee	PROPN
dpc-3650	323	7	m	m	PROPN
dpc-3650	323	8	,	,	PUNCT
dpc-3650	323	9	arends	arend	VERB
dpc-3650	323	10	lr	lr	NOUN
dpc-3650	323	11	,	,	PUNCT
dpc-3650	323	12	nijsten	nijsten	ADV
dpc-3650	323	13	t.	t.	PROPN
dpc-3650	323	14	the	the	DET
dpc-3650	323	15	prevalence	prevalence	NOUN
dpc-3650	323	16	and	and	CCONJ
dpc-3650	323	17	odds	odd	NOUN
dpc-3650	323	18	of	of	ADP
dpc-3650	323	19	depressive	depressive	ADJ
dpc-3650	323	20	symptoms	symptom	NOUN
dpc-3650	323	21	and	and	CCONJ
dpc-3650	323	22	clinical	clinical	ADJ
dpc-3650	323	23	depression	depression	NOUN
dpc-3650	323	24	in	in	ADP
dpc-3650	323	25	psoriasis	psoriasis	NOUN
dpc-3650	323	26	patients	patient	NOUN
dpc-3650	323	27	:	:	PUNCT
dpc-3650	323	28	a	a	DET
dpc-3650	323	29	systematic	systematic	ADJ
dpc-3650	323	30	review	review	NOUN
dpc-3650	323	31	and	and	CCONJ
dpc-3650	323	32	meta	meta	ADJ
dpc-3650	323	33	-	-	PUNCT
dpc-3650	323	34	analysis	analysis	NOUN
dpc-3650	323	35	.	.	PUNCT
dpc-3650	324	1	j	j	PROPN
dpc-3650	324	2	invest	invest	VERB
dpc-3650	324	3	dermatol	dermatol	NOUN
dpc-3650	324	4	.	.	PUNCT
dpc-3650	325	1	2014;134(6):1542	2014;134(6):1542	NUM
dpc-3650	325	2	-	-	SYM
dpc-3650	325	3	1551	1551	NUM
dpc-3650	325	4	.	.	PUNCT
dpc-3650	326	1	doi	doi	NOUN
dpc-3650	326	2	:	:	PUNCT
dpc-3650	326	3	10.1038	10.1038	NUM
dpc-3650	326	4	/	/	SYM
dpc-3650	326	5	jid.2013.508	jid.2013.508	PROPN
dpc-3650	326	6	.	.	PUNCT
dpc-3650	327	1	pmid	pmid	NOUN
dpc-3650	327	2	:	:	PUNCT
dpc-3650	327	3	24284419	24284419	NUM
dpc-3650	327	4	.	.	PUNCT
dpc-3650	328	1	10	10	NUM
dpc-3650	328	2	.	.	PUNCT
dpc-3650	329	1	bangemann	bangemann	PROPN
dpc-3650	329	2	k	k	PROPN
dpc-3650	329	3	,	,	PUNCT
dpc-3650	329	4	schulz	schulz	PROPN
dpc-3650	329	5	w	w	PROPN
dpc-3650	329	6	,	,	PUNCT
dpc-3650	329	7	wohlleben	wohlleben	PROPN
dpc-3650	329	8	j	j	PROPN
dpc-3650	329	9	,	,	PUNCT
dpc-3650	329	10	et	et	PROPN
dpc-3650	329	11	al	al	PROPN
dpc-3650	329	12	.	.	PUNCT
dpc-3650	330	1	depression	depression	PROPN
dpc-3650	330	2	und	und	VERB
dpc-3650	330	3	angststörung	angststörung	PROPN
dpc-3650	330	4	bei	bei	PROPN
dpc-3650	330	5	psoriasispatienten	psoriasispatienten	NOUN
dpc-3650	330	6	:	:	PUNCT
dpc-3650	330	7	schutzund	schutzund	VERB
dpc-3650	330	8	risikofaktoren	risikofaktoren	NOUN
dpc-3650	331	1	[	[	X
dpc-3650	331	2	depression	depression	NOUN
dpc-3650	331	3	and	and	CCONJ
dpc-3650	331	4	anxiety	anxiety	NOUN
dpc-3650	331	5	disorders	disorder	NOUN
dpc-3650	331	6	among	among	ADP
dpc-3650	331	7	psoriasis	psoriasis	NOUN
dpc-3650	331	8	patients	patient	NOUN
dpc-3650	331	9	:	:	PUNCT
dpc-3650	331	10	protective	protective	ADJ
dpc-3650	331	11	and	and	CCONJ
dpc-3650	331	12	exacerbating	exacerbating	ADJ
dpc-3650	331	13	factors	factor	NOUN
dpc-3650	331	14	]	]	PUNCT
dpc-3650	331	15	.	.	PUNCT
dpc-3650	332	1	hautarzt	hautarzt	NOUN
dpc-3650	332	2	.	.	PUNCT
dpc-3650	333	1	2014;65(12	2014;65(12	NUM
dpc-3650	333	2	):	):	PUNCT
dpc-3650	333	3	1056	1056	NUM
dpc-3650	333	4	-	-	SYM
dpc-3650	333	5	1061	1061	NUM
dpc-3650	333	6	.	.	PUNCT
dpc-3650	334	1	doi	doi	NOUN
dpc-3650	334	2	:	:	PUNCT
dpc-3650	334	3	10.1007	10.1007	NUM
dpc-3650	334	4	/	/	SYM
dpc-3650	334	5	s00105	s00105	PROPN
dpc-3650	334	6	-	-	PUNCT
dpc-3650	334	7	014	014	NUM
dpc-3650	334	8	-	-	PUNCT
dpc-3650	334	9	3513	3513	NUM
dpc-3650	334	10	-	-	SYM
dpc-3650	334	11	9	9	NUM
dpc-3650	334	12	.	.	PUNCT
dpc-3650	335	1	pmid	pmid	NOUN
dpc-3650	335	2	:	:	PUNCT
dpc-3650	335	3	25376619	25376619	NUM
dpc-3650	335	4	.	.	PUNCT
dpc-3650	336	1	11	11	NUM
dpc-3650	336	2	.	.	X
dpc-3650	337	1	kurd	kurd	PROPN
dpc-3650	337	2	sk	sk	PROPN
dpc-3650	337	3	,	,	PUNCT
dpc-3650	337	4	troxel	troxel	PROPN
dpc-3650	337	5	ab	ab	PROPN
dpc-3650	337	6	,	,	PUNCT
dpc-3650	337	7	crits	crit	NOUN
dpc-3650	337	8	-	-	PUNCT
dpc-3650	337	9	christoph	christoph	PROPN
dpc-3650	337	10	p	p	X
dpc-3650	337	11	,	,	PUNCT
dpc-3650	337	12	gelfand	gelfand	PROPN
dpc-3650	337	13	jm	jm	PROPN
dpc-3650	337	14	.	.	PUNCT
dpc-3650	338	1	the	the	DET
dpc-3650	338	2	risk	risk	NOUN
dpc-3650	338	3	of	of	ADP
dpc-3650	338	4	depression	depression	NOUN
dpc-3650	338	5	,	,	PUNCT
dpc-3650	338	6	anxiety	anxiety	NOUN
dpc-3650	338	7	,	,	PUNCT
dpc-3650	338	8	and	and	CCONJ
dpc-3650	338	9	suicidality	suicidality	NOUN
dpc-3650	338	10	in	in	ADP
dpc-3650	338	11	patients	patient	NOUN
dpc-3650	338	12	with	with	ADP
dpc-3650	338	13	psoriasis	psoriasis	NOUN
dpc-3650	338	14	:	:	PUNCT
dpc-3650	338	15	a	a	DET
dpc-3650	338	16	population	population	NOUN
dpc-3650	338	17	-	-	PUNCT
dpc-3650	338	18	based	base	VERB
dpc-3650	338	19	cohort	cohort	NOUN
dpc-3650	338	20	study	study	NOUN
dpc-3650	338	21	.	.	PUNCT
dpc-3650	339	1	arch	arch	ADJ
dpc-3650	339	2	dermatol	dermatol	NOUN
dpc-3650	339	3	.	.	PUNCT
dpc-3650	340	1	2010;146(8):891	2010;146(8):891	NUM
dpc-3650	340	2	-	-	SYM
dpc-3650	340	3	895	895	NUM
dpc-3650	340	4	.	.	PUNCT
dpc-3650	340	5	doi	doi	NOUN
dpc-3650	340	6	:	:	PUNCT
dpc-3650	340	7	10.1001	10.1001	NUM
dpc-3650	340	8	/	/	SYM
dpc-3650	340	9	archdermatol.2010.186	archdermatol.2010.186	PROPN
dpc-3650	340	10	.	.	PUNCT
dpc-3650	341	1	pmid	pmid	NOUN
dpc-3650	341	2	:	:	PUNCT
dpc-3650	341	3	20713823	20713823	NUM
dpc-3650	341	4	.	.	PUNCT
dpc-3650	342	1	pmcid	pmcid	NOUN
dpc-3650	342	2	:	:	PUNCT
dpc-3650	342	3	pmc2928071	pmc2928071	PROPN
dpc-3650	342	4	.	.	PUNCT
dpc-3650	343	1	12	12	NUM
dpc-3650	343	2	.	.	PUNCT
dpc-3650	344	1	sondermann	sondermann	PROPN
dpc-3650	344	2	w	w	PROPN
dpc-3650	344	3	,	,	PUNCT
dpc-3650	344	4	fiege	fiege	PROPN
dpc-3650	344	5	o	o	NOUN
dpc-3650	344	6	,	,	PUNCT
dpc-3650	344	7	körber	körber	PROPN
dpc-3650	344	8	a	a	PROPN
dpc-3650	344	9	,	,	PUNCT
dpc-3650	344	10	scherbaum	scherbaum	ADJ
dpc-3650	344	11	n.	n.	ADJ
dpc-3650	344	12	psychological	psychological	ADJ
dpc-3650	344	13	burden	burden	NOUN
dpc-3650	344	14	of	of	ADP
dpc-3650	344	15	psoriatic	psoriatic	ADJ
dpc-3650	344	16	patients	patient	NOUN
dpc-3650	344	17	in	in	ADP
dpc-3650	344	18	a	a	DET
dpc-3650	344	19	german	german	ADJ
dpc-3650	344	20	university	university	NOUN
dpc-3650	344	21	hospital	hospital	NOUN
dpc-3650	344	22	dermatology	dermatology	NOUN
dpc-3650	344	23	department	department	PROPN
dpc-3650	344	24	.	.	PUNCT
dpc-3650	345	1	j	j	PROPN
dpc-3650	345	2	dermatol	dermatol	NOUN
dpc-3650	345	3	.	.	PUNCT
dpc-3650	346	1	2021;48(6):794	2021;48(6):794	PROPN
dpc-3650	346	2	-	-	PUNCT
dpc-3650	346	3	806	806	NUM
dpc-3650	346	4	.	.	PUNCT
dpc-3650	347	1	doi	doi	NOUN
dpc-3650	347	2	:	:	PUNCT
dpc-3650	347	3	10.1111/1346	10.1111/1346	NUM
dpc-3650	347	4	-	-	SYM
dpc-3650	347	5	8138.15721	8138.15721	NUM
dpc-3650	347	6	.	.	PUNCT
dpc-3650	348	1	pmid	pmid	NOUN
dpc-3650	348	2	:	:	PUNCT
dpc-3650	348	3	33354818	33354818	NUM
dpc-3650	348	4	.	.	PUNCT
dpc-3650	349	1	13	13	NUM
dpc-3650	349	2	.	.	X
dpc-3650	350	1	duvetorp	duvetorp	PROPN
dpc-3650	350	2	a	a	PRON
dpc-3650	350	3	,	,	PUNCT
dpc-3650	350	4	mrowietz	mrowietz	PROPN
dpc-3650	350	5	u	u	NOUN
dpc-3650	350	6	,	,	PUNCT
dpc-3650	350	7	nilsson	nilsson	PROPN
dpc-3650	350	8	m	m	PROPN
dpc-3650	350	9	,	,	PUNCT
dpc-3650	350	10	seifert	seifert	PROPN
dpc-3650	350	11	o.	o.	PROPN
dpc-3650	350	12	sex	sex	NOUN
dpc-3650	350	13	and	and	CCONJ
dpc-3650	350	14	age	age	NOUN
dpc-3650	350	15	influence	influence	NOUN
dpc-3650	350	16	the	the	DET
dpc-3650	350	17	associated	associated	ADJ
dpc-3650	350	18	risk	risk	NOUN
dpc-3650	350	19	of	of	ADP
dpc-3650	350	20	depression	depression	NOUN
dpc-3650	350	21	in	in	ADP
dpc-3650	350	22	patients	patient	NOUN
dpc-3650	350	23	with	with	ADP
dpc-3650	350	24	psoriasis	psoriasis	NOUN
dpc-3650	350	25	:	:	PUNCT
dpc-3650	350	26	a	a	DET
dpc-3650	350	27	retrospective	retrospective	ADJ
dpc-3650	350	28	population	population	NOUN
dpc-3650	350	29	study	study	NOUN
dpc-3650	350	30	based	base	VERB
dpc-3650	350	31	on	on	ADP
dpc-3650	350	32	diagnosis	diagnosis	NOUN
dpc-3650	350	33	and	and	CCONJ
dpc-3650	350	34	drug	drug	NOUN
dpc-3650	350	35	-	-	PUNCT
dpc-3650	350	36	use	use	NOUN
dpc-3650	350	37	.	.	PUNCT
dpc-3650	351	1	dermatology	dermatology	NOUN
dpc-3650	351	2	.	.	PUNCT
dpc-3650	352	1	2021;237(4):595	2021;237(4):595	NUM
dpc-3650	352	2	-	-	SYM
dpc-3650	352	3	602	602	NUM
dpc-3650	352	4	.	.	PUNCT
dpc-3650	353	1	doi	doi	NOUN
dpc-3650	353	2	:	:	PUNCT
dpc-3650	353	3	10.1159/000509732	10.1159/000509732	NUM
dpc-3650	353	4	.	.	PUNCT
dpc-3650	354	1	pmid	pmid	NOUN
dpc-3650	354	2	:	:	PUNCT
dpc-3650	354	3	32927456	32927456	NUM
dpc-3650	354	4	.	.	PUNCT
dpc-3650	355	1	pmcid	pmcid	NOUN
dpc-3650	355	2	:	:	PUNCT
dpc-3650	355	3	pmc8315676	pmc8315676	NOUN
dpc-3650	355	4	.	.	PUNCT
dpc-3650	356	1	14	14	NUM
dpc-3650	356	2	.	.	PUNCT
dpc-3650	357	1	min	min	PROPN
dpc-3650	357	2	c	c	PROPN
dpc-3650	357	3	,	,	PUNCT
dpc-3650	357	4	kim	kim	PROPN
dpc-3650	357	5	m	m	PROPN
dpc-3650	357	6	,	,	PUNCT
dpc-3650	357	7	oh	oh	INTJ
dpc-3650	357	8	dj	dj	NOUN
dpc-3650	357	9	,	,	PUNCT
dpc-3650	357	10	choi	choi	PROPN
dpc-3650	357	11	hg	hg	PROPN
dpc-3650	357	12	.	.	PUNCT
dpc-3650	357	13	bidirectional	bidirectional	PROPN
dpc-3650	357	14	association	association	NOUN
dpc-3650	357	15	between	between	ADP
dpc-3650	357	16	psoriasis	psoriasis	NOUN
dpc-3650	357	17	and	and	CCONJ
dpc-3650	357	18	depression	depression	NOUN
dpc-3650	357	19	:	:	PUNCT
dpc-3650	357	20	two	two	NUM
dpc-3650	357	21	longitudinal	longitudinal	ADJ
dpc-3650	357	22	follow	follow	NOUN
dpc-3650	357	23	-	-	PUNCT
dpc-3650	357	24	up	up	ADP
dpc-3650	357	25	studies	study	NOUN
dpc-3650	357	26	using	use	VERB
dpc-3650	357	27	a	a	DET
dpc-3650	357	28	national	national	ADJ
dpc-3650	357	29	sample	sample	NOUN
dpc-3650	357	30	cohort	cohort	NOUN
dpc-3650	357	31	.	.	PUNCT
dpc-3650	358	1	j	j	PROPN
dpc-3650	358	2	affect	affect	VERB
dpc-3650	358	3	disord	disord	NOUN
dpc-3650	358	4	.	.	PUNCT
dpc-3650	359	1	2020;262:126	2020;262:126	NUM
dpc-3650	359	2	-	-	SYM
dpc-3650	359	3	132	132	NUM
dpc-3650	359	4	.	.	PUNCT
dpc-3650	360	1	doi	doi	NOUN
dpc-3650	360	2	:	:	PUNCT
dpc-3650	360	3	10.1016	10.1016	NUM
dpc-3650	360	4	/	/	SYM
dpc-3650	360	5	j.jad.2019.10.043	j.jad.2019.10.043	PROPN
dpc-3650	360	6	.	.	PUNCT
dpc-3650	361	1	pmid	pmid	NOUN
dpc-3650	361	2	:	:	PUNCT
dpc-3650	361	3	31733456	31733456	NUM
dpc-3650	361	4	.	.	PUNCT
dpc-3650	362	1	15	15	NUM
dpc-3650	362	2	.	.	X
dpc-3650	362	3	lada	lada	PROPN
dpc-3650	362	4	g	g	PROPN
dpc-3650	362	5	,	,	PUNCT
dpc-3650	362	6	chinoy	chinoy	PROPN
dpc-3650	362	7	h	h	PROPN
dpc-3650	362	8	,	,	PUNCT
dpc-3650	362	9	talbot	talbot	PROPN
dpc-3650	362	10	ps	ps	PROPN
dpc-3650	362	11	,	,	PUNCT
dpc-3650	362	12	warren	warren	PROPN
dpc-3650	362	13	rb	rb	PROPN
dpc-3650	362	14	,	,	PUNCT
dpc-3650	362	15	kleyn	kleyn	PROPN
dpc-3650	362	16	ce	ce	PROPN
dpc-3650	362	17	.	.	PUNCT
dpc-3650	363	1	the	the	DET
dpc-3650	363	2	effect	effect	NOUN
dpc-3650	363	3	of	of	ADP
dpc-3650	363	4	the	the	DET
dpc-3650	363	5	covid-19	covid-19	PROPN
dpc-3650	363	6	pandemic	pandemic	NOUN
dpc-3650	363	7	on	on	ADP
dpc-3650	363	8	illness	illness	NOUN
dpc-3650	363	9	perceptions	perception	NOUN
dpc-3650	363	10	of	of	ADP
dpc-3650	363	11	psoriasis	psoriasis	NOUN
dpc-3650	363	12	and	and	CCONJ
dpc-3650	363	13	 	 	SPACE
dpc-3650	363	14	the	the	DET
dpc-3650	363	15	role	role	NOUN
dpc-3650	363	16	of	of	ADP
dpc-3650	363	17	depression	depression	NOUN
dpc-3650	363	18	:	:	PUNCT
dpc-3650	363	19	findings	finding	NOUN
dpc-3650	363	20	from	from	ADP
dpc-3650	363	21	a	a	DET
dpc-3650	363	22	cross	cross	ADJ
dpc-3650	363	23	-	-	ADJ
dpc-3650	363	24	sectional	sectional	ADJ
dpc-3650	363	25	original	original	ADJ
dpc-3650	363	26	article	article	NOUN
dpc-3650	363	27	|	|	ADV
dpc-3650	363	28	dermatol	dermatol	ADJ
dpc-3650	363	29	pract	pract	NOUN
dpc-3650	363	30	concept	concept	NOUN
dpc-3650	363	31	.	.	PUNCT
dpc-3650	364	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	364	2	9	9	NUM
dpc-3650	364	3	doi	doi	NOUN
dpc-3650	364	4	:	:	PUNCT
dpc-3650	364	5	10.1155	10.1155	NUM
dpc-3650	364	6	/	/	SYM
dpc-3650	364	7	s1463924600000195	s1463924600000195	NOUN
dpc-3650	364	8	.	.	PUNCT
dpc-3650	365	1	pmid	pmid	NOUN
dpc-3650	365	2	:	:	PUNCT
dpc-3650	365	3	18924698	18924698	NUM
dpc-3650	365	4	.	.	PUNCT
dpc-3650	366	1	pmcid	pmcid	ADJ
dpc-3650	366	2	:	:	PUNCT
dpc-3650	366	3	pmc2562849	pmc2562849	NOUN
dpc-3650	366	4	.	.	PUNCT
dpc-3650	367	1	45	45	NUM
dpc-3650	367	2	.	.	PUNCT
dpc-3650	368	1	icsh	icsh	ADJ
dpc-3650	368	2	recommendations	recommendation	NOUN
dpc-3650	368	3	for	for	ADP
dpc-3650	368	4	measurement	measurement	NOUN
dpc-3650	368	5	of	of	ADP
dpc-3650	368	6	erythrocyte	erythrocyte	PROPN
dpc-3650	368	7	sedimentation	sedimentation	NOUN
dpc-3650	368	8	rate	rate	NOUN
dpc-3650	368	9	.	.	PUNCT
dpc-3650	369	1	international	international	ADJ
dpc-3650	369	2	council	council	PROPN
dpc-3650	369	3	for	for	ADP
dpc-3650	369	4	standardization	standardization	NOUN
dpc-3650	369	5	in	in	ADP
dpc-3650	369	6	haematology	haematology	NOUN
dpc-3650	369	7	(	(	PUNCT
dpc-3650	369	8	expert	expert	NOUN
dpc-3650	369	9	panel	panel	NOUN
dpc-3650	369	10	on	on	ADP
dpc-3650	369	11	blood	blood	NOUN
dpc-3650	369	12	rheology	rheology	NOUN
dpc-3650	369	13	)	)	PUNCT
dpc-3650	369	14	.	.	PUNCT
dpc-3650	370	1	j	j	PROPN
dpc-3650	370	2	clin	clin	PROPN
dpc-3650	370	3	pathol	pathol	PROPN
dpc-3650	370	4	.	.	PUNCT
dpc-3650	371	1	1993;46(3):198203	1993;46(3):198203	NUM
dpc-3650	371	2	.	.	PUNCT
dpc-3650	372	1	doi	doi	NOUN
dpc-3650	372	2	:	:	PUNCT
dpc-3650	372	3	10.1136	10.1136	NUM
dpc-3650	372	4	/	/	SYM
dpc-3650	372	5	jcp.46.3.198	jcp.46.3.198	PROPN
dpc-3650	372	6	.	.	PUNCT
dpc-3650	373	1	pmid	pmid	NOUN
dpc-3650	373	2	:	:	PUNCT
dpc-3650	373	3	8463411	8463411	NUM
dpc-3650	373	4	.	.	PUNCT
dpc-3650	374	1	pmcid	pmcid	NOUN
dpc-3650	374	2	:	:	PUNCT
dpc-3650	374	3	pmc501169	pmc501169	VERB
dpc-3650	374	4	.	.	PUNCT
dpc-3650	375	1	46	46	NUM
dpc-3650	375	2	.	.	PUNCT
dpc-3650	376	1	ferrante	ferrante	PROPN
dpc-3650	376	2	aw	aw	INTJ
dpc-3650	376	3	jr	jr	PROPN
dpc-3650	376	4	.	.	PUNCT
dpc-3650	376	5	obesity	obesity	NOUN
dpc-3650	376	6	-	-	PUNCT
dpc-3650	376	7	induced	induce	VERB
dpc-3650	376	8	inflammation	inflammation	NOUN
dpc-3650	376	9	:	:	PUNCT
dpc-3650	376	10	a	a	DET
dpc-3650	376	11	metabolic	metabolic	NOUN
dpc-3650	376	12	dialogue	dialogue	NOUN
dpc-3650	376	13	in	in	ADP
dpc-3650	376	14	the	the	DET
dpc-3650	376	15	language	language	NOUN
dpc-3650	376	16	of	of	ADP
dpc-3650	376	17	inflammation	inflammation	NOUN
dpc-3650	376	18	.	.	PUNCT
dpc-3650	377	1	j	j	PROPN
dpc-3650	377	2	intern	intern	PROPN
dpc-3650	377	3	med	me	VERB
dpc-3650	377	4	.	.	PUNCT
dpc-3650	378	1	2007;262(4):408	2007;262(4):408	NUM
dpc-3650	378	2	-	-	SYM
dpc-3650	378	3	414	414	NUM
dpc-3650	378	4	.	.	PUNCT
dpc-3650	379	1	doi	doi	NOUN
dpc-3650	379	2	:	:	PUNCT
dpc-3650	379	3	10.1111	10.1111	NUM
dpc-3650	379	4	/	/	SYM
dpc-3650	379	5	j.1365	j.1365	NOUN
dpc-3650	379	6	-	-	PUNCT
dpc-3650	379	7	2796.2007.01852	2796.2007.01852	NUM
dpc-3650	379	8	.x	.x	NOUN
dpc-3650	379	9	.	.	PUNCT
dpc-3650	380	1	pmid	pmid	NOUN
dpc-3650	380	2	:	:	PUNCT
dpc-3650	380	3	17875176	17875176	NUM
dpc-3650	380	4	.	.	PUNCT
dpc-3650	381	1	47	47	NUM
dpc-3650	381	2	.	.	PUNCT
dpc-3650	382	1	ferreira	ferreira	PROPN
dpc-3650	382	2	bi	bi	PROPN
dpc-3650	382	3	,	,	PUNCT
dpc-3650	382	4	abreu	abreu	PROPN
dpc-3650	382	5	jl	jl	PROPN
dpc-3650	382	6	,	,	PUNCT
dpc-3650	382	7	reis	reis	NOUN
dpc-3650	382	8	jp	jp	NOUN
dpc-3650	382	9	,	,	PUNCT
dpc-3650	382	10	figueiredo	figueiredo	PROPN
dpc-3650	382	11	am	am	NOUN
dpc-3650	382	12	.	.	PUNCT
dpc-3650	383	1	psoriasis	psoriasis	NOUN
dpc-3650	383	2	and	and	CCONJ
dpc-3650	383	3	associated	associate	VERB
dpc-3650	383	4	psychiatric	psychiatric	ADJ
dpc-3650	383	5	disorders	disorder	NOUN
dpc-3650	383	6	:	:	PUNCT
dpc-3650	383	7	a	a	DET
dpc-3650	383	8	systematic	systematic	ADJ
dpc-3650	383	9	review	review	NOUN
dpc-3650	383	10	on	on	ADP
dpc-3650	383	11	etiopathogenesis	etiopathogenesis	NOUN
dpc-3650	383	12	and	and	CCONJ
dpc-3650	383	13	clinical	clinical	ADJ
dpc-3650	383	14	correlation	correlation	NOUN
dpc-3650	383	15	.	.	PUNCT
dpc-3650	384	1	j	j	PROPN
dpc-3650	384	2	clin	clin	PROPN
dpc-3650	384	3	aesthet	aesthet	PROPN
dpc-3650	384	4	dermatol	dermatol	PROPN
dpc-3650	384	5	.	.	PUNCT
dpc-3650	385	1	2016;9(6):36	2016;9(6):36	NUM
dpc-3650	385	2	-	-	SYM
dpc-3650	385	3	43	43	NUM
dpc-3650	385	4	.	.	PUNCT
dpc-3650	386	1	pmid	pmid	NOUN
dpc-3650	386	2	:	:	PUNCT
dpc-3650	386	3	27386050	27386050	NUM
dpc-3650	386	4	.	.	PUNCT
dpc-3650	387	1	pmcid	pmcid	NOUN
dpc-3650	387	2	:	:	PUNCT
dpc-3650	387	3	pmc4928455	pmc4928455	NOUN
dpc-3650	387	4	.	.	PUNCT
dpc-3650	388	1	48	48	NUM
dpc-3650	388	2	.	.	PUNCT
dpc-3650	388	3	devrimci	devrimci	NOUN
dpc-3650	388	4	-	-	PUNCT
dpc-3650	388	5	ozguven	ozguven	PROPN
dpc-3650	388	6	h	h	NOUN
dpc-3650	388	7	,	,	PUNCT
dpc-3650	388	8	kundakci	kundakci	PROPN
dpc-3650	388	9	tn	tn	PROPN
dpc-3650	388	10	,	,	PUNCT
dpc-3650	388	11	kumbasar	kumbasar	PROPN
dpc-3650	388	12	h	h	PROPN
dpc-3650	388	13	,	,	PUNCT
dpc-3650	388	14	boyvat	boyvat	ADJ
dpc-3650	388	15	a.	a.	NOUN
dpc-3650	388	16	the	the	DET
dpc-3650	388	17	depression	depression	NOUN
dpc-3650	388	18	,	,	PUNCT
dpc-3650	388	19	anxiety	anxiety	NOUN
dpc-3650	388	20	,	,	PUNCT
dpc-3650	388	21	life	life	NOUN
dpc-3650	388	22	satisfaction	satisfaction	NOUN
dpc-3650	388	23	and	and	CCONJ
dpc-3650	388	24	affective	affective	ADJ
dpc-3650	388	25	expression	expression	NOUN
dpc-3650	388	26	levels	level	NOUN
dpc-3650	388	27	in	in	ADP
dpc-3650	388	28	psoriasis	psoriasis	NOUN
dpc-3650	388	29	patients	patient	NOUN
dpc-3650	388	30	.	.	PUNCT
dpc-3650	389	1	j	j	PROPN
dpc-3650	389	2	eur	eur	PROPN
dpc-3650	389	3	acad	acad	PROPN
dpc-3650	389	4	dermatol	dermatol	NOUN
dpc-3650	389	5	venereol	venereol	NOUN
dpc-3650	389	6	.	.	PUNCT
dpc-3650	390	1	2000;14(4):267	2000;14(4):267	PROPN
dpc-3650	390	2	-	-	PUNCT
dpc-3650	390	3	271	271	NUM
dpc-3650	390	4	.	.	PUNCT
dpc-3650	390	5	doi	doi	NOUN
dpc-3650	390	6	:	:	PUNCT
dpc-3650	390	7	10.1046	10.1046	NUM
dpc-3650	390	8	/	/	SYM
dpc-3650	390	9	j.1468	j.1468	NOUN
dpc-3650	390	10	-	-	PUNCT
dpc-3650	390	11	3083.2000.00085.x	3083.2000.00085.x	NOUN
dpc-3650	390	12	.	.	PUNCT
dpc-3650	391	1	pmid	pmid	NOUN
dpc-3650	391	2	:	:	PUNCT
dpc-3650	391	3	11204514	11204514	NUM
dpc-3650	391	4	.	.	PUNCT
dpc-3650	392	1	49	49	NUM
dpc-3650	392	2	.	.	PUNCT
dpc-3650	393	1	moon	moon	PROPN
dpc-3650	393	2	hs	hs	PROPN
dpc-3650	393	3	,	,	PUNCT
dpc-3650	393	4	mizara	mizara	PROPN
dpc-3650	393	5	a	a	PRON
dpc-3650	393	6	,	,	PUNCT
dpc-3650	393	7	mcbride	mcbride	PROPN
dpc-3650	393	8	sr	sr	PROPN
dpc-3650	393	9	.	.	PUNCT
dpc-3650	394	1	psoriasis	psoriasis	NOUN
dpc-3650	394	2	and	and	CCONJ
dpc-3650	394	3	psycho	psycho	NOUN
dpc-3650	394	4	dermatology	dermatology	NOUN
dpc-3650	394	5	.	.	PUNCT
dpc-3650	395	1	dermatol	dermatol	NOUN
dpc-3650	395	2	ther	ther	ADV
dpc-3650	395	3	(	(	PUNCT
dpc-3650	395	4	heidelb	heidelb	NOUN
dpc-3650	395	5	)	)	PUNCT
dpc-3650	395	6	.	.	PUNCT
dpc-3650	396	1	2013;3(2):117	2013;3(2):117	NUM
dpc-3650	396	2	-	-	SYM
dpc-3650	396	3	30	30	NUM
dpc-3650	396	4	.	.	PUNCT
dpc-3650	397	1	doi	doi	NOUN
dpc-3650	397	2	:	:	PUNCT
dpc-3650	397	3	10.1007	10.1007	NUM
dpc-3650	397	4	/	/	SYM
dpc-3650	397	5	s13555	s13555	PROPN
dpc-3650	397	6	-	-	PUNCT
dpc-3650	397	7	013	013	NUM
dpc-3650	397	8	-	-	PUNCT
dpc-3650	397	9	0031	0031	NUM
dpc-3650	397	10	-	-	PUNCT
dpc-3650	397	11	0	0	NUM
dpc-3650	397	12	.	.	PUNCT
dpc-3650	398	1	epub	epub	PROPN
dpc-3650	398	2	2013	2013	NUM
dpc-3650	398	3	jul	jul	PROPN
dpc-3650	398	4	10	10	NUM
dpc-3650	398	5	.	.	PUNCT
dpc-3650	399	1	pmid	pmid	NOUN
dpc-3650	399	2	:	:	PUNCT
dpc-3650	399	3	24318414	24318414	NUM
dpc-3650	399	4	;	;	PUNCT
dpc-3650	399	5	pmcid	pmcid	ADJ
dpc-3650	399	6	:	:	PUNCT
dpc-3650	399	7	pmc3889305	pmc3889305	NOUN
dpc-3650	399	8	.	.	PUNCT
dpc-3650	400	1	50	50	NUM
dpc-3650	400	2	.	.	PUNCT
dpc-3650	401	1	schmitt	schmitt	PROPN
dpc-3650	401	2	jm	jm	PROPN
dpc-3650	401	3	,	,	PUNCT
dpc-3650	401	4	ford	ford	PROPN
dpc-3650	401	5	de	de	PROPN
dpc-3650	401	6	.	.	PROPN
dpc-3650	401	7	role	role	NOUN
dpc-3650	401	8	of	of	ADP
dpc-3650	401	9	depression	depression	NOUN
dpc-3650	401	10	in	in	ADP
dpc-3650	401	11	quality	quality	NOUN
dpc-3650	401	12	of	of	ADP
dpc-3650	401	13	life	life	NOUN
dpc-3650	401	14	for	for	ADP
dpc-3650	401	15	patients	patient	NOUN
dpc-3650	401	16	with	with	ADP
dpc-3650	401	17	psoriasis	psoriasis	NOUN
dpc-3650	401	18	.	.	PUNCT
dpc-3650	402	1	dermatology	dermatology	NOUN
dpc-3650	402	2	.	.	PUNCT
dpc-3650	403	1	2007;215(1):17	2007;215(1):17	NUM
dpc-3650	403	2	-	-	SYM
dpc-3650	403	3	27	27	NUM
dpc-3650	403	4	.	.	PUNCT
dpc-3650	404	1	doi	doi	NOUN
dpc-3650	404	2	:	:	PUNCT
dpc-3650	404	3	10.1159/000102029	10.1159/000102029	NUM
dpc-3650	404	4	.	.	PUNCT
dpc-3650	405	1	pmid	pmid	NOUN
dpc-3650	405	2	:	:	PUNCT
dpc-3650	405	3	17587835	17587835	NUM
dpc-3650	405	4	.	.	PUNCT
dpc-3650	406	1	51	51	NUM
dpc-3650	406	2	.	.	PUNCT
dpc-3650	406	3	wu	wu	PROPN
dpc-3650	406	4	kk	kk	PROPN
dpc-3650	406	5	,	,	PUNCT
dpc-3650	406	6	armstrong	armstrong	PROPN
dpc-3650	406	7	aw	aw	INTJ
dpc-3650	406	8	.	.	PROPN
dpc-3650	406	9	suicidality	suicidality	NOUN
dpc-3650	406	10	among	among	ADP
dpc-3650	406	11	psoriasis	psoriasis	NOUN
dpc-3650	406	12	patients	patient	NOUN
dpc-3650	406	13	:	:	PUNCT
dpc-3650	406	14	a	a	DET
dpc-3650	406	15	critical	critical	ADJ
dpc-3650	406	16	evidence	evidence	NOUN
dpc-3650	406	17	synthesis	synthesis	NOUN
dpc-3650	406	18	.	.	PUNCT
dpc-3650	407	1	g	g	ADP
dpc-3650	407	2	ital	ital	ADJ
dpc-3650	407	3	dermatol	dermatol	NOUN
dpc-3650	407	4	venereol	venereol	NOUN
dpc-3650	407	5	.	.	PUNCT
dpc-3650	408	1	2019;154(1):56	2019;154(1):56	NUM
dpc-3650	408	2	-	-	SYM
dpc-3650	408	3	63	63	NUM
dpc-3650	408	4	.	.	PUNCT
dpc-3650	409	1	doi	doi	NOUN
dpc-3650	409	2	:	:	PUNCT
dpc-3650	409	3	10.23736	10.23736	NUM
dpc-3650	409	4	/	/	SYM
dpc-3650	409	5	s0392	s0392	NOUN
dpc-3650	409	6	-	-	PUNCT
dpc-3650	409	7	0488.18.06112	0488.18.06112	ADJ
dpc-3650	409	8	-6pmid	-6pmid	NOUN
dpc-3650	409	9	:	:	PUNCT
dpc-3650	409	10	30019576	30019576	NUM
dpc-3650	409	11	.	.	PUNCT
dpc-3650	410	1	52	52	NUM
dpc-3650	410	2	.	.	PUNCT
dpc-3650	411	1	punzi	punzi	PROPN
dpc-3650	411	2	l	l	PROPN
dpc-3650	411	3	,	,	PUNCT
dpc-3650	411	4	podswiadek	podswiadek	PROPN
dpc-3650	411	5	m	m	PROPN
dpc-3650	411	6	,	,	PUNCT
dpc-3650	411	7	oliviero	oliviero	VERB
dpc-3650	411	8	f	f	PROPN
dpc-3650	411	9	,	,	PUNCT
dpc-3650	411	10	et	et	PROPN
dpc-3650	411	11	al	al	PROPN
dpc-3650	411	12	.	.	PUNCT
dpc-3650	411	13	laboratory	laboratory	PROPN
dpc-3650	411	14	findings	finding	NOUN
dpc-3650	411	15	in	in	ADP
dpc-3650	411	16	psoriatic	psoriatic	ADJ
dpc-3650	411	17	arthritis	arthritis	NOUN
dpc-3650	411	18	.	.	PUNCT
dpc-3650	412	1	reumatismo	reumatismo	PROPN
dpc-3650	412	2	.	.	PUNCT
dpc-3650	413	1	2007;59	2007;59	NUM
dpc-3650	413	2	suppl	suppl	ADV
dpc-3650	413	3	1:52	1:52	NUM
dpc-3650	413	4	-	-	SYM
dpc-3650	413	5	55	55	NUM
dpc-3650	413	6	.	.	PUNCT
dpc-3650	414	1	doi	doi	NOUN
dpc-3650	414	2	:	:	PUNCT
dpc-3650	414	3	10.4081	10.4081	NUM
dpc-3650	414	4	/	/	SYM
dpc-3650	414	5	reumatismo.2007.1s.52	reumatismo.2007.1s.52	PROPN
dpc-3650	414	6	.	.	PROPN
dpc-3650	415	1	pmid	pmid	PROPN
dpc-3650	415	2	:	:	PUNCT
dpc-3650	415	3	17828345	17828345	NUM
dpc-3650	415	4	.	.	PUNCT
dpc-3650	416	1	53	53	NUM
dpc-3650	416	2	.	.	PUNCT
dpc-3650	416	3	cooksey	cooksey	NOUN
dpc-3650	416	4	r	r	PROPN
dpc-3650	416	5	,	,	PUNCT
dpc-3650	416	6	brophy	brophy	PROPN
dpc-3650	416	7	s	s	PROPN
dpc-3650	416	8	,	,	PUNCT
dpc-3650	416	9	et	et	PROPN
dpc-3650	416	10	al	al	PROPN
dpc-3650	416	11	.	.	PUNCT
dpc-3650	417	1	cardiovascular	cardiovascular	ADJ
dpc-3650	417	2	risk	risk	NOUN
dpc-3650	417	3	factors	factor	NOUN
dpc-3650	417	4	predicting	predict	VERB
dpc-3650	417	5	cardiac	cardiac	ADJ
dpc-3650	417	6	events	event	NOUN
dpc-3650	417	7	are	be	AUX
dpc-3650	417	8	different	different	ADJ
dpc-3650	417	9	in	in	ADP
dpc-3650	417	10	patients	patient	NOUN
dpc-3650	417	11	with	with	ADP
dpc-3650	417	12	rheumatoid	rheumatoid	NOUN
dpc-3650	417	13	arthritis	arthritis	NOUN
dpc-3650	417	14	,	,	PUNCT
dpc-3650	417	15	psoriatic	psoriatic	ADJ
dpc-3650	417	16	arthritis	arthritis	NOUN
dpc-3650	417	17	,	,	PUNCT
dpc-3650	417	18	and	and	CCONJ
dpc-3650	417	19	psoriasis	psoriasis	NOUN
dpc-3650	417	20	.	.	PUNCT
dpc-3650	418	1	semin	semin	PROPN
dpc-3650	418	2	arthritis	arthritis	PROPN
dpc-3650	418	3	rheum	rheum	PROPN
dpc-3650	418	4	.	.	PUNCT
dpc-3650	419	1	2018;48(3):367	2018;48(3):367	NUM
dpc-3650	419	2	-	-	PUNCT
dpc-3650	419	3	373	373	NUM
dpc-3650	419	4	.	.	PUNCT
dpc-3650	420	1	doi	doi	NOUN
dpc-3650	420	2	:	:	PUNCT
dpc-3650	420	3	10.1016	10.1016	NUM
dpc-3650	420	4	/	/	SYM
dpc-3650	420	5	j.semarthrit.2018.03.005	j.semarthrit.2018.03.005	PROPN
dpc-3650	420	6	.	.	PUNCT
dpc-3650	421	1	pmid	pmid	NOUN
dpc-3650	421	2	:	:	PUNCT
dpc-3650	421	3	29656791	29656791	NUM
dpc-3650	421	4	.	.	PUNCT
dpc-3650	422	1	54	54	NUM
dpc-3650	422	2	.	.	X
dpc-3650	423	1	fleming	fleme	VERB
dpc-3650	423	2	p	p	NOUN
dpc-3650	423	3	,	,	PUNCT
dpc-3650	423	4	roubille	roubille	NOUN
dpc-3650	423	5	c	c	NOUN
dpc-3650	423	6	,	,	PUNCT
dpc-3650	423	7	richer	rich	ADJ
dpc-3650	423	8	v	v	NOUN
dpc-3650	423	9	,	,	PUNCT
dpc-3650	423	10	et	et	PROPN
dpc-3650	423	11	al	al	PROPN
dpc-3650	423	12	.	.	PROPN
dpc-3650	423	13	effect	effect	NOUN
dpc-3650	423	14	of	of	ADP
dpc-3650	423	15	biologics	biologic	NOUN
dpc-3650	423	16	on	on	ADP
dpc-3650	423	17	depressive	depressive	ADJ
dpc-3650	423	18	symptoms	symptom	NOUN
dpc-3650	423	19	in	in	ADP
dpc-3650	423	20	patients	patient	NOUN
dpc-3650	423	21	with	with	ADP
dpc-3650	423	22	psoriasis	psoriasis	NOUN
dpc-3650	423	23	:	:	PUNCT
dpc-3650	423	24	a	a	DET
dpc-3650	423	25	systematic	systematic	ADJ
dpc-3650	423	26	review	review	NOUN
dpc-3650	423	27	.	.	PUNCT
dpc-3650	424	1	j	j	PROPN
dpc-3650	424	2	eur	eur	PROPN
dpc-3650	424	3	acad	acad	PROPN
dpc-3650	424	4	dermatol	dermatol	NOUN
dpc-3650	424	5	venereol	venereol	NOUN
dpc-3650	424	6	.	.	PUNCT
dpc-3650	425	1	2015;29(6):1063	2015;29(6):1063	NUM
dpc-3650	425	2	-	-	PUNCT
dpc-3650	425	3	1070	1070	NUM
dpc-3650	425	4	.	.	PUNCT
dpc-3650	426	1	doi	doi	NOUN
dpc-3650	426	2	:	:	PUNCT
dpc-3650	426	3	10.1111	10.1111	NUM
dpc-3650	426	4	/	/	SYM
dpc-3650	426	5	jdv.12909	jdv.12909	X
dpc-3650	426	6	.	.	PUNCT
dpc-3650	427	1	pmid	pmid	NOUN
dpc-3650	427	2	:	:	PUNCT
dpc-3650	427	3	25490866	25490866	NUM
dpc-3650	427	4	.	.	PUNCT
dpc-3650	428	1	55	55	NUM
dpc-3650	428	2	.	.	PUNCT
dpc-3650	429	1	bayramgürler	bayramgürler	PROPN
dpc-3650	429	2	d	d	PROPN
dpc-3650	429	3	,	,	PUNCT
dpc-3650	429	4	karson	karson	PROPN
dpc-3650	429	5	a	a	PROPN
dpc-3650	429	6	,	,	PUNCT
dpc-3650	429	7	ozer	ozer	PROPN
dpc-3650	429	8	c	c	PROPN
dpc-3650	429	9	,	,	PUNCT
dpc-3650	429	10	utkan	utkan	ADJ
dpc-3650	429	11	t.	t.	NOUN
dpc-3650	429	12	effects	effect	NOUN
dpc-3650	429	13	of	of	ADP
dpc-3650	429	14	longterm	longterm	NOUN
dpc-3650	429	15	etanercept	etanercept	NOUN
dpc-3650	429	16	treatment	treatment	NOUN
dpc-3650	429	17	on	on	ADP
dpc-3650	429	18	anxietyand	anxietyand	NOUN
dpc-3650	429	19	depression	depression	NOUN
dpc-3650	429	20	-	-	PUNCT
dpc-3650	429	21	like	like	ADJ
dpc-3650	429	22	neurobehaviors	neurobehavior	NOUN
dpc-3650	429	23	in	in	ADP
dpc-3650	429	24	rats	rat	NOUN
dpc-3650	429	25	.	.	PUNCT
dpc-3650	430	1	physiol	physiol	PROPN
dpc-3650	430	2	behav	behav	PROPN
dpc-3650	430	3	.	.	PUNCT
dpc-3650	431	1	2013;119:145	2013;119:145	NUM
dpc-3650	431	2	-	-	SYM
dpc-3650	431	3	148	148	NUM
dpc-3650	431	4	.	.	PUNCT
dpc-3650	432	1	doi	doi	NOUN
dpc-3650	432	2	:	:	PUNCT
dpc-3650	432	3	10.1016	10.1016	NUM
dpc-3650	432	4	/	/	SYM
dpc-3650	432	5	j.physbeh.2013.06.010	j.physbeh.2013.06.010	PROPN
dpc-3650	432	6	.	.	PUNCT
dpc-3650	433	1	pmid	pmid	NOUN
dpc-3650	433	2	:	:	PUNCT
dpc-3650	433	3	23769689	23769689	NUM
dpc-3650	433	4	.	.	PUNCT
dpc-3650	434	1	56	56	NUM
dpc-3650	434	2	.	.	PUNCT
dpc-3650	435	1	[	[	X
dpc-3650	435	2	gottlieb	gottlieb	PROPN
dpc-3650	435	3	ab	ab	PROPN
dpc-3650	435	4	,	,	PUNCT
dpc-3650	435	5	dunn	dunn	PROPN
dpc-3650	435	6	m	m	PROPN
dpc-3650	435	7	,	,	PUNCT
dpc-3650	435	8	chiou	chiou	NOUN
dpc-3650	435	9	cf	cf	NOUN
dpc-3650	435	10	,	,	PUNCT
dpc-3650	435	11	patel	patel	PROPN
dpc-3650	435	12	v	v	PROPN
dpc-3650	435	13	,	,	PUNCT
dpc-3650	435	14	jahreis	jahreis	PROPN
dpc-3650	435	15	a.	a.	NOUN
dpc-3650	435	16	effects	effect	NOUN
dpc-3650	435	17	of	of	ADP
dpc-3650	435	18	etanercept	etanercept	NOUN
dpc-3650	435	19	therapy	therapy	NOUN
dpc-3650	435	20	on	on	ADP
dpc-3650	435	21	fatigue	fatigue	NOUN
dpc-3650	435	22	and	and	CCONJ
dpc-3650	435	23	symptoms	symptom	NOUN
dpc-3650	435	24	of	of	ADP
dpc-3650	435	25	depression	depression	NOUN
dpc-3650	435	26	in	in	ADP
dpc-3650	435	27	subjects	subject	NOUN
dpc-3650	435	28	treated	treat	VERB
dpc-3650	435	29	for	for	ADP
dpc-3650	435	30	moderate	moderate	ADJ
dpc-3650	435	31	to	to	ADP
dpc-3650	435	32	severe	severe	ADJ
dpc-3650	435	33	plaque	plaque	NOUN
dpc-3650	435	34	psoriasis	psoriasis	NOUN
dpc-3650	435	35	for	for	ADP
dpc-3650	435	36	up	up	ADP
dpc-3650	435	37	to	to	PART
dpc-3650	435	38	96	96	NUM
dpc-3650	435	39	weeks	week	NOUN
dpc-3650	435	40	.	.	PUNCT
dpc-3650	436	1	br	br	PROPN
dpc-3650	436	2	j	j	PROPN
dpc-3650	436	3	dermatol	dermatol	NOUN
dpc-3650	436	4	.	.	PUNCT
dpc-3650	437	1	2007;157(6):12757	2007;157(6):12757	NUM
dpc-3650	437	2	57	57	NUM
dpc-3650	437	3	.	.	PUNCT
dpc-3650	438	1	menter	menter	PROPN
dpc-3650	438	2	a	a	PROPN
dpc-3650	438	3	,	,	PUNCT
dpc-3650	438	4	augustin	augustin	PROPN
dpc-3650	438	5	m	m	PROPN
dpc-3650	438	6	,	,	PUNCT
dpc-3650	438	7	signorovitch	signorovitch	VERB
dpc-3650	438	8	j	j	PROPN
dpc-3650	438	9	,	,	PUNCT
dpc-3650	438	10	et	et	PROPN
dpc-3650	438	11	al	al	PROPN
dpc-3650	438	12	.	.	PUNCT
dpc-3650	439	1	the	the	DET
dpc-3650	439	2	effect	effect	NOUN
dpc-3650	439	3	of	of	ADP
dpc-3650	439	4	adalimumab	adalimumab	NOUN
dpc-3650	439	5	on	on	ADP
dpc-3650	439	6	reducing	reduce	VERB
dpc-3650	439	7	depression	depression	NOUN
dpc-3650	439	8	symptoms	symptom	NOUN
dpc-3650	439	9	in	in	ADP
dpc-3650	439	10	patients	patient	NOUN
dpc-3650	439	11	with	with	ADP
dpc-3650	439	12	moderate	moderate	ADJ
dpc-3650	439	13	to	to	ADP
dpc-3650	439	14	severe	severe	ADJ
dpc-3650	439	15	psoriasis	psoriasis	NOUN
dpc-3650	439	16	:	:	PUNCT
dpc-3650	439	17	a	a	DET
dpc-3650	439	18	randomized	randomized	ADJ
dpc-3650	439	19	clinical	clinical	ADJ
dpc-3650	439	20	trial	trial	NOUN
dpc-3650	439	21	.	.	PUNCT
dpc-3650	440	1	j	j	PROPN
dpc-3650	440	2	am	be	AUX
dpc-3650	440	3	acad	acad	ADJ
dpc-3650	440	4	dermatol	dermatol	NOUN
dpc-3650	440	5	.	.	PUNCT
dpc-3650	441	1	2010;62(5):812	2010;62(5):812	NUM
dpc-3650	441	2	-	-	PUNCT
dpc-3650	441	3	818	818	NUM
dpc-3650	441	4	.	.	PUNCT
dpc-3650	442	1	doi	doi	NOUN
dpc-3650	442	2	:	:	PUNCT
dpc-3650	442	3	10.1016	10.1016	NUM
dpc-3650	442	4	/	/	SYM
dpc-3650	442	5	j	j	PROPN
dpc-3650	442	6	.jaad.2009.07.022	.jaad.2009.07.022	PUNCT
dpc-3650	442	7	.	.	PUNCT
dpc-3650	443	1	pmid	pmid	NOUN
dpc-3650	443	2	:	:	PUNCT
dpc-3650	443	3	20219265	20219265	NUM
dpc-3650	443	4	.	.	PUNCT
dpc-3650	444	1	58	58	NUM
dpc-3650	444	2	.	.	PUNCT
dpc-3650	445	1	langley	langley	PROPN
dpc-3650	445	2	rg	rg	PROPN
dpc-3650	445	3	,	,	PUNCT
dpc-3650	445	4	feldman	feldman	PROPN
dpc-3650	445	5	sr	sr	PROPN
dpc-3650	445	6	,	,	PUNCT
dpc-3650	445	7	han	han	PROPN
dpc-3650	445	8	c	c	PROPN
dpc-3650	445	9	,	,	PUNCT
dpc-3650	445	10	et	et	PROPN
dpc-3650	445	11	al	al	PROPN
dpc-3650	445	12	.	.	PROPN
dpc-3650	445	13	ustekinumab	ustekinumab	NOUN
dpc-3650	445	14	significantly	significantly	ADV
dpc-3650	445	15	improves	improve	VERB
dpc-3650	445	16	symptoms	symptom	NOUN
dpc-3650	445	17	of	of	ADP
dpc-3650	445	18	anxiety	anxiety	NOUN
dpc-3650	445	19	,	,	PUNCT
dpc-3650	445	20	depression	depression	NOUN
dpc-3650	445	21	,	,	PUNCT
dpc-3650	445	22	and	and	CCONJ
dpc-3650	445	23	skinrelated	skinrelate	VERB
dpc-3650	445	24	quality	quality	NOUN
dpc-3650	445	25	of	of	ADP
dpc-3650	445	26	life	life	NOUN
dpc-3650	445	27	in	in	ADP
dpc-3650	445	28	patients	patient	NOUN
dpc-3650	445	29	with	with	ADP
dpc-3650	445	30	moderate	moderate	ADJ
dpc-3650	445	31	-	-	PUNCT
dpc-3650	445	32	to	to	ADP
dpc-3650	445	33	-	-	PUNCT
dpc-3650	445	34	severe	severe	ADJ
dpc-3650	445	35	psoriasis	psoriasis	NOUN
dpc-3650	445	36	:	:	PUNCT
dpc-3650	445	37	results	result	VERB
dpc-3650	445	38	from	from	ADP
dpc-3650	445	39	a	a	DET
dpc-3650	445	40	randomized	randomized	ADJ
dpc-3650	445	41	,	,	PUNCT
dpc-3650	445	42	double	double	ADJ
dpc-3650	445	43	-	-	PUNCT
dpc-3650	445	44	blind	blind	ADJ
dpc-3650	445	45	,	,	PUNCT
dpc-3650	445	46	placebo	placebo	NOUN
dpc-3650	445	47	-	-	PUNCT
dpc-3650	445	48	controlled	control	VERB
dpc-3650	445	49	29	29	NUM
dpc-3650	445	50	.	.	PUNCT
dpc-3650	446	1	fredriksson	fredriksson	PROPN
dpc-3650	446	2	t	t	PROPN
dpc-3650	446	3	,	,	PUNCT
dpc-3650	446	4	pettersson	pettersson	PROPN
dpc-3650	446	5	u.	u.	PROPN
dpc-3650	446	6	severe	severe	ADJ
dpc-3650	446	7	psoriasis	psoriasis	NOUN
dpc-3650	446	8	--	--	PUNCT
dpc-3650	446	9	oral	oral	ADJ
dpc-3650	446	10	therapy	therapy	NOUN
dpc-3650	446	11	with	with	ADP
dpc-3650	446	12	a	a	DET
dpc-3650	446	13	new	new	ADJ
dpc-3650	446	14	retinoid	retinoid	NOUN
dpc-3650	446	15	.	.	PUNCT
dpc-3650	447	1	dermatologica	dermatologica	PROPN
dpc-3650	447	2	.	.	PUNCT
dpc-3650	448	1	1978;157(4):238	1978;157(4):238	NUM
dpc-3650	448	2	-	-	SYM
dpc-3650	448	3	244	244	NUM
dpc-3650	448	4	.	.	PUNCT
dpc-3650	448	5	doi	doi	NOUN
dpc-3650	448	6	:	:	PUNCT
dpc-3650	448	7	10.1159/000250839	10.1159/000250839	NUM
dpc-3650	448	8	.	.	PUNCT
dpc-3650	449	1	pmid	pmid	NOUN
dpc-3650	449	2	:	:	PUNCT
dpc-3650	449	3	357213	357213	NUM
dpc-3650	449	4	.	.	PUNCT
dpc-3650	450	1	30	30	NUM
dpc-3650	450	2	.	.	PUNCT
dpc-3650	451	1	bonifati	bonifati	PROPN
dpc-3650	451	2	c	c	PROPN
dpc-3650	451	3	,	,	PUNCT
dpc-3650	451	4	berardesca	berardesca	PROPN
dpc-3650	451	5	e.	e.	PROPN
dpc-3650	451	6	clinical	clinical	PROPN
dpc-3650	451	7	outcome	outcome	NOUN
dpc-3650	451	8	measures	measure	NOUN
dpc-3650	451	9	of	of	ADP
dpc-3650	451	10	psoriasis	psoriasis	NOUN
dpc-3650	451	11	.	.	PUNCT
dpc-3650	452	1	reumatismo	reumatismo	NOUN
dpc-3650	452	2	.	.	PUNCT
dpc-3650	453	1	2007;59	2007;59	PROPN
dpc-3650	453	2	suppl	suppl	ADV
dpc-3650	453	3	1:64	1:64	NUM
dpc-3650	453	4	-	-	SYM
dpc-3650	453	5	67	67	NUM
dpc-3650	453	6	.	.	PUNCT
dpc-3650	454	1	doi	doi	NOUN
dpc-3650	454	2	:	:	PUNCT
dpc-3650	454	3	10.4081	10.4081	NUM
dpc-3650	454	4	/	/	SYM
dpc-3650	454	5	reumatismo	reumatismo	PROPN
dpc-3650	454	6	.2007.1s.64	.2007.1s.64	PROPN
dpc-3650	454	7	.	.	PUNCT
dpc-3650	455	1	pmid	pmid	NOUN
dpc-3650	455	2	:	:	PUNCT
dpc-3650	455	3	17828348	17828348	NUM
dpc-3650	455	4	.	.	PUNCT
dpc-3650	456	1	31	31	NUM
dpc-3650	456	2	.	.	PUNCT
dpc-3650	457	1	feldman	feldman	PROPN
dpc-3650	457	2	sr	sr	PROPN
dpc-3650	457	3	,	,	PUNCT
dpc-3650	457	4	krueger	krueger	PROPN
dpc-3650	457	5	gg	gg	PROPN
dpc-3650	457	6	.	.	PUNCT
dpc-3650	457	7	psoriasis	psoriasis	NOUN
dpc-3650	457	8	assessment	assessment	NOUN
dpc-3650	457	9	tools	tool	NOUN
dpc-3650	457	10	in	in	ADP
dpc-3650	457	11	clinical	clinical	ADJ
dpc-3650	457	12	trials	trial	NOUN
dpc-3650	457	13	.	.	PUNCT
dpc-3650	458	1	ann	ann	PROPN
dpc-3650	458	2	rheum	rheum	PROPN
dpc-3650	458	3	dis	dis	PROPN
dpc-3650	458	4	.	.	PUNCT
dpc-3650	459	1	2005;64	2005;64	NUM
dpc-3650	459	2	suppl	suppl	PROPN
dpc-3650	459	3	2(suppl	2(suppl	PROPN
dpc-3650	459	4	2):ii65	2):ii65	PROPN
dpc-3650	459	5	-	-	PUNCT
dpc-3650	459	6	ii68	ii68	PROPN
dpc-3650	459	7	;	;	PUNCT
dpc-3650	459	8	discussion	discussion	NOUN
dpc-3650	459	9	ii69	ii69	PROPN
dpc-3650	459	10	-	-	PUNCT
dpc-3650	459	11	73	73	NUM
dpc-3650	459	12	.	.	PUNCT
dpc-3650	460	1	doi	doi	NOUN
dpc-3650	460	2	:	:	PUNCT
dpc-3650	460	3	10.1136	10.1136	NUM
dpc-3650	460	4	/	/	SYM
dpc-3650	460	5	ard.2004.031237	ard.2004.031237	PROPN
dpc-3650	460	6	.	.	PUNCT
dpc-3650	461	1	pmid	pmid	NOUN
dpc-3650	461	2	:	:	PUNCT
dpc-3650	461	3	15708941	15708941	NUM
dpc-3650	461	4	.	.	PUNCT
dpc-3650	462	1	pmcid	pmcid	NOUN
dpc-3650	462	2	:	:	PUNCT
dpc-3650	462	3	pmc1766877	pmc1766877	PROPN
dpc-3650	462	4	.	.	PUNCT
dpc-3650	463	1	32	32	NUM
dpc-3650	463	2	.	.	PUNCT
dpc-3650	464	1	robinson	robinson	PROPN
dpc-3650	464	2	a	a	PROPN
dpc-3650	464	3	,	,	PUNCT
dpc-3650	464	4	kardos	kardos	PROPN
dpc-3650	464	5	m	m	PROPN
dpc-3650	464	6	,	,	PUNCT
dpc-3650	464	7	kimball	kimball	PROPN
dpc-3650	464	8	ab	ab	PROPN
dpc-3650	464	9	.	.	PROPN
dpc-3650	464	10	physician	physician	PROPN
dpc-3650	464	11	global	global	ADJ
dpc-3650	464	12	assessment	assessment	NOUN
dpc-3650	464	13	(	(	PUNCT
dpc-3650	464	14	pga	pga	PROPN
dpc-3650	464	15	)	)	PUNCT
dpc-3650	464	16	and	and	CCONJ
dpc-3650	464	17	psoriasis	psoriasis	NOUN
dpc-3650	464	18	area	area	NOUN
dpc-3650	464	19	and	and	CCONJ
dpc-3650	464	20	severity	severity	NOUN
dpc-3650	464	21	index	index	NOUN
dpc-3650	464	22	(	(	PUNCT
dpc-3650	464	23	pasi	pasi	NOUN
dpc-3650	464	24	):	):	PUNCT
dpc-3650	464	25	why	why	SCONJ
dpc-3650	464	26	do	do	VERB
dpc-3650	464	27	both	both	PRON
dpc-3650	464	28	?	?	PUNCT
dpc-3650	465	1	a	a	DET
dpc-3650	465	2	systematic	systematic	ADJ
dpc-3650	465	3	analysis	analysis	NOUN
dpc-3650	465	4	of	of	ADP
dpc-3650	465	5	randomized	randomized	ADJ
dpc-3650	465	6	controlled	control	VERB
dpc-3650	465	7	trials	trial	NOUN
dpc-3650	465	8	of	of	ADP
dpc-3650	465	9	biologic	biologic	ADJ
dpc-3650	465	10	agents	agent	NOUN
dpc-3650	465	11	for	for	ADP
dpc-3650	465	12	moderate	moderate	ADJ
dpc-3650	465	13	to	to	ADP
dpc-3650	465	14	severe	severe	ADJ
dpc-3650	465	15	plaque	plaque	NOUN
dpc-3650	465	16	psoriasis	psoriasis	NOUN
dpc-3650	465	17	.	.	PUNCT
dpc-3650	466	1	j	j	PROPN
dpc-3650	466	2	am	be	AUX
dpc-3650	466	3	acad	acad	ADJ
dpc-3650	466	4	dermatol	dermatol	NOUN
dpc-3650	466	5	.	.	PUNCT
dpc-3650	467	1	2012;66(3):369	2012;66(3):369	NUM
dpc-3650	467	2	-	-	PUNCT
dpc-3650	467	3	375	375	NUM
dpc-3650	467	4	.	.	PUNCT
dpc-3650	468	1	doi	doi	NOUN
dpc-3650	468	2	:	:	PUNCT
dpc-3650	468	3	10.1016	10.1016	NUM
dpc-3650	468	4	/	/	SYM
dpc-3650	468	5	j	j	PROPN
dpc-3650	468	6	.jaad.2011.01.022	.jaad.2011.01.022	PUNCT
dpc-3650	468	7	.	.	PUNCT
dpc-3650	469	1	pmid	pmid	NOUN
dpc-3650	469	2	:	:	PUNCT
dpc-3650	469	3	22041254	22041254	NUM
dpc-3650	469	4	.	.	PUNCT
dpc-3650	470	1	33	33	NUM
dpc-3650	470	2	.	.	PUNCT
dpc-3650	471	1	spuls	spuls	PROPN
dpc-3650	471	2	pi	pi	PROPN
dpc-3650	471	3	,	,	PUNCT
dpc-3650	471	4	lecluse	lecluse	PROPN
dpc-3650	471	5	ll	ll	PROPN
dpc-3650	471	6	,	,	PUNCT
dpc-3650	471	7	poulsen	poulsen	VERB
dpc-3650	471	8	ml	ml	PROPN
dpc-3650	471	9	,	,	PUNCT
dpc-3650	471	10	bos	bos	PROPN
dpc-3650	471	11	jd	jd	PROPN
dpc-3650	471	12	,	,	PUNCT
dpc-3650	471	13	stern	stern	ADJ
dpc-3650	471	14	rs	rs	NOUN
dpc-3650	471	15	,	,	PUNCT
dpc-3650	471	16	nijsten	nijsten	ADJ
dpc-3650	471	17	t.	t.	PROPN
dpc-3650	471	18	how	how	SCONJ
dpc-3650	471	19	good	good	ADJ
dpc-3650	471	20	are	be	AUX
dpc-3650	471	21	clinical	clinical	ADJ
dpc-3650	471	22	severity	severity	NOUN
dpc-3650	471	23	and	and	CCONJ
dpc-3650	471	24	outcome	outcome	NOUN
dpc-3650	471	25	measures	measure	NOUN
dpc-3650	471	26	for	for	ADP
dpc-3650	471	27	psoriasis	psoriasis	NOUN
dpc-3650	471	28	?	?	PUNCT
dpc-3650	472	1	:	:	PUNCT
dpc-3650	472	2	quantitative	quantitative	ADJ
dpc-3650	472	3	evaluation	evaluation	NOUN
dpc-3650	472	4	in	in	ADP
dpc-3650	472	5	a	a	DET
dpc-3650	472	6	systematic	systematic	ADJ
dpc-3650	472	7	review	review	NOUN
dpc-3650	472	8	.	.	PUNCT
dpc-3650	473	1	j	j	PROPN
dpc-3650	473	2	invest	invest	VERB
dpc-3650	473	3	dermatol	dermatol	NOUN
dpc-3650	473	4	.	.	PUNCT
dpc-3650	474	1	2010;130(4):933	2010;130(4):933	NUM
dpc-3650	474	2	-	-	SYM
dpc-3650	474	3	943	943	NUM
dpc-3650	474	4	.	.	PUNCT
dpc-3650	475	1	doi	doi	NOUN
dpc-3650	475	2	:	:	PUNCT
dpc-3650	475	3	10.1038	10.1038	NUM
dpc-3650	475	4	/	/	SYM
dpc-3650	475	5	jid.2009.391	jid.2009.391	PROPN
dpc-3650	475	6	.	.	PUNCT
dpc-3650	476	1	pmid	pmid	NOUN
dpc-3650	476	2	:	:	PUNCT
dpc-3650	476	3	20043014	20043014	NUM
dpc-3650	476	4	.	.	PUNCT
dpc-3650	477	1	34	34	NUM
dpc-3650	477	2	.	.	PUNCT
dpc-3650	477	3	bożek	bożek	VERB
dpc-3650	477	4	a	a	DET
dpc-3650	477	5	,	,	PUNCT
dpc-3650	477	6	reich	reich	PROPN
dpc-3650	477	7	a.	a.	NOUN
dpc-3650	477	8	the	the	DET
dpc-3650	477	9	reliability	reliability	NOUN
dpc-3650	477	10	of	of	ADP
dpc-3650	477	11	three	three	NUM
dpc-3650	477	12	psoriasis	psoriasis	NOUN
dpc-3650	477	13	assessment	assessment	NOUN
dpc-3650	477	14	tools	tool	NOUN
dpc-3650	477	15	:	:	PUNCT
dpc-3650	477	16	psoriasis	psoriasis	NOUN
dpc-3650	477	17	area	area	NOUN
dpc-3650	477	18	and	and	CCONJ
dpc-3650	477	19	severity	severity	NOUN
dpc-3650	477	20	index	index	NOUN
dpc-3650	477	21	,	,	PUNCT
dpc-3650	477	22	body	body	NOUN
dpc-3650	477	23	surface	surface	NOUN
dpc-3650	477	24	area	area	NOUN
dpc-3650	477	25	and	and	CCONJ
dpc-3650	477	26	physician	physician	NOUN
dpc-3650	477	27	global	global	ADJ
dpc-3650	477	28	assessment	assessment	NOUN
dpc-3650	477	29	.	.	PUNCT
dpc-3650	478	1	adv	adv	PROPN
dpc-3650	478	2	clin	clin	PROPN
dpc-3650	478	3	exp	exp	PROPN
dpc-3650	478	4	med	med	PROPN
dpc-3650	478	5	.	.	PUNCT
dpc-3650	479	1	2017;26(5	2017;26(5	NUM
dpc-3650	479	2	):	):	PUNCT
dpc-3650	479	3	851	851	NUM
dpc-3650	479	4	-	-	SYM
dpc-3650	479	5	856	856	NUM
dpc-3650	479	6	.	.	PUNCT
dpc-3650	480	1	doi	doi	NOUN
dpc-3650	480	2	:	:	PUNCT
dpc-3650	480	3	10.17219	10.17219	NUM
dpc-3650	480	4	/	/	SYM
dpc-3650	480	5	acem/69804	acem/69804	NOUN
dpc-3650	480	6	.	.	PUNCT
dpc-3650	481	1	pmid	pmid	NOUN
dpc-3650	481	2	:	:	PUNCT
dpc-3650	481	3	29068583	29068583	NUM
dpc-3650	481	4	.	.	PUNCT
dpc-3650	482	1	35	35	NUM
dpc-3650	482	2	.	.	X
dpc-3650	483	1	finlay	finlay	VERB
dpc-3650	483	2	ay	ay	PROPN
dpc-3650	483	3	,	,	PUNCT
dpc-3650	483	4	khan	khan	PROPN
dpc-3650	483	5	gk	gk	PROPN
dpc-3650	483	6	.	.	PROPN
dpc-3650	483	7	dermatology	dermatology	NOUN
dpc-3650	483	8	life	life	NOUN
dpc-3650	483	9	quality	quality	NOUN
dpc-3650	483	10	index	index	NOUN
dpc-3650	483	11	(	(	PUNCT
dpc-3650	483	12	dlqi)--a	dlqi)--a	VERB
dpc-3650	483	13	simple	simple	ADJ
dpc-3650	483	14	practical	practical	ADJ
dpc-3650	483	15	measure	measure	NOUN
dpc-3650	483	16	for	for	ADP
dpc-3650	483	17	routine	routine	ADJ
dpc-3650	483	18	clinical	clinical	ADJ
dpc-3650	483	19	use	use	NOUN
dpc-3650	483	20	.	.	PUNCT
dpc-3650	484	1	clin	clin	PROPN
dpc-3650	484	2	exp	exp	NOUN
dpc-3650	484	3	dermatol	dermatol	NOUN
dpc-3650	484	4	.	.	PUNCT
dpc-3650	485	1	1994;19(3):210	1994;19(3):210	NUM
dpc-3650	485	2	-	-	PUNCT
dpc-3650	485	3	216	216	NUM
dpc-3650	485	4	.	.	PUNCT
dpc-3650	486	1	doi	doi	NOUN
dpc-3650	486	2	:	:	PUNCT
dpc-3650	486	3	10.1111	10.1111	NUM
dpc-3650	486	4	/	/	SYM
dpc-3650	486	5	j.1365	j.1365	NOUN
dpc-3650	486	6	-	-	PUNCT
dpc-3650	486	7	2230.1994	2230.1994	NUM
dpc-3650	486	8	.tb01167.x	.tb01167.x	PUNCT
dpc-3650	486	9	.	.	PUNCT
dpc-3650	487	1	pmid	pmid	NOUN
dpc-3650	487	2	:	:	PUNCT
dpc-3650	487	3	8033378	8033378	NUM
dpc-3650	487	4	.	.	PUNCT
dpc-3650	488	1	36	36	NUM
dpc-3650	488	2	.	.	X
dpc-3650	488	3	upton	upton	PROPN
dpc-3650	488	4	,	,	PUNCT
dpc-3650	488	5	j.	j.	PROPN
dpc-3650	488	6	(	(	PUNCT
dpc-3650	488	7	2013	2013	NUM
dpc-3650	488	8	)	)	PUNCT
dpc-3650	488	9	.	.	PUNCT
dpc-3650	489	1	beck	beck	PROPN
dpc-3650	489	2	depression	depression	PROPN
dpc-3650	489	3	inventory	inventory	PROPN
dpc-3650	489	4	(	(	PUNCT
dpc-3650	489	5	bdi	bdi	PROPN
dpc-3650	489	6	)	)	PUNCT
dpc-3650	489	7	.	.	PUNCT
dpc-3650	490	1	in	in	ADP
dpc-3650	490	2	:	:	PUNCT
dpc-3650	490	3	gellman	gellman	NOUN
dpc-3650	490	4	,	,	PUNCT
dpc-3650	490	5	m.d	m.d	PROPN
dpc-3650	490	6	.	.	PROPN
dpc-3650	490	7	,	,	PUNCT
dpc-3650	490	8	turner	turner	PROPN
dpc-3650	490	9	,	,	PUNCT
dpc-3650	490	10	j.r	j.r	PROPN
dpc-3650	490	11	.	.	PROPN
dpc-3650	490	12	(	(	PUNCT
dpc-3650	490	13	eds	ed	NOUN
dpc-3650	490	14	)	)	PUNCT
dpc-3650	490	15	encyclopedia	encyclopedia	NOUN
dpc-3650	490	16	of	of	ADP
dpc-3650	490	17	behavioral	behavioral	ADJ
dpc-3650	490	18	medicine	medicine	NOUN
dpc-3650	490	19	.	.	PUNCT
dpc-3650	491	1	springer	springer	NOUN
dpc-3650	491	2	,	,	PUNCT
dpc-3650	491	3	new	new	PROPN
dpc-3650	491	4	york	york	PROPN
dpc-3650	491	5	,	,	PUNCT
dpc-3650	491	6	ny	ny	PROPN
dpc-3650	491	7	.	.	PUNCT
dpc-3650	492	1	pp	pp	PROPN
dpc-3650	492	2	178–179	178–179	NUM
dpc-3650	492	3	available	available	ADJ
dpc-3650	492	4	from	from	ADP
dpc-3650	492	5	:	:	PUNCT
dpc-3650	492	6	https://	https://	PROPN
dpc-3650	492	7	doi.org/10.1007/978-1-4419-1005-9_441	doi.org/10.1007/978-1-4419-1005-9_441	VERB
dpc-3650	492	8	37	37	NUM
dpc-3650	492	9	.	.	PUNCT
dpc-3650	493	1	giannakou	giannakou	PROPN
dpc-3650	493	2	m	m	PROPN
dpc-3650	493	3	,	,	PUNCT
dpc-3650	493	4	roussi	roussi	PROPN
dpc-3650	493	5	p	p	X
dpc-3650	493	6	,	,	PUNCT
dpc-3650	493	7	kosmides	kosmide	VERB
dpc-3650	493	8	me	i	PRON
dpc-3650	493	9	,	,	PUNCT
dpc-3650	493	10	kiosseoglou	kiosseoglou	PROPN
dpc-3650	493	11	g	g	PROPN
dpc-3650	493	12	,	,	PUNCT
dpc-3650	493	13	adamopoulou	adamopoulou	ADV
dpc-3650	493	14	a	a	DET
dpc-3650	493	15	,	,	PUNCT
dpc-3650	493	16	garyfallos	garyfallos	PROPN
dpc-3650	493	17	gadaptation	gadaptation	NOUN
dpc-3650	493	18	of	of	ADP
dpc-3650	493	19	the	the	DET
dpc-3650	493	20	beck	beck	NOUN
dpc-3650	493	21	depression	depression	PROPN
dpc-3650	493	22	inventory	inventory	PROPN
dpc-3650	493	23	-	-	PUNCT
dpc-3650	493	24	ii	ii	NOUN
dpc-3650	493	25	to	to	PART
dpc-3650	493	26	greek	greek	VERB
dpc-3650	493	27	population	population	NOUN
dpc-3650	493	28	.	.	PUNCT
dpc-3650	494	1	hellenic	hellenic	ADJ
dpc-3650	494	2	journal	journal	PROPN
dpc-3650	494	3	of	of	ADP
dpc-3650	494	4	psychology	psychology	NOUN
dpc-3650	494	5	.	.	PUNCT
dpc-3650	495	1	2013,vol.10(january	2013,vol.10(january	NUM
dpc-3650	495	2	2013	2013	NUM
dpc-3650	495	3	)	)	PUNCT
dpc-3650	495	4	,	,	PUNCT
dpc-3650	495	5	p.p120–146	p.p120–146	PROPN
dpc-3650	495	6	.	.	PUNCT
dpc-3650	496	1	38	38	NUM
dpc-3650	496	2	.	.	PUNCT
dpc-3650	497	1	kyriakou	kyriakou	PROPN
dpc-3650	497	2	a	a	PRON
dpc-3650	497	3	,	,	PUNCT
dpc-3650	497	4	patsatsi	patsatsi	PROPN
dpc-3650	497	5	a	a	PRON
dpc-3650	497	6	,	,	PUNCT
dpc-3650	497	7	sotiriadis	sotiriadis	PROPN
dpc-3650	497	8	,	,	PUNCT
dpc-3650	497	9	goulis	goulis	PROPN
dpc-3650	497	10	dg	dg	PROPN
dpc-3650	497	11	.	.	PUNCT
dpc-3650	498	1	adipokines	adipokine	NOUN
dpc-3650	498	2	in	in	ADP
dpc-3650	498	3	psoriasis	psoriasis	NOUN
dpc-3650	498	4	.	.	PUNCT
dpc-3650	499	1	,	,	PUNCT
dpc-3650	499	2	british	british	ADJ
dpc-3650	499	3	journal	journal	PROPN
dpc-3650	499	4	of	of	ADP
dpc-3650	499	5	dermatology	dermatology	NOUN
dpc-3650	499	6	.	.	PUNCT
dpc-3650	499	7	 	 	SPACE
dpc-3650	500	1	volume	volume	NOUN
dpc-3650	500	2	179	179	NUM
dpc-3650	500	3	,	,	PUNCT
dpc-3650	500	4	issue	issue	NOUN
dpc-3650	500	5	2	2	NUM
dpc-3650	500	6	,	,	PUNCT
dpc-3650	500	7	1	1	NUM
dpc-3650	500	8	 	 	SPACE
dpc-3650	500	9	august	august	PROPN
dpc-3650	500	10	2018	2018	NUM
dpc-3650	500	11	;	;	PUNCT
dpc-3650	500	12	179(2):e94	179(2):e94	NUM
dpc-3650	500	13	.	.	PUNCT
dpc-3650	501	1	https://doi.org/10.1111/bjd.16948	https://doi.org/10.1111/bjd.16948	PROPN
dpc-3650	501	2	.	.	PROPN
dpc-3650	501	3	39	39	NUM
dpc-3650	501	4	.	.	PUNCT
dpc-3650	502	1	buechler	buechler	PROPN
dpc-3650	502	2	c	c	PROPN
dpc-3650	502	3	,	,	PUNCT
dpc-3650	502	4	feder	feder	PROPN
dpc-3650	502	5	s	s	PART
dpc-3650	502	6	,	,	PUNCT
dpc-3650	502	7	haberl	haberl	VERB
dpc-3650	502	8	em	em	PRON
dpc-3650	502	9	,	,	PUNCT
dpc-3650	502	10	aslanidis	aslanidis	PROPN
dpc-3650	502	11	c.	c.	PROPN
dpc-3650	502	12	chemerin	chemerin	PROPN
dpc-3650	502	13	isoforms	isoform	NOUN
dpc-3650	502	14	and	and	CCONJ
dpc-3650	502	15	activity	activity	NOUN
dpc-3650	502	16	in	in	ADP
dpc-3650	502	17	obesity	obesity	NOUN
dpc-3650	502	18	.	.	PUNCT
dpc-3650	503	1	int	int	PROPN
dpc-3650	503	2	j	j	PROPN
dpc-3650	503	3	mol	mol	ADP
dpc-3650	503	4	sci	sci	PROPN
dpc-3650	503	5	.	.	PUNCT
dpc-3650	504	1	2019;20(5):1128	2019;20(5):1128	NUM
dpc-3650	504	2	.	.	PUNCT
dpc-3650	505	1	doi	doi	NOUN
dpc-3650	505	2	:	:	PUNCT
dpc-3650	505	3	10.3390	10.3390	NUM
dpc-3650	505	4	/	/	SYM
dpc-3650	505	5	ijms20051128	ijms20051128	PROPN
dpc-3650	505	6	.	.	PUNCT
dpc-3650	506	1	pmid	pmid	NOUN
dpc-3650	506	2	:	:	PUNCT
dpc-3650	506	3	30841637	30841637	NUM
dpc-3650	506	4	.	.	PUNCT
dpc-3650	507	1	pmcid	pmcid	ADJ
dpc-3650	507	2	:	:	PUNCT
dpc-3650	507	3	pmc6429392	pmc6429392	NOUN
dpc-3650	507	4	.	.	PUNCT
dpc-3650	508	1	40	40	NUM
dpc-3650	508	2	.	.	PUNCT
dpc-3650	509	1	ì	ì	PROPN
dpc-3650	509	2	soldatos	soldato	VERB
dpc-3650	509	3	cr	cr	PROPN
dpc-3650	509	4	,	,	PUNCT
dpc-3650	509	5	dikeos	dikeo	NOUN
dpc-3650	509	6	dg	dg	PROPN
dpc-3650	509	7	,	,	PUNCT
dpc-3650	509	8	paparrigopoulos	paparrigopoulos	PROPN
dpc-3650	509	9	tj	tj	PROPN
dpc-3650	509	10	.	.	PROPN
dpc-3650	509	11	athens	athens	PROPN
dpc-3650	509	12	insomnia	insomnia	PROPN
dpc-3650	509	13	scale	scale	NOUN
dpc-3650	509	14	:	:	PUNCT
dpc-3650	509	15	validation	validation	NOUN
dpc-3650	509	16	of	of	ADP
dpc-3650	509	17	an	an	DET
dpc-3650	509	18	instrument	instrument	NOUN
dpc-3650	509	19	based	base	VERB
dpc-3650	509	20	on	on	ADP
dpc-3650	509	21	icd-10	icd-10	DET
dpc-3650	509	22	criteria	criterion	NOUN
dpc-3650	509	23	.	.	PUNCT
dpc-3650	510	1	j	j	PROPN
dpc-3650	510	2	psychosom	psychosom	PROPN
dpc-3650	510	3	res	re	NOUN
dpc-3650	510	4	.	.	PUNCT
dpc-3650	511	1	2000;48(6):555	2000;48(6):555	NUM
dpc-3650	511	2	-	-	SYM
dpc-3650	511	3	560	560	NUM
dpc-3650	511	4	.	.	PUNCT
dpc-3650	512	1	doi	doi	NOUN
dpc-3650	512	2	:	:	PUNCT
dpc-3650	512	3	10.1016	10.1016	NUM
dpc-3650	512	4	/	/	SYM
dpc-3650	512	5	s0022	s0022	PROPN
dpc-3650	512	6	-3999(00)00095	-3999(00)00095	NOUN
dpc-3650	512	7	-	-	PUNCT
dpc-3650	512	8	7	7	NUM
dpc-3650	512	9	.	.	PUNCT
dpc-3650	513	1	pmid	pmid	NOUN
dpc-3650	513	2	:	:	PUNCT
dpc-3650	513	3	11033374	11033374	NUM
dpc-3650	513	4	.	.	PUNCT
dpc-3650	514	1	41	41	NUM
dpc-3650	514	2	.	.	PUNCT
dpc-3650	514	3	soldatos	soldatos	PROPN
dpc-3650	514	4	cr	cr	PROPN
dpc-3650	514	5	,	,	PUNCT
dpc-3650	514	6	dikeos	dikeo	NOUN
dpc-3650	514	7	dg	dg	PROPN
dpc-3650	514	8	,	,	PUNCT
dpc-3650	514	9	paparrigopoulos	paparrigopoulos	PROPN
dpc-3650	514	10	tj	tj	PROPN
dpc-3650	514	11	.	.	PUNCT
dpc-3650	515	1	the	the	DET
dpc-3650	515	2	diagnostic	diagnostic	ADJ
dpc-3650	515	3	validity	validity	NOUN
dpc-3650	515	4	of	of	ADP
dpc-3650	515	5	the	the	DET
dpc-3650	515	6	athens	athens	PROPN
dpc-3650	515	7	insomnia	insomnia	PROPN
dpc-3650	515	8	scale	scale	NOUN
dpc-3650	515	9	.	.	PUNCT
dpc-3650	516	1	j	j	PROPN
dpc-3650	516	2	psychosom	psychosom	PROPN
dpc-3650	516	3	res	re	NOUN
dpc-3650	516	4	.	.	PUNCT
dpc-3650	517	1	2003;55(3):263	2003;55(3):263	NUM
dpc-3650	517	2	-	-	PUNCT
dpc-3650	517	3	267	267	NUM
dpc-3650	517	4	.	.	PUNCT
dpc-3650	517	5	doi	doi	NOUN
dpc-3650	517	6	:	:	PUNCT
dpc-3650	517	7	10.1016	10.1016	NUM
dpc-3650	517	8	/	/	SYM
dpc-3650	517	9	s0022	s0022	NOUN
dpc-3650	517	10	-	-	PUNCT
dpc-3650	517	11	3999(02)00604	3999(02)00604	NUM
dpc-3650	517	12	-	-	PUNCT
dpc-3650	517	13	9	9	NUM
dpc-3650	517	14	.	.	PUNCT
dpc-3650	518	1	pmid	pmid	NOUN
dpc-3650	518	2	:	:	PUNCT
dpc-3650	518	3	12932801	12932801	NUM
dpc-3650	518	4	.	.	PUNCT
dpc-3650	519	1	42	42	NUM
dpc-3650	519	2	.	.	PUNCT
dpc-3650	520	1	gowda	gowda	PROPN
dpc-3650	520	2	s	s	PROPN
dpc-3650	520	3	,	,	PUNCT
dpc-3650	520	4	goldblum	goldblum	PROPN
dpc-3650	520	5	om	om	PROPN
dpc-3650	520	6	,	,	PUNCT
dpc-3650	520	7	mccall	mccall	PROPN
dpc-3650	520	8	wv	wv	PROPN
dpc-3650	520	9	,	,	PUNCT
dpc-3650	520	10	feldman	feldman	PROPN
dpc-3650	520	11	sr	sr	PROPN
dpc-3650	520	12	.	.	PUNCT
dpc-3650	521	1	factors	factor	NOUN
dpc-3650	521	2	affecting	affect	VERB
dpc-3650	521	3	sleep	sleep	NOUN
dpc-3650	521	4	quality	quality	NOUN
dpc-3650	521	5	in	in	ADP
dpc-3650	521	6	patients	patient	NOUN
dpc-3650	521	7	with	with	ADP
dpc-3650	521	8	psoriasis	psoriasis	NOUN
dpc-3650	521	9	.	.	PUNCT
dpc-3650	522	1	j	j	PROPN
dpc-3650	522	2	am	be	AUX
dpc-3650	522	3	acad	acad	ADJ
dpc-3650	522	4	dermatol	dermatol	NOUN
dpc-3650	522	5	.	.	PUNCT
dpc-3650	523	1	2010;63(1):114	2010;63(1):114	NUM
dpc-3650	523	2	-	-	SYM
dpc-3650	523	3	123	123	NUM
dpc-3650	523	4	.	.	PUNCT
dpc-3650	524	1	doi	doi	NOUN
dpc-3650	524	2	:	:	PUNCT
dpc-3650	524	3	10.1016	10.1016	NUM
dpc-3650	524	4	/	/	SYM
dpc-3650	524	5	j.jaad.2009.07.003	j.jaad.2009.07.003	PROPN
dpc-3650	524	6	.	.	PUNCT
dpc-3650	525	1	pmid	pmid	NOUN
dpc-3650	525	2	:	:	PUNCT
dpc-3650	525	3	19944485	19944485	NUM
dpc-3650	525	4	.	.	PUNCT
dpc-3650	526	1	43	43	NUM
dpc-3650	526	2	.	.	PUNCT
dpc-3650	527	1	aaron	aaron	PROPN
dpc-3650	527	2	t.	t.	PROPN
dpc-3650	527	3	beck	beck	PROPN
dpc-3650	527	4	,	,	PUNCT
dpc-3650	527	5	bai	bai	PROPN
dpc-3650	527	6	,	,	PUNCT
dpc-3650	527	7	beck	beck	PROPN
dpc-3650	527	8	anxiety	anxiety	NOUN
dpc-3650	527	9	inventory	inventory	NOUN
dpc-3650	527	10	,	,	PUNCT
dpc-3650	527	11	manual	manual	ADJ
dpc-3650	527	12	publisher	publisher	NOUN
dpc-3650	527	13	,	,	PUNCT
dpc-3650	527	14	psychological	psychological	ADJ
dpc-3650	527	15	corporation	corporation	NOUN
dpc-3650	527	16	,	,	PUNCT
dpc-3650	527	17	 	 	SPACE
dpc-3650	527	18	1990	1990	NUM
dpc-3650	527	19	 	 	SPACE
dpc-3650	527	20	;	;	PUNCT
dpc-3650	527	21	length	length	NOUN
dpc-3650	527	22	,	,	PUNCT
dpc-3650	527	23	22	22	NUM
dpc-3650	527	24	pages	page	NOUN
dpc-3650	527	25	44	44	NUM
dpc-3650	527	26	.	.	PUNCT
dpc-3650	528	1	wei	wei	PROPN
dpc-3650	528	2	tq	tq	PROPN
dpc-3650	528	3	,	,	PUNCT
dpc-3650	528	4	kramer	kramer	PROPN
dpc-3650	528	5	s	s	PROPN
dpc-3650	528	6	,	,	PUNCT
dpc-3650	528	7	chu	chu	PROPN
dpc-3650	528	8	vp	vp	PROPN
dpc-3650	528	9	,	,	PUNCT
dpc-3650	528	10	et	et	PROPN
dpc-3650	528	11	al	al	PROPN
dpc-3650	528	12	.	.	PUNCT
dpc-3650	529	1	an	an	DET
dpc-3650	529	2	improved	improved	ADJ
dpc-3650	529	3	automated	automate	VERB
dpc-3650	529	4	immunoassay	immunoassay	NOUN
dpc-3650	529	5	for	for	ADP
dpc-3650	529	6	c	c	NOUN
dpc-3650	529	7	-	-	PUNCT
dpc-3650	529	8	reactive	reactive	ADJ
dpc-3650	529	9	protein	protein	NOUN
dpc-3650	529	10	on	on	ADP
dpc-3650	529	11	the	the	DET
dpc-3650	529	12	dimension	dimension	NOUN
dpc-3650	529	13	clinical	clinical	ADJ
dpc-3650	529	14	chemistry	chemistry	NOUN
dpc-3650	529	15	system	system	NOUN
dpc-3650	529	16	.	.	PUNCT
dpc-3650	530	1	j	j	PROPN
dpc-3650	530	2	autom	autom	PROPN
dpc-3650	530	3	methods	methods	PROPN
dpc-3650	530	4	manag	manag	VERB
dpc-3650	530	5	chem	chem	NOUN
dpc-3650	530	6	.	.	PUNCT
dpc-3650	531	1	2000;22(5):125	2000;22(5):125	NUM
dpc-3650	531	2	-	-	SYM
dpc-3650	531	3	131	131	NUM
dpc-3650	531	4	.	.	PUNCT
dpc-3650	532	1	10	10	NUM
dpc-3650	532	2	original	original	ADJ
dpc-3650	532	3	article	article	NOUN
dpc-3650	532	4	|	|	ADV
dpc-3650	532	5	dermatol	dermatol	ADJ
dpc-3650	532	6	pract	pract	NOUN
dpc-3650	532	7	concept	concept	NOUN
dpc-3650	532	8	.	.	PUNCT
dpc-3650	533	1	2024;14(2):e2024104	2024;14(2):e2024104	NUM
dpc-3650	534	1	64	64	NUM
dpc-3650	534	2	.	.	PUNCT
dpc-3650	535	1	moon	moon	PROPN
dpc-3650	535	2	hs	hs	PROPN
dpc-3650	535	3	,	,	PUNCT
dpc-3650	535	4	mizara	mizara	PROPN
dpc-3650	535	5	a	a	PRON
dpc-3650	535	6	,	,	PUNCT
dpc-3650	535	7	mcbride	mcbride	PROPN
dpc-3650	535	8	sr	sr	PROPN
dpc-3650	535	9	.	.	PUNCT
dpc-3650	536	1	psoriasis	psoriasis	NOUN
dpc-3650	536	2	and	and	CCONJ
dpc-3650	536	3	psycho	psycho	NOUN
dpc-3650	536	4	dermatology	dermatology	NOUN
dpc-3650	536	5	.	.	PUNCT
dpc-3650	537	1	dermatol	dermatol	NOUN
dpc-3650	537	2	ther	ther	ADV
dpc-3650	537	3	(	(	PUNCT
dpc-3650	537	4	heidelb	heidelb	NOUN
dpc-3650	537	5	)	)	PUNCT
dpc-3650	537	6	.	.	PUNCT
dpc-3650	538	1	2013;3(2):117	2013;3(2):117	NUM
dpc-3650	538	2	-	-	SYM
dpc-3650	538	3	130	130	NUM
dpc-3650	538	4	.	.	PUNCT
dpc-3650	539	1	doi	doi	NOUN
dpc-3650	539	2	:	:	PUNCT
dpc-3650	539	3	10.1007	10.1007	NUM
dpc-3650	539	4	/	/	SYM
dpc-3650	539	5	s13555	s13555	PROPN
dpc-3650	539	6	-	-	PUNCT
dpc-3650	539	7	013	013	NUM
dpc-3650	539	8	-	-	PUNCT
dpc-3650	539	9	0031	0031	NUM
dpc-3650	539	10	-	-	PUNCT
dpc-3650	539	11	0	0	NUM
dpc-3650	539	12	.	.	PUNCT
dpc-3650	540	1	pmid	pmid	NOUN
dpc-3650	540	2	:	:	PUNCT
dpc-3650	540	3	24318414	24318414	NUM
dpc-3650	540	4	.	.	PUNCT
dpc-3650	541	1	pmcid	pmcid	ADJ
dpc-3650	541	2	:	:	PUNCT
dpc-3650	541	3	pmc3889305	pmc3889305	NOUN
dpc-3650	541	4	.	.	PUNCT
dpc-3650	542	1	65	65	NUM
dpc-3650	542	2	.	.	PUNCT
dpc-3650	543	1	lavda	lavda	PROPN
dpc-3650	543	2	ac	ac	PROPN
dpc-3650	543	3	,	,	PUNCT
dpc-3650	543	4	webb	webb	PROPN
dpc-3650	543	5	tl	tl	PROPN
dpc-3650	543	6	,	,	PUNCT
dpc-3650	543	7	thompson	thompson	PROPN
dpc-3650	543	8	ar	ar	PROPN
dpc-3650	543	9	.	.	PROPN
dpc-3650	544	1	a	a	DET
dpc-3650	544	2	meta	meta	ADJ
dpc-3650	544	3	-	-	PUNCT
dpc-3650	544	4	analysis	analysis	NOUN
dpc-3650	544	5	of	of	ADP
dpc-3650	544	6	the	the	DET
dpc-3650	544	7	effectiveness	effectiveness	NOUN
dpc-3650	544	8	of	of	ADP
dpc-3650	544	9	psychological	psychological	ADJ
dpc-3650	544	10	interventions	intervention	NOUN
dpc-3650	544	11	for	for	ADP
dpc-3650	544	12	adults	adult	NOUN
dpc-3650	544	13	with	with	ADP
dpc-3650	544	14	skin	skin	NOUN
dpc-3650	544	15	conditions	condition	NOUN
dpc-3650	544	16	.	.	PUNCT
dpc-3650	545	1	br	br	PROPN
dpc-3650	545	2	j	j	PROPN
dpc-3650	545	3	dermatol	dermatol	NOUN
dpc-3650	545	4	.	.	PUNCT
dpc-3650	546	1	2012;167(5):970	2012;167(5):970	NUM
dpc-3650	546	2	-	-	SYM
dpc-3650	546	3	979	979	NUM
dpc-3650	547	1	.	.	PUNCT
dpc-3650	547	2	doi	doi	NOUN
dpc-3650	547	3	:	:	PUNCT
dpc-3650	547	4	10.1111	10.1111	NUM
dpc-3650	547	5	/	/	SYM
dpc-3650	547	6	j.1365	j.1365	NOUN
dpc-3650	547	7	-	-	PUNCT
dpc-3650	547	8	2133.2012.11183.x	2133.2012.11183.x	NUM
dpc-3650	547	9	.	.	PUNCT
dpc-3650	548	1	pmid	pmid	NOUN
dpc-3650	548	2	:	:	PUNCT
dpc-3650	548	3	22924999	22924999	NUM
dpc-3650	548	4	.	.	PUNCT
dpc-3650	549	1	66	66	NUM
dpc-3650	549	2	.	.	PUNCT
dpc-3650	549	3	sin	sin	PROPN
dpc-3650	549	4	nl	nl	PROPN
dpc-3650	549	5	,	,	PUNCT
dpc-3650	549	6	lyubomirsky	lyubomirsky	ADJ
dpc-3650	549	7	s.	s.	PROPN
dpc-3650	549	8	enhancing	enhance	VERB
dpc-3650	549	9	well	well	ADV
dpc-3650	549	10	-	-	PUNCT
dpc-3650	549	11	being	be	AUX
dpc-3650	549	12	and	and	CCONJ
dpc-3650	549	13	alleviating	alleviate	VERB
dpc-3650	549	14	depressive	depressive	ADJ
dpc-3650	549	15	symptoms	symptom	NOUN
dpc-3650	549	16	with	with	ADP
dpc-3650	549	17	positive	positive	ADJ
dpc-3650	549	18	psychology	psychology	NOUN
dpc-3650	549	19	interventions	intervention	NOUN
dpc-3650	549	20	:	:	PUNCT
dpc-3650	549	21	a	a	DET
dpc-3650	549	22	practice	practice	NOUN
dpc-3650	549	23	-	-	PUNCT
dpc-3650	549	24	friendly	friendly	ADJ
dpc-3650	549	25	meta	meta	ADJ
dpc-3650	549	26	-	-	PUNCT
dpc-3650	549	27	analysis	analysis	NOUN
dpc-3650	549	28	.	.	PUNCT
dpc-3650	550	1	j	j	PROPN
dpc-3650	550	2	clin	clin	PROPN
dpc-3650	550	3	psychol	psychol	PROPN
dpc-3650	550	4	.	.	PUNCT
dpc-3650	551	1	2009;65(5):467	2009;65(5):467	PROPN
dpc-3650	551	2	-	-	SYM
dpc-3650	551	3	487	487	NUM
dpc-3650	551	4	.	.	PUNCT
dpc-3650	552	1	doi	doi	NOUN
dpc-3650	552	2	:	:	PUNCT
dpc-3650	552	3	10.1002	10.1002	NUM
dpc-3650	552	4	/	/	SYM
dpc-3650	552	5	jclp.20593	jclp.20593	PROPN
dpc-3650	552	6	.	.	PUNCT
dpc-3650	552	7	pmid	pmid	NOUN
dpc-3650	552	8	:	:	PUNCT
dpc-3650	552	9	19301241	19301241	NUM
dpc-3650	552	10	.	.	PUNCT
dpc-3650	553	1	67	67	NUM
dpc-3650	553	2	.	.	PUNCT
dpc-3650	554	1	bolier	bolier	PROPN
dpc-3650	554	2	l	l	PROPN
dpc-3650	554	3	,	,	PUNCT
dpc-3650	554	4	haverman	haverman	NOUN
dpc-3650	554	5	m	m	NOUN
dpc-3650	554	6	,	,	PUNCT
dpc-3650	554	7	westerhof	westerhof	PROPN
dpc-3650	554	8	gj	gj	PROPN
dpc-3650	554	9	,	,	PUNCT
dpc-3650	554	10	riper	riper	NOUN
dpc-3650	554	11	h	h	NOUN
dpc-3650	554	12	,	,	PUNCT
dpc-3650	554	13	smit	smit	PROPN
dpc-3650	554	14	f	f	PROPN
dpc-3650	554	15	,	,	PUNCT
dpc-3650	554	16	bohlmeijer	bohlmeijer	PROPN
dpc-3650	554	17	e.	e.	PROPN
dpc-3650	554	18	positive	positive	PROPN
dpc-3650	554	19	psychology	psychology	NOUN
dpc-3650	554	20	interventions	intervention	NOUN
dpc-3650	554	21	:	:	PUNCT
dpc-3650	554	22	a	a	DET
dpc-3650	554	23	meta	meta	ADJ
dpc-3650	554	24	-	-	PUNCT
dpc-3650	554	25	analysis	analysis	NOUN
dpc-3650	554	26	of	of	ADP
dpc-3650	554	27	randomized	randomized	ADJ
dpc-3650	554	28	controlled	control	VERB
dpc-3650	554	29	studies	study	NOUN
dpc-3650	554	30	.	.	PUNCT
dpc-3650	555	1	bmc	bmc	ADJ
dpc-3650	555	2	public	public	ADJ
dpc-3650	555	3	health	health	NOUN
dpc-3650	555	4	.	.	PUNCT
dpc-3650	556	1	2013	2013	NUM
dpc-3650	556	2	feb	feb	NOUN
dpc-3650	556	3	8	8	NUM
dpc-3650	556	4	;	;	PUNCT
dpc-3650	556	5	13:119	13:119	NUM
dpc-3650	556	6	.	.	PUNCT
dpc-3650	557	1	doi	doi	NOUN
dpc-3650	557	2	:	:	PUNCT
dpc-3650	557	3	10.1186/1471	10.1186/1471	NUM
dpc-3650	557	4	-	-	PUNCT
dpc-3650	557	5	2458	2458	NUM
dpc-3650	557	6	-	-	SYM
dpc-3650	557	7	13	13	NUM
dpc-3650	557	8	-	-	SYM
dpc-3650	557	9	119	119	NUM
dpc-3650	557	10	.	.	PUNCT
dpc-3650	558	1	pmid	pmid	NOUN
dpc-3650	558	2	:	:	PUNCT
dpc-3650	558	3	23390882	23390882	NUM
dpc-3650	558	4	;	;	PUNCT
dpc-3650	558	5	pmcid	pmcid	ADJ
dpc-3650	558	6	:	:	PUNCT
dpc-3650	558	7	pmc3599475	pmc3599475	NOUN
dpc-3650	558	8	.	.	PUNCT
dpc-3650	559	1	68	68	NUM
dpc-3650	559	2	.	.	PUNCT
dpc-3650	560	1	greenblatt	greenblatt	PROPN
dpc-3650	560	2	dj	dj	PROPN
dpc-3650	560	3	.	.	PUNCT
dpc-3650	560	4	elimination	elimination	NOUN
dpc-3650	560	5	half	half	ADJ
dpc-3650	560	6	-	-	PUNCT
dpc-3650	560	7	life	life	NOUN
dpc-3650	560	8	of	of	ADP
dpc-3650	560	9	drugs	drug	NOUN
dpc-3650	560	10	:	:	PUNCT
dpc-3650	560	11	value	value	NOUN
dpc-3650	560	12	and	and	CCONJ
dpc-3650	560	13	limitations	limitation	NOUN
dpc-3650	560	14	.	.	PUNCT
dpc-3650	560	15	annu	annu	PROPN
dpc-3650	560	16	rev	rev	VERB
dpc-3650	560	17	med	med	PROPN
dpc-3650	560	18	.	.	PUNCT
dpc-3650	561	1	1985;36:421	1985;36:421	NUM
dpc-3650	561	2	-	-	PUNCT
dpc-3650	561	3	7	7	NUM
dpc-3650	561	4	.	.	PUNCT
dpc-3650	561	5	doi	doi	NOUN
dpc-3650	561	6	:	:	PUNCT
dpc-3650	561	7	10.1146	10.1146	NUM
dpc-3650	561	8	/	/	SYM
dpc-3650	561	9	annurev.me.36	annurev.me.36	NUM
dpc-3650	561	10	.020185.002225	.020185.002225	ADJ
dpc-3650	561	11	.	.	PUNCT
dpc-3650	562	1	pmid	pmid	NOUN
dpc-3650	562	2	:	:	PUNCT
dpc-3650	562	3	3994325	3994325	NUM
dpc-3650	562	4	.	.	PUNCT
dpc-3650	563	1	phase	phase	NOUN
dpc-3650	563	2	iii	iii	NUM
dpc-3650	563	3	trial	trial	NOUN
dpc-3650	563	4	.	.	PUNCT
dpc-3650	564	1	j	j	PROPN
dpc-3650	564	2	am	be	AUX
dpc-3650	564	3	acad	acad	ADJ
dpc-3650	564	4	dermatol	dermatol	NOUN
dpc-3650	564	5	.	.	PUNCT
dpc-3650	565	1	2010;63(3):457	2010;63(3):457	NUM
dpc-3650	565	2	-	-	PUNCT
dpc-3650	565	3	465	465	NUM
dpc-3650	565	4	.	.	PUNCT
dpc-3650	566	1	doi	doi	NOUN
dpc-3650	566	2	:	:	PUNCT
dpc-3650	566	3	10.1016	10.1016	NUM
dpc-3650	566	4	/	/	SYM
dpc-3650	566	5	j.jaad.2009.09.014	j.jaad.2009.09.014	VERB
dpc-3650	566	6	.	.	PUNCT
dpc-3650	567	1	pmid	pmid	NOUN
dpc-3650	567	2	:	:	PUNCT
dpc-3650	567	3	20462664	20462664	NUM
dpc-3650	567	4	.	.	PUNCT
dpc-3650	568	1	59	59	NUM
dpc-3650	568	2	.	.	PUNCT
dpc-3650	568	3	strober	strober	ADV
dpc-3650	568	4	be	be	AUX
dpc-3650	568	5	.	.	PUNCT
dpc-3650	569	1	new	new	ADJ
dpc-3650	569	2	therapies	therapy	NOUN
dpc-3650	569	3	for	for	ADP
dpc-3650	569	4	psoriasis	psoriasis	NOUN
dpc-3650	569	5	.	.	PUNCT
dpc-3650	570	1	semin	semin	PROPN
dpc-3650	570	2	cutan	cutan	PROPN
dpc-3650	570	3	med	med	PROPN
dpc-3650	570	4	surg	surg	NOUN
dpc-3650	570	5	.	.	PUNCT
dpc-3650	571	1	2016;35(4s):s71	2016;35(4s):s71	X
dpc-3650	571	2	-	-	PUNCT
dpc-3650	571	3	s73	s73	NOUN
dpc-3650	571	4	.	.	PUNCT
dpc-3650	572	1	doi	doi	NOUN
dpc-3650	572	2	:	:	PUNCT
dpc-3650	572	3	10.12788	10.12788	NUM
dpc-3650	572	4	/	/	SYM
dpc-3650	572	5	j.sder.2016.020	j.sder.2016.020	PROPN
dpc-3650	572	6	.	.	PUNCT
dpc-3650	573	1	pmid	pmid	NOUN
dpc-3650	573	2	:	:	PUNCT
dpc-3650	573	3	29850660	29850660	NUM
dpc-3650	573	4	.	.	PUNCT
dpc-3650	574	1	60	60	NUM
dpc-3650	574	2	.	.	PUNCT
dpc-3650	575	1	[	[	X
dpc-3650	575	2	haider	haider	NOUN
dpc-3650	575	3	as	as	ADP
dpc-3650	575	4	,	,	PUNCT
dpc-3650	575	5	lowes	lowes	PROPN
dpc-3650	575	6	ma	ma	PROPN
dpc-3650	575	7	,	,	PUNCT
dpc-3650	575	8	suárez	suárez	NOUN
dpc-3650	575	9	-	-	PUNCT
dpc-3650	575	10	fariñas	fariñas	NOUN
dpc-3650	575	11	m	m	PROPN
dpc-3650	575	12	,	,	PUNCT
dpc-3650	575	13	et	et	PROPN
dpc-3650	575	14	al	al	PROPN
dpc-3650	575	15	.	.	PUNCT
dpc-3650	575	16	identification	identification	NOUN
dpc-3650	575	17	of	of	ADP
dpc-3650	575	18	cellular	cellular	ADJ
dpc-3650	575	19	pathways	pathway	NOUN
dpc-3650	575	20	of	of	ADP
dpc-3650	575	21	“	"	PUNCT
dpc-3650	575	22	type	type	NOUN
dpc-3650	575	23	1	1	NUM
dpc-3650	575	24	,	,	PUNCT
dpc-3650	575	25	”	"	PUNCT
dpc-3650	575	26	th17	th17	PROPN
dpc-3650	575	27	t	t	NOUN
dpc-3650	575	28	cells	cell	NOUN
dpc-3650	575	29	,	,	PUNCT
dpc-3650	575	30	and	and	CCONJ
dpc-3650	575	31	tnfand	tnfand	NOUN
dpc-3650	575	32	inducible	inducible	ADJ
dpc-3650	575	33	nitric	nitric	ADJ
dpc-3650	575	34	oxide	oxide	NOUN
dpc-3650	575	35	synthase	synthase	NOUN
dpc-3650	575	36	-	-	PUNCT
dpc-3650	575	37	producing	produce	VERB
dpc-3650	575	38	dendritic	dendritic	ADJ
dpc-3650	575	39	cells	cell	NOUN
dpc-3650	575	40	in	in	ADP
dpc-3650	575	41	autoimmune	autoimmune	ADJ
dpc-3650	575	42	inflammation	inflammation	NOUN
dpc-3650	575	43	through	through	ADP
dpc-3650	575	44	pharmacogenomic	pharmacogenomic	ADJ
dpc-3650	575	45	study	study	NOUN
dpc-3650	575	46	of	of	ADP
dpc-3650	575	47	cyclosporine	cyclosporine	PROPN
dpc-3650	575	48	a	a	PRON
dpc-3650	575	49	in	in	ADP
dpc-3650	575	50	psoriasis	psoriasis	NOUN
dpc-3650	575	51	.	.	PUNCT
dpc-3650	576	1	j	j	PROPN
dpc-3650	576	2	immunol	immunol	NOUN
dpc-3650	576	3	.	.	PUNCT
dpc-3650	577	1	2008;180(3):1913	2008;180(3):1913	NUM
dpc-3650	577	2	-	-	SYM
dpc-3650	577	3	1920	1920	NUM
dpc-3650	577	4	.	.	PUNCT
dpc-3650	578	1	doi	doi	NOUN
dpc-3650	578	2	:	:	PUNCT
dpc-3650	578	3	10.4049	10.4049	NUM
dpc-3650	578	4	/	/	SYM
dpc-3650	578	5	jimmunol.180.3.1913	jimmunol.180.3.1913	PROPN
dpc-3650	578	6	.	.	PUNCT
dpc-3650	579	1	pmid	pmid	NOUN
dpc-3650	579	2	:	:	PUNCT
dpc-3650	579	3	18209089	18209089	NUM
dpc-3650	579	4	.	.	PUNCT
dpc-3650	580	1	61	61	NUM
dpc-3650	580	2	.	.	PUNCT
dpc-3650	581	1	kraus	kraus	PROPN
dpc-3650	581	2	c	c	PROPN
dpc-3650	581	3	,	,	PUNCT
dpc-3650	581	4	castrén	castrén	ADV
dpc-3650	581	5	e	e	NOUN
dpc-3650	581	6	,	,	PUNCT
dpc-3650	581	7	kasper	kasper	PROPN
dpc-3650	581	8	s	s	PROPN
dpc-3650	581	9	,	,	PUNCT
dpc-3650	581	10	lanzenberger	lanzenberger	PROPN
dpc-3650	581	11	r.	r.	NOUN
dpc-3650	581	12	serotonin	serotonin	NOUN
dpc-3650	581	13	and	and	CCONJ
dpc-3650	581	14	neuroplasticity	neuroplasticity	NOUN
dpc-3650	581	15	links	link	NOUN
dpc-3650	581	16	between	between	ADP
dpc-3650	581	17	molecular	molecular	ADJ
dpc-3650	581	18	,	,	PUNCT
dpc-3650	581	19	functional	functional	ADJ
dpc-3650	581	20	and	and	CCONJ
dpc-3650	581	21	structural	structural	ADJ
dpc-3650	581	22	pathophysiology	pathophysiology	NOUN
dpc-3650	581	23	in	in	ADP
dpc-3650	581	24	depression	depression	NOUN
dpc-3650	581	25	.	.	PUNCT
dpc-3650	582	1	neurosci	neurosci	PROPN
dpc-3650	582	2	biobehav	biobehav	PROPN
dpc-3650	582	3	rev	rev	PROPN
dpc-3650	582	4	.	.	PUNCT
dpc-3650	583	1	2017;77:317	2017;77:317	PROPN
dpc-3650	583	2	-	-	PUNCT
dpc-3650	583	3	326	326	NUM
dpc-3650	583	4	.	.	PUNCT
dpc-3650	584	1	doi	doi	NOUN
dpc-3650	584	2	:	:	PUNCT
dpc-3650	584	3	10.1016	10.1016	NUM
dpc-3650	584	4	/	/	SYM
dpc-3650	584	5	j.neubiorev.2017.03.007	j.neubiorev.2017.03.007	PROPN
dpc-3650	584	6	.	.	PUNCT
dpc-3650	585	1	pmid	pmid	NOUN
dpc-3650	585	2	:	:	PUNCT
dpc-3650	585	3	28342763	28342763	NUM
dpc-3650	585	4	.	.	PUNCT
dpc-3650	586	1	62	62	NUM
dpc-3650	586	2	.	.	PUNCT
dpc-3650	587	1	patel	patel	PROPN
dpc-3650	587	2	n	n	CCONJ
dpc-3650	587	3	,	,	PUNCT
dpc-3650	587	4	nadkarni	nadkarni	VERB
dpc-3650	587	5	a	a	PRON
dpc-3650	587	6	,	,	PUNCT
dpc-3650	587	7	cardwell	cardwell	PROPN
dpc-3650	587	8	la	la	PROPN
dpc-3650	587	9	,	,	PUNCT
dpc-3650	587	10	et	et	PROPN
dpc-3650	587	11	al	al	PROPN
dpc-3650	587	12	.	.	PUNCT
dpc-3650	587	13	psoriasis	psoriasis	NOUN
dpc-3650	587	14	,	,	PUNCT
dpc-3650	587	15	depression	depression	NOUN
dpc-3650	587	16	,	,	PUNCT
dpc-3650	587	17	and	and	CCONJ
dpc-3650	587	18	inflammatory	inflammatory	ADJ
dpc-3650	587	19	overlap	overlap	NOUN
dpc-3650	587	20	:	:	PUNCT
dpc-3650	587	21	a	a	DET
dpc-3650	587	22	review	review	NOUN
dpc-3650	587	23	.	.	PUNCT
dpc-3650	588	1	am	be	AUX
dpc-3650	588	2	j	j	PROPN
dpc-3650	588	3	clin	clin	PROPN
dpc-3650	588	4	dermatol	dermatol	NOUN
dpc-3650	588	5	.	.	PUNCT
dpc-3650	589	1	2017	2017	NUM
dpc-3650	589	2	oct;18(5):613	oct;18(5):613	NUM
dpc-3650	589	3	-	-	PUNCT
dpc-3650	589	4	620	620	PROPN
dpc-3650	589	5	.	.	PUNCT
dpc-3650	589	6	doi	doi	NOUN
dpc-3650	589	7	:	:	PUNCT
dpc-3650	589	8	10.1007	10.1007	NUM
dpc-3650	589	9	/	/	SYM
dpc-3650	589	10	s40257	s40257	NOUN
dpc-3650	589	11	-	-	PUNCT
dpc-3650	589	12	017	017	NUM
dpc-3650	589	13	-	-	PUNCT
dpc-3650	589	14	0279	0279	NUM
dpc-3650	589	15	-	-	SYM
dpc-3650	589	16	8	8	NUM
dpc-3650	589	17	.	.	PUNCT
dpc-3650	590	1	pmid	pmid	NOUN
dpc-3650	590	2	:	:	PUNCT
dpc-3650	590	3	28432649	28432649	NUM
dpc-3650	590	4	.	.	PUNCT
dpc-3650	591	1	63	63	NUM
dpc-3650	591	2	.	.	PUNCT
dpc-3650	592	1	crnković	crnković	PROPN
dpc-3650	592	2	d	d	NOUN
dpc-3650	592	3	,	,	PUNCT
dpc-3650	592	4	buljan	buljan	ADJ
dpc-3650	592	5	d	d	NOUN
dpc-3650	592	6	,	,	PUNCT
dpc-3650	592	7	karlović	karlović	NOUN
dpc-3650	592	8	d	d	NOUN
dpc-3650	592	9	,	,	PUNCT
dpc-3650	592	10	krmek	krmek	PROPN
dpc-3650	592	11	m.	m.	NOUN
dpc-3650	592	12	connection	connection	NOUN
dpc-3650	592	13	between	between	ADP
dpc-3650	592	14	inflammatory	inflammatory	ADJ
dpc-3650	592	15	markers	marker	NOUN
dpc-3650	592	16	,	,	PUNCT
dpc-3650	592	17	antidepressants	antidepressant	NOUN
dpc-3650	592	18	and	and	CCONJ
dpc-3650	592	19	depression	depression	NOUN
dpc-3650	592	20	.	.	PUNCT
dpc-3650	593	1	acta	acta	PROPN
dpc-3650	593	2	clin	clin	PROPN
dpc-3650	593	3	croat	croat	PROPN
dpc-3650	593	4	.	.	PUNCT
dpc-3650	594	1	2012;51(1):25	2012;51(1):25	NUM
dpc-3650	594	2	-	-	SYM
dpc-3650	594	3	33	33	NUM
dpc-3650	594	4	.	.	PUNCT
dpc-3650	595	1	pmid	pmid	NOUN
dpc-3650	595	2	:	:	PUNCT
dpc-3650	595	3	22919999	22919999	NUM
dpc-3650	595	4	.	.	PUNCT